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Summary 
Cancer is a cellular disease. In consequence, the management of cancer ideally requires access 
to a method of imaging that identifies and locates every cancerous cell in the patient’s body, 
coupled with a treatment modality that can exclusively target individual cells.  In practice, the 
best spatial accuracy in external beam radiotherapy is about 1 millimetre, about 100 times 
larger than the size of a cell, so exclusively targeting a single cell is not possible in external 
beam radiotherapy. The weakest link in the whole process is, however, not treatment, but 
imaging, not because of the limits of spatial resolution, which are better for imaging than for 
treatment, but because it is very hard to determine from standard anatomical imaging where 
the tumour is. It is much easier to see what the tumour may have done, in terms of disruption 
to blood vessels, erosion of bones, and areas of increased density in lung tissue, but this does 
not necessarily accurately indicate the location and extent of the tumour. Anatomical imaging 
detects the different attenuation of tissues within the human body, and so does allow accurate 
registration of treatment beams to anatomical landmarks such as bones, but this does not 
necessarily mean that the tumour itself is accurately localised. Functional imaging relies on 
the injection and uptake of biological molecules that have been labelled with a radioactive 
isotope. When these radioactive isotopes decay, they emit radiation, and functional imaging 
can detect individual atom decay events, which makes it the closest thing to cellular imaging 
available. Unfortunately, the images must be built up of many such events, are noisy, and 
have spatial resolution worse than that of anatomical imaging and even treatment spatial 
localisation capabilities. A radioactively labelled glucose molecule has the capability to show 
the increased uptake of glucose typical of highly metabolically active tumours, and so has the 
capacity to show what a tumour is currently doing, rather than what it has done. Anatomical 
and functional imaging thus present different but complementary information, to the extent 
that a reviewing physician will often query the spatial registration of the two imaging 
modalities. It is natural to address this crisis of clinical confidence in the registration between 
anatomical and functional imaging by acquiring both in a single imaging session, without the 
patient moving from the imaging couch, and devices built for that purpose are termed hybrid 
imaging devices.      
 
The author was fortunate to be able to make a personal contribution to the introduction of 
functional imaging at a cancer centre, at a time when the use of functional imaging in 
radiotherapy was far from widespread. The author developed a method to incorporate 
functional imaging, co-registered with anatomical imaging using fiducials, into a radiotherapy 
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treatment planning system designed only for anatomical imaging. This basic enabling work 
underpinned the use of functional imaging for clinical treatment of lung tumours and 
oesophageal tumours guided by functional imaging. Subsequently the author developed a 
further adaptation of this system to allow use of functional imaging for targeting intracranial 
radiotherapy treatment. 
 
The author saw, first hand, three recurring problems become apparent. Firstly, there was no 
clear consensus on how to segment a tumour from functional images. Secondly, many 
problems of information transfer were encountered, and a method was required to allow these 
problems to be addressed. Thirdly, it was not enough to have functional imaging co-registered 
with anatomical imaging at the time of acquisition, it was also necessary to establish another 
registration, to the treatment isocentre in the radiotherapy centre, remote from the imaging 
centre and at a subsequent time. Chapter 1 relates this experience and these observations, 
drawing from them to set the direction and theme of the thesis. 
Chapter 2 relates to the first problem, and begins with a review of the literature of tumour 
segmentation from functional imaging. The work then deals with the most idealised basic 
problem of functional tumour segmentation, a spherical, stationary tumour with uniform 
isotope uptake. A simple model of functional imaging as a Gaussian blurring of the object 
was applied, and subsequently a perturbation for image noise was added. There are many 
short explanations in the literature of functional imaging that ascribe particular effects as 
consequences of spatial blurring and noise various effects, but a more rigorous, model based 
determination of the observations that these two effects could explain was undertaken. 
Applying the model involved deriving equations to calculate threshold values, which were 
then compared to values in the literature that were experimentally obtained, values that 
underpin diverse clinical trials with 2D PET imaging. Further equations were derived to 
explore the limitations of a threshold of the tumour average applied to non spherical 
geometry.  The chapter concludes with a demonstration of the limitations of the model when 
applied to 3D PET.  It is shown that relative threshold methods cannot differentiate between 
spheres of different volume below a volume of about 2 cubic centimetres.  
Chapter 3 establishes the theoretical basis of a method for resolving problems with 
information transfer, and then shows how it can be applied in practice by reference to three 
clinical examples. The first example is the sudden failure of a PACS system, where this 
method is used to resolve the cause of failure. The second example is the discovery of an 
underlying fault with an existing radiotherapy treatment planning system that rendered it 
unable to receive images, where the method is used to implement a solution without any 
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interruption to clinical activity. The third example is a malfunction in the production of a 
hardcopy image required for existing treatment processes, where the method was used to 
resolve a problem that was otherwise intractable. The work presented is a distillation of many 
years of preparation, and hard experience of solving many problems.      
Chapter 4 deals with the problem of registration to the treatment isocentre, first reviewing the 
general capabilities in the field, and then focussing on the procedures associated with a 
kilovoltage x-ray localisation technique. The principle of rotational invariance is applied to 
derive a method of statistical inference to verify the spatial accuracy of the system in clinical 
practice, using only the results obtained as part of that clinical practice. The most important 
result was to prove that the system was sufficiently accurate in clinical practice. Additionally, 
changes to clinical practice (imaging at two couch angles before treatment) that would 
enhance that accuracy were determined and implemented. Estimates of the diminishing 
returns in clinical accuracy expected as a result of reducing positional tolerances were 
determined. The method was also used to determine the validity of two clinical procedural 
observables, firstly the number of corrections required for an isocentre placement and 
secondly the distance moved in the last correction, as indicators of superior or inferior 
registration accuracy. The method derived in chapter 4 is universally applicable in any 
radiotherapy centre using the described kilovoltage x-ray localisation technique. 
Chapter 5 briefly draws together the results from chapters 2-4 to provide an overall 
conclusion to the work, and to emphasize the coupled nature of the three disparate problems 
with respect to the widespread clinical implementation of radiotherapy and hybrid imaging. 
This work provides a novel but universally applicable method for verifying the accuracy in 
clinical practice of a kilovoltage x-ray localisation technique. No special equipment is 
required, nor is any extra radiation dose required. The kilovoltage x-ray localisation technique 
does not require a volumetric CT scan acquired in the treatment room, but can utilise a CT 
scan acquired anywhere, including one acquired in a remote nuclear medicine department as 
part of a hybrid imaging study. The innate co-registration of functional and anatomic imaging 
provided by hybrid imaging is thus enhanced by being verifiably registered to the 
radiotherapy treatment isocentre.   
The kilovoltage x-ray localisation technique is efficient, accurate and clinically verifiable, but 
it relies on un-interrupted information flow, from the nuclear medicine department to the 
radiotherapy department. This flow can be interrupted at any time, but this work demonstrates 
that there is an achievable, hospital based method to resolve these problems, that does not 
require any specialised equipment. It has been shown theoretically and demonstrated 
practically that it is possible to intercept and analyse the DICOM information exchange 
 xix
Summary 
without any vendor assistance, and in some circumstances to implement a resolution of a 
problem locally using available resources. 
Before considering problems of registration or information flow, the problem of tumour 
segmentation from functional imaging must be considered. In this work only the simplest 
scenario has been considered, the segmentation of spherical, stationary, uniform 
concentrations of FDG. The evidence for the clinical value of FDG for tumour volume 
marking is still being gathered. Some of it relies on 2D-PET clinical trials using different 
segmentation thresholds. Where these trials report conflicting results, this work provides a 
method of estimating the impact of these thresholds on segmentation. It is especially 
important that this method relies only on noise and spatial characteristics, as these are 
generally well characterised in the available literature. These trials require significant follow 
up periods of years before the results can be published, during which time many so many of 
the 2D PET units have been replaced by 3D PET units that it may no longer be possible to 
determine the required thresholds by direct experiment. For the 3D PET units, the 
identification of a lower volume threshold for the applicability of relative threshold methods 
adds an important consideration to the ongoing clinical debate over the comparative value of 
relative versus absolute threshold methods. 
There is much to follow beyond the work in this thesis. Problems of image segmentation for 
functional imaging should be addressed by clinically relevant methods, not constrained by 
what is possible with commercially available radiotherapy treatment planning systems. For 
large clinical trials, clinicians should be provided with purpose designed applications to 
achieve tumour segmentation. Such applications should take as input the DICOM output of 
hybrid imaging devices, provide a user interface for the clinician to implement segmentation 
according to the protocol, and produce as output DICOM RT structure sets of the segmented 
tumour. This will produce more uniform implementation of the trial methodology, as well as 
insulating the clinician from the complexity of the segmentation algorithm. 
Implementing such applications will require yet another vulnerable link in the DICOM 
information exchange. If the method of dealing with information transfer problems that the 
author has outlined is implemented more widely, the reliability of such information exchanges 
should gradually be improved by better resolution of problems leading ultimately to more 
reliable applications, and ultimately a more robust standard. 
Finally, the method of verifying registration to isocentre developed in this thesis is universally 
applicable. If other centres apply this method, it will be possible to build up a profile of 
accuracy achieved by different clinical methods. Eventually, centres will be able to review the 
 xx
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literature to select clinical registration protocols with accuracy tailored to the requirements of 
the clinical application.    
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Chapter 
1 
Prelude 
 
Radiologist: The next case is a recurrent lung cancer. The CT scan showed an area of 
consolidation within the lung. This has been biopsied, and is negative for cancer. I ask the 
Radiation Oncologist to describe the radiotherapy treatment strategy. 
 
Radiation Oncologist “I will treat the consolidation…” 
 
Radiologist “…perhaps you misheard me, the consolidation biopsy came back negative…” 
 
Radiation Oncologist “I will treat the consolidation…you have to go with what you know.” 
 
Recollections from lung clinic, 1991. 
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1.0 Introduction 
This subject of this thesis is the synergy of Radiotherapy and Hybrid Imaging. Radiotherapy is the use of ionizing 
radiation for treatment, most often of cancer. Hybrid imaging is the combination of an anatomical imaging modality, 
such as a computed tomography (CT) scanner, and a functional imaging modality, such as a positron emission 
tomography (PET) scanner, to image a patient on the same bed. This introduction seeks to describe the fundamentals 
of radiotherapy and hybrid imaging to show why it is clinically useful to combine them. The case for incorporating 
hybrid imaging into radiotherapy is made by following the authors own attempts to do so. This involved 
incorporating PET images into radiotherapy planning systems, incorporating PET images for tumour volume 
marking for Lung Cancer treatment, incorporating PET images for oesophageal cancer tumour volume marking, and 
finally adapting single photon emission tomography (SPECT – another form of functional imaging) images into a 
stereotactic treatment planning system to guide irradiation to control epileptic seizures. The motivation and structure 
of this thesis; the need to solve the three coupled problems of thresholds, information transfer and registration, are 
dealt with in sections 1.9 and 1.10 at the end of the chapter.  
1.1 Radiotherapy 
Radiotherapy is the use of radiation as a medical treatment. Radiotherapy began in the world in the year of the 
discovery of x-rays by Roentgen1, 1895, with the first recorded treatment by Emil Grubbé2, but it was not until the 
following year that Freund began specialty treatments3, and radiotherapy also began in Australia as early as 18964 
with treatments of skin diseases. Since then progress has been driven by three main factors, the refinement of 
technology for producing radiation, the refinement of imaging technology for detecting cancer, and improvements in 
clinical practice resulting from empirical observation of the efficacy of different radiotherapy treatments. 
1.2 Refinements of technology for producing radiation. 
X-rays were first produced by electrons accelerated by a static electric potential colliding with a solid cathode, and 
emitting photons as Bremsstrahlung or “braking radiation”. The energy was limited to a maximum of about 120 
thousand electron volts or 120 keV. At these energies, the maximum dose from radiation occurred at the patient 
surface. Subsequently a range of accelerating technologies were developed using time varying electric fields and or 
magnetic fields, such as the betatron5, linear accelerator6, and synchrotron7. This allowed for production of x-rays of 
maximum energy in the range of 4-25 million electron volts (MeV). At these energies the maximum dose was 
deposited at a depth of 1 cm to 5 cm inside the patient. This allowed the treatment of deeper tumours. 
 
Methods evolved to improve the spatial accuracy of the treatment. The highest accuracy achieved was for treating 
intracranial lesions, using methods of localization borrowed from Neurosurgery to fix the skull using a neurosurgical 
frame. Indeed the pioneer of stereotactic radiosurgery (SRS), as it came to be called, was Lars Leksell, himself a 
trained neurosurgeon. The spatial accuracy is of the order of 1mm. 
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The current state of the art involves the wide clinical use of multi leaf collimators, which move as the patient is 
irradiated to modulate the intensity of the radiation. This technique, termed intensity modulated radiation therapy or 
IMRT, allows the distribution of dose to be shaped to conform to the shape of the tumour.  
 
Sophisticated imaging technology has been introduced into the radiotherapy treatment room to allow localization of 
the patient tumour on the day of treatment, in the treatment position, moments before the treatment commences. For 
intracranial applications, this technique can achieve a localization accuracy superior to neurosurgical frame based 
stereotactic treatment as well as halving the treatment appointment time. This technique is broadly termed image 
guided radiotherapy (IGRT). 
 
All of these applications are reliant on the availability of three dimensional (3-D) volumetric imaging of the patient. 
1.2.1 Basic theory of radiotherapy 
We consider here only x-ray radiation, although other types of radiation are used in radiotherapy, such as electrons, 
neutrons, protons, and heavy ions. X-rays in clinical radiotherapy use in Australia are almost exclusively produced 
by electrons striking a target, resulting in Bremsstrahlung radiation. This produces x-rays with a particular energy 
spectrum and angular distribution. 
 
As the energy increases, the x-ray production is peaked in the forward direction. The energy spectrum is roughly 
triangular, with lower energy photons being more likely. Thus the average energy of the spectrum is about one third 
of the maximum energy. Such a spectrum is described by the maximum energy of the spectrum, which also 
corresponds to energy of the electron that created the x-ray. A bremsstrahlung energy spectrum with a maximum 
energy of 120 kilo electron volts (keV) is designated as a 120 kilo volt peak (kVp) beam. A bremsstrahlung spectrum 
with a maximum energy of 6 MeV is designated a 6 MV beam. 
 
A 6 MV x-ray beam has a half value thickness of about 15 cm in tissue, which is to say that after it has traveled 
through 15 cm of tissue, only half the photons will remain un-attenuated. This penetrative power is the most useful 
quality of x-rays for therapy. It allows an interior tumour to be treated non invasively as an outpatient service. When 
the x-ray passes through tissue, it interacts with the tissue and sets in motion lower energy electrons and sometimes 
electron positron pairs. These charged particles cause ionization within the tissue, which is the agency by which 
radiation affects living cells. The amount of energy per unit of matter deposited in tissue by the x-rays is termed the 
Dose of x-rays in tissue. The effect of radiation on tissue increases monotonically with Dose. The unit of Dose is the 
Gray (Gy). 
1.2.2 Practical implementations and design constraints of radiotherapy. 
Linear accelerators used for radiotherapy can produce a dose rate of around 6 Gy per minute (Gy/min) at their 
normal treatment distance of 1 meter from the patient. The usual treatment times are of the order of 20 seconds of 
beam time, perhaps broken into several portals. Attenuation of the x-ray beam by the patient and /or beam modifiers 
can mean that the treatment time is longer.  
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The unit requires substantial shielding, and the waveguide can be quite long. The linear accelerators usually rotate 
around a fixed point (the isocentre) to a nominal accuracy of the order of 1 mm. 
1.3 Anatomical Imaging 
When only superficial tumours were detectable, palpation was sufficient to identify them. The history of anatomical 
imaging began with the first radiograph, in 1896, of Roentgen’s wife’s hand. Hounsfield’s8 invention of the CT 
scanner in 1947 allowed visualisation of internal anatomy in 2 dimensional (2-D) digital form. 
 
Currently multi slice CT scanners make anatomical imaging effectively 3-D, with acquisition speeds fast enough to 
image a beating heart, and axial fields of view large enough to trace the movement of a whole tumour with 
respiration. The spatial resolution can be as fine as 0.625 mm in the axial dimension, and 0.5 mm in the transaxial 
plane. 
 
Anatomical imaging relies on the attenuation of kVp x-rays. As the x-ray tube rotates around the patient, the CT 
scanner detectors make a planar map of the attenuation of x-rays from each direction. By solving the 2-D inverse 
radon transform, a map of the x-ray attenuation within the patient is digitally reconstructed. 
 
The inverse radon transform cannot be solved locally in an even number of dimensions, so when inverting the 2-D 
radon transform it is necessary to have an attenuation map that spans the patient. That is to say, the x-ray beam and 
the detector bank must be wider than the patient. Attenuating objects outside the field of view are otherwise 
reconstructed as a ring around the outside of the circular field of view. 
 
The ideal energy to operate the x-ray tube at is of the order of 120kVp. At this energy the photoelectric effect 
dominates photon absorption, which is strongly dependent on atomic number, so the image has good low contrast 
resolution. The energy gives the maximum angle subtended by the useful x-ray beam as it emerges from the x-ray 
tube, and this with the width of a patient specifies the distance that the x-ray tube has to be from a patient. This has 
implications for the intensity of x-ray beam required, and the spatial resolution, which gets worse as the tube moves 
further away. To this complex interaction of constraints must also be added the cost of the unit. Fortunately due to 
the large installed base, the designs have been optimized to a very high degree. The software on the newer CT 
scanners is so well developed, that the answer to every functionality query is affirmative, the difficult part is 
negotiating the maze of capabilities to determine which one to access. 
1.4 Functional imaging  
Cancer is a cellular disease, so the ideal clinical requirement is to image individual cells. Unfortunately an individual 
cell is too small to be seen on anatomical images. The attenuation of a single cell is too small for a standard x-ray 
imager to display it in air, much less detect the difference in x-ray absorption between a tumour cell and a non 
tumour cell. A single tumour cell, or even a micro cluster of tumour cells, cannot be detected with anatomical 
imaging. The best that can be achieved is to image structural consequences of what the tumour has done, so for 
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example calcifications in the breast, leakage of intravenous iodinated contrast medium into tissue on the periphery of 
tumours due to the damage caused to blood vessels, creating so called ring enhancing lesions, and tumours 
obstructing the bifurcating airways of the bronchial tree to produce consolidation in areas of lung. These are all signs 
of what the tumour has done, and give no indication of what the tumour currently is doing. 
 
Conversely functional imaging is achieved by the introduction of radio-labeled compounds into the body, which can 
then be imaged when they decay. The compounds can distribute in the extra-cellular or cellular space, they may be 
metabolized inside the cell, they may be cleared by the body, or they may be preferentially uptaken by the tumour 
cells. The spatial resolution is generally inferior to anatomical imaging, and the images are very noisy in comparison 
also, but the imaging apparatus will detect individual quantum events. So a decay of one single labeled radionuclide 
molecule within a single cell will contribute to the image. Thus functional imaging is the closest thing to cellular 
imaging that is available. 
1.4.1 PET 
Positron Emission tomography relies on the introduction into the body of a compound labeled with a positron 
emitting radionuclide. When the radionuclide decays, it emits a positron, which travels through tissue before it 
annihilates. The distance it travels depends on the energy of the positron, which depends principally on the isotope. 
There are also range straggling effects, but for Fluorine 18 (F18) decay positrons this distance is on average 1 mm. 
This sets a limit on the best spatial resolution that can be achieved, because it is the positron annihilation that is 
detected, not the F18 positron decay itself. The positron annihilates with an electron to produce an annihilation pair 
of coincidence photons. These photon pairs are then detected by coincidence detectors around the outside of the 
body. Some of the photons are attenuated before they reach the detectors. Depending on how much kinetic energy 
the positron had, the photons do not travel in exactly opposite directions. The spatial resolution of the detector 
system is also limited by cost, and these three factors, the distance annihilation, the less than opposite directions of 
travel of the photons, and the resolution of the detector system, contribute more or less equally to produce a spatial 
resolution of the order of 4mm. 
 
The first use of annihilation imaging dates back to development in the early 1950s9, culminating in the development 
of the first PET camera in 1961. In Australia, the introduction of PET cameras began in 1992 and was strictly 
controlled. Installations were initially limited to centres that undertook to run clinical trials of PET imaging. 
 
The current state of the art involves PET cameras with resolution of 2-4 mm, mounted in combination with a PET 
scanner for attenuation correction and innate registration with functional imaging. FluroDeoxyGlucose (FDG) is 
used as well as many other more esoteric compounds for assaying different things such as tumour growth, but the 
compound most used for oncology is FDG. FDG is a glucose analogue, with a radioactive F18 atom replacing a 
single atom of oxygen. Axial fields of view of up to 18 cm are supported. PET is a statistically limited medium. If 
more radioactive compound is injected, this increases the chance of false coincidences or randoms. It is not always 
possible to increase the image quality by increasing the amount of radiation injected. 
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FDG is a glucose analogue, but it only participates in the first step of the metabolic glucose cycle, and FDG that 
enters a cell is generally trapped there as a result. This simplifies the compartment model for FDG. 
 
Early PET imagers used metal septa to collimate the annihilation photons so that each ring of detectors imaged a 
single slice, termed 2-D PET. Subsequently 3-D reconstruction algorithms were developed, allowing un-collimated 
detector rings to be used to reconstruct a cylindrical volume, termed 3-D PET. 3-D PET allowed the use of lower 
activity concentrations and much faster image acquisition times. 
 
F18 has a half life of 109.74 minutes, image acquisitions are therefore corrected for decay, especially if the axial 
field of view (FOV) is too small and the patient must be moved to acquire a full 3-D PET image. Geometric 
considerations dictate that the lines of response, approximately equally separated in the centre of the detector ring, 
will be denser closer to the detector ring, correcting for this is termed non uniform radial sampling correction. Either 
annihilation photon may fail to be detected because it interacts within the patient before the detectors, correction for 
this effect is termed attenuation correction. Even if they do interact, a scattered annihilation photon may still be 
detected in coincidence with its paired un-scattered annihilation photon. It will then be reconstructed using an 
incorrect back projection line. This effect is particularly important in 3-D as opposed to 2-D PET. An image 
reconstructed with compensation for this scatter is termed scatter corrected. Immediately after detecting an event the 
detectors are unable to register another event for a short period of time. An image reconstructed with a compensation 
for this is termed dead time corrected. No matter how small the coincidence window is set, some photons that are not 
from the same annihilation will inevitably arrive at different detectors within the coincidence window, these events 
are termed randoms, and correcting for them in image reconstruction is called randoms corrected. Not all lines of 
reconstruction are detected with uniform sensitivity due to varying angle of incidence on the detector and individual 
detector characteristics, correcting for this is termed detector normalization correction.   
1.4.2 Functional imaging SPECT 
Single photon emission computed tomography differs from PET in that the isotope emits a single photon. 
Coincidence counts are not possible, but because a single photon is emitted with the decay of the radionuclide, it will 
have a defined energy. An energy window can be used to reject scattered photons. In theory the spatial resolution of 
SPECT could rival that of PET, but in practice a lack of development means that SPECT resolution is around 6-8 
mm. SPECT does have the advantage of allowing simultaneous tracing of two radio-nuclides, through the use of 
different isotopes with different energies, which can be useful for simultaneously tracing the distribution of two 
drugs. The first SPECT images were obtained in 196110, and the current state of the art has progressed to SPECT-CT 
scanners with diagnostic quality multi slice CT scanners. 
1.5 Incorporating PET Images into Radiotherapy Treatment Planning 
in a clinical research environment. 
As well as improved imaging and treatment technology, radiotherapy has advanced through refinements of clinical 
technique guided by empirical evidence, such as comparative statistics from rival treatment techniques. Further 
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advancement in clinical research requires the implementation of clinical trials. One area of controversy is the use of 
PET FDG imaging for tumour volume marking. A review of aspects of the author’s own involvement in one early 
endeavor in this area is included to establish the motivation for the inclusion of functional imaging in the 
radiotherapy process. 
 
The International Commission on Radiation Units and Measurements (ICRU) report 6211 identifies the marking of 
target contours from CT scans as the largest contributor to the global uncertainty of radiation therapy treatment 
planning, drawing primarily on the work of Leunens12 with regard to neurologic cases. Difficulty marking target 
volumes from CT scans is also a problem in lung cancer13,14. 
 
PET had been in use at Peter MacCallum Cancer Institute (PMCI) since 1996. It had been used as a clinical staging 
tool, and patient management had been influenced by PET study results. In early 2001, the radiotherapy department 
held a meeting in the anticipation of the imminent release of a system to enable importation and co-registration of 
PET image data into a 3D radiotherapy treatment planning system. The methodology proposed was to use a simple 
system of fiducials. It was intended to duplicate the patient position at the CT scanner and the PET scanner. In this 
way the problem of co-registration would be reduced to selecting the appropriate translation from one coordinate 
system to another. 
 
The chosen radiotherapy treatment planning (CADPLAN, Varian Medical Systems, Palo Alto, USA) was selected 
because the most likely clinical site was expected to be lung15 and it was the system routinely used for lung planning. 
Additionally the image format and patient data was well documented16 and in particular the Computer Aided 
Radiation Therapy (CART) format of the image files was well understood. There was already experience of reading 
the CT files for stereotactic localisation17 and volume calculations18. It was expected that it would be possible to 
swap the image in and out of the CART files while leaving the image header intact. This would allow the marked 
contours to be superimposed over whatever image data was desired. 
1.5.1 Method for incorporating PET. 
The viability of this concept was initially tested by simply swapping in a blank image. It was found that the 
radiotherapy treatment planning system (RTPS) updated each image direct from the CART file every time that the 
user caused the CT slice display to be refreshed. Thus it was possible in the X Window19 environment to run a 
separate process parallel to the RTPS, a menu based C program (CADPET) that sampled the Digital Imaging 
Communication in Medicine (DICOM) PET image file (Nuclear Medicine (NM) multislice format) and created a 
matching co-registered set of PET images in CART format. When it was desired to change to PET display in RTPS, 
it was only necessary to move the mouse pointer into the CADPET window (Seen with heading “dterm” on the 
middle left of Figure 1.5.1-1), select a menu item to change to PET image display and then move the mouse back to 
the lower RTPS window to select a slice and update the display. The menu instruction initiated a series of low level 
writes of data into each and every transverse CART file for that patient. Despite the large amount of data transferred 
(About 0.1 megabytes per slice) the transfer was fast enough not to be noticed on an isolated system. In contrast to 
execute the same volume write commands across the networked CADPLAN system took 1-2 seconds – a noticeable 
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lag. The process was reversible and in practice users found it convenient to change between PET and CT mode 
several times each slice as they marked target contours. 
 
The RTPS directory structure had multiple patients in each directory. For each patient in a directory, a separate 
CART format file existed for each transverse CT scan (as well as for views in other planes.). CADPET made a list of 
these files that were accessed by the RTPS, and created a copy of each of the transverse slices for a particular patient, 
together with the matched co-registered PET CART format files. The CART files accessed by the RTPS were listed 
in a database file in each directory, but individual files were also stamped with the patient name and unique record 
(UR) number in the header, as well as having a filename derived from the UR number and the slice number. The 
external program searched a nominated directory and sorted the files and collated the filenames by their header data 
and offered a menu choice listing available patients. The PET data file also needed to be specified by the same 
method. Subsequently CADPET offered a looping menu allowing the user to swap between PET and CT data 
display. Although this process was adequate for a clinical research environment, it was clear that a more universally 
applicable, robust and user friendly method of information transfer would be advantageous for routine clinical use. 
At the outset of the project, the most common response when viewing Figure 1.5.1-1 was a query as to why the 
phantom was not visible, which was a reflection of the primacy of anatomical rather than functional imaging in 
radiotherapy practice at that time. 
Fig. 1.5.1-1 The PET emission scan in the RTPS display. The 
left hand image is a transverse slice through the 18FDG 
loaded linear sources. Note that the middle of the fiducials 
are black because the signal is greater than 3000, at which 
the RTPS greyscale display clocks over. The right of screen 
reference image is a reconstruction of the coronal plane 
from co-registered axial emission slices. Note that in both 
images, the ANTHROP phantom itself is invisible because it 
is not a significant source of annihilation photons. The lower 
window is the standard RTPS contouring workspace 
window. Switching between PET and CT images is achieved by the CADPET program running in the floating dterm 
window. 
1.5.2 Phantom tests. 
The next step after proving the concept was to obtain some PET data using an anthropomorphic phantom (RANDO20 
, Alderson Research Laboratories, Stanford, CN, USA). Flexible line sources (tubes filled with 18FDG) were 
attached to the side of the anthropomorphic phantom (ANTHROP) for a PET and CT scan. Figure 1.5.1-1 shows the 
emission scan. Although the fiducial line sources are clearly visible, there is no internal anatomy visible, since 
ANTHROP is not radioactive. The centre of the fiducials are black rather than white because the CADPLAN 
greyscale is intended for use with CT values and “clocks over” at values over 3000. 
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Figure 1.5.2-1 shows the transmission scan from the PET camera. In order to perform attenuation correction, the PET 
camera rotates a radioactive source around the patient to do a poor image quality CT scan. The transmission data is 
different from a CT scan in a number of ways. It uses a larger source, whose energy spectrum is different, and the 
spatial resolution is poorer, but it does have the virtue of being innately co-registered with the emission scan. 
Fig. 1.5.2-1. Co-registered transmission scan from PET 
camera. The small circles on the anterior and lateral 
surfaces are the outlines of the fiducials from the PET 
emission scan. The lung outlines are from the co-
registered CT scan of the ANTHROP phantom. The 
coarseness of the PET transmission scan can be seen. 
The halo effect at the air lung interface is an artefact 
caused by an image translation problem that was made 
evident by the transmission scan. 
Using the PET emission fiducials, the PET emission scan was lined up with the CT scan by a simple x,y,z shift. The 
alignment was checked by comparing the lung contours from the diagnostic CT with the co-registered PET 
transmission data. The agreement can be viewed in Figure 1.5.2-2. The major weakness of this system is the lack of z 
sensitivity, so it was changed to a system of discrete fiducials for patient images. This is discussed in detail in section 
1.5.6. 
Fig. 1.5.2-2. Reconstructed coronal slice calculated 
from co-registered axial transmission scans using the 
standard RTPS image creation tool. The lateral outlines 
are the outlines of the line sources marked on the co-
registered PET emission scans. The lines marking the 
lungs in the center of the thorax are derived from co-
registered CT scan data, and should coincide with the 
dark region in the transmission scan. It can be seen that 
the line fiducials are relatively insensitive to superior 
inferior displacement, as shown by the discrepancy of 
the lung level. 
 
 
 
The problem with the halo effect (Figure 1.5.2-1) due to image translation serves to emphasize the problem of 
interfacing to multiple image modality formats. It is clear that a universal image communication format (IE DICOM) 
is a requirement for widescale implementation. Even with a phantom rather than a patient, co-registration was non 
trivial. 
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1.5.3 Interpolation 
The ANTHROP PET images were sampled onto the RTPS CT display screen by a bilinear interpolation. Inevitably, 
CT and PET pixels do not exactly line up, so the PET image has to be sampled by either a nearest neighbour or 
bilinear interpolation method. A nearest neighbour approach would produce a higher contrast, more pixilated image, 
but the RTPS already used a bilinear interpolation when mapping CT data to pixels. The ability to choose between 
methods of interpolation in the display of images is a common feature of dedicated NM viewstations. The nearest 
neighbour interpolation emphasizes pixel to pixel variation which is most useful for detecting small metastases. The 
bilinear interpolation effectively introduces a low pass filter and has a smoothing effect on the image which removes 
some of the noise, making it better suited for the recognition of larger area structures that are generally required in 
radiotherapy practice. This subtle difference was invariably remarked upon by NM physicians that viewed the 
images on the RTPS screen, but may not be immediately apparent to those that routinely view the bilinear 
interpolation used in radiotherapy images. Figures 1.5.3-1, 1.5.3-2 and 1.5.3-3 represent an attempt to explain in 
visual terms the qualitative difference in the image representations under the two different interpolation systems. The 
subject represented is a CT scan of a small high z component in a cavity. This is a CT scan analogue of a PET scan 
node, chosen in place of a PET scan because it will be more familiar to readers with a radiotherapy background. 
Figure 1.5.3-1 is linked with table 1.5.3-1 to show that the clocking over of the grayscale with the display of PET 
images, rather than being an artefact associated specifically with PET images, is an intrinsic function of the RTPS 
display that values of 3000 or more are always displayed as black, on CT scans as well as PET scans. 
Fig. 1.5.3-1. Images taken from the 
RTPS workstation. On the right is the 
unzoomed RTPS CT axial image of a 
tissue equivalent block with a small 
high atomic number substance in the 
central cavity. On the left is a zoomed 
RTPS view of the cavity showing the 
bilinear interpolation giving a smooth 
image and the clocking over of the 
greyscale to black. In the centre is an image from a display system other than RTPS using the nearest neighbour 
image of the same slice. It looks similar to the RTPS image at this scale, but exhibits differences when zoomed as 
shown in Figure 1.5.3-2. 
 
Fig. 1.5.3-2. This is a zoom of the cavity in Figure 1.5.3-1 
under a nearest neighbour interpolation. The pixelated nature 
of the image is different from the smooth image on the left of 
Figure 1.5.3-1 that results from the bilinear interpolation. The 
greyscale is not provided by the RTPS, and so does not clock 
over, so there is no central black region. 
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Fig. 1.5.3-3. A close up on the central cavity. 
The individual CART pixels are centred on the 
vertices of the grid. Note that the CT value tool 
on the RTPS averages the CT value of the 
central pixel with that of the eight nearest 
neighbour pixels, but the bilinear greyscale 
display is based upon interpolation between 
individual pixels. The individual pixel values 
tabulated in table 1 show 5 pixels above 3000, 
and the clocking over of the greyscale in the 
immediate vicinity of the corresponding vertices 
can clearly be seen. The grid in this figure was 
drawn using the RTPS contouring tool. The 
RTPS stores contour points as ordered pairs of 
integer pixel coordinates, so the points, which 
are the intersections of the grid lines, are 
located in the centre of each pixel. The lines of 
the grid do not define the edges of the pixels. 
Regardless of zoom factor, CADPLAN will not allow specification of points in between pixels. 
 
The nuance of interpolated image representation in functional as opposed to anatomical image caused some 
exasperation amongst clinical staff, who were initially unable to reconcile the guidance they had been given by NM 
staff for interpreting the image as displayed in the NM department with the image as displayed on the RTPS. This 
was universally manifest in the clinician querying as to whether there had been a co-registration error.  
0 0 0 0 0 0 0 
0 162 900 783 162 252 0 
0 1143 1980 1989 747 126 0 
0 927 1836 1989 1125 72 0 
0 261 999 10026 5310 927 0 
0 288 3429 1080 13941 405 0 
0 189 171 5076 1278 99 0 
0 0 0 0 0 0 0 
Table 1.5.3-1 Table of individual pixel values at grid vertices in Figure 1.5.3-3. Those values greater than 3000 are 
in bold. This table is 7 cells wide and 8 cells high, whereas the grid in Figure 1.5.3-3 is 6 cells wide and 7 cells high 
because the cells in table 1.5.3-1 correspond to the grid vertices in Figure 1.5.3-3. 
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1.5.4 Medical Image Formats 
The PET images were obtained indirectly from the PET camera via a digital image and analysis suite (Digital 
Jacket21, DesAcc Inc, Chicago, IL, USA).  The digital suite PET files are DICOM part 10 compliant. The tags of the 
data elements used for co-registration are given in table 1.5.4-1. The CT images were already present on the system 
in CART format. Although both formats support a patient name and a patient identification (ID), the two must be 
compared by user inspection because the usage is different. For example the patient’s first and last name is stamped 
in that order on the CT files, but the order is customarily reversed by the PET centre operators. The specifications of 
co-ordinates, dimensions and orientations are also different in the two protocols, but it is possible to automate the 
translation and take into account all these parameters. In practice some assumptions regarding orientations were 
made that relied on the imaging protocols, for example it was known that all images were to be taken with the patient 
feet first supine. Both formats recorded the z position of each slice in integer mm, so all co-registration could only be 
achieved to the nearest mm. The limiting factor on the accuracy of the co-registration was the spatial resolution of 
the PET data, whose voxels were 4 mm in all 3 dimensions. The fiducials were matched to determine the required 
translation. The external contour and the outline of the left and right lungs were then marked from the CT images in 
the RTPS. Then the external program was used to swap in the PET transmission scan with the same translation 
parameters as the PET emission scan. The external contour and the outline of the lungs could also be discerned on 
the PET transmission scan, and the overlay of the CT determined contours on this image data was the main check of 
the alignment of the data sets. A supplementary check was the position of the fiducials on the PET emission scan 
relative to the external contour from the CT scan. On the basis of these comparisons changes to the defined volumes 
from CT were not made unless the discrepancy between CT and PET data was greater than 4 mm. 
CART VARIABLE NAME DATA 
FILTYP File identification number, value = 6 
ORIENT Slice Orientation 
PATNAM Patient Name 
PATID Patient ID 
ZPOS Relative Z Position of the Slice in mm 
XPXSZE The physical x pixel size in μm 
YPXSZE The physical y pixel size in μm 
Derived from CART Filename Slice Number 
Table 1.5.4-1 CART data elements of use for co-registration. 
1.5.5 Applying the method in clinical practice 
The first co-registered patient images were obtained for a clinical purpose not originally anticipated. A non-radical 
case was co-registered with the aim of classifying metastatic disease in the neck. In accordance with standard 
imaging protocols, the patient was scanned from chin to mid abdomen on both CT and PET, so it was possible to 
view the primary as well as co-registered images. The only variation was the placement of an 18FDG loaded circular 
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fiducial during the PET scan on the Anterior Midline 10 cm inferior to sternal notch (SN) (See Figure 1.5.5-3a). 
Although the co-registered data offered little insight into the nature of the glucose activity in the neck, due to the 
unreliability of co-registration in the neck relative to the chest, review of the co-registered CT and PET data sets 
provided much useful insight into the clinical implementation of co-registered PET and CT data. CT and co-
registered PET images for this patient are shown in Figures 1.5.5-1, 1.5.5-2, and 1.5.5-3. Observations from the first 
patient experience were broadly as follows. 
 
1. The fiducials did not disrupt the interpretation of the PET emission image. (See Figures 1.5.5-1a, 1.5.5-2a, and 
1.5.5-3a) 
2. Co-registration outside the thorax region seemed to be less reliable. There appeared to be some twisting of the 
torso at the level of the diaphragm, and in the neck region the co-registration could not be relied upon to be accurate. 
3. 18FDG signal in the vicinity of the spine on the PET scan was seen to match both obvious (See Figure 1.5.5-1) 
and sometimes barely perceptible (See Figure 1.5.5-2) damage to the vertebral column on the CT data. 
4. There was some 18FDG activity associated with a pleural effusion (see Figure 1.5.5-2) in addition to the usual 
physiological 18FDG activity below the level of the diaphragm. 
5. Quiet respiration at CT and PET did not seem to be a problem for imaging or co-registration in the thorax, except 
at the level of the diaphragm. 
6. The co-registration was sufficiently accurate to provide useful information that could not be discerned from review 
of the two data sets separately. 
7. Diagnosis, as opposed to demarcation of target volumes, is best done on dedicated imaging software. A number of 
deficiencies in the radiotherapy display made it difficult to distinguish near background signal from remote nodal 
involvement. 
8. Inspection of the PET data showed that the Gross Tumour Volume (GTV) drawn from CT data would have been 
modified if the coregistered PET data had been available (See Figure 1.5.5-3b) but because this particular treatment 
involved a palliative posterior to anterior and anterior to posterior (PA-AP) opposed pair treatment, no change to the 
treatment plan was required. 
 
 
 
 
 
 
 
 
 
Fig. 1.5.5-1. PET data corresponding to slice level –8.0 cm (a) and CT data at slice level –8.0 cm (b). 
The coincidence of metabolic activity in the PET scan with the irregularity of the boney structure of the vertebral 
column in the CT data can be clearly seen. Note also the approximate coincidence of the GTV marked from the CT 
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data with the metabolic activity on the corresponding PET scan. The comparative lack of physiological 18FDG 
signal from the lungs is also well demonstrated. 
 
Figure 1.5.5-2a and 1.5.5-2b again demonstrate the capability of PET to show spinal involvement. At the time of the 
review of this image, the radiation oncologist, although aware of a metastasis at slice level –8.0 cm, had only briefly 
reviewed the CT data, and was not yet aware that there was a discrete metastasis at this level. 
 
Figure 1.5.5-3a and 1.5.5-3b show that the PET and CT target shapes are different. 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5.5-2. PET data corresponding to slice level –15.0 cm (a) and CT data at slice level –15.0 cm (b). 
The area marked 4 posterior to the left lung surrounded by the thick line shows a glucose signal which is believed to 
have been due to pleural effusion (fluid in the pleural space). 
 
 
 
 
 
 
 
Fig. 1.5.5-3. PET data corresponding to slice level –10.0 cm (a) and CT data at slice level –10.0 cm (b). 
Note the dark area in the centre of the anterior midline PET fiducial is due to the greyscale clocking over at a value 
of 3000. The GTV marked from the CT scan is indicated by the thick solid line. When the GTV is superimposed over 
the co-registered PET data, it can be seen that the pattern of glucose uptake suggests a different shape that is 
partially coincident with the CT derived GTV. 
 
The apparent spinal involvement in Figure 1.5.5-2 was later confirmed. This is an example of the synergy of 
functional and anatomical imaging. Review of the anatomical imaging alone by qualified clinical staff had not 
(initially at least) detected the spinal involvement, and although the increased glucose uptake was visible on the PET 
image, its significance might not have been realized. The combination of the two images is thus superior to the 
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separate review of both, as the increased glucose uptake and its significance are both obvious when viewing co-
registered functional and anatomical images. 
1.5.6 Fiducial Alignment System 
The positioning on the CT and PET couch were reproduced by the use of a personalised polyurethane foam support 
(Figure 1.5.6-4 and Figure 1.5.6-5). The support was locked to the treatment couch with effilock, a PMCI in house 
lock fit solution. The size of the foam support was limited so that it would fit through the bore of the PET camera. 
The arms also were supported above the head to get through the PET camera bore. The CT scan had the fiducials 
filled with water, but to enable them to be imaged on the PET scanner, the tubes were filled with water containing 
approximately 1 microcurie of F-18 FDG and solidified with a gelling agent, (Alcosorb G5, Ciba Speciality 
Chemicals, Thomastown, Vic., Australia). This produced a solid substance within the tube, thereby reducing the risk 
of leakage and contamination. It was decided to use a system of discrete fiducials (See Figure 1.5.6-3). The size of 
the fiducials was a compromise to ensure that they could be seen on the RTPS CART (256 x 256 pixels) CT scan 
while retaining sufficient accuracy of spatial registration. PET fiducials were placed on the anterior midline at SN 
and at 10 and 20 cm inferior to SN on midline. The fiducial on the anterior midline at 10 cm inferior to SN was 
placed with its long axis in the lateral direction to facilitate determination of the Z shift. The fiducial on SN and 20 
cm inferior to SN were placed with their long axis in the superior-inferior direction to provide determination of the 
lateral shift. Discrete fiducials were also placed laterally, on the half anterior posterior (AP) line, at 10 and 20 cm 
inferior to SN. The lateral fiducials had their long axis aligned in the superior inferior direction to facilitate the 
determination of the AP shift. The fiducials were loaded with approximately 37 kBq per marker, as compared to the 
patient dose of 111 MBq of 18FDG, a dose chosen to make the fiducials visible for localisation without disrupting 
the information content of the emission image. Figure 1.5.6-1 shows the placement of the fiducials in a reconstructed 
sagittal slice on a patient. 
 
While two orthogonal line lasers were available both overhead and from the patient right side, there was only one 
line laser on the patient left side at the PET camera, so that the superior inferior position of the left lateral fiducials 
was less accurate than the right lateral fiducials. Additionally, adjustment of patient arms moved the position of these 
fiducials in the sup inf direction, as seen in Figure 1.5.6-2. Fortunately the AP position was stable regardless, and 
these fiducials are only used for determination of the AP shift. 
Fig. 1.5.6-1. Discrete fiducials visible in a reconstructed 
saggital slice on the RTPS display. The image is derived from 
coregistered axial PET emission slices using the standard 
RTPS contouring image construction tool. The image data is 
from one of the patients in the trial mentioned in the next 
section. The body outline is derived from the CT scan data and 
the match of the fiducials with the anterior surface is clear. 
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At the level of the diaphragm some twisting of the torso becomes possible despite the polyurethane cast, and we can 
see that the fiducials at this level do not both match the skin surface. Since the fiducials have been matched 
elsewhere it is clear that this cannot be corrected for with a simple translation, or even a rotation. Since both PET and 
CT are without geometric distortion, introducing an affine will probably introduce distortion elsewhere in the image 
data set. Registration outside the thorax is not of significance in this clinical scenario, but it does emphasize the 
limits of accuracy that is achievable. 
 
Fig. 1.5.6-2 Lateral discrete fiducials on a 
reconstructed coronal plane. The image is derived from 
co-registered axial PET emission slices using the 
standard RTPS contouring image construction tool. The 
image data is from one of the patients in the trial 
mentioned in the next section. It is clear to see that the 
fiducials are not at the same level in the superior-
inferior direction. Also note that one of the lower 
fiducials intrudes within the external contour derived 
from the CT scan data. At the level of the diaphragm 
some flexion of the torso can occur despite the 
polyurethane cast, making it impossible to achieve a 
valid match over the full image space even with a full translation and rotation transformation. Below the level of the 
diaphragm the normal physiological 18FDG signal from the abdomen is visible. 
 
Fig. 1.5.6-3. One of the seven discrete fiducials which is placed 
on the patient and filled with water for the CT scan, 18FDG for 
the PET scan. 
 
 
 
 
Also at the level of the diaphragm, distortion due to quiet respiration during the PET scan is most apparent (Figure 
1.5.6-2). Away from the diaphragm, the co-registration was seen to be accurate to within 4 mm in the transverse 
plane, or one PET pixel. This is not surprising since the required translation derived from the pixel co-ordinates of 
fiducials in the PET images. In the superior inferior direction the accuracy is slightly better at just over half the slice 
separation, or 2-3 mm. Comparison with the line fiducial method used in the phantom study (Figure 1.5.2-2) shows 
superior registration with the discrete fiducials on a patient except at the level of the diaphragm. Quiet respiration is 
accomplished almost entirely by the movement of the diaphragm22 so the superior z discrimination of the discrete 
fiducial method is best demonstrated by the agreement at the superior margin of the lungs in the patient data (Figure 
1.5.6-6), compared with that in the linear source phantom study. 
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Fig. 1.5.6-4 Superior-anterior view of the polyurethane foam 
support used for patient positioning for the PET and CT 
scans. 
 
Fig. 1.5.6-5. Lateral view of the polyurethane support used 
for patient positioning for the CT and PET scans. 
 
Fig. 1.5.6-6 Coronal plane view of the PET 
transmission image with the lungs outlined from the 
CT scan. The z discrimination is superior with the 
discrete fiducial system. A 4mm margin has been 
drawn around the lung contours to demonstrate the 
scale of the discrepancy. 4 mm was taken as the 
limit below which discrepancy between PET and 
CT was taken to be a product of misregistration. In 
the vicinity of the diaphragm the respiration 
induced. In addition the RTPS algorithms for 
determining cross sections in coronal planes and 
for adding three dimensional margins both fail to deal with the complex crescent shape of the axial lung cross 
section at the level of the diaphragm. Thus the jagged shape of the contours at the level of the diaphragm in this 
coronal view, and the intrusion of the calculated expanded volume being into the lung volume from which it was 
calculated at the level of the diaphragm are both artefacts of the RTPS system. 
Just as radiotherapy staff lacked familiarity with NM practice, so too the NM staff had difficulty understanding the 
radiotherapy staff practice of aligning to the lasers. They would often, for example, adjust the patient’s arms in the 
overhead pose for comfort immediately before image acquisition commencement, thus potentially invalidating the 
alignment of the patient and the fiducials to the lasers. For this reason, a radiation therapist was initially present for 
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the image acquisition. Ultimately synergy of practice was achieved, with high quality images being obtained with an 
accurately aligned patient. 
1.5.7 Trial 
On the basis of these results, it was next decided to embark upon a trial consisting of at least 10 patients. Only those 
patients suitable for radical treatment on the basis of PET staging were included. 
 
There were some decisions to be made regarding imaging protocols for CT scans and PET scans. The PET scans 
were fixed always as 4 mm cubic voxels, slice thickness 4 mm and pixel size 4 mm by 4 mm. The slice spacings 
available for the CT scanner were 3 mm, 5 mm and 10 mm. Standard lung CT protocols had previously used 10 mm 
thick CT slices. Since bilinear interpolation was being used, 10 mm CT slice separation meant 40% of the PET slices 
would be discarded. 3 mm CT slice separation was felt to involve too much contouring. 5 mm slice separation was 
adopted as a compromise. 
 
On one occasion the transmission scan was not complete and interpolated slices had to be used. For an automated 
system this could cause problems. There needs to be close liaison with the PET camera operators to be able to know 
when this situation occurs. 
 
The results of the trial are more fully reviewed in section 1.7, but Figure 1.5.7-1 gives an example of a single slice 
from a trial case where it was possible to reduce the GTV. 
Fig. 1.5.7-1 PET negative tumor extension can be excluded from 
radical target volume. Showing a simultaneous view of CT and 
coregistered PET data for the same axial slice, we can see how 
the low PET signal in the lateral extension of the mass (indicated 
as marked on the CT scan by the thick dotted line) in the left can 
be used to exclude that area (the line of exclusion determined 
from the PET data being indicated by the thick solid line) from 
the GTV. 
 
1.5.8 Oesophageal cancer 
In addition to the trial cases, we have also used PET coregistration for an oesophageal case for IMRT treatment, as 
shown in Figure 1.5.8-1. This was a precursor to a trial of oesophageal patients dealt with in section 1.7. 
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Fig. 1.5.8-1 Coronal plane reconstruction of a co-registered PET emission study of on oesophageal cancer. The 
thick outline around the oesophagus is the projection of the GTV marked on the CT onto this plane. The high 
intensity PET signal in the lower part of the oesophagus corresponded with results from visual inspection of the 
lumen, and the GTV was subsequently reduced for treatment. This case was not actually part of the trial, but was 
referred because of conflicting information about the extent of the GTV from visual inspection of the lumen and CT. 
The three images on the right are close ups of the oesophagus as they would appear to the clinician when rendered 
with different greyscales. It is readily apparent that the determination of the extent of oesophageal involvement is 
strongly coupled with the threshold.  
1.5.9 Greyscale Display 
An early criticism of the system was that the poor resolution (inability to image nodal involvement) was due to using 
a linear greyscale map. The RTPS allows only a linear setting of the greyscale window (although it does have a 
sophisticated non linear greyscale interpretation, this is only for the active window, and not for the whole data set). 
Any arbitrary greyscale transformation has to be made on the whole image set to avoid disrupting clinical 
interpretation, as the variation of PET intensity from slice to slice also carries information. A range of non linear 
greyscale options was implemented in CADPET, including simple inversion, square root, logarithmic, and adaptive 
histogram equalisation23. Extra contrast was seen using the square root and the adaptive histogram equalisation 
greyscale maps, however the logarithmic greyscale showed a large change in contrast resulting in the image being 
unusable. Thus it seems that it is likely to be the size of the image and the bilinear approximation that jointly reduce 
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the contrast of the PET emission image rather than the greyscale. Clinical interpretation would be aided by the use of 
a nearest neighbour method, and the demagnification of the image so that each PET pixel corresponded to one screen 
pixel (smallest possible image size). The RTPS will not allow us to demagnify. We have another viewer (See Figure 
1.5.3-1) on the system written previously for a stereotactic localization application which we can use to display the 
same CART file with nearest neighbour approximation and each PET emission pixel mapped to four screen pixels 
(The RTPS maps each CT pixel to 49 screen pixels). Using this program it was possible to achieve superior 
resolution. 
1.5.10 Clinically useful aspects of a PET display. 
To be able to display co-registered PET scans it is useful that a radiotherapy treatment planning system be able to: 
 
• Toggle between nearest neighbour and bilinear interpolation. 
• Shrink the PET image until it is mapped pixel to pixel. 
• Display a colour PET threshold image over the CT scan for simultaneous inspection of both image sets. 
• Rotate a representation of the PET data in three dimensions. 
• Allow dose to be superimposed over the PET scan. 
 
An understanding of the importance of these aspects based on experience was very useful in evaluating commercial 
implementations that subsequently became available. 
1.5.11 Clinical Observations 
Use of the initial version of CADPET was confined to use in the Physical Sciences department under direct physics 
supervision. It was intended to develop a more robust general use version, implemented to enable co-registration by 
planners within 15 minutes. To achieve this it would have been necessary for the external program to automatically 
vary the superior inferior translational shift to maximise the PET image activity within an outline drawn by the RTPS 
user of the image of a fiducial in the CT scan. To do this the program must be able to read the coordinates of the 
outlines that are stored in the header of the CART files (As distinct from the actual image data which it currently 
swaps in and out.). Essentially the RTPS CT contour statistic function that calculates the maximum CT value within 
a user marked contour must be emulated by CADPET. Although the programming task was ultimately achieved, the 
initial motivation lapsed when the department aquired its first hybrid imaging device, a PET-CT. The capability was 
put to a different use, to facilitate analysis of phantom experiments on PET volume thresholds (see section 2.8.2). 
 
A recurring issue is the intensity above which the 18FDG signal becomes significant. Although this is a complex 
issue involving relative intensities and normal physiological signals, it would be desirable to develop region specific 
protocols for the use of PET data for target demarcation. This could involve input data from the radiologists report, 
such as, in the absence of any nodal involvement, only areas with an intensity of greater than a proportion of the 
maximum intensity of the PET signal should be included in the GTV. 
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1.5.12 Technical summary 
The aim of the trial was to determine the proportion of cases for which use of 3-D co-registered PET data will 
modify the target volume, as a measure of the utility of functional imaging for tumour volume marking. This is the 
central topic of the next two sections (1.6 and 1.7). 
 
From a technical point of view it has been shown that it is possible to modify the RTPS to display co-registered PET 
images in a way which is clinically useful for Radiation Therapy Treatment planning. It has also been shown that it is 
possible to utilize radiotherapy patient immobilisation and repositioning expertise coupled with simple but adequate 
methods of co-registration, to achieve radiotherapy target volume demarcation with the aid of structural and 
functional imaging. The efficacy of all fractionated treatments depends on positioning patients accurately, and as a 
consequence this skill is very well developed in radiotherapy centres. It can be used to great advantage in the search 
for more certain target volume marking using functional imaging. Longer term as this art was improved by image 
guidance techniques, improvements in registration of functional imaging to the isocentre became necessary, which is 
the main topic of chapter 4. 
1.6 Lung Cancer 
Radical radiotherapy (RT) can provide appropriately selected patients with unresectable non-small-cell lung cancer 
(NSCLC) with prolonged survival and even cure,24,25 particularly when given with platinum-based chemotherapy26,27 
or delivered as continuous hyperfractionated accelerated RT.28 Failure to accurately image all gross disease and to 
define an appropriate GTV runs the risk of underdosing regions of tumour when RT planning is carried out. In some 
cases, inaccurate imaging can even cause complete geographic miss of gross tumour subvolumes. Treatment 
planning based on suboptimal 3-D imaging could increase the risk of loco-regional relapse and lead to unnecessary 
irradiation of uninvolved normal tissue. In an era when highly conformal RT is becoming more widely used, accurate 
delineation of gross tumour is essential. Modern radiotherapeutic treatment of NSCLC often uses narrow margins 
around gross tumour, typically without elective irradiation of clinically uninvolved lymph nodes.29 
 
The 3-D RT treatment planning for lung cancer has long been based on the use of anatomical imaging, specifically 
CT scanning.30 Unfortunately, published surgical reports have shown that CT scanning is often inaccurate in staging 
NSCLC, particularly with respect to lymph node involvement, delineation of tumour extension into soft tissues and 
demarcation of the border between tumour and atelectatic (collapsed alveoli) lung.31,32 Therefore, treatment planning 
based on CT alone, although until recently the best available non-invasive method, may not be a good basis on which 
to embark highly conformal RT planning. 
 
Staging with PET, using FDG, is an important advance in the imaging of patients with NSCLC who are candidates 
for radical RT. Numerous studies with clinical–pathological correlation have shown that PET delivers a much more 
accurate estimate of the true extent of disease in NSCLC than CT alone, particularly if CT and PET are used together 
in synergy.33 PET is valuable in selecting candidates for radical RT in two main ways. First, by facilitating selection 
of patients without gross systemic metastatic disease and without intra-thoracic disease too extensive for radical RT, 
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use of PET ensures that only patients most likely to benefit from aggressive therapy are treated aggressively.34 
Second, because the extent of intra-thoracic disease is more accurately imaged, PET facilitates RT target delineation 
and should thereby help minimize the risks of geographic miss of gross tumour and avoid unnecessary irradiation of 
normal tissues.35,36 This is particularly in the case of patients who are not suitable for mediastinal nodal sampling. 
 
In a prospective study of PET staging at PMCI, 30% of 153 consecutive patients were deemed ineligible for radical 
RT after PET. PET data were used to assist with treatment planning for the remaining 70%.15 Initially, PET data 
were visually incorporated into the RT treatment planning process, using the ability of the radiation oncologist to 
estimate the location and extent of PET-positive structures on the treatment-planning CT scan. Either no attempt was 
made to co-register PET and CT data or a simple 2-D co-registration was made based on anatomic landmarks. It was 
estimated that approximately one-quarter of patients planned in this way required significant alterations to their RT 
fields to ensure adequate coverage of PET-detected tumour. 
 
As seen in the preceding section 1.5, 3-D co-registration software was developed that enabled PET images to be 
imported directly into the RT treatment planning system in use at the time (CADPLAN, version 6, Varian Medical 
Systems, Palo Alto, USA)37. PET images could be co-registered with treatment planning CT images using fiducial 
markers. To test the utility and feasibility of this approach in clinical practice, a pilot study was commenced. In this 
section the methods of image acquisition, co-registration and treatment planning using co-registered PET/CT images 
are described. The effects of 3-D PET/CT based treatment planning on tumour coverage and on normal tissue 
irradiation are described in a cohort of 10 consecutive patients who underwent both conventional and PET/CT-based 
planning as part of this prospective study. This method makes full use of the 3-D capabilities of PET and could 
potentially provide RT centres without access to the latest integrated PET/CT scanners with 3-D PET-assisted RT 
planning. 
1.6.1 Elligibility criteria 
All patients had NSCLC and were candidates for radical RT. To be eligible for PET scanning, all patients should 
have undergone conventional (non-PET) staging investigations including CT scanning of chest, abdomen and brain 
and radionuclide bone scanning, without evidence of distant metastasis or intrathoracic disease too extensive for 
radical RT. Additionally, to be eligible for the planning part of the study, patients were required to have no evidence 
of distant metastatic disease on their PET scans and to have PET-detected intrathoracic disease that could potentially 
be safely encompassed in a radical RT planning target volume (PTV). Patients with Eastern Cooperative Oncology 
Group (ECOG) performance status 2 or with weight loss greater than 10% of body mass were ineligible for the 
study. 
1.6.2 Acquisition of PET and CT data for treatment planning. 
Patients immobilization is as described in section 1.5.6. The same immobilization apparatus was used for CT 
scanning, PET scanning and treatment delivery. Patients were set up for imaging or treatment, lying on flat rigid bed 
tops, using lasers installed in the CT and PET simulator and treatment rooms. Patients were instructed to exercise 
gentle breathing throughout the scanning process. Fiducial markers were used as described in section 1.5.6 to 
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facilitate image coregistration. Tattoos were placed at the reference points. Patients were scanned on a CT scanner, 
and 0.5-cm axial images were obtained to include the entire lung volume. Patients underwent fluoroscopy on the 
simulator to record tumour movement with respiration, and orthogonal simulator films were taken to enable port film 
comparison during treatment. 
 
All PET scans were completed within 48 h of the planning CT scans using the standard clinical lung acquisition 
protocol. Patients were asked to fast for more than 6 h before the scan. The scans were acquired on a dedicated PET 
scanner (General Electric (GE) Quest 300-H, UGM Medical Systems, Philadelphia, PA, USA) at least 1 h after i.v. 
injection of 50–120 MBq of F-18 FDG. Radiation therapists positioned the patient in the PET suite in the same 
manner as for the planning CT scan using a customized flat palette bed insert. Fiducial markers were used as detailed 
in section 1.5.6. The areas scanned included the lower neck, chest and abdomen to the level of the pelvis, and data 
were acquired over 40 min. Acquisition included a transmission scan using a single-photon Cs-137 source. After 
reconstruction of both attenuation-corrected emission and transmission data into 4.0-mm transaxial slices, the scans 
were transferred to the RTPS in DICOM format as described in section 1.5.4. An example of a PET scan showing 
fiducial markers is shown in Figure 1.6.2-1. 
Fig. 1.6.2-1 PET image viewed in the RTPS, 
illustrating fiducial markers on the anterior, right 
and left chest wall. The chest wall (1), lungs (2 and 
3), spinal cord (4) and vertebral body (5) have been 
contoured on the corresponding co-registered CT 
slice and are projected over the PET image. The CT 
GTV (7) is shown corresponding to this slice (solid 
red) and the slice superiorly (crossed red), 
demonstrating medial extension to encompass 
atelectatic lung. No margin was applied to the CT 
GTV where it abutted the chest wall or vertebral body. The PET/CT GTV (8) is shown corresponding to this slice 
(solid tan) and the slice superiorly (crossed tan). An area of less-intense FDG uptake was observed adjacent to the 
primary tumour in atelectatic lung, requiring extension of the PET/CT PTV to cover it on the slice superiorly.  
1.6.3 PET and CT image coregistration. 
Co-registration was achieved by matching the planning CT fiducials with the PET emission scan fiducials, using an 
x, y, z shift, and this was verified by comparing lung contours from the planning CT scan and the PET transmission 
data as previously described in section 1.5.6. The RTPS version in use in our department did not support the use of 
co-registered PET/CT images for treatment planning, necessitating the development of the CADPET software. 
Quality control for the process of co-registration was initially investigated using an ANTHROP as described in 
section 1.5.2. The method was found to be accurate to within 4 mm and therefore suitable for use in RT planning for 
lung cancer. It was considered that this level of accuracy could not be significantly improved with the equipment 
available because of the intrinsic spatial resolution of the PET data, with voxels of 4 mm in all dimensions. 
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1.6.4 Contouring of GTV using CT alone and CT plus PET 
Once images were co-registered, the radiation oncologist, first in association with a diagnostic radiologist and 
subsequently with a NM physician, contoured two separate gross primary tumour volumes for each patient, one 
using CT information alone (GTV-CT) and the other using co-registered CT and PET data (GTV-PET/CT). These 
GTVs were then transferred to planning CT images on the RTPS. Lymph node volumes considered positive for 
tumour by the radiologist were marked separately at different stations and were designated GTV1-CT, GTV2-CT etc. 
The following rules were followed for GTV contouring with CT alone: 
 
1 All areas of gross primary lung tumour were contoured, using lung window settings for the interface between 
tumour and lung and using mediastinal window settings for the interface between tumour and mediastinum. 
2 All mediastinal or hilar lymph nodes with a short axis <1 cm were contoured. 
3 If a clear separation could be distinguished between tumour and atelectatic lung, only visible tumour was 
contoured. If there was no separation apparent, the entire volume of atelectatic lung was contoured. Recent contrast-
enhanced CT scans were used to help in this situation. 
 
The radiation oncologist, in consultation with a NM physician, then marked the FDG-avid tumour on the relevant 
series of PET images. Transverse CT and PET slices were displayed side by side as each CT slice was marked with 
the GTV contour. The GTV data points were simultaneously displayed on the PET image as they were marked and 
were edited until the radiation oncologist was satisfied that the contour was as accurate as possible. The following 
rules were followed for contouring GTV with PET/CT: 
 
1 All areas of gross FDG-avid lung tumour were contoured, using lung window settings for the interface between 
tumour and lung and using mediastinal window settings for the interface between tumour and mediastinum. The 
superior resolution of CT was used in defining the tumour–lung interface. If PET showed tumour extension into the 
chest wall or mediastinum that was not apparent on CT, this was included within the GTV. If part of the 
circumference of a tumour was FDG negative, commonly because of necrosis, the entire tumour circumference was 
still included within the GTV. 
2 All FDG-avid mediastinal or hilar lymph nodes were contoured regardless of their dimensions if they were 
considered by the NM physician to contain tumour. Because of partial volume effects, nodes >1 cm with significant 
FDG uptake were considered positive, even if measured standardized uptake value (SUV) was <2.5. 
3 If a clear separation could be distinguished between tumour and atelectatic lung when PET and CT images were 
co-registered, FDG-avid tumour was contoured even if there was no apparent separation apparent on CT alone. 
However, if the entire volume of atelectatic lung was strongly FDG positive, it was included within the GTV. 
1.6.5 Creation of the PTV and treatment plan 
In all cases, the treatment prescription was 60 Gy in 30 fractions to the PTV delivered in 2-Gy fractions over 6 weeks 
using a conformal arrangement of coplanar beams. Constraints on normal tissues included a maximum spinal cord 
dose of 46 Gy and a maximum lung V20 (percentage of the total lung volume receiving 20 Gy or more) of less than 
35%. The PTV was created by the radiation oncologist by applying a 3-D 1.5-cm margin to the GTV. This margin 
Chapter 1: Prelude 
26
was reduced or omitted in regions where the tumour abutted a fixed anatomical boundary (e.g. vertebral body or 
posterior chest wall without invasion). If the primary tumour and nodal volumes were widely separated, they were 
connected by contouring intervening lymphatic regions (e.g. if a left lower lobe tumour and right paratracheal nodes 
were the only sites of involvement, the intervening subcarinal region was contoured to connect the two regions of 
gross tumour). Each CT-derived PTV was increased to allow for respiratory movement measured on fluoroscopy of 
the tumour at the time of simulation. This was unnecessary for PET/CT plans because the PET image was acquired 
over many respiratory cycles. Two separate PTVs were contoured for each patient. The first using the GTV-CT and 
the second using the GTV-PET/CT. A radiation therapist then prepared two separate treatment plans for each patient, 
based on each of the PTVs. Dosimetry for all patients was carried out by a single radiation therapist. Identical 
guidelines were followed with respect to treatment prescriptions and beam arrangements. In each case, 6-MV 
photons were used and tissue inhomogeneity corrections were accounted for. When required, beam modification 
devices were used to optimize dosimetry. ICRU guidelines were followed when assessing dose to the target and 
surrounding normal tissues. In cases where the proximity of spinal cord placed restrictions on dose homogeneity to 
the target, the radiation therapist and oncologist collaborated to achieve an acceptable outcome. Treatment was 
delivered using the PET/CT plan as it was considered most likely to be accurate. 
1.6.6 Comparison of CT alone and PET/CT derived treatment plans 
For the purposes of comparison of the CT-alone and PET/CT derived treatment plans, the target volume derived 
from the latter was considered to be the ‘gold standard’ or the ‘true PTV’. Deviations from this plan in the CT-alone 
plan were therefore considered to be errors. This was justified on the basis that all published studies show PET/CT 
staging to be much more accurate than CT staging alone, although it was recognized that no imaging study can give 
perfectly accurate results and that the only true gold standard in this case would be autopsy. Differences in tumour 
coverage and volumes of lung included in the treatment plans were analysed using simple descriptive statistics. The 
V20 has been reported as a clinically relevant indicator of irradiation of normal lung. 
1.6.7  Results 
The procedures for CT and PET co-registration and treatment planning described sections 1.6.1-1.6.5 were readily 
implemented in clinical practice during the study. However, the method did significantly increase the time taken to 
plan each patient and required additional time commitments from the radiation oncologist, imaging physician and 
radiation therapists. Approximately 4 h of additional planning time was required per patient. After recruitment of the 
first few patients, the team became more confident and the process was more efficient. It is likely that the need for 
additional planning time could be further reduced with more experience and more automated software. 
1.6.8 Patient characteristics 
Details of the post-PET clinical stages for the patients in the study are given in Table 1.6.10-1, together with details 
of the location of the primary tumour, the presence of atelectasis and the influence of PET on treatment planning. 
Two patients, A and B, had undergone prior resections for NSCLC and were receiving radical RT for recurrent 
disease. Most patients in this study had stage III disease, and in six cases (60%), there was significant atelectasis 
associated with the primary tumour. 
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1.6.9 Effect of PET on the coverage of the primary tumour. 
In five patients (E, F, G, H and I), significant areas of lung collapse and/or consolidation were present that were 
contiguous with the primary tumour. In each case, it was possible to distinguish an area of high FDG uptake on the 
PET scan, presumed to be tumour, from areas of lower uptake in consolidated lung, presumed to be free from 
tumour. These boundaries between atelectatic lung and tumour could not be distinguished using CT alone. There 
were therefore significant variations in shape and volumes between the GTV on the CT and PET/CT plans. In four 
patients with atelectasis, treatment plans based on CT alone significantly overestimated the GTV and consequently 
the PTV. 
1.6.10 Effect of PET on coverage of involved lymph nodes. 
Pre- and post-PET stage group allocations were the same for all patients except one; PET scanning for patient D 
resulted in upstaging from stage N2 IIIA to N3 IIIB. Despite the similarity in stage groupings, the extent of lymph 
node disease imaged by PET and PET in combination was often significantly different from that observed on CT 
alone. In three cases (C, D and J), tumour was identified on CT/PET images at lymph node stations that appeared 
normal on CT images. Despite identification of additional tumour on PET, the size of the PTV remained similar in 
patients C and D. In case C, discrete hilar node involvement was detected on PET, whereas on CT, the nodes were 
indistinguishable from the primary tumour. This altered the shape of the PTV. Although the entire gross tumour mass 
was still included within the high-dose volume on the CT plan, a significant part of the PET/CT PTV was missed on 
the CT-alone plan. This had the effect of reducing the irradiated margins around the gross tumour. Although the 
PET/CT PTV was larger, the beam arrangement used covered similar volumes of normal tissues and, therefore, no 
significant changes in dose to lung occurred. 
 
In patient D, in addition to the abnormal ipsilateral hilar nodes apparent on the CT scan, neoplastic subcarinal and 
contralateral mediastinal nodes were detected on the PET scan. A four-field plan was used to cover both PTVs, but 
the field dimensions and gantry angles were quite different, being significantly larger to cover the extent of disease 
noted on PET scan. Although the subcarinal mass would have been treated adequately on the CT plan, the 
contralateral nodal disease would have been outside the CT/PTV. 
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Patient Stagea Site of primary or 
recurrent tumour 
Influence of PET on 
RT plan 
Minimum PTVb 
dose with CT-only 
plan 
Atelectasis /consolidation 
A Recurrence Mediastinum Decreased lung V20 39 Gy Node 
B Recurrence RML and 
mediastinum 
Little change 14.6 Gy Minor infective 
consolidation 
C T2 N1 LLL Better PTV marginal 
coverage 
53 Gy Node 
D T2 N3 LUL Avoided geographic 
miss 
0.8 Gy Node 
E T4 N0 RUL/RML Avoided geographic 
miss, decreased lung 
V20 
3.4 Gy RML and RML collapse 
F T4 N3 LUL Decreased lung V20 36 Gy Minor infective 
consolidation 
G T4 N2 LUL Avoided geographic 
miss 
9.7 Gy LUL collapse 
H T2 N0 LLL Little change 54.7 Gy LLL collapse 
I T2 N1 LLL Better PTV marginal 
coverage 
29.4 Gy LLL collapse 
J T2 N2 RML Better PTV marginal 
coverage, decreased 
lung V20 
30.5 Gy RML collapse 
Table 1.6.10-1 Patient characteristics and overall effect of PET on treatment plan. (a) indicates stage after PET, (b) 
indicates PTV referred to in table is the “true” or PET/CT PTV. LLL denotes left lower lobe, LUL denotes left upper 
lobe; RML denotes right middle lobe; RUL denotes right upper lobe; V20 is the percentage of the total lung volume 
receiving 20 Gy or more. 
1.6.11 Influence of PET scanning on PTV. 
The PTV derived from CT scans alone ranged from 230.5 to 1034.3 cm3 and on average were not significantly 
different from those planned using CT/PET images (p = 0.322). However, this gives a misleading impression of the 
effect of PET. In three cases, the volume of PTV was more than 10% greater for the PET-assisted plan (average 
increase in volume 124 cc) compared with that of the CT-alone plan. In six patients, the PET/CT PTV was smaller 
by 10% or more (average 188 cc). In one case (patient D), the absolute volumes were almost identical, but they 
occupied significantly different anatomic locations (Figure. 1.6.11-1). 
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Fig. 1.6.11-1 Beam’s eye view projection of 
PET/CT (red open hatched) and CT PTVs (blue 
solid colour) for patient D. The PET/CT plan 
included subcarinal and contralateral 
mediastinal lymphadenopathy in the PTV that 
was not apparent on CT. PET, positron 
emission tomography; PTV, planning target 
volume. 
 
 
 
1.6.12 Risk of geographic miss. 
In every case, a part of the PET/CT PTV (ranging from 10 to 40%) was located outside the CT PTV. In three cases, 
regions of the CT/PET GTV were located entirely outside the CT PTV. This situation was regarded as a ‘geographic 
miss’ because regions of gross tumour, apparent on PET/CT, would not have been contained within the target 
volume had treatment been delivered using the CT-derived plan. 
1.6.13 Minimum doses in the PTV 
Inadequate radiation dose given to the ‘true’ PTV (a target volume that contains all gross tumour and is most closely 
approximated by the PET/CT plan) is likely to be associated with a decreased probability of tumour control. In this 
study, when PET/CT and CT-alone treatment plans were compared, there was a statistically significant difference in 
the percentage of the ‘true’ PTV that received, 57 Gy (P = 0.015) and there was also a difference in the minimum 
dose given to the PTV (P = 0.004). The percentage of CT/PET PTV that was not included within the CT PTV ranged 
from 10 to 60%. 
 
According to ICRU recommendations for inhomogeneity within target volumes, the minimum dose within a PTV 
prescribed to 60 Gy should ideally be 57 Gy or more. The mean percentage volume of the CT/PET-derived PTV that 
received a dose less than 57 Gy when this PTV was used for planning was 2.2%. In two cases, there were cold spots 
within the PTV of less than 50 Gy because of proximity of tumour to the spinal cord, leading to deliberate 
underdosing of part of the PTV to remain within our stated spinal cord dose constraints. However, when the CT-
alone PTV was used for planning, the mean volume of the ‘true’ PTV (i.e. the PET/CT PTV) that would have 
received less than 57 Gy was 12.3%, and in eight of 10 patients, there would have been cold spots that received less 
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than 50 Gy, primarily because of inadequate coverage of the ‘true’ PTV. In three cases, more than 10% of the 
PET/CT PTV was not included with the CT-alone PTV, and in two of these, the figure was ≥40%. A dose volume 
histogram from a patient with inadequate coverage of the PET/CT PTV is shown in Figure 1.6.13-1. 
 
 
Fig. 1.6.13-1. Patient E. Cumulative dose volume 
histograms showing coverage of PET/CT PTV by PET/CT-
derived treatment plan (red) and CTalone-derived 
treatment plan (blue). Assuming that PET/CT accurately 
imaged the tumour, the plan prepared using CT alone is 
clearly inferior to the PET/CT.  
 
 
 
1.6.14 Effect on dose to a normal lung. 
Median lung dose and V20 were not significantly different in CT plans compared with that in PET/CT plans (p = 
0.801 and p = 0.816, respectively), again reflecting the fact that PTV could be increased or decreased after PET and 
that these changes tended to cancel out one another when an average was calculated. However, in two cases, both of 
which had atelectasis, adequate coverage of the CT PTV could only be achieved if a lung V20 of >35% was 
accepted. When the PET/CT PTV was used for planning, the V20 was less than 35% in all cases. 
1.6.15 Inspiration 
Sections 1.6.1-14 described in detail a practical method for the incorporation of PET/CT data into a widely used 
RTPS. Provided the patient can be set up with fiducial markers in an identical position on the PET scanner and the 
planning CT scanner and PET images can be exported to the RT planning programme, the method could be 
potentially have been used in any appropriately equipped RT centre, but in the event the subsequent availability of 
commercial systems (PET-CT and RTPS) designed for this purpose made such efforts un-necessary. In the pilot 
study of the technique in clinical practice, it was found that the method worked well, although it did require 
additional resources to implement and needed a significant time commitment by radiation oncologists, imaging 
specialists and radiation therapists, as well as the Medical Physics expertise for the development of the study. As 
mentioned in section 1.5.11 CADPET was never developed enough to be robust enough to be recommended for use 
unsupervised. The groups worked closely together as a team to implement the technique. 
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For all the 10 patients in the study, there were changes to the PTV as a result of the method. These were sometimes 
subtle, often affecting only the margins applied around the gross tumour and in the majority of cases probably would 
have had no significant effect on the probability of local control. However, in three cases (30%), there were highly 
significant changes to the PTV, without which some regions of PET-detectable gross tumour would have been 
located outside the PTV had the CT-alone plan been used to deliver therapy. In these cases, the probability of 
attaining local control could potentially be very much reduced by failure to incorporate PET into the treatment 
planning process. The use of PET did not have a consistent effect on other parameters such as the size of the PTV or 
the V20, although in a larger study, significant effects might become apparent. There was a tendency for the V20 to 
become smaller in cases with extensive atelectasis when PET was used to determine the boundary between tumour 
and consolidated lung. There was an unusually high proportion of patients in the study with atelectasis, which could 
reflect some inadvertent selection bias in recruitment. There were more eligible patients during the trial period than 
there were available places in the study. It has been reported that PET-based scanning can have a particularly 
powerful effect in patients with atelectasis.38,39 
 
The study, although it contains a relatively small number of patients, is consistent with other published studies of 
PET assisted planning in NSCLC.40,41 In all studies, PET has had a significant influence on the estimate of the GTV 
in a substantial proportion of patients and in those cases has influenced the design of the PTV and consequently the 
design of the RT treatment plan. Typically, one-third or more of patients have significant changes to their treatment 
plans, either to ensure adequate tumour coverage or to reduce unnecessary irradiation of normal tissues. There is 
controversy over the best way to use PET to define the GTV and how to use PET to take account of tumour 
movement. The ideal goal is the synergy of PET and CT to take advantage of the benefits of each; that is, PET can 
often tell the nature of a lesion (neoplastic or not) and although CT may be capable of defining its edge more 
accurately, movement of lesions during respiration is more adequately captured by the temporally integrated 
information in the FDG-PET images. Exclusive use of SUV thresholds (absolute thresholds of pixel value as 
opposed to relative ratios) to define tumour edges was considered unlikely to be useful because of the variability of 
this parameter in tumours and inflammatory processes and because of partial volume effects.42 
 
The method described in this study has been superseded due to the advent of PET/CT hybrid scanners. Nevertheless, 
the findings with respect to the changes in treatment plans with combined PET/CT remain unaffected, and similar 
results should be obtained with co-registered images from separate CT and PET scanners or fused images from a 
combined scanner, provided the patient positioning is reproducible. In section 1.7 we will review some clinical work 
that was motivated by experience with standalone PET images, but executed with a PET/CT scanner.  
 
These results were a tremendous motivation to pursue the synergy of radiotherapy and functional imaging. Promising 
new combined method approaches and rapid technical advances in RT delivery held the promise of dose escalation 
to the tumour while preserving normal tissue toxicities at acceptable levels. In lung cancer, dose escalation using 
highly conformal RT, facilitated by methods such as intensity-modulated RT, was likely to be futile if treatment 
planning was not based on an accurate estimation of the true gross tumour extent.43 It was clear that PET can 
improve accuracy of lung cancer imaging, and it should be considered a complementary technology to these new 
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treatment delivery methods. With better patient selection, more accurate imaging and superior treatment delivery, 
significant further progress towards improving local control of unresectable lung cancer with RT might be made. 
1.7 Oesophageal cancer 
The majority of patients with locally advanced oesophageal cancer are managed primarily with chemoradiation. 
However, the prognosis for such patients is poor with published five-year survival rates of around 20% 44,45,46. For 
radiotherapy treatment planning, CT represents the standard method for tumour volume delineation, despite some 
inherent limitations47. For oesophageal cancer, CT is not always accurate, particularly when defining the cranial and 
caudal extent of the primary tumour in the oesophagus. Methods to increase the accuracy of tumour volume 
delineation have the potential to improve local tumour control. 
 
As introduced in section 1.4.1 PET using FDG is a functional imaging modality that provides physiologic 
information based on altered tissue metabolism. The role and potential value of PET scanning in certain tumours, 
including oesophageal cancer, has been widely investigated. When used for initial staging of oesophageal cancer, 
PET is more accurate than CT for detecting lymph node and distant metastases, thereby allowing more accurate 
selection of the most appropriate treatment48,49,50. PET has high sensitivity and specificity for disease within the 
oesophagus with a sensitivity of 90–100% 51. It also demonstrates higher sensitivity (30–77%) and specificity (86–
99%) for diagnosis of pathological lymph nodes than does CT (sensitivity 11–57%, specificity 69–99%)50,52,53,54,55,,56. 
Although, the precise role of PET in the management of oesophageal cancer continues to evolve, it is apparent that 
this imaging modality is being utilized with increasing frequency. 
 
For radiation oncology, there was mounting evidence to support the need for this type of functional information on 
tumours and their surroundings for the purpose of radiotherapy treatment planning57,58. Several reported studies had 
shown that the incorporation of FDG-PET into conventional CT-based radiotherapy treatment planning for patients 
with lung cancer could result in alterations to patient management and delineation of target volumes when compared 
to CT alone39,41,59,60,. Similar studies had also been reported for head and neck cancer and lymphoma61,62,63. 
 
This prospective study was designed to evaluate the impact of PET on CT-based radiotherapy treatment planning for 
patients with oesophageal cancer using an integrated PET/CT scanner. It is likely that the increasing availability of 
this technology will lead to more widespread use of PET/CT units for radiotherapy treatment planning. This study 
sought to determine how the use of combined PET/CT would alter the delineation of tumour volumes compared to 
CT alone if PET/CT is assumed to more accurately represent true disease extent. 
1.7.1 Study Schema 
The study schema is depicted in Figure 1.7.1-1 Eligible patients were those with histologically proven squamous or 
adenocarcinoma of the oesophagus stages I–III and ECOG performance status 0–2, where the treatment intent was 
radical chemoradiotherapy (radiation dose 50 Gy) following completion of all non-PET staging investigations that 
did not reveal evidence of metastatic disease. As a minimum requirement, all patients were required to have 
undergone oesophagoscopy, CT scan of the chest and abdomen, and routine laboratory blood tests as part of their 
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non-PET staging investigations. The study was approved by the PMCI Ethics Committee and all patients gave 
written informed consent. 
 
 
 
Fig. 1.7.1-1 Flow diagram outlining study schema. 
1.7.2  Patient simulation and acquisition of PET-CT data sets. 
Each patient underwent a combined PET/CT scan in the radiotherapy treatment position using an integrated PET/CT 
scanner (Discovery LS, GE Medical Systems, Milwaukee, WI) that served as both a diagnostic and radiotherapy 
planning scan. Simulation was performed according to standard protocols for oesophageal cancer patients receiving 
3D conformal RT at PMCI. The PET/CT scan incorporated the lower neck, thorax, abdomen and pelvis in all 
patients. Patients were injected with between 320 and 400 MBq of FDG and rested lying on a bed for at least 1 h 
prior to scanning. A four-slice helical mode CT scan was acquired during quiet respiration with parameters as 
required for routine PET attenuation correction and co-registration. These were 140 kVp and 80 mA, 5.0 mm slices 
with an interval of 4.25 mm. The trans-axial FOV was 50 cm for both CT and PET. The minimum bore diameter for 
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the PET/CT scanner was 60 cm. PET scanning was performed in 2D mode, in the cephalic to caudal direction, and 
required five or six bed positions at 5 min per step. Data was reconstructed using an ordered subset expectation 
maximisation algorithm and attenuation correction derived from CT data. The PET, CT and coregistered PET/CT 
images were then reviewed on a workstation (GE Entegra, GE Medical Systems, Milwaukee, WI). 
 
All of the PET images were reviewed by an experienced PET physician for staging purposes. Patients with PET 
detected metastatic disease came off study with no further data collection, while patients who did not have metastatic 
disease on PET and were deemed suitable for radical treatment proceeded to the radiotherapy planning phase of the 
study. The CT and PET data sets were converted to DICOM format and transferred via a network link to the RTPS 
(FOCUS, CMS alphatech, St Louis, MO) for tumour volume delineation and treatment planning. 
1.7.3  Delineation of target volumes and treatment planning 
For each patient, two separate GTVs were defined, one based on CT data alone (GTV-CT) and another based on 
combined PET/CT data (GTV-PET). Radiologist/PET physicians who were dually qualified to read both CT and 
PET images would initially mark the regions of gross tumour (primary tumour and involved lymph nodes) on hard 
copy planning CT and PET/CT scans according to predefined study guidelines. In an effort to minimise bias, two 
separate radiologist/PET physicians were assigned to mark the CT alone and PET/CT data sets for the same patient 
in a blinded fashion. Hard copies of diagnostic CT scans and barium swallow studies, as well as oesophagoscopy, 
bronchoscopy and pathology reports were made available to each radiologist/PET physician when marking the hard 
copy planning CT and PET/CT data sets, and these were taken into account when defining the GTV. 
 
For the CT alone data set, the primary tumour in the oesophagus was defined as regions of abnormal oesophageal 
wall thickening (including focal mural nodules or masses) as determined by an experienced radiologist according to 
established standard protocols. In addition, regions of tumour described on oesophagoscopy but not seen on CT were 
also included in the GTV-CT. Regional lymph nodes greater than or equal to 10 mm in maximal diameter were 
considered tumour and included in the GTV. 
 
For the PET/CT data set, regions of gross tumour were defined according to predefined consensus guidelines 
established by experienced radiation oncologists and radiologist/ PET physicians at PMCI. Areas of gross tumour 
were defined using the complementary features of PET and CT. Using this approach, a visual interpretation of the 
PET image was used to determine the nature of a lesion and the CT image to determine its anatomical boundary (e.g. 
outer wall of oesophagus, or radial extent of primary tumour). In cases where no boundary was visible on CT (e.g. 
cranial or caudal extent of primary tumour), the FDG avid tumour volume was defined using a qualitative visual 
assessment of the PET image that was applied with rigorous thresholding to normal tissues. The PET images were 
evaluated qualitatively on a SUV-normalized grey scale for the intensity and distribution of abnormal FDG uptake. 
FDG PET scans were normalised using the liver as the reference tissue, on the reasoning that, apart from the brain 
and, variably, the heart, hepatic tissue has the highest normal soft tissue uptake of FDG under fasting conditions. 
Using a linear grey scale, the liver is set in the middle of the 256-level grey scale (mid-grey). For fused PET/CT 
images a rainbow colour scale was used for the PET data with the liver set at the interface between blue and green. 
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Using these guidelines the intensity of tissues such as mediastinal blood pool, and bone marrow can be reproducibly 
compared to hepatic activity and the relative intensity of tumour deposits can also be appreciated between studies. 
Tumour boundaries are usually defined at the junction between yellow and orange on the rainbow scale. Since 
comparable colour scales are not currently available on our planning systems, the colour scales were manually 
adjusted to provide comparable demarcation of tumour to that outlined on the PET/CT images by the radiologist/PET 
physician. This method was considered by the clinical staff to be more accurate and reproducible than 
semiquantitative methods such as the use of SUV scales or FDG intensity levels, which were felt to be problematic64. 
This problem has been highlighted in a study by Nestle et al. that compared four different methods for delineation of 
FDG-avid tumour volume in patients undergoing radiotherapy planning for non-small cell lung cancer65. It was 
assumed that FDG avid regions correlating with possible location of tumour on CT were true positives. Enlarged 
lymph nodes on CT that were not FDG-avid were included if thought to be clinically suspicious. 
 
Following hard copy marking of the two data sets for each patient by separate radiologist/PET physicians (CT alone 
data set by first radiologist/PET physician and PET/CT data set by second radiologist/PET physician), the treating 
radiation oncologist would then use each hard copy image separately to contour the GTV-CT and GTV-PET on the 
treatment planning computer (i.e. GTV-CT copied from hard copy CT data set, and GTV-PET copied from hard 
copy PET/CT data set). An appropriate clinical target volume (CTV) was generated for each GTV by applying 
standard margins (5 mm radially and 4 cm longitudinally), and the PTV was then generated by applying a volumetric 
10 mm margin. Separate, optimised treatment plans were produced for both the PTV-CT and the PTV-PET in 
accordance with ICRU 50/62 recommendations. Patients were treated according to the PET/CT-based plan. 
1.7.4  Plan Comparison 
The two treatment plans for each patient were compared with respect to the contoured GTV, PTV and normal tissue 
structures. Parameters describing the GTV were assessed to determine if there was any change to the delineation of 
active tumour resulting from the addition of PET information. For each patient, volumetric analysis of GTV-CT and 
GTV-PET was performed to quantify the proportion of PETavid disease that was not included in the GTV if CT data 
alone were used for radiotherapy planning (shaded region in Figure. 1.7.4-1a). This parameter provides an estimate 
of the magnitude of the difference in determining the GTV. Similarly, volumetric analysis of PTV-CT and GTV-PET 
was performed to quantify the proportion of PET-avid disease that was not included in the PTV if CT data alone 
were used for radiotherapy planning (shaded region in Figure. 1.7.4-1b). This parameter determines whether or not a 
geographic miss of gross tumour would have occurred if PET is assumed to be the gold standard. For the purpose of 
this study, inadequate coverage of the GTV-PET has been defined as a ‘grade 1 geographic miss’. Assessment of the 
cranial and caudal extent of the primary tumour GTV as defined by CT alone vs PET/CT was also compared. 
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Fig. 1.7.4-1. Comparison of treatment plans. (a) The proportion of PET-avid disease (GTV-PET) excluded from the 
CT-based GTV (GTV-CT) was quantified for each patient and is represented in this diagram by the shaded region. 
(b) The proportion of PET-avid disease (GTV-PET) excluded from the CT-based PTV (PTV-CT) was quantified for 
each patient and is represented in this diagram by the shaded region. Incomplete coverage of GTV-PET by PTV-CT 
was defined as a grade 1 geographic miss (geographic miss of gross tumour). (c) Diagram illustrating how a CT-
based treatment plan (PTV-CT) may adequately cover the GTV-PET but not the PTV-PET (shaded region), thereby 
potentially resulting in a geographic miss of microscopic tumour. Inadequate coverage of PTV-PET was defined as a 
grade 2 geographic miss. (d) DVH for PTV-PET generated for the CT-based treatment plan. Coverage of the PTV 
was considered to be adequate if at least 95% of PTV-PET received at least 95% of the prescription dose. A lesser 
value was scored as a grade 2 geographic miss. 
Because of the generous longitudinal margins applied to the GTV to generate the PTV when treating oesophageal 
cancer, it is possible that a treatment plan based on CT information alone may adequately cover the GTV-PET but 
not the PTV-PET (shaded region in Figure. 1.7.4-1c). This could also potentially result in a geographic miss of 
tumour through underdosing of regions containing microscopic disease. For the purpose of this study, inadequate 
coverage of the PTV-PET has been defined as a ‘grade 2 geographic miss’. To assess the adequacy of PTV coverage, 
the method described by Mah et al. in a study of PET for radiotherapy treatment planning for non-small cell lung 
cancer was employed39. Dose-volume histograms (DVH) for PTV-PET were generated for the treatment plan based 
on CT information alone (Figure. 1.7.4-1d). Coverage of the PTV was considered to be adequate if at least 95% of 
PTV-PET received at least 95% of the prescription dose. A lesser value was considered to indicate inadequate 
coverage and was scored as a grade 2 geographic miss. We had previously established that no study patient failed to 
receive at least 95% of the prescribed dose to 95% of the PTV in the plan based on the same imaging modality. 
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The impact of PET information on dose limiting normal tissues including lung, spinal cord and liver (for tumours 
involving the gastro-oesophageal junction) was also evaluated with DVH analysis. The parameters assessed were; 
the volume of lung receiving ≥20 Gy (v20), maximum spinal cord dose, and the volume of liver receiving ≥30 Gy 
(V30). 
1.7.5 Results 
23 patients were enrolled on this prospective study. One patient was excluded because he was unable to undergo 
PET/CT scanning in the required radiotherapy treatment position, and a further patient was excluded because the 
primary oesophageal tumour demonstrated very low FDG-avidity. Of the remaining 21 patients, 2 (9%) had tumours 
in the upper third of the oesophagus, 6 (29%) had tumours in the middle third and 13 (62%) had tumours in the lower 
third or gastro-oesophageal junction. The addition of PET information altered the clinical stage in 8 of 21 patients 
(38%); 4 patients (19%) were found to have distant metastatic disease [upstaged from M0 to M1 (M1a in one patient 
and M1b in three patients)] and an additional four patients (19%) were found to have unsuspected regional nodal 
disease (upstaged from N0 to N1) that was not apparent on the initial staging CT scans (Table 1.7.5-1). The PET 
findings led to a change in management from radical chemoradiation to treatment with palliative intent in five 
patients (24%). 
 
Sixteen patients proceeded to the radiotherapy planning phase of the study and received definitive chemoradiation 
planned with the PET/CT data set. Volumetric analysis of GTV-CT and GTV-PET showed that PET-avid disease 
was excluded from the GTV in 11 patients (69%) if CT data alone were used for radiotherapy planning. The median 
percentage volume of GTV-PET not included in the GTV-CT was 38% (range: 2–100%). To assess the adequacy of 
coverage of the GTV, a similar comparison of PTV-CT and GTV-PET was performed, which showed that PET-avid 
disease was excluded from the PTV in five patients (31%) if CT data alone were used for radiotherapy planning. 
Exclusion of gross tumour from the PTV in these patients would have resulted in a grade 1 geographic miss. The 
median percentage volume of GTV-PET not included in the PTV-CT was 6% (range: 2–92%). The geographic 
misses involved inadequate coverage of the primary oesophageal tumour in two patients, exclusion of unsuspected 
nodal disease from the irradiated volume in two patients, and a combination of both in one patient. 
 
Evaluation of the longitudinal extent of the primary tumour in the oesophagus by CT vs. PET–CT was compared by 
assessing the cranial and caudal limits of GTV-CT and GTVPET. Assuming PET represents the true extent of 
disease, CT overestimated the cranial extent of the tumour in six patients by a median value of 1.5 cm (range: 0.4–
3.4), and underestimated the cranial extent of the tumour in six patients by a median value of 1.7 cm (range: 0.4–
2.6). CT overestimated the caudal extent of the tumour in eight patients by a median value of 0.6 cm (range: 0.4–
5.5), and underestimated the caudal extent of the tumour in five patients by a median value of 1.3 cm (range: 0.4–
4.3). 
 
To assess the adequacy of PTV coverage, DVHs for PTV-PET were generated for the treatment plan based on CT 
information alone, which demonstrated inadequate coverage of PTV-PET in six patients (38%). Exclusion of 
potential microscopic tumour from the PTV in these patients would have resulted in a grade 2 geographic miss. As 
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described above, coverage of the PTV was considered to be inadequate if less than 95% of PTV-PET received at 
least 95% of the prescription dose. The median percentage volume of PTV-PET receiving at least 95% of the 
prescription dose for the patients with a grade 2 geographic miss was 86% (range: 63– 92%). Included in this group 
are the five patients with a grade 1 geographic miss. 
 
Figure. 1.7.5-1 shows an example case that illustrates the impact of PET information on delineation of target 
volumes. The upper panel shows coronal and sagittal reconstructions of the GTV as delineated by CT alone (GTV-
CT in blue), while the lower panel shows coronal and sagittal reconstructions of the GTV as delineated by PET/CT 
(GTV-PET in purple). The main difference is in the cranial extent of the primary oesophageal tumour, which is 
higher with CT alone. In this case, the PTV-CT (in red) completely covers the GTV-PET so a geographic miss would 
not have occurred. 
 
DVH analysis was also used to assess the impact of PET information on dose limiting normal tissues. There were no 
clinically significant differences on average, in the radiation doses to the lungs, spinal cord and liver between the 
treatment plans based on CT vs PET/CT (data not shown). In general, increases in the GTV led to increased radiation 
doses to the lungs and liver, while decreases in the GTV led to reduced doses. In no case did the radiation doses 
exceed our accepted tolerance doses for these normal tissues (either CT alone or PET/CT plan). 
 
Fig. 1.7.5-1. Upper panel: coronal and sagittal 
CT reconstructions showing the GTV as 
delineated by CT alone (GTV-CT in blue). Note. 
The GTV was not outlined using these images, 
but on serial axial CT slices. Lower panel: 
coronal and sagittal PET/CT reconstructions 
showing the GTV as delineated by PET/CT 
(GTV-PET in purple). The GTV-CT is also shown 
in blue. In this case, the cranial extent of the 
primary oesophageal tumour is higher with CT 
alone. The PTV-CT (in red) completely covers 
the GTV-PET so a geographic miss would not 
have occurred. 
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Patient Pre-PET stage PET findings Post-PET stage Change from radical to 
palliative intent 
1 TxN1M0 Metastases to bone and 
distant nodes in neck 
TxN1M1 Yes 
2 TxN0M0 Metastases to bone and 
bilateral adrenal glands 
TxN0M1 Yes 
3 TxN0M0 Metastases to regional 
nodes and distant nodes 
in the left neck 
TxN1M1 Yes 
4 TxN0M0 Metastases to bone TxN0M1 Yes 
5 TxN0M0 Nodal disease upper 
mediastinum and left 
peri-gastric 
TxN1M0 Yes 
6-8 TxN0M0 Regional nodal disease TxN1M0 No 
TABLE 1.7.5-1 FDG-PET findings that altered clinical staging and treatment intent. 
Note: Accurate assessment of T-stage was not possible as the majority of patients did not undergo endoscopic 
ultrasound. 
1.7.6 Impetus for functional imaging for contouring  
The use of FDG-PET for initial staging of oesophageal cancer is well established. PET has a higher sensitivity for 
detection of metastatic disease than does the combined use of CT and endoscopic ultrasound (EUS). In a prospective 
study by Flamen et al. FDG-PET demonstrated higher accuracy for detection of metastatic disease (82 vs 64%), 
mainly due to superior sensitivity (74 vs 47%), that resulted in the upstaging of 15% of the patients from M0 to M1 
disease48 . These findings are similar to those here where 19% of patients were found to have distant metastases by 
PET. 
 
In this study, the GTV based on CT data alone excluded PET-avid disease in 69% of patients, and in 31% of patients 
this would have resulted in a geographic miss of gross tumour. As there is no standard definition in the radiotherapy 
literature for what constitutes a ‘geographic miss’ of tumour, there were defined for the purposes of this study, two 
separate grades of geographic miss. A grade 1 geographic miss was defined as exclusion of any gross disease (PET-
avid disease) from the PTV. This constitutes the most serious grade of geographic miss since there can be little 
chance of tumour cure if gross disease lies outside the radiation treatment fields. Although of lesser importance, it is 
also possible that a geographic miss could potentially arise from inadequate coverage of the PTV through 
underdosing of regions containing microscopic tumour. This has been termed a grade 2 geographic miss where 
coverage of the PTV was considered to be inadequate if less than 95% of PTV-PET received at least 95% of the 
prescription dose based on DVH analysis. It should be noted that these parameters were arbitrarily defined following 
an initial review of PTV coverage in the plan based on the same imaging modality for patients comprising the study 
cohort (see section 1.7.4). According to this definition, radiotherapy treatment planning based on CT data alone 
would have resulted in a grade 2 geographic miss in 38% of patients. 
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One of the main advantages of adding PET information to CT-based planning for oesophageal cancer is the ability to 
more accurately define the cranial and caudal limits of the primary tumour GTV. Current methods for defining the 
longitudinal extent of the primary tumour in the oesophagus, such as CT and oesophagography performed at the time 
of radiotherapy planning, are not always accurate. PET allows the longitudinal extent of the tumour to be more 
clearly defined, and is particularly useful for determining the caudal extent of tumours that extend to the gastro-
oesophageal junction and proximal stomach, where visualisation with CT alone is often difficult. In this study, the 
cranial extent of the primary tumour as defined by CT vs PET/CT differed in 12 patients (75%), while the caudal 
extent differed in 13 patients (81%). In contrast to the longitudinal extent of the GTV, the radial extent, which is 
defined by the outer wall of the oesophagus, is usually clearly visible with CT alone. The advantage of adding PET 
information is therefore less, except when determining the radial extent of tumours that extend into the proximal 
stomach as described above. 
 
Pathological confirmation of tumour extent in the oesophagus was not performed because it is not possible to 
accurately correlate the upper and lower tumour levels measured on CT and PET with those determined at 
endoscopy. Furthermore, there are limitations of endoscopy in determining true pathological tumour extent, and 
some tumours are inaccessible to endoscopy due to tight stricturing. Although, pathological confirmation of PET 
findings is desirable, this is not always a straightforward process, nor is it appropriate in this group of unresectable 
patients66. Although increased FDG could reflect inflammatory changes in association with tumoural uptake, a paper 
by Choi et al. suggests that the tumour length on PET is an independent predictor of survival in patients with 
oesophageal cancer, supporting the contention that it more accurately reflects tumour extent than conventional 
imaging techniques and therefore ought to be included in the GTV67. 
 
An important finding is that PET was able to detect unsuspected regional lymph nodes in three patients that would 
not have been encompassed in the CT-delineated volume. A limitation is that not all lymph nodes detected by PET 
were sampled pathologically, with the potential for false positive results. However, given the high specificity of PET 
for detecting nodal disease, the likelihood of a false positive result is low and PET has been reported in several 
studies to be more accurate than CT and EUS52,54,55,56. In these studies, the major limitation of PET was its inability 
to detect peri-tumoural nodes. This likely relates to the spatial resolution limits of PET. These nodes are those that 
are most likely to be sampled pathologically, allowing detection of even small volume disease below the resolution 
of any imaging modality. However, such peritumoural nodes are less likely to be of significance to radiation 
treatment planning compared to more distant regional nodes since they are necessarily included in the treatment 
volume even if not independently resolved on PET. Supporting this contention, a recent study assessing the 
prognostic significance of various PET findings demonstrated that in patients with pathological stage III disease 
(regional nodal metastases), there was a significantly superior survival in those without discrete nodal abnormalities 
on PET (false negatives) compared to those with this finding (true positives)67. 
 
Because most radiation oncologists are not adequately trained in the interpretation of PET, it was felt important that 
an experienced PET specialist be available to both confirm that the patient has no remote metastatic disease and to 
assist with contouring of the GTV. In all cases, interpretation of the PET findings was performed by a skilled 
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imaging specialist with training and experience in oncological PET taking into account knowledge of the natural 
history of the disease, clinical information, and pattern recognition. For the purposes of incorporating the information 
from other correlative imaging results into the GTV-PET, radiologists with dual training in structural and PET 
imaging were used in this study. As with the use of other imaging modalities, pathological confirmation was 
performed when there was doubt about the PET findings. 
 
With these caveats, the results of this study demonstrate that if combined PET/CT is used for radiotherapy treatment 
planning, there will be alterations to the delineation of tumour volumes when compared to CT alone. If PET/CT is 
assumed to more accurately detect disease extent, then treatment based on CT alone may potentially result in a 
geographic miss of tumour. Because pathological verification of PET findings was not performed, there is the 
potential for false positive results with the risk of over treatment and increased toxicity. However, the clinical 
consequences of over treatment are significantly less than those of a geographic miss if PET-avid regions are not 
included in the radiation treatment fields. A further caveat with the use of PET is that false negative findings may 
occur with small volume tumours (T≤2) or those that are not FDG avid. In our experience, FDG non-avidity is 
uncommon with oesophageal cancer (4% in this series), and the vast majority of patients treated with radiotherapy 
will have locally advanced tumours (T≥3). Although not advocating that PET should be the new gold standard, it is 
believed that the use of combined PET/CT information for radiotherapy treatment planning is an improvement on the 
standard of CT alone and should take precedence over other non-invasive staging techniques when discordance 
cannot otherwise be resolved. Whether improvements in target volume delineation and treatment planning will 
translate into better clinical outcome remains to be determined and will require supportive evidence from larger, 
multi-institutional trials evaluating local tumour control, survival and treatment toxicity.  
1.8 Ictal SPECT images 
SRS is a technique coupling image guided neurosurgical intracranial localisation techniques with single dose 
external beam irradiation to achieve non invasive treatment of small, easily visualised lesions. The RTPS (XKnife 
RT™, Radionics, Burlington, MA, USA) allows the routine use of CT and Magnetic Resonance Imaging (MRI) 
images for stereotactic treatment planning of medical linear accelerator based radiosurgery. Ictal (during seizure) 
SPECT with Technetium-99m is the preferred imaging modality for epilepsy68. Ictal SPECT images acquired at the 
NM department of the Austin and Repatriation Medical Centre (ARMC) have been incorporated into the stereotactic 
radiosurgical treatment planning at the William Buckland Radiotherapy Centre (WBRC) of the Alfred Hospital. The 
original ictal SPECT images consisted of 65 slices separated by 2.3 mm covering an axial field of view (FOV) of 149 
mm, each slice made up of 128 by 128 square pixels of side length 1.8 mm covering a transaxial FOV of side length 
230 mm. The spatial resolution of the SPECT imaging system was a nominal 8 mm full width at half maximum. In 
consultation with the WBRC, the volumetric SPECT data was co-registered at the ARMC with a volumetric MRI 
data set, a technique that has been validated by O’Brien et. al.69. Both the original MRI and the re-sampled co-
registered SPECT image data sets were then saved in RAW pixel only format, 256 by 256 pixels per slice, 124 slices, 
16 bits per pixel, little endian integer format. These images could not be imported directly into the WBRC 
stereotactic RTPS. Although the RTPS supported the importation and use of DICOM70 format CT and MRI, it did 
not support the importation or display of SPECT images71. Additionally, Radionics71 did not have a RAW to DICOM 
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converter available. At this point the PMCI undertook to create a translator from RAW to DICOM format, so that the 
RAW SPECT image was effectively embedded in the pixel data section of multiple DICOM CT files forming part of 
a DICOM PART 10 conformant image set. In this way the SPECT data would be split up and reassembled inside the 
xknife computer under the alias of a CT image. The first treatment went ahead as planned at the WBRC. This section 
describes the implementation of the RAW to CT and RAW to MRI conversion. 
1.8.1 Clinical Procedure  
The MRI and SPECT scans were initially performed six weeks prior to the treatment of the patient. The two scans 
were co–registered and the SPECT scan was sampled and transformed to create a new SPECT scan that had the same 
number of slices, orientation, positioning and geometrical frame of reference as the Magnetic Resonance (MR) scan. 
The original MR scan and the new SPECT scan were then exported as two RAW format image files. These two 
RAW format images were then translated into two DICOM file sets. Osiris72 was used to create a DICOMDIR73 for 
each file set, and the two filesets with their respective DICOMDIRs were then burnt onto a CD-rom in two separate 
subdirectories. The MR scan was represented as a DICOM MR file set, the SPECT scan was represented as a 
DICOM CT file set. A week prior to the treatment the image data in the file sets was uploaded into the RTPS system 
using the image translation utility, and at that time a pre-inspection of the MR and SPECT(CT) data was done before 
the booking for treatment was confirmed. 
 
On the treatment day a stereotactic CT scan was performed with the BRW head ring74 and localisation frame 
attached. Once the MR and SPECT image sets were converted to DICOM the files were loaded into the RTPS Image 
Fusion module. The stereotactic CT and the MR data was loaded first and the fusion performed as normal. The 
Image Fusion module requires the user to select a minimum of three landmark positions before the fusion process 
can begin. It is extremely difficult to landmark anatomical references75 on a functional (SPECT) dataset due to the 
absence of anatomical information. Usually external fudicial markers are used when functional fusion is performed76. 
 
The fusion of the MR and CT data results in the creation of a transform file that specifies the transformation used to 
map the MR dataset into the stereotactic CT coordinate system. As the MR and SPECT(CT) datasets represent 
exactly the same volume, the SPECT(CT) transformation to match the stereotactic CT is identical to the MR 
transformation. The MR transform file was copied and renamed as the SPECT(CT) transform file. 
 
The Image Fusion module was loaded as normal with the CT and the SPECT(CT) image sets selected. The Image 
Fusion module then determined that a transform (fusion) has already been performed, by reading the SPECT 
transform file, and so loaded the SPECT dataset in the transformed orientation. The fusion of the CT and the SPECT 
was then reviewed and checked against hard copies of the MR – SPECT overlays. The fusion was saved and the 
treatment planning commenced. 
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1.8.2 Conversion from RAW format to DICOM Fileset 
To produce a DICOM File set from a RAW data file requires that each slice of the RAW data file be incorporated 
into a separate DICOM Data Set, preceded by the DICOM File Meta Information to form a file. So each RAW data 
file containing 124 slices had to be split into 124 separate DICOM files. This is shown schematically in Figure  
1.8.2-1 
 
Fig. 1.8.2-1 File translation schematic. 
1.8.3 File Meta Information 
The File Meta Information includes identifying information on the encapsulated data set73 as well as specifying the 
encoding rules for the same. The DICOM File Meta Information itself is encoded as a stream of byte data that 
consists of a prefix of 128 bytes that are not read, followed by the four characters DICM(HEX 44 49 43 4D), 
followed by the series of DICOM Data elements listed under File Meta Information. The structure of the File Meta 
Information DICOM Data elements is shown in Figure 1.8.3-1. 
Fig. 1.8.3-1. DICOM Data Set and Data Element Structure for 
File Meta Header “Val Rep” is a contraction standing for Value 
Representation, two bytes that define the encoding rules for the 
value field. “Val Len” is a contraction standing for Value Length, 
a two byte integer equal to the length of the value field in bytes. 
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1.8.4 Unique identifiers in the File Meta Information 
There are four unique identifiers in the File Meta Information, which serve to unambiguously specify the type of 
image represented, the encoding rules for that image, the application that last modified the file, and the “serial 
number” of the file, as specified below. 
 
The Media Storage SOP Class UID (0002,0002) is defined by the DICOM protocol. It specifies the nature of the 
object that the DICOM file represents and is required to be 1.2.840.10008.5.1.4.1.1.2 for a CT Image73, or 
1.2.840.10008.5.1.4.1.1.4 for an MRI Image73.  
 
The Transfer Syntax UID (0002,0010) is also defined by the DICOM protocol. It specifies the encoding rules for the 
DICOM Data set (But not the File Meta Information). For the widest possible generality we chose the default 
DICOM transfer, Implicit VR Little Endian, designated by UID 1.2.840.10008.1.1 which all DICOM applications 
are required to support. Implicit VR means that the value representation tag is omitted from the DICOM Data, and 
the value representation of a specific data element is only identified indirectly by its group and item number. Little 
Endian refers to the byte ordering of integers, the least significant byte is encoded first. The pixel data is transmitted 
in native, uncompressed format. The DICOM data set and data element structure for the default syntax is shown in 
Figure 1.8.4-1. 
Fig. 1.8.4-1. DICOM Data Set and Data Element Structure for 
Default DICOM Transfer. This is a specialisation of Figure 7.1.1 
from Part 5. 
 
 
 
The Implementation Class UID (0002,0012) identifies uniquely the last application that wrote to the file. To ensure 
that the UID is unique, the authorised use of the UID prefix 1.2.826.0.1.3680043.2.647. was graciously provided by 
David Harvey of Medical Connections77. The specific UID of 1.2.826.0.1.3680043.2.647.243.0.1 was assigned to 
this program. All files created with this program are stamped with this UID. 
 
The Media Storage SOP Instance UID (0002,0003) identifies uniquely each DICOM file. In order to guarantee that 
the UID is unique, the format is set to make the UID unique to the program, computer, and time (to the second) that 
the program is started. The UIDs produced within a single execution of the program are then incremented to make 
them all different. This guarantees that the UID will be unique unless the same program is run at the same time down 
to the nearest second on the same machine. This is given to be sufficiently unlikely to occur that it is considered 
sufficient simply to instruct the user to ensure that it does not occur. 
1.8.5 DICOM Data Set 
The contents of each DICOM File includes the File Meta Information followed by the DICOM Data Set. The 
DICOM standard defines 26 different value representations, or data types, which specify the way the information is 
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encoded into a sequence of bytes. To construct a DICOM file requires that 10 of the 26 are used to encode 
mandatory data in the DICOM shell around the raw pixel data for each slice. 
 
The most involved part of the project was coding all the extraneous data tags that were required under the DICOM 
standard as part of the DICOM DATA Set. These data elements are specified as either type 1, 1C, 2, 2C or 3. Type 1 
elements are mandatory, they must be present and they must have valid information content. Type 1C elements are 
conditionally mandatory. They are not required under all cases, but if they are required then they must have valid 
content. Type 2 elements must be present but they can have zero data length. Type 2C elements are not required 
under all cases, but if they are required then the data length can be zero. Type 3 items are entirely optional. Data 
elements are also specified by a unique combination of a group number and element number. Unless forming part of 
a sequence, the order of appearance of data elements is mandated by the group number and element number, they 
must be in increasing order. The list of DICOM elements required is obtained by first examining the COMPUTED 
TOMOGRAPHY IMAGE OBJECT DEFINITION and the MAGNETIC RESONANCE INFORMATION OBJECT 
DEFINITION, to determine the required modules in each case. Then each of these modules was searched through to 
find all the type 1, 1C, 2 and 2C items. Also one type 3 item, the Slice Location, is included in the list because it was 
known that this is or had in the past been required by some radiotherapy systems. 
1.8.6 Implementation 
Figure 1.8.6-1 shows SPECT data as viewed in the contouring window of the stereotactic treatment planning system. 
From inspection the target volume is too small to have been marked solely from the low spatial resolution SPECT 
images. Effectively the SPECT image draws attention to an identifiable anatomical region in the higher spatial 
resolution co-registered MRI images; section (1.8.11) deals with SPECT image resolution. The images are rendered 
with a bilinear interpolation, which is suited to the display of CT and MRI, rather than the nearest neighbour 
interpolation often used in NM image display37 (See section 1.5.3). 
 
Fig. 1.8.6-1 Ictal SPECT data as viewed in the 
contouring window of the stereotactic treatment 
planning system. Note the large numbers in the 
window level setting. The small white circle is the 
outline of the circular stereotactic collimator used 
for treatment, centred on the treatment isocentre. 
The dark structure outlined within it is the 
spect_lesion. 
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1.8.7 Race to implementation 
The work was required to be completed within a generous but limited clinical timetable. Several options were 
considered for importing the SPECT images into the RTPS, but two quickly emerged as the most viable. Option 1 
was to convert from RAW direct to ima, the internal data format of the RTPS. This had the advantage that the ima 
format was expected to have only minimum extraneous patient demographic data in it, just the patient name and vital 
spatial information. The disadvantage was that we did not have any documentation about the image format, and 
Radionics were not able at the time to provide a RAW to ima converter. Consequently option 2 was chosen, which 
was to convert from RAW to DICOM, and then import the resulting DICOM files into the RTPS using the standard 
RTPS utilities. The disadvantage was that many patient demographic details and DICOM transfer syntax 
specifications would need to be added to the raw image. The major advantage was that the DICOM standard was 
well documented if complex. Also a DICOM translator would be more generally useful and might be adaptable to 
other purposes. It was decided to write a command line driven utility using the C-compiler bundled with the xknife 
computer. This would allow other sites to modify and recompile the source for particular requirements, but would 
require using the pre ANSI Kernighan and Ritchie version of the C programming language78, without an integrated 
compiler environment to write the program. 
1.8.8 Orientation of the image sets 
The RTPS fusion module displays markers for left, right, superior, inferior, anterior and posterior as appropriate for 
the field of view. Although the image fusion will arrange the image in the right orientation by translation etc, the 
view is disconcerting if the markers are clearly in the wrong place. Also there is the possibility of a mirror reflection 
where one or all of the three marker pairs are reversed, from which the fusion module will not necessarily be able to 
provide a transformation to recover the right handedness of the image coordinate system. It is therefore desirable that 
when the images are translated from RAW to DICOM the orientation of the image can be specified, and command 
line switches to designate the resulting DICOM file set as representing coronal, sagittal or axial planes were 
implemented to allow the specification of the orientation. The RTPS implements viewing of images in the 
radiological convention79,80, and it is vitally important to avoid misrepresenting the left side of the patient as the right 
side in the image space. From inspection even the untrained eye can determine superior from inferior, and anterior 
from posterior, but the approximate symmetry of the human form makes it difficult to determine right from left and 
we had to verify this. In this particular case there was a significant deficit on the patients’ right side that was clearly 
visible in the MR and SPECT scans, which made it easy to differentiate left from right. The byte ordering within the 
RAW data sets is chosen arbitrarily at the time of export to the RAW format from the imaging modality, so it is 
important to have a hardcopy output from the imaging modality that shows the orientation of the image set for 
verification purposes. Alternatively the placement of a Technetium-99m loaded fiducial on a specified side of the 
SPECT image plan is worth considering. 
1.8.9 Dark area within the SPECT data. 
When the SPECT data set was sampled to form a new SPECT data set in the same geometrical frame of reference as 
the MRI data set, those areas of the MR data set for which there was no matching SPECT data were assigned as 
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having a zero pixel value. This can be seen as the dark area at the bottom of the first two SPECT slices shown in 
Figure 1.8.2-1. The presence of this artefact caused some lack of confidence in the translation from RAW to 
DICOM, until it was pointed out that the stereotactic treatment program fusion algorithm also produces dark areas. 
Clinical confidence in registration is a recurring theme across implementation of different functional imaging 
modalities. 
1.8.10 Byte ordering 
The translation from RAW to DICOM assumes that the RAW pixel data is encoded as 16 bit Little Endian (least 
significant byte encoded first) format integers. It is expected that RAW export from imaging modalities is 
configurable to either little endian or big endian(most significant byte encoded first), so that this specification is no 
impediment as long as it is known about before the export is done. 
1.8.11 SPECT image spatial resolution and stereotactic localisation 
accuracy 
It would seem at first inspection SPECT imaging is of questionable use for stereotactic treatment, since the strength 
of stereotactic radiosurgery is the accuracy of the spatial localisation, and this would be compromised by the low 
spatial resolution of the SPECT data. It is apparent from inspecting Figure 1.8.6-1 showing the target volume marked 
on the SPECT data that the contour has been marked with better resolution than is available from the SPECT image. 
The co-registration with the MRI data allows the SPECT image to flag a general area, which can be discerned better 
on a structural basis from the superior spatial resolution MRI image. The combination of the low spatial resolution 
SPECT images depicting functional information fused to the high spatial resolution MRI images showing structural 
information is suitable for radiosurgical treatment planning. 
1.8.12 DICOM broadcast of SPECT data vs. removable media creation 
Initially it was proposed to broadcast the DICOM data  files to xknife using OFFIS81. With the Radionics DICOM 
Server set to auto-translate, if each file was sent by a separate call to the storescp binary, each scan would overwrite 
the previous one and instead of an image set with 124 slices an image set with only one slice would be created. To 
obtain a multi-slice image set required the DICOM files to be sent using a single call of the storescu program. 
Besides being cumbersome this effectively limited the image sets to 56 slices (Limit of 64 command line arguments, 
including 6 required DICOM protocol transmission specifications). This limitation was overcome by saving the 
DICOM data sets onto a CD-ROM and importing the DICOM file sets from the CD-ROM using the RTPS image 
translation tools. Subsequently it was found that the full 124 slices of the DICOM fileset could have been broadcast 
to the stereotactic treatment planning system if we the DICOM server had simply been configured not to 
automatically translate images. 
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1.8.13 Requirement to rescale the pixel values of the DICOM SPECT(CT)data 
sets 
The stereotactic treatment planning system will only display pixel values between 0 and 4095, but the SPECT data 
used the full 16 bit data resolution to provide pixel values from 0 to 65,535. It was therefore necessary to divide the 
SPECT RAW pixel values by 16 before writing them into the SPECT(CT) DICOM Fileset Files. The easiest way of 
doing this would have been to change the rescale slope (0028 ,1053) to a non unity value, but this method was not 
chosen because reliance on the correct interpretation of the rescale slope by a DICOM server was deemed not 
advisable. The 16 bit integers comprising the pixel data were all rescaled instead, as a more robust but less efficient 
way of achieving the required rescaling. 
1.8.14 Outcome 
SPECT data was successfully integrated into the stereotactic RTPS in time for planning of stereotactic radiosurgery, 
and the initial treatment was delivered on schedule. The investment of significant resources to achieve this was 
motivated primarily by the clinical requirements of the first case but was sustained by the growing interest in SPECT 
for treatment planning. With relative ease the method could be generalised to incorporate SPECT data into other 
radiotherapy planning systems, as all of them support import of DICOM CT data. The recasting of a SPECT image 
as a CT image is technically a gross violation of the DICOM protocol, but it is considered justified in this case 
because the professional interpretation of the images is enhanced by enabling them to be viewed within the 
stereotactic treatment planning system. The concise specification of the minimum necessary requirements to create a 
DICOM Part 10 Compliant File Set particular to CT and MR, coalesced from the thousands of pages of the DICOM 
standard, may be of value to others who require for clinical purposes to create CT or MR DICOM file sets. Radionics 
have informed us that they plan to incorporate PET images, and perhaps SPECT images, as part of their product 
development. Apart from this further vindicating our endeavours, we have also been in a position to provide advice 
on how this could best be done. 
1.9 Motivation 
Three problems recur throughout these endeavors to realize the synergy of functional and anatomical imaging. First, 
there was always uncertainty about how to segment tumours from PET images, the most basic manifestation of 
which was an uncertainty over what greyscale level to use for the boundary of the tumour.  Secondly, enormous 
efforts were required to enable the flow of information in digital form, to the extent that the implementation of entire 
clinical programs were obstructed solely by difficulties with data transfer. Thirdly there was always a need to co-
register the functional imaging, at the outset to anatomical forms of imaging for staging but ultimately to the 
treatment isocentre for tumour volume marking. 
 
These three coupled problems must be addressed to enable soundly founded clinical trials to establish the clinical 
efficacy of hybrid imaging for tumour volume marking in radiotherapy. 
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1.10 Thesis structure 
The problem of tumour segmentation is the motivation for the central work of chapter 2, the study of Erdi’s and other 
threshold methods that consider the simplest problem in PET image tumour segmentation, finding the boundaries of 
stationary, spherical, uniform concentrations of FDG. It is shown that for 2-D PET, a qualitative explanation of 
thresholds can be achieved by applying a simple Gaussian blurring model, and quantitative explanation of thresholds 
can be achieved by adding an estimation of noise effects. Diverse published results from the literature are shown to 
be explainable by the same model. A publication is in preparation based on this work. 
 
The problem of information transfer is the motivation behind the deployment in chapter 3 of DICOM Packet 
Sniffing. This chapter shows how DICOM packet sniffing can be used to pinpoint the cause of problems in a multi 
vendor environment, to guide solutions that can be implemented with local resources, and that some information 
transfer problem can only be solved by the application of this technique. This chapter forms the basis of a paper that 
has been published in the journal Australasian Physical and Engineering Sciences in Medicine82. 
 
The general problem of clinical confidence in co-registration is a recurring theme across all forms of functional 
imaging. The specific problem of co-registration to the treatment isocentre is considered in its most demanding form 
in radiotherapy, stereotactic frameless intracranial treatment. The principle of rotational invariance is used to derive 
and test a universally applicable method of determining the spatial accuracy of registration to the isocentre. This is 
used to establish accuracy sufficient for clinical practice, guide changes in treatment technique, explore correlation of 
accuracy with distance moved, the number of corrections required, and the fraction of treatment. The accuracy to 
which the patient is rotated to the correct angle is also reviewed by applying the same method adapted to rotation 
rather than translation. Artifacts of the method are estimated using a combination of optimization and statistical 
estimation. This application of the principle of rotational invariance formed the basis of a paper published in Medical 
Physics83. A follow up paper is being prepared for submission to the journal Australasian Physical and Engineering 
Sciences in medicine. 
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Chapter 
2 
Segmenting tumours from functional imaging. 
 
Having been the discoverer of many splendid things, he is said to have asked his friends and 
relations that, after his death, they should place on his tomb a cylinder enclosing a sphere, 
writing on it the proportion of the containing solid to that which is contained. 
Plutarch: Life of Marcellus 
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2.0 Segmenting tumours from functional imaging 
There is no general consensus on the method that should be followed when segmenting tumour volumes using 
functional imaging. For this reason, a description of the particular segmentation method often forms a large part of 
any study evaluating the use of PET images in radiotherapy treatment planning. In sections 1.6.4 and 1.7.3 examples 
of such image segmentation methods have been presented. This chapter begins with an acknowledgement of the 
clinical controversy over the level of human input into tumour segmentation with functional imaging. The focus then 
narrows to the first documented and clinically most widely implemented segmentation method, the relative threshold 
method. The impact of this method is established by a review of the associated literature, ranging from phantom 
studies to different clinical sites. There is in the literature no model to explain the predictions of the relative threshold 
method for 2-D PET, so a qualitative model is developed and refined into an extendable quantitative theory. The 
limitations of this model are demonstrated by applying it to 3D-PET. The chapter concludes with a consideration of 
the clinical question that the theory answers.  
2.1 Documented Segmentation methods. 
Any description of segmentation methods would be incomplete if it did not begin with an acknowledgement that 
there is a controversy over whether such methods should be documented. Proponents of documentation such as 
Lavrenkov et al.1 advocate for a clearly established methodology of primary GTV definition in NSCLC using 
thresholding techniques. In contrast, MacManus and Hicks2 advocated against automated methods and for flexibility 
in target volume definition protocols to allow for the incorporation of other information. They pointed out that “Fully 
automated contouring can sometimes be 100% reproducible but 100% wrong.” The middle way between these two 
polarized outlooks seeks to incorporate clinical judgment and automated methods. A similar collaborative group 
extended this threshold method to deal with background and non tumour PET avid structures3.  
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Clinical studies document many different methods to segment tumour volumes from PET images. Some methods are 
simply not specified, the target volume is simply described as being left to “board certified radiologists”4. Some 
methods rely on an SUV ratio, which is the ratio to the signal expected given the patient’s height, weight, and the 
amount of injected FDG5. Some methods rely on intensity relative to a physiological PET intensity, so for example 
the blood pool in the aorta6. Some methods introduce constraints on the expected size or shape of the segmented 
volume to constrain segmentation, so for example through the use of “snakes”7. Amongst all of these methods, the 
one that has been implemented most widely, documented the most and yet one of the simplest methods, is the 
relative threshold method. 
2.2 A review of the relative threshold method (Erdi’s method) 
The relative threshold method is a very simple segmentation method that can be easily implemented within a 
radiotherapy treatment planning system. All PET image voxels with a greyscale value higher than a fixed threshold 
are segmented as part of the tumour. The threshold is a percentage of the maximum PET pixel value within the 
tumour, which can in general be volume dependent. Erdi et al obtained these thresholds by imaging spheres of 
known volume, and then applied these thresholds to segment tumours of corresponding volume but arbitrary shape8. 
There are over 100 references that cite this original work by Erdi8. A review of this body of literature is perhaps the 
best way to demonstrate the breadth of the impact of this method. 
2.2.1 Validations of Erdi’s method 
Some of the literature is best classified as independent validations of the original experimental work. Aside from 
reconfirming the validity of the original work, some of them contain additional insights on the applicability of the 
method. 
  
Yaremko et al.9 essentially validated Erdi’s threshold measurements on a different PET unit (C-PET, Philips-ADAC 
Medical Systems, Milpitas, CA, USA). They observed the increase of threshold with decreasing volume, and 
postulated spatial resolution and noise as the likely reason. An extension of this postulate underpins two of the three 
hypotheses of this chapter in section 2.3. Wang et al.10 used Erdi’s threshold method to obtain volumes of poorly 
differentiated thyroid lesions. They then showed that the volumes obtained were the single strongest predictor of 
survival. Sgouros et al.11 refer to Erdi’s threshold method agreeing with volumes they have estimated independently 
by a combination of single photon emission planar imaging and CT scan segmentation of the spleen loaded with 
213Bi. They use these volumes to estimate the dose from the alpha emitting isotope for patients with Leukemia. 
Nehmeh et al.12 used Erdi’s threshold method to determine volumes from PET images of oscillating FDG loaded 
phantoms, with and without gating as a method of determining the effectiveness of the gating corrections.  A similar 
group13 went on to evaluate respiratory gated (4-D) PET/CT imaging of the thorax, using centroids of volumes 
segmented using Erdi’s threshold method. Caldwell14 et al used Erdi’s method to segment volumes from ungated 
PET images of moving FDG loaded phantoms. They found that these volumes encapsulated the phantom and its 
movement. 
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2.2.2 Overviews of imaging in radiotherapy 
In a generalized review of imaging in radiotherapy15 that references Erdi’s threshold method, variable effect of 
thresholds or other criteria used to define tumour margins is given as a drawback of PET imaging. In a review of 
targeted molecular imaging for radiotherapy, Nimmagadda et al.16 again identify Erdi’s threshold method, and the 
lack of a robust segmentation method due to an uncertainty about the tumour threshold, as being an impediment to 
the use of PET for tumour volume marking.  
2.2.3 Reported clinical applications of Erdi’s method 
In a 2005 lung cancer pilot study, Jarritt et al.17 would not modify their treatment plans based on PET GTVs because 
of the uncertainty they had about the validity of Erdi’s threshold method among others. Mamede et al.18 in preference 
to Erdi’s method, used a threshold based on a level 2 standard deviations above background, and used these volumes 
to explore the usefulness of PET-CT in assessing the response to treatment of esophageal cancer. Ford et al.19 noted 
in a planning study of head and neck lesions that the thresholds of Erdi’s method are dependent on the reconstruction 
method used. El-Bassiouni et al.20 sought to define the best threshold for PET significance in head and neck cancer 
for tumour volume marking by determining the threshold level that best matched the volume determined by CT 
alone. Additionally, they used a fiducial based image fusion offset of up to 2mm.  The key observation was that a 
single threshold value could not be used. Erdi’s threshold method was self referenced by Fox et al.21 who used it to 
segment NSCLC GTVs from PET images as the underpinning of a study of the effect of PET on tumour volume 
variability. Hong et al.22 compared Erdi’s threshold with CT based segmentation and SUV > 2.5 segmentation for 
NSCLC in a planning study, and recommended SUV > 2.5 for NSCLC because of tumour heterogeneity. Erdi’s 
threshold method was used by Sura et al.23 to segment volumes of post radiotherapy recurrence as part of an 
assessment of local failure. McDermott et al.24 used Erdi’s threshold method to monitor the change in volume of PET 
images of primary breast tumours during chemotherapy. Erdi’s threshold method has been used as the PET volume 
segmentation method in a study on patients of Thyroid Cancer Therapy 131I internal dosimetry25. Song et al.26 used 
Erdi’s threshold method to determine the volume and thus calculate the dose for radioiodine treatment of diffuse lung 
metastases. Vera et al.27 used Erdi’s threshold method to segment PET regions of interest (ROIs) as part of a 
determination that the use of contrast enhanced CT for attenuation correction has no significant effect on 
quantification of FDG uptake for Lymphoma (Hodkin’s disease and Non-Hodgkins Lymphoma). Erdi’s threshold 
method was used to determine Non-Hodgkins Lymphoma volumes, from which the intensity of indolent and 
aggressive sub populations was compared28. Burt et al.29  used Erdi’s threshold method to determine tumour volumes 
from PET studies of human colorectal cancer cell lines xenografted into rats. Ciernik et al.30 reference Erdi’s 
threshold method in support of a positive evaluation of automated threshold based segmentation of rectal cancer 
GTVs.  Bassi et al.31 used Erdi’s threshold method to segment PET GTVs in a comparison to GTVs segmented from 
CT data, which showed a 25% increase in GTV volume if PET was used. Leboulleux et al.32 used Erdi’s threshold 
method to determine tumour volumes to evaluate PET imaging for diagnosis and prognosis of adrenocortical 
carcinoma. 
Chapter 2: Segmenting tumours from functional imaging 
 59
2.2.4 Segmentation Methods: Other segmentation models. 
Erdi’s threshold method rates only a passing mention as an application for image segmentation in Boudraa and 
Zaidi’s detailed theoretical review33 of image segmentation techniques in Nuclear Medicine imaging. Topics covered 
include thresholding, region growing, classifiers, clustering-based, edge detection, edge thresholding, markov 
random field models, artificial neural networks, deformable models, atlas guided approaches, and analysis of time 
activity curves.  
 
Erdi’s thresholding method is often cited by groups proposing other models. For example Daisne et al.34 compare 
their own PET volume segmentation with Erdi’s Threshold method. They incorrectly report Erdi’s method as 
requiring a priori knowledge of the volume. This paper was incorporated by Daisne35 as a chapter in his thesis. 
 
Black et al.36 cite Erdi’s method to compare with their own segmentation method. Black used the average activity 
within the segmented volume, rather than the maximum activity that Erdi used, to determine the threshold. This 
method is reviewed and contrasted to Erdi’s method in section 2.7. 
 
Baardwijk et al.37 reviewed the status of FDG-PET in tumour volume definition in radiotherapy treatment planning 
and observed “Only few studies use automatic segmentation, based on a certain intensity level, such as SUV-level, a 
percentage of the maximal SUV or the source to background ratio.” 
 
Aristophanous et al.38 proposed a gaussian mixture model, which Boudraa and Zaidi33 classify as an unsupervised 
clustering based approach using the expectation maximization algorithm. The main disadvantage of clustering is that 
the appropriate number of clusters must be decided before hand. In this case three clusters were used, labeled as 
tumour, background, and uncertain, on the basis of a review of the image intensity histogram. It is not clear if this 
number of clusters would in general be the correct choice. 
 
Jarritt et al.39 observed that thresholding is the most widely used method to determine volumes automatically from 
PET images. 
 
Nestle et al.40 found that for FDG positive mediastinal lymph nodes, the automatic segmentation method used did not 
matter: all produced volumes that were clinically the same. 
 
Hatt et al.41 apply fuzzy hidden markov chains for segmentation of PET volumes. The method is more complex than 
thresholding, but is compared against fixed thresholding rather than the adaptive thresholding of Erdi’s method.  This 
work is aware that it is just as important to get the right volume as it is to get the volume in the right place. They 
therefore compared the total classification errors, positive and negative, rather than volume errors. Positive 
classification errors are background voxels that are incorrectly classified as belonging to the tumour. Negative 
classification errors are tumour voxels that are incorrectly classified as belonging to the background. The fixed 
thresholds were better at larger spheres with higher signal to noise ratio, but much worse for smaller volumes at 
lower signal to noise ratios. The correct threshold should have equal number of NCEs and PCEs (Negative 
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classification errors and positive classification errors). 42% is a nominal threshold for larger spheres at higher signal 
to noise ratios. It is known that the threshold must be increased for very small volumes, and is approximately 42% 
for very large volumes, but decreases in between. So the threshold needs to be lower for smaller spheres. As the 
threshold used is too high for these spheres, all of the tumour is included (no NCEs) and many pixels are incorrectly 
promoted from background to tumour. It is also known that the threshold depends on the signal to noise ratio. 
Predictably, PCEs are responsible for all of the errors. The conclusion presented by the paper, that fuzzy hidden 
markov chains segment the volumes better than threshold methods, does not apply to Erdi’s threshold method. The 
concept of NCEs and PCEs is not seen elsewhere in the literature. It is useful recognition because in radiotherapy we 
are interested in the correct positioning of the tumour as well as getting the volume right, as we will explore in 
chapter 4. This limitation is also present in most histological studies, there is no correlation of position, only volume 
or maximal linear dimension. We will see later in section 2.8 and chapter 4 that this consideration is important in 
radiotherapy, and that there is a limitation to the ability to the accuracy with which the center of a sphere can be 
determined from the PET image data of the sphere. 
 
Drever et al.42 proposed a local contrast method in which the tumour was segmented independently on each slice of a 
3D volume, using thresholds that varied with cross sectional area and slice position. They were also aware of the 
radius of curvature effect, but they had too many parameters to be predictive. 
The same group followed up in 200743 with an iterative slice specific iterative threshold technique. They were aware 
of the effect of pixels for small volumes, and they looked at some non spherical phantoms.  
 
A third paper by the same group44 compared three of the methods identified by Boudraa and Zaidi33; thresholding, 
Sobel edge detection, and the watershed approach. They found from phantom studies that only the threshold 
technique could accurately determine phantom volumes, but that the threshold was volume dependent. The 
thresholding technique that they used was different from Erdi’s in that they used a cross section threshold method, 
rather than the 3D method used by Erdi. 
Sobel edge detection is a subset of edge detection methods. Since edges are local features, differential operators are 
used in edge detection, such as the Roberts gradient, Sobel gradient, Prewitt gradient and the laplacian operator. 
The sobel mask operators used in this circumstance were 
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for horizontal and vertical edges respectively. 
The watershed algorithm in this case acts on the gradient vector field of the image, grows regions around the local 
minima until they meet other regions, and uses the boundaries as closed contours that segment the image. The 
algorithm is known to over segment noisy images45 which the authors attempted to avoid by marker selection. 
 
Jentzen et al.46 used Erdi’s threshold method, but without any initial estimate of the volume of the tumour. They 
called their method the iterative threshold method (ITM).  They observed “The published thresholding methods 
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provide reliable estimates only if the image activity distribution is homogenous”. They found large deviations for 
volumes less than 0.5 mL. For volumes larger than 1.0 mL, they got 10% variation.  
 
Montgomery et al.47 identify that the main limitation of Erdi’s threshold method is that “…the results are coupled too 
tightly with the thresholds used, where any change can completely alter the results of the segmentation.” They 
propose the use of Markov random field model, in which a voxel is in or out of the region depending only on its 
value and that of its immediate neighbours. 
  
El Naqa et al.48 reference Erdi’s threshold method as an example of a segmentation method that uses only a single 
modality, as an introduction to their preliminary investigation of a proposed method of segmentation based on PET 
and CT information. 
 
Brambilla et al.49 referenced Erdi’s method as an introduction to a determination of the threshold from phantom 
observations which depended on the target to background ratio, the sphere diameter, the scan duration and the 
activity. They split the match into two distinct areas above and below 1 cm diameter. They eliminated scan duration 
and injected activity as parameters of significance. So they were left with just the diameter and target to background 
ratio. We review their method in section 2.11. 
2.2.5 Segmentation checked against pathology 
The final test of a segmentation method is by direct pathological determination. Baardwijk et al.50 observed a good 
correlation between auto-delineated contours and pathological sizes. 
2.2.6 Planning Studies 
Chetty et al.51 examined the effect of varying the threshold used in Erdi’s thresholding method on the dose to the 
tumour and to normal tissue (lung) and found that it can have potentially clinically significant impact for both. Grills 
et al.52 did a planning study on NSCLC comparing CT and PET volumes, and tabulated the variations in clinical 
study methods of tumour segmentation. They also tabulated number of patients, whether a dedicated CT-PET was 
used, whether there was separate PET staging, what target volume changes were observed, what normal tissue DVH 
evaluation was made, and how inter-observer variability was evaluated. 
 
In a general review of the use of PET for radiotherapy53, Erdi points out that the SUV threshold method, where all 
regions with an SUV>2.5 are included, has been validated for staging but not for segmentation. He goes on to self 
reference his own threshold method as the preferred solution. 
2.2.7 Phantom characterization of Movement 
Yaremko et al.54 show from phantom experiments that correctly segmenting moving volumes requires thresholds 
lower than those used by Erdi’s threshold method. Nagel et al.55 used thresholds straight from Erdi’s method, but 
they averaged the maximum across breathing cycles, which would change some of the effect of noise. On the basis 
of the calculated volumes, they concluded that attenuation maps for each respiratory phase are as important as 
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emission gates for correctly segmenting volumes. Bosmans56 incorporated this work as a chapter in his thesis. Chi et 
al.57 self referenced Erdi’s threshold method to segment tumour volume regions of interest to underpin a design study 
of respiration averaged CT for attenuation correction of the PET data from PET/CT. 
2.2.8 Qualitative work 
Krak et al.58 reference Erdi’s threshold method in passing as having the advantage of being able to assess 
“metabolic” tumour volume. Their main emphasis was on quantitative work, rather than tumour segmentation. 
Schoder et al.59 self reference Erdi’s threshold method as informing their choice of FDG phantom volume to avoid 
partial volume effect. This paper is also important in pointing out the influence of reconstruction parameters on the 
clinical interpretation of PET images. Hamill et al.60 observe the effect of respiration on quantitative PET in the 
region of the diaphragm. They observe that attenuation data must be matched in phase to the PET data phase. They 
note in passing the implications for thresholding techniques such as Erdi’s, that they cannot be applied accurately 
without such data. Berriolo-Riedinger et al.61 suggest averaging the SUV over volumes defined by Erdi’s threshold 
method as a way of improving the predictive value of reduction in SUV by neo-adjuvant chemotherapy in breast 
cancer.  
2.2.9 Ubiquity 
The two major reasons that Erdi’s method is so widely referred to in the clinical context are that it is simple and easy 
to implement. Any radiotherapy treatment planning system allows the implementation of Erdi’s method without any 
modification of the software. The method provides a simple answer to a complex problem, a voxel is segmented as a 
part of the tumour if the PET image value is above the threshold given by Erdi. 
2.3 Erdi’s threshold method hypotheses 
Three hypotheses are proposed with respect to Erdi’s threshold method. 
Firstly, that a qualitative explanation for the threshold behaviour observed can be obtained by treating the image as 
an idealized continuous function and modeling the 2-D PET imaging process as a simple Gaussian blurring. 
Secondly, that by introducing a noise approximation as a perturbation, it is possible to obtain a quantitative model to 
predict the thresholds of Erdi’s method for 2-D PET from the spatial resolution and noise characteristics of the 
scanner. 
Thirdly, the same model can be used to draw parallels between diverse threshold methods proposed by investigators, 
with some limited relevance even to 3-D PET. 
2.4 QUALITATIVE EXPLANATION OF ERDI’S RESULTS  
The qualitative explanation for the threshold behavior observed by Erdi, where as the volume of the sphere 
decreases, the threshold drops from 50% and then rises again to more than 50%, can be explained by the interaction 
of the spatial blurring on the image of the center of the sphere, and the effect of the curvature of the surface of the 
sphere.  
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For very large spheres, the surface is effectively flat, and the effect of spatial blurring on the magnitude of the 
maximum imaged concentration at the centre of the sphere is negligible.  Neither factor impacts so the threshold is 
50%. 
 
For intermediate size spheres, the curvature at the surface of the sphere becomes significant, while the effect of 
spatial blurring at the centre of the sphere is still negligible. Spatial blurring at the surface of the sphere means that 
the imaged concentration is a weighted sum of the concentrations in the immediate vicinity, as the surface curvature 
becomes significant, more than half the points in the immediate vicinity have zero concentration (Figure 2.4-1). 
 
Fig. 2.4-1 As the curvature of the surface of the sphere (red line) 
increases relative to the FWHM (diameter of green circle), the 
number of points in the immediate vicinity of a point on the periphery 
of the sphere (small black circle) that are within the sphere 
diminishes below half. A horizontal diameter has been drawn (black 
line) to illustrate this. 
 
 
 
 
For very small spheres, where the radius of the sphere is small compared with the full width at half maximum 
(FWHM), the blurring begins to affect the magnitude of the signal at the center of the sphere, which increases the 
threshold. The threshold rises above 50% when the geometrical effect of surface curvature is overcome by the 
exponential decrease of signal from the center of the sphere due to the spatial blurring. 
2.5 QUANTITATIVE MODELLING OF ERDI’S RESULTS. 
To determine the magnitude of these effects quantitatively, the spatial distribution of the concentration of FDG 
within a spherical phantom filled with FDG of concentration C within the sphere, and zero outside the sphere, can be 
described in an idealised mathematical form by a rectangular function. Using spherical polar coordinates with the 
origin at the centre of the sphere, the distribution of concentration ( )θφ ,,rP  is given by the equation  
 
( )
⎩⎨
⎧
>
≤=
Rr
RrC
rP
0
,, 0θφ        Equation 2.5-1 
where  
0C is the concentration of FDG within the sphere in units of Bq/ml. 
R is the radius of the sphere in units of cm 
P is a continuous function describing the concentration of FDG at any point . 
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By hypothesis the imaging process can be described purely as a Gaussian convolution, and the image of the 
concentration of radioactive isotope, ( )θφ,,rI  is a continuous function given by a convolution integral  
( ) ( ) ( ) ( )∫ ∫ ∫∞ ′′′′′−′′′′=
0 0
2
0
2 sin,,,,
π π
φθθθφθφ rdddrrrgrPrI    Equation 2.5-2 
where  
r  is a vector from the origin to the point described by the spherical polar coordinates r , φ , θ . 
r ′  is a vector from the origin to the point described by the spherical polar coordinates r ′ , φ′ , θ ′ . 
( )rg  is a 3-D gaussian spread function, with FWHM of w in cm. 
The form of the gaussian spread function is then  
( ) ( ) 2krAergrg −==         Equation 2.5-3 
Since the value of the FWHM is w  in units of cm, we have 
( )
( )
2
4
2
1
0
2/ kwe
g
wg −==         Equation 2.5-4 
Which implies that  
( )
2
2log4
w
k e=          Equation 2.5-5 
Normalisation of the gaussian spread function also requires that 
( ) ( )∫ ∫ ∫∞ =
0 0
2
0
2 1sin
π π
φθφ drddrrg        Equation 2.5-6 
Since the gaussian spread function is a function of r only, and 
( )∫ =
π
φφ
0
2sin d          Equation 2.5-7 
as well as the trivial evaluation 
πθ
π
2
2
0
=∫ d          Equation 2.5-8 
So equation 2.5-6 becomes 
( ) 14 2
0
=∫∞ drrrgπ         Equation 2.5-9 
This integral can be solved by integrating by parts 
dr
dr
dU
VUVdr
dr
dV
U ∫∫ −=       Equation 2.5-10 
Using the substitution 
rU =          Equation 2.5-11 
and 
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2
2
1 kre
k
V −−=         Equation 2.5-12 
so that  
1=
dr
dU
        Equation 2.5-13 
and 
2krre
dr
dV −=         Equation 2.5-14 
So that equation 2.5-9 becomes 
∫∫∫ ∞ −−∞
∞
−
∞
− ==−−−=×
0000
12
2
14
2
44
2222
dre
k
Adre
k
Ae
k
ArdrrerA krkrkrkr ππππ    
Equation 2.5-15 
The definite integral of a gaussian over this range is known 
π∫
∞
− =
0 2
12 dre r        Equation 2.5-16 
So we have 
1
2
122 5.1
0
2 =⎟⎠
⎞⎜⎝
⎛==∫∞ − kAkkdrek
A kr ππππ     Equation 2.5-17 
Which allows us to evaluate the constant A 
( ) 5.1
2
5.1 2log4 ⎟⎠
⎞⎜⎝
⎛=⎟⎠
⎞⎜⎝
⎛= ππ w
kA e       Equation 2.5-18 
2.5.1 Approximating a discrete function with a continuous one. 
The image from a PET scanner is a voxelised image, but equation 2.5-2 casts it, by hypothesis, as a continuous 
function. So in addition to idealizing the imaging process, equation 2.5-2 also deals with an idealized image. The 
impact of these two idealisations must be considered when evaluating any conclusion reached from evaluating 
equation 2.5-2. (See section 2.6.3 Image voxelisation) 
2.5.2 Using equation 2.5-2 to obtain Erdi’s threshold results. 
The threshold required to segment the sphere depends on the image at the surface of the sphere and the maximum 
within the image, which in the idealised model will always be at the centre of the sphere. So the threshold to segment 
the sphere is  
( )
( )0,0,0
0,0,
I
RI=λ         Equation 2.5.2-1 
where 
( )0,0,0I  is the maximum value within the image, at the center of the sphere of radius R  
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( )0,0,RI is the value of the image at the surface of the sphere. 
λ is the threshold ratio required to segment the sphere. 
To segment the sphere, all points with an image value greater than or equal toλ  times the maximum are included, 
all those with a lower value are excluded. The threshold percentage is obtained by multiplying the threshold ratio by 
100. 
To obtain λ , we must evaluate the numerator and denominator of equation 2.5.2-1. 
( ) ( ) ( ) ( )∫ ∫ ∫∞ ′′′′′′′′′=
0 0
2
0
2 sin,,0,0,0
π π
φθθθφ rdddrrgrPI    Equation 2.5.2-2 
Since from equation 1, ( )θφ ,,rP  is zero when Rr > ; 
( ) ( ) ( ) drreACrdddrrgCI R krR 2
0
0
0 0
2
0
2
0
2
4sin0,0,0 ∫∫ ∫ ∫ −=′′′′′′= πφθθπ π  Equation 2.5.2-3 
Integrating by parts and substituting U and V as before in equations 2.5-10 to 2.5-14 yields 
( ) dre
k
ACe
k
ArCdrreACI kr
RR
kr
R
kr 222
0
0
0
02
0
0 2
14
2
4
40,0,0 −−− ∫∫ −−−== πππ  
Equation 2.5.2-4 
( ) dre
k
ACe
k
ARCdrreACI kr
R
kR
R
kr 222
0
0
02
0
0 2
14
2
40,0,0 −−− ∫∫ −−−== πππ  
         Equation 2.5.2-5 
The integral in equation 2.5.2-5 cannot be evaluated analytically, but it can be expressed in terms of tabulated 
functions, such as the erf function from MATLAB or the NORMSDIST function from excel. 
( ) dtexerf x t∫ −=
0
22
π        Equation 2.5.2-6 
( ) dtedtezNORMSDIST z tz t ∫∫ −
∞−
− +==
0
22
22
2
1
2
1
2
1
ππ   Equation 2.5.2-7 
( ) ( )kRerf
k
ACe
k
ARCI kR
5.1
0
0 220,0,0 ⎟⎠
⎞⎜⎝
⎛+−= − ππ    Equation 2.5.2-8 
or substituting out k  and A  from equation 2.5-5 and 2.5-18 respectively, 
( ) ( ) ⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛+⎟⎠
⎞⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛−= ⎟⎠
⎞⎜⎝
⎛−
w
RerfCe
w
RCI e
w
R
e e 2log2
2log4
20,0,0 0
2log4
0
2
π   
Equation 2.5.2-9 
To use NORMSDIST, we make use of the value of NORMSDIST(0)=0.5 
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( ) ( )( )5.02220,0,0 5.1 05.10 2 −+−= − kRNORMSDISTk ACek ARCI kR ππ  
         Equation 2.5.2-10 
( ) ( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛ −⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛+⎟⎠
⎞⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛−= ⎟⎠
⎞⎜⎝
⎛−
5.02log82
2log4
20,0,0 0
2log4
0
2
w
RNORMSDISTCe
w
RCI e
w
R
e e
π   
        Equation 2.5.2-11 
It is clear by inspection of equation 2.5.2-9 or 2.5.2-11 that ( )0,0,0I  is a function only of the ratio ⎟⎠
⎞⎜⎝
⎛
w
R
, the radius 
of the sphere to the FWHM of the scanner. This equation is graphed in Figure 2.5.2-1. Since the FWHM varies from 
scanner to scanner, this equation is graphed with a logarithmic x axis, so that the basic shape of the graph will be 
invariant with FWHM. A change in the FWHM of the scanner will only move the graph to the left or right, without 
changing the shape, on a logarithmic scale. From Figure 2.5.2-1 it can be seen that once the radius of the sphere 
increases to twice the FWHM, ( )0,0,0I  is effectively constant. The extrapolation to small values of ⎟⎠
⎞⎜⎝
⎛
w
R
 
predicted by the model is not correct in practice, because at some point the volume of the sphere becomes smaller 
than the voxel volume. In practice such small spheres eventually cannot be resolved from background signal.  
 
Fig. 2.5.2-1 This figure is a log-linear 
plot of the image value at the centre of 
the sphere against the ratio of the 
radius of the sphere to the full width at 
half maximum spatial resolution of the 
imaging process. The relationship is 
obtained by considering the imaging 
process as purely a Gaussian blurring. 
 
 
 
 
 
Now the denominator of equation 2.5.2-1 is evaluated 
( ) ( ) ( ) ( )∫ ∫ ∫∞ ′′′′′−′′′′=
0 0
2
0
2 sin,,0,0,
π π
φθθθφ rdddrrrgrPRI   Equation 2.5.2-12 
where )0,0,(Rr = is any point on the surface of the sphere of radius R. 
From the diagram it is clear that although the spread function has spherical symmetry, the integration has cylindrical 
symmetry. The equation is therefore recast in terms of cylindrical polar coordinates. (Figure 2.5.2-2) 
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Fig. 2.5.2-2 Cylindrical polar coordinates. 
A cylindrical coordinate system with origin O, 
polar axis A, and longitudinal axis L. The dot 
is the point with radial distance ρ = 4, angular 
coordinate φ = 130°, and height z = 4. 
 
 
 
 
 
 
 
 
 
 
 
( ) ( )( )∫ ∫ ∫
−
−
−+−=
R
R
zR
Rzk ddzdAeCRI
π
ρ ρϕρ
2
0 0
0
22
22
0,0,     Equation 2.5.2-13 
Since the integral has cylindrical symmetry, this becomes 
( ) ( )( ) ρρπ ρ dzdeACRI R
R
zR
Rzk∫ ∫
−
−
−+−=
22
22
0
020,0,     Equation 2.5.2-14 
( ) ( ) ρρπ ρ dedzeACRI R
R
zR
kRzk∫ ∫
−
−
−−−=
22
22
0
020,0,     Equation 2.5.2-15 
Substituting 2ρku −= ; du
k
d
2
1−=ρρ ; 00 =→= uρ ; ( )2222 zRkuzR −−=→−=ρ ; 
( ) ( ) ( )due
k
dzeACRI
R
R
zRk
uRzk∫ ∫
−
−−
−− −=
22
2
0
0 2
120,0, π     Equation 2.5.2-16 
( ) ( ) ( )( )dzee
k
ACRI zRk
R
R
Rzk 222 10,0, 0 −−
−
−− −= ∫π     Equation 2.5.2-17 
( ) ( )22 42022
0
2
5.1
0 122
10,0, kR
Rk t
e
Rk
ACdte
k
ACRI −− −−⎟⎠
⎞⎜⎝
⎛= ∫ ππ
π
  Equation 2.5.2-18 
from equation 2.5-18 
( ) ( )22 4022
0
2
0 122
10,0, kR
Rk t
e
kR
CdteCRI −− −−= ∫ ππ    Equation 2.5.2-19 
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from equation 2.5-5 
( ) ⎟⎟⎟⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−= ⎟⎠
⎞⎜⎝
⎛−−
⎟⎠
⎞⎜⎝
⎛
−∫
2
2log161
0
2log24
0
2
0 12log42
10,0,
2
w
R
e
w
R
t e
e
e
w
RCdteCRI ππ   
         Equation 2.5.2-20 
( ) ⎟⎟⎟⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−= ⎟⎠
⎞⎜⎝
⎛−−
⎟⎠
⎞⎜⎝
⎛
−∫
2
2log161
0
2log4
0
0 12log42
10,0,
2 w
R
e
w
R
t e
e
e
w
RCdteCRI ππ   
         Equation 2.5.2-21 
( ) ⎟⎟⎟⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛= ⎟⎠
⎞⎜⎝
⎛−−
2
2log161
00 1
2log4
2log4
2
0,0, w
R
e
e
e
e
w
RC
w
Rerf
C
RI π   
         Equation 2.5.2-22 
( ) ⎟⎟⎟⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−⎟⎟⎠
⎞
⎜⎜⎝
⎛ −⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛= ⎟⎠
⎞⎜⎝
⎛−−
2
2log161
0
0 12log4
5.02log240,0, w
R
e
e
e
e
w
RC
w
RNORMSDISTCRI π  
        Equation 2.5.2-23 
Again it is clear by inspection of equation 2.5.2-22 or 2.5.2-23 that ( )0,0,RI  is a function only of the ratio ⎟⎠
⎞⎜⎝
⎛
w
R
, 
the radius of the sphere to the FWHM of the scanner. This equation is graphed in Figure 2.5.2-3. Again since the 
FWHM varies from scanner to scanner, this equation is graphed with a logarithmic x axis, so that the basic shape of 
the graph will be invariant with FWHM. A change in the FWHM of the scanner will only move the graph to the left 
or right, without changing the shape, on a logarithmic scale. From figure 2.5.2-3 it can be seen that once the radius of 
the sphere is 100 times the FWHM, ( )0,0,RI  is effectively constant at a value of 0.5. The extrapolation to small 
values of ⎟⎠
⎞⎜⎝
⎛
w
R
 predicted by the model is not correct in practice, because at some point the diameter of the sphere 
becomes smaller than the voxel size. At that point the surface of the sphere and the centre of the sphere can both be 
within the same voxel. In practice such small spheres eventually cannot be resolved from background signal. 
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Fig 2.5.2-3 This figure is a 
log-linear plot of the image 
value at the surface of the 
sphere against the ratio of 
the radius of the sphere to 
the full width at half 
maximum spatial resolution 
of the imaging process. This 
relationship is derived on the 
basis that the imaging 
process is a Gaussian 
blurring. 
 
 
 
Now that the numerator and denominator of equation 2.5.2-1 have been determined, we can graph the threshold 
required to segment the sphere. Since the numerator and denominator are both functions only of the ratio ⎟⎠
⎞⎜⎝
⎛
w
R
, it 
follows that the threshold depends only on that ratio. The threshold is graphed in Figure 2.5.2-4. It can be seen that 
for large spheres, the threshold asymptotes from below to a value of 0.5. The surface of a large sphere is essentially a 
planar surface, and the intensity at the centre of the sphere is fully saturated. 
 
As the radius of the sphere gets smaller, the surface of the sphere becomes more and more curved. The fraction of the 
volume in the immediate vicinity of a point on the surface that is within the sphere and therefore contains activity 
that can be blurred into the surface point begins to decrease below 0.5. At these intermediate sizes, the centre of the 
sphere is still saturated, and does not decrease. So geometrical factors at the surface cause a decrease in the 
threshold.  
 
As the radius of the sphere reduces further, the centre of the sphere becomes unsaturated and the imaged intensity at 
the centre of the sphere begins to drop. This increases the ratio of the threshold. 
 
For very small spheres, when the diameter is comparable to the FWHM, the whole volume of the sphere can 
contribute to the intensity at both the surface and the center of the sphere, and the threshold rises above 0.5 in 
consequence. 
 
The model predicts that the threshold rises to 1 for a sphere size with a radius one fiftieth of the FWHM, but in 
practice the quantized nature of the image means that at this point the surface and the center of the sphere can all be 
contained within one voxel.  
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Fig. 2.5.2-4 Threshold Ratio 
This figure is a log-linear plot of the threshold 
ratio against the ratio of the radius of the sphere 
to the full width at half maximum spatial 
resolution of the imaging process. The 
relationship is derived from the assumption that 
the imaging process is a Gaussian blurring. 
 
 
 
2.5.3 Minimum threshold 
It is clear from figure 2.5.2-4 that there is a minimum value of the threshold ratio, we now determine what this is 
numerically. 
From equation 2.5.2-1, it is clear that the minimum threshold value will be given by 
0=
ds
dλ
        Equation 2.5.3-1 
where the variable s is given by ⎟⎠
⎞⎜⎝
⎛=
w
Rs  
The value of the minimum can be found numerically to be 0.3760 at 1612.1=⎟⎠
⎞⎜⎝
⎛=
w
Rs  
This means that this model cannot predict a threshold value below 0.3760, regardless of the size of the sphere or the 
FWHM of the imaging process. 
2.5.4 Fitting to Erdi’s data. 
The predictions of equation 2.5.2-1 can be compared with the results of Erdi8, with the FWHM treated as an 
optimized parameter. Table 2.5.4-1 shows the data that Erdi graphed in figure 1 of the 1997 paper. 
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Table 2.5.4-1 Modelling of Erdi threshold data 
Volume 
(mL) 
Radius (cm) Erdi experimental 
threshold 2007 
(pure number) 
FWHM 
0.1146 cm 
FWHM 
0.5 cm 
FWHM 
0.9406 cm 
Erdi Exponential 
Parameter 
Fit 
0.4 0.457 0.60 0.46 0.39 0.607 0.54 
1.5 0.710 0.44 0.47 0.38 0.436 0.49 
2.0 0.782 0.42 0.48 0.39 0.412 0.47 
4.0 0.985 0.38 0.48 0.41 0.379 0.39 
5.5 1.095 0.38 0.48 0.42 0.376 0.34 
Sum square error 
 
0.04 0.05 0.0002 0.01 
Table 2.5.4-1 
This table shows the variation of threshold ratio with sphere volume determined experimentally by Erdi8 in 1997 in 
column three. The next three columns show the predictions from the idealized model (Equation 2.5.2-1) for different 
values of the FWHM. The last column show the thresholds predicted by Erdi’s exponential curve parameter match 
from 1997. 
If the FWHM is taken to be a parameter in a fit of the equation for λ  (Equation 2.5.2-1) graphed in figure 2.5.2-3 to 
the measured threshold ratios in table 2.5.4-1, it is found that the optimal match is for a FWHM of 0.9406 cm.  This 
optimization needs to be detailed, since there is a competing local minimum at FWHM of 0.1146 cm. Figure 2.5.5-1 
shows the variation of residuals with FWHM. Since the fminsearch function of MATLAB implements the simplex 
search method62 which may only find local minima, the global minimum was found by a brute force method of 
determining the sum of the square of the residuals for each FWHM in steps of 0.0001 cm. The two minima of this 
linear search are used to calculate the threshold values in column 4 and 6 of table 2.5.4-1, headed “FWHM 0.1146 
cm” and “FWHM 0.9406 cm”. These curves are graphed in Figure 2.5.7-1 and 2.5.7-2 as the lines indicated as 
“FWHM=0.9406 cm” and “FWHM=0.1146 cm” in the legend. 
2.5.5 Calculation of residuals 
A sum square error is listed in table 2.5.4-1 at the bottom of columns 4-7. For each of the five volumes, the 
difference between the threshold ratio predicted by the model (as shown in the table) and the experimentally 
determined threshold ratio (as shown in column three of table 2.5.4-1) is calculated. Then each difference is squared 
and all five squares are summed to get the sum square error. 
 
To put this mathematically, if we take the case of the FWHM=0.1146 cm data. The calculated thresholds are  
{ }48.048.048.047.046.0 54321 ====== CCCCcCi λλλλλλ   
While the experimentally determined thresholds are 
{ }38.038.042.044.060.0 54321 ====== EEEEEEi λλλλλλ  
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And the sum square error is then given by 
( )25
1
∑
=
−=
i
EiCisse λλ         Equation 2.5.5-1 
The sum square error variation with FWHM is graphed in Figure 2.5.5-1 to show the presence of two local minima. 
 
Fig. 2.5.5-1 Variation of residual from fit to 
Erdi data. There are two local minima in the fit 
of the ideal model to Erdi’s experimental data, 
this figure shows the brute force determination 
of the global minimum. 
 
 
 
 
2.5.6 Spatial resolution estimates 
Also, Erdi’s experimental results are from a particular PET scanner (GE Advance, GE Medical Systems, Milwaukee, 
WI), the spatial resolution of which has been characterized by Delgado et. al66, as follows: 
 
“Transaxial resolution (FWHM) is 3.8 mm at the center and increases to 5.0 mm tangential and 7.3 mm radial at R = 
20 cm. Average axial resolution decreases from 4.0 mm FWHM at the center to 6.6 mm at R = 20 cm. Scatter 
fraction is 9.4% and 10.2% for direct and cross slices, respectively. With septa out, the average scatter fraction is 
34%. Total system sensitivity for true events (in kcps/(µCi/cc)) is 223 with septa in and 1200 with septa out. Dead-
time losses of 50% correspond to a radioactivity concentration of 4.9 (0.81) µCi/cc and a true event count rate of 489 
(480) kcps with septa in (out). Noise-equivalent count rate (NECR) for the system as a whole shows a maximum of 
261 (159) kcps at a radioactivity concentration of 4.1 (0.65) µCi/cc with septa in (out). NECR is insensitive to 
changes in lower gamma-energy discrimination between 250–350 keV.” 
 
So we will use a nominal 5 mm spatial resolution as a realistic estimate. 9.4 mm FWHM is beyond the realms of 
possibility. The thresholds calculated by equation 2.5.2-1 are shown in column 5 of table 2.5.4-1, under the heading 
“FWHM 0.5 cm” and are graphed in fig 2.5.7-1 and 2.5.7-2 as the line indicated in the legend as “FWHM=0.5cm”.  
2.5.7 Exponential parameterization of threshold ratio. 
Erdi fitted the function in equation 2.5.7-1 in the original paper as a parametric fit to the data,  
( )( )mLVolumeCATHRESHOLD .exp.% −=     Equation 2.5.7-1 
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this will be modified slightly so that the fit is to the actual ratio, rather than a percentage, as expressed in equation 
2.5.7-2. 
( )( )mLVolumeCAMATCHERDI .exp. −=−λ     Equation 2.5.7-2 
And when the two parameters are optimized to fit the data, the result is equation 2.5.7-3.  
⎟⎠
⎞⎜⎝
⎛−=− 33
4.0905.0exp.5577.0 RMATCHERDI πλ     Equation 2.5.7-3 
Where A=0.5577, C=0.0905 mL-1 
The thresholds predicted by Erdi’s exponential model (equation 2.5.7-3) are displayed in column 7 of table 2.5.4-1, 
under the heading “Erdi Exponential Parameter Fit” and graphed in Figure 2.5.7-1 and 2.5.7-2 as the line indicated in 
the legend as “A=0.5577 C=0.0905”. 
 
 
Fig. 2.5.7-1 Modelling 
of Erdi Threshold 
Ratios 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.7-1 shows the modelling of the sphere threshold ratio when the background is zero. The blue asterisks are 
Erdi’s measured data for this case – the y values of the discrete points are the values tabulated in column two of table 
2.5.4-1. The green line is obtained from a parameter match of the FWHM to the data with equation 2.5.2-1.  The 
match is very good, with a sum of the square of residual error of 0.0002 . This fits better than the exponential 
function used by Erdi. Unfortunately a FWHM of 9.4 mm is greater than any measured in the literature. A more 
realistic FWHM of 5 mm is shown by the light blue line, but does not match nearly as well as Erdi’s exponential fit 
or the optimized FWHM of 9.4 mm. The red line shows the curve predicted by the model if the FWHM is specified 
as 0.1146 cm, a local minimum. Although the curve is almost constant throughout the region of the experimental 
results, and in fact increases slightly with radius where the experimental points decrease with radius, it does explain 
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graphically how the local minimum arises because the value is near to the average experimental threshold. If the 
FWHM is increased or decreased, the model prediction will move away from the average threshold so the summed 
squared error will increase, hence the local minimum. 
 
 
Fig. 2.5.7-2 Modelling of Erdi 
Threshold Ratios with logarithmic x 
axis. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.7-2 shows the same data as figure 2.5.7-1, but with a logarithmic x axis. This is sufficient to ensure that if 
any change in the FWHM parameter of the model is made, the model will retain the same shape of curve, but shifted 
to the right or left. This again demonstrates how the local minimum at FWHM 0.9406 cm exists. 
 
We have reproduced the shape of Erdi’s results, but not the actual values. The only parameter of the model is the full 
width at half maximum, the spatial resolution. Changing the FWHM is like multiplying the variable s by a constant. 
Because we have a logarithmic scale, this will only move the curve in the figure to the left or right, it will not change 
the shape of the curve. This can clearly by comparing the three “FWHM” curves. Although a superior fit to the data 
has been achieved with FWHM as a parameter, the value obtained for the optimal FWHM is outside what could 
reasonably be expected. 
2.5.8 Possible reasons that the model does not fit. 
The parameter match is so good, and the best fit FWHM is approximately twice the expected FWHM, that it must be 
explicitly considered whether the model has been cast in terms of the half width at half maximum in error, or if the 
figures for spatial resolution quoted in the literature actually refer to half width at half maximum error, not FWHM. 
The first possibility can be dismissed simply by reviewing equation 2.5-4, which is very definitely cast in terms of 
FWHM. The second possibility is discounted by a careful reading from Delgado et al.66 
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Another possibility is that the PET scanner in use, for reasons not known to us, was not performing to specification, 
and so had a much worse spatial resolution. However as mentioned in section 2.2.1, there have been many 
independent verifications of Erdi’s method without any such discrepancies being noted. 
 
Another possibility is a digital fault; that it was possible that somewhere in the display chain that the pixel data had 
been aggregated, so that one pixel represented the average of four others. This would have doubled the effective 
spatial resolution. This possibility is also discounted by the multiple independent verifications of section 2.2.1. 
 
Another possibility is detector saturation, but the concentration of 2-3μCi/mL that Erdi reported is below the 50% 
deadtime threshold of 4.9μCi/mL for 2D mode with the septa in position. With the septa retracted, in 3D mode 50% 
deadtime occurs at 0.81 μCi/mL. Erdi did not explicitly report whether the data are acquired in 3D or 2D mode. It is 
expected that deadtime corrections will in any case not significantly perturb the image in 2D mode63 . In 3D mode an 
approximation to evaluate the corrections required is given by Badawi and Marsden64, high frequency artifacts can 
perturb the image, but it is unlikely they would perturb it to such an extent, and there remains as before the multiple 
independent repeats of the method to account for. 
2.5.9 Image voxel size. 
Another possibility is that for smaller volume spheres, the discrete voxelization of the image confounds the 
continuous variable assumption. This would explain the bad match for smaller spheres but not for larger ones. We 
will review this possibility in section 2.6.3. 
 
Having eliminated the obvious causes of the quantitative discrepancies resulting from the idealized model, we must 
look elsewhere to find a missing factor that can be incorporated into an enhanced model to obtain a quantitative, 
predictive model. Unfortunately it is not immediately obvious, from the data we have, what that enhancement should 
be. The best way to demonstrate what is missing with the model turns out to be to use the idealized model to predict 
the image pixel values at all points within and without the sphere, rather than just at the centre and the surface. Since 
in the idealized model perfect spheres create images with spherical symmetry, the image values depend only on the 
distance from the centre of the sphere. The relationship between the image values and the distance from the centre of 
the sphere predicted by the idealized model is thus termed the “radial equation”. The original motivation for 
determining the radial equation was as a stepping stone to evaluating the effect of image voxel size on the threshold. 
2.6 Deriving the radial equation. 
To begin to see why the model does not fit, why the model is inadequate, we begin by calculating the image value at 
a point P, located at a distance r from the centre of the sphere. P may be outside or inside the sphere. 
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and in a manner analogous to that for equation 2.5.2-13, we come to 
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Again substituting as before for equation 2.5.2-15 
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So 
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Recalling again equation 2.5-5 
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So now we see that ( )0,0,rI  is a function of ⎟⎠
⎞⎜⎝
⎛
w
R
 and ⎟⎠
⎞⎜⎝
⎛
w
r
 . We term this relationship the radial equation. We 
can graph this for specified sphere radius R  and FWHM w  as r changes from zero to any limit within or outside 
the sphere. 
2.6.1 The radial equation at the centre and periphery of a sphere. 
Since the value that the radial equation must take at the surface (equation 2.5.2-21) and the centre (equation 2.5.2-9) 
of a sphere has already been derived, the radial equation should reduce to the same expression when evaluated at 
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these two points. To do this, the limit of the radial equation is taken at the surface and the centre of the sphere as 
follows.  
In the limit Rr →  the radial equation becomes: 
( )
( )
( )
( )
( ) ( )
⎟⎟
⎟
⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−=→ ⎟⎠
⎞⎜⎝
⎛ +−⎟⎠
⎞⎜⎝
⎛ −−
⎟⎠
⎞⎜⎝
⎛ −
⎟⎠
⎞⎜⎝
⎛ −−
−∫
2
2 2log4
2
2log4
0
2log8
2log8
2
0 2log42
10,0, w
rR
w
rR
e
w
rR
w
rR
t ee
e
e
ee
r
wCdteCRrI ππ  
        Equation 2.6.1-1 
( )
( ) ( )
( ) ( )
⎟⎟
⎟
⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛−=→ ⎟⎠
⎞⎜⎝
⎛ +−⎟⎠
⎞⎜⎝
⎛ −−
−
−∫
2
2 2log4
2
2log4
0
0
2log32
2
0 2log42
10,0, w
RR
w
RR
e
w
R
t ee
e
ee
R
wCdteCRrI ππ  
         Equation 2.6.1-2 
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         Equation 2.6.1-4 
And equation 2.6.1-4 is identical to equation 2.5.2-20. 
Note however that the limit 0→r  of the radial equation is much more difficult 
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The first term is straight forward 
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But the second term is more difficult, so we must evaluate 
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At which point we can apply L’Hospital’s Rule65, that the limit of a fraction where the numerator and denominator 
both tend to zero is given by the limit of the derivative of the numerator over the derivative of the deniminator  
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so 
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         Equation 2.6.1-13 
And equation 2.6.1-13 is identical to equation 2.5.2-9. 
So the radial equation fits the points at the centre of the sphere and at the surface of the sphere, as expected. 
2.6.2 Relative radial equation. 
If we divide through by the intensity at the centre of the sphere, we obtain the relative radial function, normalized to 
unity at the centre of the sphere, an example of which is graphed in Figure 2.6.2-1. 
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Fig. 2.6.2-1 The relative radial function, 
drawn in this case for a radius of 1 cm 
and a FWHM of 1 cm. 
 
 
 
 
 
 
2.6.3 Image voxelisation.  
The radial equation can be used to estimate the effect of image voxelisation on the image value at the centre of the 
sphere. On the assumption that the voxel value is the average of the continuous function over the volume of a voxel, 
we can state 
 ( ) ( )dxdydzrIzcycxcI Z
Z
Y
Y
X
X
pixel ∫ ∫ ∫
− −
=
2/
2/
2/
2/
2/
2/
,,       Equation 2.6.3-1 
where 
( ) ( ) ( )222 zczycyxcxr −+−+−=        Equation 2.6.3-2 
and xc,yc,zc is the coordinates of the true centre of the sphere relative to the centre of the voxel. The point (xc,yc,zc) 
could be anywhere within the voxel, but the minimum value of Ipixel is when xc=X/2, yc=Y/2, zc=Z/2;  in that 
circumstance the centre of the sphere is located at a vertex of the voxel, and in the ideal model the centre of the 
sphere would compose 8 voxels with equal image value. 
 
The maximum value of Ipixel is when xc=0, yc=0, zc=0 (The centre of the sphere is located at the centre of the voxel.) 
 
This integral cannot be done analytically, so a numeric integration is resorted to. The voxel size is taken as 4 mm (x) 
by 4 mm (y) by 4.25 mm (z). To find the minimum value of Ipixel, equation 2.6-13 is averaged over a three 
dimensional rectangular grid that breaks each axis into 100 separate evenly spaced gradations that exactly fit within a 
voxel. To find the maximum value of Ipixel, equation 2.6-13 is averaged over a three dimensional rectangular grid 
that breaks each axis of the positive octant of the voxel into 100 separate evenly spaced gradations. The grid thus has 
twice the linear density of that used to calculate the minimum, the average over the positive octant is by symmetry 
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the average over the whole voxel. In both cases, the resultant average must be divided through by the value at the 
centre of the sphere, obtained by evaluating equation 2.5.2-9, to get the average of the relative radial function.  
 
Table 2.6.3-1 Modelling of Erdi threshold data including voxelisation 
Volume (mL) Radius (cm) Threshold FWHM 0.65 
cm 
FWHM 0.65 
cm TOP 
FWHM 0.65 
cm 
BOT 
Error 
0.4 0.457 0.60 0.458 0.818 0.532  
1.5 0.710 0.44 0.377 0.484 0.398  
2.0 0.782 0.42 0.376 0.450 0.390  
4.0 0.985 0.38 0.390 0.393 0.411 0.013 
5.5 1.095 0.38 0.400 0.401 0.409 0.021 
 
Table 2.6.3-2 Modelling of Erdi threshold data including voxelisation 
Volume (mL) Radius (cm) Threshold FWHM 0.50 
cm 
FWHM 0.50 
cm TOP 
FWHM 0.50 
cm 
BOT 
Error 
0.4 0.457 0.60 0.462 0.462 0.769  
1.5 0.710 0.44 0.394 0.394 0.458  
2.0 0.782 0.42 0.398 0.398 0.435  
4.0 0.985 0.38 0.414 0.414 0.420 0.034 
5.5 1.095 0.38 0.423 0.423 0.424 0.043 
 
The results of this calculation are shown in tables 2.6.3-1 and 2.6.3-2, for FWHM of 0.65 and 0.5 cm respectively. 
For the realistic FWHM value of 0.5 cm, the only mismatch is for the larger volume spheres. If we allow the FWHM 
to be as large as 0.65 cm, there is an effective match. The range of thresholds given is perhaps too large for the 
smaller spheres. If we were interested in a distribution, it would tend strongly towards the average. The extreme 
values can only be reached by a point at the centre or a point at the vertex. There would be a large volume associated 
with the middle, and this would tend to mean that the 2 sigma limit would be closer. Additionally, for the smallest 
spheres, the finite voxel size impacts on the value at the periphery as well as that at the centre, and the two effects 
may be coupled. This is a good candidate for a monte carlo evaluation, and we will return to this question later in 
section 2.9, but now that we have the relative radial equation, we are in a position to consider the results obtained by 
Black et al.36 
2.7 Blacks equation. 
Black’s method relies on a threshold which is the ratio of the periphery image value to the average image value over 
the volume. Using the radial equation, we can determine the average over the volume and thus determine the 
relationship analytically. 
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2.7.1 Integrating the radial equation. 
Since the image value at the periphery of the sphere is already known (Equation 2.5.2-23), only the average image 
value over the volume of the sphere, ( )RI , must be found to determine Black’s threshold. To find it, the radial 
equation (Equation 2.6-13) is integrated over the volume of the sphere. 
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where ( )0,0,rI ′  is given by the radial equation (Equation 2.6-13). So 
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Considering first term4…  
Substituting rRu −= ; ( )uRr −= ; dudr −= ; Rur =→= 0 ; 0=→= uRr  gives equation 2.7.1-3; 
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Equation 2.7.1-3 
Considering secondly term3… 
Substituting rRu += ; ( )Rur −= ; dudr = ; Rur =→= 0 ; RuRr 2=→=  gives equation 2.7.1-4; 
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Equation 2.7.1-4 
Combining the first two terms gives equation 2.7.1-5 
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        Equation 2.7.1-5 
Then we must evaluate the two terms 
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Equation 2.7.1-6 
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         Equation 2.7.1-7 
So putting the terms 5 and 6 together gives and substituting back into equation 2.7.1-5, gives equation 2.7.1-8 
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Going back to the very first two terms, for term1, substitute ( ) ⎟⎠
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Which can be evaluated using the identity given by equation 2.7.1-10 
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Which can be evaluated using the identity given by equation 2.7.1-12 
( ) ( ) ( ) ( ) ( ) ( )⎟⎠⎞⎜⎝⎛ ++−+−++−=−− ++−∫ 122326 1 22332
22
xxaaxaerfxaaeedxxaerfx xaxa ππ  
        Equation 2.7.1-12 
So that term1 and term2 sum to give 
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Equation 2.7.1-13 
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So equation 2.7.1-2 can be rewritten as equation 2.7.1-14 
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         Equation 2.7.1-14 
where ( ) ⎟⎠
⎞⎜⎝
⎛=
w
Ra e 2log2  
Computationally, this is difficult to evaluate, as for larger values of R and smaller values of w within the clinical 
range, 
24ae−  can effectively go to zero, and 
24ae  goes to infinity. 
So we rewrite equation 2.7.1-14 as equation 2.7.1-15 
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         Equation 2.7.1-15 
To determine the average of the image value over the volume of the sphere, it is necessary to divide ( )RI  by the 
volume of the sphere, which gives us equation 2.7.1-16.  
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        Equation 2.7.1-16 
Equation 2.7.1-16 is a function only of the ratio 
w
R
, and enables the determination of an expression for Black’s 
threshold ratio solely as a function of the ratio 
w
R
. 
2.7.2 Black’s threshold 
Black’s threshold is then 
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( ) ( ) ( )( ) 33
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RIRI
sphere
BLACK πλ =⎪⎭
⎪⎬
⎫
⎪⎩
⎪⎨
⎧÷=     Equation 2.7.2-1 
As ( )0,0,RI is a function only of the ratio 
w
R
, and we know from equation 2.7.1-16 that 
( )
sphereV
RI
 is also a function 
only of the ratio 
w
R
, then we know that Black’s threshold is a function only of the ratio 
w
R
.  In figure 2.7.2-1, 
equations 2.7.1-16 and 2.5.2-23 have been used to determine the curve showing the relationship between the 
threshold SUV and the average SUV. The threshold SUV and average SUV are in this model both only determined 
up to the same arbitrary constant, which will arbitrarily change the scale of the x and y axes by the same factor, but 
will not change the shape of the curve. The global shape of the curve is also independent of the FWHM of the PET 
scanner, in this model the FWHM of the scanner simply changes the point on the curve to which a particular volume 
of sphere corresponds. Black’s volume experiment used sphere volumes ranging in volume from 12.2 to 291.0 cc, 
and the domain to which these volumes apply for three different FWHM values is indicated in Fig 2.7.2-1 by straight 
lines drawn below and parallel to the global curve. 
 
Fig. 2.7.2-1 Threshold SUV vs Mean SUV. 
In figure 2.7.2-1 the global curve shows the predicted variation of threshold SUV against mean SUV for the full 
range of sphere volumes from zero to infinity. The gradient of the curve is 1 at zero volume, when the mean and 
threshold SUV are both close to zero, regardless of the FWHM. This makes sense even in a pixelised image, when 
the volume is small enough, it occupies only one voxel, in which case the threshold SUV and the mean SUV are the 
same. Both increase by the same amount, hence the gradient is unity. For volumes close to infinity, the threshold 
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SUV is one half of the mean SUV, and the gradient of the curve is 1/3, again regardless of the FWHM. In fact this 
curve has the same shape regardless of the value of the FWHM of the PET scanner. For a finite range of volumes, 
the FWHM just governs the segment of the global curve that is pertinent. For reasonable estimates of the FWHM, 
and clinically relevant volumes, the gradient of the curve should be approaching 0.333 from above. As we see in 
table 2.7.2-1, there is very little variation of the local gradient of the global curve with FWHM. The three straight 
lines parallel to and below the global curve designated in the legend by FWHMs of 0.4 cm, 0.5 cm and 0.65 cm show 
the domain of the curve that applies to spheres of volumes 12.2 cc to 129.0 cc. 
 
Experimentally, Black reported the linear relationship between mean SUV and threshold SUV given by equation 
2.7.2-2. 
UVThresholdSMeanSUV =+× 588.0307.0     Equation 2.7.2-2 
The reason that the linear relationship does not pass through the origin is apparent from the shape of the global curve 
in figure 2.7.2-1 and the part of the curve which corresponds to the volumes of the spheres used in the experiment. 
The gradient of the curve is 1 for the smallest volume spheres, and this makes sense for a voxelised image even 
though the voxelisation is not modelled in determining equation 2.7.2-1. For very small spheres, since the smallest 
spheres will be within a voxel, the threshold SUV and the average SUV are identical, so the gradient is unity.  
The spatial resolution of the PET scanner66 has already been noted in section 2.5.6, and values of 0.4-0.65 cm are 
reasonable values for a single FWHM parameter. For spheres in the clinical range of interest, for the expected range 
of FWHM values, the curve is effectively linear and has a gradient approaching 0.333 from above. For this reason, 
the linear relationship does not pass through the origin. 
Black’s linear relationship is obtained using SUV values that are obtained by multiplying the PET voxel values by an 
undocumented global constant. This global constant makes the y axis intercept of the linear relationship an arbitrary 
positive value, but it leaves the gradient of the linear relationship unchanged, so we can compare the gradient value 
of 0.307 found by Black with the values predicted by equation 2.7.2-1. Table 2.7.2-1 gives these values.   
Table 2.7.2-1 Gradient values predicted by equation 2.7.2-1 
FWHM Gradient Constant Sum square error 
4.0 mm 0.336 0.335 0.035 
5.0 mm 0.337 0.350 0.035 
6.0 mm 0.339 0.339 0.036 
6.5 mm 0.340 0.334 0.036 
7 mm 0.341 0.328 0.036 
8 mm 0.343 0.318 0.037 
9 mm 0.346 0.302 0.038 
10 mm 0.349 0.289 0.038 
Black’s fit 0.307 0.588 0.066 
So we can show that if the imaging process is merely a Gaussian convolution process, then the mean pixel value over 
the sphere is related to the threshold value over the range of clinical values, and the gradient is 0.336-0.342 over the 
range of volumes observed clinically. Experimentally Black observed 0.307. Black’s fit was to data that included 
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results from varying FDG concentration for the same volume, as well as an experiment that varied the volume. The 
six data points associated with the volume experiment have been isolated and graphed in Figure 2.7.2-2. 
 
Fig. 2.7.2-2 Fits to Black’s Data 
Black’s experimental data 
comparing the mean SUV to the 
Threshold SUV is shown as green 
crosses. Black’s fit to the whole 
experimental data set, which 
includes results obtained on 
different days with different 
concentrations, is shown as the red 
line. Fitting a line with a gradient of 
0.34 to this data produces a better 
fit. 
2.7.3 Calculation of residuals 
A sum square error is listed in table 2.7.2-1 in the right hand column. For each of the six sphere volumes, the 
difference between the threshold ratio predicted by the model with the specified FWHM or for the last row by 
Black’s linear fit and the experimentally determined threshold values determined experimentally by Black is 
calculated. Then each difference is squared and all six squares are summed to get the sum square error. For the 
different FWHM values the values of the constant is determined by optimizing it to minimize the sum square error, 
while the gradient is calculated theoretically from the FWHM. The sum square errors for the all of the FWHM values 
are smaller than for the fit by Black. 
2.7.4 Reasons for gradient discrepancy with Blacks equation. 
There are a number of possible reasons for the discrepancy of approximately 10 % in the gradient predicted 
theoretically and the experimentally determined gradient of 0.307 determined by Black. 
1. The major cause is expected to be experimental error. 
2. Additionally, the concentration is close to the 50% dead-time for a 3D study66, the paper does not specify 
whether the scepta are in (2D mode) or out (3D mode). 
3. The spheres have a 1 mm thick shell, in which there is no background activity. This tends to reduce the 
signal at the periphery of the sphere more than it affects the average over the sphere. So in the experiment a 
lower threshold is measured, resulting in a lower gradient. 
4. Black relies on the ADAC Pinnacle (ADAC Laboratories, Milpitas, CA) segmentation algorithm to 
calculate the volume. The ADAC Pinnacle volume calculation uses a summation of voxels, with boundary 
voxels off weighted to 50%67. In the radiotherapy scenario, applied to CT contours with smaller voxels than 
PET voxels, the ADAC volume algorithm has been shown to calculate a volume always smaller than a 
geometric method.68  
Figure 2.7.2-2 Fits to Black's Data
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5. The walls of the volume are glass. The range of FDG positrons are around 1 mm in tissue, but less in glass. 
6. Effect of voxelisation at smaller volumes. This not such a problem because voxelisation puts an average in 
each voxel, so the average intensity will not be affected. The threshold is not greatly affected because the 
relationship near the periphery is nearly linear.  
7. The mean SUV and the average SUV may simply have been renormalized differently. 
8. The model is incomplete. For example, the measurements of variable volume had a background 
concentration of 0.144 μCi/cc, as opposed to the concentration within the spheres of 1.87 μCi/cc. The model 
(and Black) predict that this will not change the gradient, but there may be second order effects not 
considered by the model. 
2.7.5 Background effect on the gradient value in Blacks model 
In this model it is expected that background has no effect on the gradient, and Black also claims this to hold. This 
section seeks to explain why, in terms of the model, the background is not expected to effect the gradient. 
 
If the background concentration is 0.144 μCi/cc and the sphere concentration is 1.87 μCi/cc. Then the concentration 
distribution can be considered as two imaginary spatially intersecting compartments, one sphere compartment 
holding 1.87-0.144=1.726 μCi/cc concentration, and one universal background concentration of 0.144 μCi/cc that is 
uniformly present everywhere, including within the sphere. The universal background of 0.144 μCi/cc, when imaged, 
will produce a uniform signal everywhere. No matter what the spatial resolution, there will be as much background 
signal scattered out of a voxel as scattered into it. The effect of the sphere compartment will be the same as 
calculated, except diminished in weight by the ratio 1.726/1.87. 
 
The mean SUV will thus map to the value of (mean SUV) x 1.726/1.87+0.144 in the presence of background. The 
threshold SUV will thus also map to (threshold SUV) x 1.726/1.87+0.144 in the presence of background. So there 
will be an identical linear transformation to both axes, which can change the y intercept but not the gradient. The 
primary assumption is that the two compartments will add in the imaging process, but any deviation from this is most 
likely to be a second order effect. 
2.7.6 Limitation of Blacks method 
Black’s method of segmenting requires only two parameters, regardless of the level of background, whereas Erdi’s 
threshold method requires two parameters for every background level, which would appear to make Black’s method 
the better choice. The limitation of Black’s method is that it depends upon the volume being spherical in shape, since 
the ratio of the threshold to the average of the volume depends on the shape. So Black’s method cannot be 
generalized to non spherical shapes. This can be demonstrated by considering a spherical shell69. Although this is 
computationally convenient, since we have a model for the radial distribution and the spherical shell has radial 
symmetry, it is not without clinical relevance, since lung volume lesions can have quite lobular shapes that are better 
approximated by a spherical shell than a sphere, as seen in figure 2.7.6-1 below. There is also the known metabolic 
quiescence of tumour cells in the centre of a large tumour, which effectively gives rise to a spherical shell tumour in 
function if not in form. We proceed in the next section to determine the thresholds for the inner and outer surface of a 
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spherical shell tumour, based only on the assumption that the imaging process can be modeled as a Gaussian 
blurring. 
Fig. 2.7.6-1 Some 
tumours do have 
shapes that 
approximate a 
spherical shell. 
 
 
 
Figure 2.7.6-1 shows a lung tumour imaged with FDG on a stand alone PET camera (left) next to a co-registered CT 
scan of the same slice, taken from the author’s own early work with functional imaging. Lung tumours can appear 
quite irregular and lobular when imaged, and there are some lung tumours for which a spherical shell is a reasonable 
conceptual model of the overall shape. 
2.7.7 Thresholds for a spherical shell tumour. 
The spheroidal shell tumour (or spherical toroid or spherical doughnut) has a radial distribution given by the radial 
function of the solid sphere (calculated with the centre filled), minus the radial function of an inner sphere 
(calculated with the centre filled but the spherical shell empty). We can find the threshold from this function. In fact 
there will be two thresholds, an inner and an outer. (We will choose the inner and outer radii to make the thresholds 
equal, if possible). To calculate the average threshold over the volume, we want the integral of the radial function 
from the inner radius to the outer radius.  
Given inner radius R1 and outer radius R2, the radial function is then 
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The value of the radial function at the inner radius R1 is then 
( )
⎭⎬
⎫
⎩⎨
⎧
⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛ −−−⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛ −=
w
RRerf
w
RRerfCwRRI eeI 1212021 2log22log22
,,  
Chapter 2: Segmenting tumours from functional imaging 
 92
⎭⎬
⎫
⎩⎨
⎧
⎟⎟⎠
⎞⎜⎜⎝
⎛ ⎟⎠
⎞⎜⎝
⎛ −+
w
RerfC e 10
22log2
2
 
( ) ( )
⎟⎟
⎟
⎠
⎞
⎜⎜
⎜
⎝
⎛
−⎟⎠
⎞⎜⎝
⎛− ⎟⎠
⎞⎜⎝
⎛ +−⎟⎠
⎞⎜⎝
⎛ −−−
2
1212 2log4
2
2log41
10
2log4
w
RR
w
RR
e
ee
ee
w
RC
π  
( )
⎟⎟⎠
⎞
⎜⎜⎝
⎛
−⎟⎠
⎞⎜⎝
⎛+ ⎟⎠
⎞⎜⎝
⎛−−
2
12log161
10 1
2log4
w
R
e
e
e
w
RC
π     Equation 2.7.7-2 
The value of the radial function at the outer radius is then 
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And the integrated value over the volume is then 
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Breaking the spheroidal toroid radial function up into additive parts, we write 
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Using the identity given by equation 2.7.7-10, 
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gives the solution for the first term, equation 2.7.7-11. 
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Now considering  the second term 
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Using the identity given by equation 2.7.7-14 
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allows solution of the second term, equation 2.7.7-15. 
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Considering the third term 
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Using the identity given by equation 2.7.7-17 
( ) ( ) ( ) ( ) ( ) ( )( )12232
6
1 2
1
2
1
2
1
3
1
3
11
2 1
22
1
22
1 +++−−+−−=− ++−∫ xxaaexaerfxaaeedxxaerfx xaxaxa ππ
         Equation 2.7.7-18 
gives the solution for the third term, equation 2.7.7-19. 
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Considering the fourth term 
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Using the identity of equation 2.7.7-22 
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gives the solution for the fifth term, equation 2.7.7-23 
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Considering the fifth term 
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         Equation 2.7.7-27 
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         Equation 2.7.7-28 
Which allows us to write the solution for the fifth term as equation 2.7.7-29 
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        Equation 2.7.7-29 
Considering term 6 
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         Equation 2.7.7-30 
Substituting rRu ′+= 2 ; ( )2Rur −=′ ; durd =′ ; 121 RRuRr +=→=′ ; 22 2RuRr =→=′  gives 
equation 2.7.7-31; 
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         Equation 2.7.7-31 
Then substituting ( ) 22log4 ⎟⎠
⎞⎜⎝
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Gives the first component of term 6 as equation 2.7.7-32 
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         Equation 2.7.7-32 
Substituting into the second component of term 6 ( ) ⎟⎠
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gives equation 2.7.7-33; 
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         Equation 2.7.7-33 
So summing the two components gives term 6 as equation 2.7.7-34. 
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         Equation 2.7.7-34 
Considering term 7 
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         Equation 2.7.7-35 
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Substituting rRu ′−= 1 ; ( )uRr −=′ 1 ; durd −=′ ; 01 =→=′ uRr ; 212 RRuRr −=→=′  gives 
equation 2.7.7-36; 
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         Equation 2.7.7-36 
Substituting into the first component of term 7 ( ) ⎟⎠
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         Equation 2.7.7-37 
Substituting into the second component of term 7 ( ) 22log4 ⎟⎠
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         Equation 2.7.7-38 
Then combining the two components gives term 7 as equation 2.7.7-39. 
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Considering term 8 
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         Equation 2.7.7-40 
Substituting rRu ′+= 1 ; ( )1Rur −=′ ; durd =′ ; 11 2RuRr =→=′ ; 212 RRuRr +=→=′ gives 
equation 2.7.7-41 
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Substituting into the first component of term 8 ( ) 22log4 ⎟⎠
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         Equation 2.7.7-42 
Substituting into the second component of term 8 ( ) ⎟⎠
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        Equation 2.7.7-43 
Which allows us to write term 8 as equation 2.7.7-44. 
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 Equation 2.7.7-44 
Finally adding up all terms gives the integrated value over the sphere as equation 2.7.7-45. 
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         Equation 2.7.7-45 
To obtain the average value of the volume requires division by the volume, and this relationship has been graphed in 
figure 2.7.7-1. 
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Fig. 2.7.7-1 
Average value 
over volume of 
spherical shell. 
 
 
 
 
 
 
 
 
 
 
 
Note that for small inner radii, the average over the volume is insensitive to changes in the small inner radius. As the 
inner radius gets larger, the average appears to be invariant when the outer radius equals the inner radius plus a 
constant. The volume changes considerably over this range. So from a spheroidal shell with R1=0.779, R2=2.0, 
av=0.8, V=31.5 cc to a spheroidal shell with R1=4.892, R2=6, av=0.8, V=414 cc; the volume changes more than 10 
fold but the average does not change at all. We can plot the inner threshold and the outer threshold for these spherical 
shells where the average over the volume stays constant, this shows how much variation in the y axis can be 
expected for the single value of mean SUV of 0.8 in Fig 2.7.8-1.  
2.7.8 Results of applying Black’s threshold to a spherical shell 
Black’s threshold model requires that the ratio of the threshold SUV to the average SUV over the volume be a 
constant. Using equation 2.7.7-45, we can estimate the error caused by applying Black’s ratio method to a spherical 
shell. Given a spherical shell that has an average of 0.8, for a scanner with a FWHM of 6.5 mm, the volume can vary 
significantly from a minimum of 18.4 cc for a solid spherical tumour with a zero internal radius. How does the 
interior threshold compare to the internal threshold as volume changes? How does the volume segmented by Black’s 
method compare to the actual volume of a spherical shell? What is the distance between the surfaces detected by the 
Black threshold and the actual surface of the spherical shell? 
 
Figure 2.7.8-1 shows the interior and exterior thresholds as a function of the volume of a spherical shell with a 
volume average of 0.8, for a scanner with a FWHM of 0.65 cm. For a solid spherical tumour, this would correspond 
to a volume of 18.4 cc, radius 1.6 cm, approximately the same volume as the smallest volume sphere used 
experimentally by Black. The inner threshold around a small cavity is high, as the inner cavity increases in radius, 
the inner threshold decreases. The outer threshold increases with volume.  
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Fig. 2.7.8-1 The 
inner threshold is 
very high for a 
small cavity in the 
middle of a 
spherical shell, 
effectively dropping 
from nearly 100%. 
The thresholds are 
calculated from 
equations 2.7.7-2 
and 2.7.7-3. 
 
 
 
 
Figure 2.7.8-2 shows the variation of the segmented volume as a ratio of the actual volume. Black’s largest sphere 
had a volume of 291 cc, and for a spherical shell of this volume Black’s method overestimates the volume by 8% or 
about 23cc.   
 
Fig 2.7.8-2 The 
volume ratio is the 
volume of the 
volume segmented 
by Black’s rule 
divided by the 
actual volume of the 
spherical shell. The 
jagged nature of the 
curve is a 
computational 
artifact resulting 
from grid estimation 
of the parameters 
required to keep the 
average value at 
0.8. 
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Figure 2.7.8-3 shows the distance of the Black threshold from the inner and outer surface of the spherical shell 
tumour. At the inner surface, a small hole of up to 9 mm diameter is nevertheless falsely included in the volume. For 
larger volume spherical shells, the distance quite quickly drops to less than a mm. At the outer surface, the error is 
almost insignificant in comparison, not reaching more than 0.5 mm in the most extreme case. As the volume 
increases, this small systematic distance does translate to a large volume. 
 
Fig. 2.7.8-3 Since the 
Black threshold always 
underestimates the size of 
the central cavity, the 
distance to the inner 
surface is the distance 
from the interior surface of 
the actual sphere towards 
the centre of the spherical 
shell and the inner surface 
of the volume segmented 
by the Black threshold. At 
the exterior of the 
spherical shell, the Black 
threshold is within the 
actual spherical shell. 
The clinically most significant discrepancy in applying the Black threshold is that a hole of up to 9 mm diameter in 
the middle of a tumour will be included in the tumour. One can generalize from that to the difficulty that would be 
encountered in applying the Black threshold model to irregular shaped tumours.  
2.8 EXPERIMENTAL TEST OF THE RADIAL EQUATION 
The preceding sections have derived a model and compared its predictions to values available in the literature. In this 
section the radial equation is tested against experimental values that are not available within the literature. This work 
began with an extension of previous work to incorporate PET images into the RTPS (see section 1.5), first to 
incorporate PET-CT images into the RTPS as shown in figure 2.8-1, then to develop tools for analyzing the PET 
images that were not available in the RTPS. The RTPS was in the latter case used primarily as a visualization and 
contouring tool. These contours were then accessed and analysed by invoking options in the separate menu based C 
program running on the same workstation. 
2.8.1 Interfacing PET-CT images into the RTPS 
This was accomplished by a simple extension of the program mentioned in section 1.5.1 A separate interface was 
written to deal with the PET-CT data format, and a different menu structure due to the availability of matching CT 
slices from the PET-CT, so that there were now three images sets including the planning CT and the PET image. The 
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innate co-registration of the PET-CT data was a major motivation promoting more systematic tumour segmentation 
from PET images. 
 
Fig. 2.8-1 CT-PET 
images uploaded into the 
RTPS 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8.1 Shows images relating from PET-CT images imported into the RTPS. On the left is the PET image from 
the CT-PET, on the right is the CT image from the CT-PET. The lung contour marked in blue has been segmented 
using the RTPS based on the CT images from the PET-CT. The lung contour is shown super-imposed over the PET 
image. The correlation between the edge of the lung contour and the margin of the pet avid mediastinal mass is 
immediately apparent, even with the inferior spatial resolution of the PET-CT. Note also the curved couch top of the 
PET-CT in the CT image on the right and the black dot in the mediastinal mass in the PET image on the left. Flat top 
couches of identical construction to radiotherapy couch tops subsequently became commercially available. The black 
dot is a manifestation of the 3000 limit of the RTPS display seen in sections 1.5.1 and 1.5.3, and ultimately this 
restriction caused the program to be terminated for a commercial solution when one became available. 
2.8.2 PET Image analysis tools for the RTPS. 
This was a further extension of the menu based C program to allow it to read and interpret RTPS contour information 
as well as PET image pixel values. This allowed the inclusion of some extra menu items that implemented analysis 
algorithms, one of which allowed for testing of the radial function. To do this, each sphere had to be considered 
separately, so as a first step, an exclusive volume was drawn around each sphere, large enough to ensure that all of 
the actual sphere volume was included, but small enough to ensure that no other sphere was included, as shown in 
figure 2.8.2-1. 
 
Chapter 2: Segmenting tumours from functional imaging 
 105
Fig. 2.8.2-1 FDG 
sphere images 
imported into the 
RTPS. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8.2-1 shows a slice from the PET image of a PET phantom (Jaszczak phantom, Data Spectrum Corp., 
Chapel Hill, NC, USA) with six FDG loaded spheres of various volumes up to 20 cc. (1,2,5.5,11.5,16,20) The left 
and right images are identical. Contours have been marked around the spheres using the RTPS to delineate each 
individual sphere. Each contour has a number from 1-6 assigned to it by the RTPS. Contour 1 is the active contour 
and so is marked by a green contour, contours 2-6 are marked in blue.  
2.8.3 Algorithm to test the radial equation. 
To test the radial equation required producing a graph with PET voxel values as the y axis, and the corresponding 
distance of the voxel from the centre of the sphere as the x axis. The first step in this was to consider each sphere 
individually. Since each sphere had an exclusive contour drawn around it, this was accomplished by testing each 
voxel to see if it lay within the contour. This could be considered as a 2 dimensional problem executed separately on 
each slice. The standard method of determining if a point is inside a closed contour was implemented, a straight line 
was drawn from the voxel in the axial plane to infinity (in this case the edge of the image matrix was sufficient) and 
an odd number of intercepts with the contour indicated a voxel that was within the contour, an even number one that 
was outside. A minor complication was that as both the contour and the voxel coordinates were stored as integers, 
the normally unlikely possibility of tangential/vertex intersection had to be considered correctly rather than ignored. 
The distance from the centre (in 3 dimensions) and the value of the voxel were then readily determined, once the 
centre of the sphere was found. The x,y data was then written out in a format that could be read by a spreadsheet to 
produce the graph. Finding the centre of the sphere was the last component of the algorithm that was not initially 
straightforward.    
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2.8.4 Finding the centre of a sphere. 
The algorithm chosen to find the centre of the sphere was to first search all of the voxels within the exclusive contour 
to find the voxel with the maximum value and its coordinates. If there were multiple maxima of identical value then 
the first one found was taken as the sole maximum. This voxel was then used as a seed voxel for constructing a 
contiguous set of voxels whose values were all above a threshold that was iterated from the maximum pixel value to 
zero until the segmented volume was equal to the known actual volume of the sphere. The centre of the sphere was 
then taken as the centre of mass of the segmented volume. One arbitrary choice involved in implementing this 
algorithm is the choice of the threshold for the segmented volume, since it can be seen (Figures 2.8.4-1, 2.8.4-2, and 
2.8.4-3) that the position of the centre of mass of the volume can vary significantly and that this variation can be 
monotonic or oscillatory depending on the axis. 
 
Fig. 2.8.4-1 Variation of centroid of 
20 cc sphere in X axis. In this context 
the X axis means the L-R axis. When 
the threshold is 100%, the sphere 
volume is eight voxels centered half 
way between pixel number 184 and 
183 in the left right direction. In this 
particular case the pixels are 0.23 cm. 
Initially as the threshold drops, the 
addition of extra voxels has a large 
effect on the centroid because of the 
small number of voxels in the volume. In the mid range of thresholds the variation becomes oscillatory with a 
magnitude of about one quarter of a pixel or 0.6 mm. When the threshold is very low, and the volume expands well 
beyond the surface of the actual sphere, the influence irregular exclusive contour displaces the centroid. 
  
Fig 2.8.4-2 Variation of centroid of 20 
cc sphere in Y axis. In this context the Y 
axis means the anterior-posterior axis. 
When the threshold is 100%, the sphere 
volume is eight voxels centered half way 
between pixel number 122 and 123 in 
the anterior-posterior direction. In this 
particular case the pixels are 0.23 cm. 
Initially as the threshold drops, the 
addition of extra voxels has a large 
effect on the centroid because of the 
small number of voxels in the volume. In the high range of thresholds the variation becomes oscillatory with a 
magnitude of about one half to one quarter of a pixel or 1.2 to 0.6 mm. When the threshold is at medium level, the 
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centroid is still oscillating, but with a very low amplitude of about 0.1 mm, and is thus effectively stable in this range. 
When the threshold is very low, and the volume expands well beyond the surface of the actual sphere, the influence 
irregular exclusive contour displaces the centroid. 
 
Fig. 2.8.4-3 Variation of centroid of 20 cc 
sphere in Z axis. In this context the Z axis 
means the superior-inferior axis. When the 
threshold is 100%, the sphere volume is 
entirely on slice 17. In this particular case the 
slice thickness is 0.3375 cm. Initially as the 
threshold drops, the addition of extra voxels 
has a large effect on the centroid because of 
the small number of voxels in the volume. In 
the high range of thresholds the centroid 
variation is almost monotonic with decreasing threshold. When the threshold is at medium level, the centroid is still 
monotonic, but with a lower rate of change. When the threshold is very low, and the volume expands well beyond the 
surface of the actual sphere, the influence of the irregular exclusive contour displaces the centroid. 
 
Fig. 2.8.4-4 Positional error of circular fiducial of radius four pixels shows the positional error that results from the 
two dimensional displacement of the centre of a circular fiducial relative to the pixel grid. The colour is given by the 
two dimensional radial distance between the centroid of the pixelated image and the centroid of the object itself. The 
maximum deviation is 0.22 of a pixel. The distribution is complex, but once the deviation is more than half a pixel in 
any direction, the pattern naturally repeats. The size of the fiducial is chosen to be approximately representative of 
the central slice of the 20 cc sphere PET image. 
Finding the centre of a sphere is in many ways analogous to finding the centre of a fiducial, a subject which has a 
substantial and sophisticated body of literature70. The location of the centroid of a circular fiducial object in a pixel is 
influenced by the position of the true center of the fiducial relative to the pixel grid, as shown in Fig 2.8.4-4. The 
arbitary choice was made to use the threshold that matched the actual volume of the sphere to determine the centroid, 
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because that threshold is the main point of interest. There was also a choice to make between weighting all voxels 
equally when determining the centroid, or weighting them by the pixel value. Although use of the pixel value is held 
to increase the accuracy of the centroid determination by an order of magnitude, a uniform weighting for the voxels 
was chosen because the segmentation is binary, a voxel is either determined to be entirely in the volume or entirely 
out. 
2.8.5 Testing the radial equation on a 20 cc sphere. 
Now the theoretically predicted shape of the radial equation for the 20 cc sphere (Figure 2.8.5-1) can be compared to 
the experimentally determined shape of the radial curve for a 20 cc sphere (Figure 2.8.5-2). The experimental data is 
very noisy, and the predicted curve does not model the influence of noise. Although the experimental data 
approximately follows the shape of the predicted curve, the maximum is not at the centre, as the theoretical model 
predicts. If the noise is random, the maximum is more likely to be located away from the centre than at the centre of 
the sphere. Clearly the noise will increase the maximum, and thus reduce the threshold. This image is obtained with 
no background distribution of FDG, so the volume of the sphere cannot be segmented without taking the noise into 
account. Figure 2.8.5-3 shows a comparison of the experimental results, the published values of Erdi and the 
theoretical model. The experimental results match well for the smaller spheres but the thresholds are lower than 
predicted for the larger spheres. There is also some experimental noise in the graph, sufficient to disrupt the smooth 
trend slightly for large spheres. This emphasizes the need for a clean set of experimental data. In the next section the 
effect of noise on Erdi’s results is approximated. 
Figure 2.8.5-1 Radial equation prediction for 20 cc sphere. 
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Fig. 2.8.5-2 Observed radial distribution graph for 20 cc sphere. The data approximately follows the predicted 
shape, but is very noisy. Each PET pixel has in fact been mapped to four CT pixels with a nearest neighbour 
interpolation, so there are four times the number of points in this graph, but the noisy experimental data would 
completely obscure any underlying curve. It is also immediately apparent that the maximum is not located at the 
centre of the sphere. 
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Figure 2.8.5-3 shows Erdi’s results (brown line) and the results determined experimentally using spheres of volume 
1,2, 5.5, 11.5, 16 and 20 cc (pink line). A value of 0.7 cm is used for the FWHM to predict the theoretical green 
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curve. This also gives the experimental values a specific x axis shift, since the spheres are plotted not according to 
the volume, but according to the natural log of the radius of the sphere divided by the FWHM. 0.7 cm was chosen as 
the largest conceivable FWHM. The pink line matches closely for the smaller spheres but the thresholds are lower 
than predicted for larger spheres. There is also some experimental error in the threshold results, sufficient to disrupt 
the pattern.  
2.8.6 Noise and segmentation 
In the preceding section it was seen that image noise must be taken into account when segmenting sphere volumes 
from PET images. 
 
For larger volume spheres, we can estimate the effect of noise on the maximum within the sphere (and therefore the 
reduction in the effective threshold) by direct calculation. If there is a central area within the volume of the sphere 
that has uniform intensity before noise is taken into account, we can estimate how much the noise from many equal 
voxels will increase the maximum. 
 
If there are N independent observations, each distributed in a standard normal distribution  about mean zero with a 
standard deviation of one, this means that each independent observation has probability density function given by 
equation 2.8.6-1. 
( ) 2
2
2
1 zezf
−
= π          Equation 2.8.6-1 
We want to know the probability distribution of the maximum. This is answered simply by remembering by 
definition, that if the maximum is m then all of the independent variables must be less than or equal to m. Since they 
are independent the probabilities multiply. The probability distribution functions for the maximum for six different 
orders of magnitude of N independent standard normally distributed variables are graphed in figure 2.8.6-1. 
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Fig. 2.8.6-1 Probability distribution for the maximum. 
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Figure 2.8.6-1 shows the probability distribution functions for the maximum from left to right of 1, 10, 100, 1,000, 
10,000, and 100,000 independent standard normally distributed independent variables. As the number increases, so 
does the maximum, and it also becomes easier to predict the maximum. 
2.8.7 Estimating the effect of noise on Erdi’s results. 
Knowing that the scan time is 15 minutes from the paper by Erdi, and using a figure of 400KBq/cc in a 20 cm 
diameter phantom giving 800kcps71 we can estimate about 490 counts in each voxel. We assume that the volume of 
each voxel is 0.066 cc (4mm x 4mm pixel with interslice spacing of 4.25 mm72 ) and take as an estimate of the 
standard deviation of statistical noise within the sphere voxel the square root of the number of counts. We further 
approximate that the number of voxels that can be the maximum pixel is given by the volume of the sphere divided 
by the volume of a voxel. This is an overestimate, since the voxels near the surface have a lower voxel value, and so 
are unlikely to contribute to the maximum. The effect of image voxelisation is also included in the model as 
previously described in section 2.6.3. The results are shown in table 2.8.7-1 
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Table 2.8.7-1 Match to Erdi data including noise 
Volume 
(mL) 
Radius (cm) N Threshold FWHM 
0.65 cm 
FWHM 
0.65 cm 
TOP 
FWHM 
0.65 cm 
BOT 
Error 
0.4 0.457 6 0.60 0.448 0.800 0.520  
1.5 0.710 22 0.44 0.357 0.459 0.377  
2.0 0.782 29 0.42 0.356 0.426 0.369  
4.0 0.985 59 0.38 0.370 0.373 0.390  
5.5 1.095 81 0.38 0.380 0.381 0.389 0.001 
 
This is sufficient to get a match to the experimental data, and encourages us to pursue the model further. In this crude 
approximation, all the voxels are counted as possible maxima, and so the noise from each decreases the threshold. In 
the smaller spheres, the noise reduction of the threshold is very small, and the threshold is dramatically increased 
(within a broad envelope) by the pixelisation. It is obvious that there is some interaction between the change in signal 
from the centre of the sphere and the noise. The noise can also increase the size of the envelope for smaller spheres, 
but also if the pixelisation is at a vertex, it will increase the threshold ratio, but more voxels will be able to contribute 
to the maximum. So this suggests a Monte Carlo evaluation. 
2.9 Noise pixelation de-correlation by Monte Carlo integration 
Monte Carlo simulations are especially suited to solving problems that require averaging over a large number of 
dimensions, for which standard grid based numerical calculation methods become computationally impractical. The 
disadvantage of a Monte Carlo method is that rather than the answer within a known accuracy, what is obtained is a 
statistical estimate of the answer.73 
 
To determine the Erdi threshold of a sphere of a given volume by the Monte Carlo method, where the coupled effects 
of noise and voxel quantization are at play, a simulation of a large enough number of trials to obtain a reliable 
estimate of the confidence interval for the threshold is executed, for each trial proceeding as follows: 
 
For a sphere of a given radius r, and thus volume 3
3
4 rV π= , imaged with a known voxel grid side lengths 
of Vx by Vy by Vz, consider a three dimensional array of voxels that is two voxels larger than the sphere in 
each direction. 
 
First randomly sample the location of the true centroid of the sphere relative to the central voxel. This is 
achieved by sampling a uniformly distributed random variable over the ranges –Vx/2 to +Vx/2, -Vy/2 to 
+Vy/2, and –Vz/2 to +Vz/2. Values outside this range simply repeat the pattern with periodic effect relative 
to another voxel, and thus do not need to be considered. 
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Using the radial equation, a value is computed for each voxel. For the volume containing the central voxel, 
a numerical integration is performed with steps of 100th of a voxel length in each axis. All other voxels are 
determined using the average of the value in each of the 8 vertices of the voxel as an approximation to the 
average value of the radial function over the volume. 
  
Then noise is added to the values, by sampling a standard normally distributed random variable to assign 
positive or negative coefficient of the noise standard deviation. The product is added to the voxel value. The 
noise standard deviation is determined in accordance with section 2.10.4. 
 
Then the maximum voxel value over the grid is determined. This achieved by brute force, iterating through 
all voxels to determine the maximum. 
 
Then the threshold is iterated from 0.5% to 99.5% of the maximum, and for each threshold the number of 
voxels greater than or equal to the threshold is determined.  
 
An upper threshold is determined, which is the highest threshold that gives a volume less than one voxel 
smaller than the actual volume of the sphere. 
 
A lower threshold is determined, which is the lowest threshold that gives a volume no less than one voxel 
greater than the actual volume of the sphere. 
 
Multiple trials are executed, and the top 2.5% of the upper thresholds are excluded. The maximum threshold 
of the remaining 97.5% is taken as the upper limit of the thresholds for a two sigma, 95% confidence 
interval. Similarly the lowest 2.5% of the lower thresholds are excluded and the minimum of the remainder 
taken as the lower limit of the thresholds for a two sigma interval. The upper and lower thresholds are 
treated as independent in this determination. 
 
Results of these calculations are used to determine the values in the calculated upper and lower thresholds in table 
2.10.1-1. The calculation is quite resource intensive, so only 200 trials were run for each point. 
 
For smaller spheres especially, there can be a range of thresholds that segment the same volume, and the thresholds 
to segment a number of voxels with a combined volume just larger than the actual volume can be different from the 
thresholds that segment a number of voxels with a combined volume just smaller than the actual volume36. The use 
of upper and lower thresholds includes this quantization uncertainty into the determined confidence interval. The 
upper and lower thresholds are paired, for each upper threshold there is a corresponding lower threshold. In 
excluding outliers to obtain a confidence interval, the upper and lower thresholds are treated as independent, simply 
because it is procedurally easier to do so. Coupled exclusion would not change the end result, as there are no pairs 
which are simultaneously represented in the upper and lower rejection fractions.    
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The random position of the true centroid of the sphere is only randomized within a single voxel. By definition, this 
then becomes the central voxel. As noted in section 2.8.4, this accommodates the full generality of the problem, since 
the distribution repeats outside the central voxel. 
 
There exists a range of ways to estimate the noise component of a PET image in both the clinical74,75 and 
experimental76,77,78,79,80 context. As the noise is a small perturbation to the threshold, the model used in 2.10.4, 
estimating noise from variation in an area expected to have uniform concentration of FDG and negligible partial 
volume effect, is considered adequate for use for this calculation. List mode methods75 were not possible in the 
experiment in section 2.10 because the PET scanner did not support it.  
2.10 3D PET Sphere experiment 
Previous sections treated exclusively with 2D PET, but in this section it is desired to see the extent to which the 
simple model is valid for 3D PET. A PET phantom (Jaszczak phantom, Data Spectrum Corp., Chapel Hill, NC, 
USA) with six spheres of volume 0.5 cc, 1.0 cc, 2.0 cc, 4.0 cc, 8.0 cc and 16.0 cc were filled with F18. FDG was not 
used, but in the experimental scenario the use of F18 in solution is equivalent. Five sphere to background 
concentration ratios of infinity (zero background), 7.4, 5.5, 3.1 and 2.8 were imaged in separate measurements. 
Between each measurement, extra activity was added to the background compartment of the PET phantom, which 
was never completely full. The PET phantom was then shaken to mix the activity in, before the phantom was 
replaced on the PET couch and left to settle. Imaging was achieved using a PET-CT (Gemini Dual PET-CT scanner, 
Philips Medical Systems, Cleveland, OH, USA) using the 3D-row action maximum likelihood algorithm (RAMLA) 
reconstruction algorithm. A CT scan was required to be acquired prior to each PET image to enable attenuation 
correction. The PET images were saved to a CD-ROM in Dicom part 10 format, and then read into analyis software 
(MATLAB, The MathWorks Inc., Natick, MA, USA) using a purpose written m file that opened each slice file in 
turn, and read the image matrix, as well as the slice specific rescale slope (0028,1053) and rescale intercept 
(0028,1052). All other parameters were global and were determined by inspection, and are as listed in table 2.10-1.  
 
It is instructive to note the corrections that have been applied to the PET images. DECY= decay corrected, 
RADL=non uniform radial sampling corrected, ATTN=attenuation corrected, SCAT=scatter corrected, DTIM=dead 
time corrected, RAN=randoms corrected, and NORM=detector normalization. 
 
There was no contouring capability to segment the individual spheres, instead the matlab environment was used to 
determine a threshold at which the six spheres were individually resolved in an isosurface plot. This visualization 
was used to determine a bounding rectangular prism around each sphere. (see figure 2.10-1)  
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Parameter in PET slice file Value 
Service Object Pair Class 1.2.840.10008.5.1.4.1.1.128  
(Nuclear Medicine Image Storage) 
Transfer Syntax 1.2.840.10008.1.2.1 (Little Endian Explicit Value 
Representation-Non default) 
Implementation Version Name BRCONN.3.0 
Image Type Primary 
Modality PT (PET) 
Manufacturer Philips Medical Systems 
Station Name G130-svr 
Manufacturer’s Model Name Allegro Body.C. 
Slice Thickness 4 mm 
Device Serial Number  2182 
Software Version 9.1.0\PMSPT1.44 
Protocol Name ANM Wholebody PET/CT 
Field of view shape CYLINDRICAL RING 
Field of view dimension 864\180 
Samples per pixel 1 
Photometric Interpretation  MONOCHROME2 
Rows 144 
Columns 144 
Pixel Spacing 4 mm x 4mm 
Corrected Image DECY\RADL\ATTN\SCAT\DTIM\RAN\NORM 
Bits Allocated 16 
Bits stored 16 
High Bit 15 
Pixel Representation 1 
Rescale Intercept 0 
Rescale Slope Slice specific 
Table 2.10-1 PET scanner image parameters. 
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Figure 2.10-1 PET 
isosurface visualization. 
The six spheres are here 
visualized with a 
threshold voxel value of 
500, chosen because it 
was close to the 
minimum value at which 
the spheres were 
individually resolved. 
Below this value a point 
is reached where the two 
largest spheres join. 500 
is just under 3% of the 
maximum voxel value of 
the smallest sphere. 
 
The spatial resolution of the PET scanner has been reported as 6.8-7.2 mm axially, 5.0-5.3 mm in the transverse 
radial direction and 5.0-5.4 mm in the transverse tangential direction.81 The spatial resolution of PET scanners has 
been noted to vary from unit to unit.82 A value of 6.5 mm was arbitrarily chosen as the mean of 7.2 and 5.4 rounded 
to the nearest half mm, and was used as the FWHM for the calculated thresholds. 
2.10.1 Erdi thresholds 
The Erdi thresholds are given in table 2.10.1-1. As the voxels are stored as integers but multiplied by a slice specific 
rescale slope that is stored as a finite resolution digital string, the thresholds are offset half a percent to reduce the 
influence of round off on sampling. 
Chapter 2: Segmenting tumours from functional imaging 
 117
 
Volume Signal to 
background 
ratio 
Experimental 
Threshold 
Monte Carlo 
calculation 
upper threshold 
for 95% CI 
Monte Carlo 
calculation 
lower threshold 
for 95% CI 
Error 
FWHM 
6.5 mm 
0.5 cc ∞ 66.5 51.5 39.5 -15 
1.0 cc ∞ 45.5 43.5 36.5 -2 
2.0 cc ∞ 29.5 40.5 32.5 3 
4.0 cc ∞ 32.5 39.5 32.5 0 
8.0 cc ∞ 36.5 39.5 35.5 0 
16.0 cc ∞ 38.5 40.5 36.5 0 
0.5 cc 7.4 65.5 58.1 47.7 -7.4 
1.0 cc 7.4 58.5 51.1 45.1 -7.4 
2.0 cc 7.4 36.5 48.5 41.6 5.1 
4.0 cc 7.4 40.5 47.7 41.6 1.1 
8.0 cc 7.4 41.5 47.7 44.2 2.7 
16.0 cc 7.4 42.5 48.5 45.1 2.6 
0.5 cc 5.5 75.5 60.3 50.5 -15.2 
1.0 cc 5.5 65.5 53.8 48.0 -11.7 
2.0 cc 5.5 40.5 51.3 44.8 4.3 
4.0 cc 5.5 42.5 50.5 44.8 2.3 
8.0 cc 5.5 42.5 50.5 47.2 4.7 
16.0 cc 5.5 46.5 51.3 48.0 1.5 
0.5 cc 3.1 79.5 67.1 59.0 -12.4 
1.0 cc 3.1 65.5 61.7 57.0 -3.8 
2.0 cc 3.1 46.5 59.7 54.3 7.8 
4.0 cc 3.1 42.5 59.0 54.3 11.8 
8.0 cc 3.1 44.5 59.0 56.3 11.8 
16.0 cc 3.1 46.5 59.7 57.0 10.5 
0.5 cc 2.8 90.5 68.8 61.1 -21.7 
1.0 cc 2.8 72.5 63.7 59.2 -8.8 
2.0 cc 2.8 65.5 61.8 56.6 -3.8 
4.0 cc 2.8 54.5 61.1 56.6 2.1 
8.0 cc 2.8 47.5 61.1 58.5 11 
16.0 cc 2.8 54.5 61.8 59.2 4.7 
Table 2.10.1-1 Erdi thresholds. The calculated threshold 95% confidence interval was determined as specified in 
section 2.9. The FWHM used was 6.5 mm. 
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The experimental data was within the calculated 95% confidence interval for large spheres with no background 
present. The low threshold for sphere 3, the 2.0 cc sphere, with no background present, was initially without 
explanation, but is believed to have resulted from the unique proximity of the sphere to an air water interface (See 
Figure 2.10.1-1). Scatter in 3D PET is much more important than 2D PET, and is strongly influenced by proximity to 
an air water boundary (see figure 3.23 from Bailey83 ). For the smaller spheres in the range of 2 cc and below, in 3D 
PET the power of the algorithm to discriminate between different volumes is very weak, as the radial curves overlap 
(see Figure 2.10.3-1). This is also believed to be the reason that the model proposed in section 2.9 will not fit when 
any background is present.  
Fig. 2.10.1-1 CT slice through the PET phantom. The PET phantom was 
never completely filled with water, so that extra activity could be added 
to the background compartment. This meant that sphere 3, the third 
smallest sphere with a volume of 2 cc, was close to an air water 
interface, unlike the other five spheres. 
 
 
 
2.10.2 Black thresholds 
The Black thresholds are displayed in figure 2.10.2-1. It is apparent from the graph that a best fit of Black’s threshold 
relationship for 3D PET would not accurately predict the threshold for all background levels. The model does not 
take into account the greater scatter fraction of 3D PET. This additional signal outside the volume of the sphere 
means that the concept of linear superposition cannot be applied to the background signal, even at low levels of 
background. 
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Fig. 2.10.2-1 The continuous line is calculated from a scaled version of the relationship displayed in figure 2.7.2-1. 
The scaling was obtained by making the change in  the Mean SUV from the smallest and largest and largest sphere 
in the absence of background equal to what the model predicts. The curve predicts the general form of the data 
trend, but a good fit is not possible because of the variation with background concentration, whereas the model 
predicts that there should be no variation. The experimental points for different spheres and different background 
levels have been plotted with different colours for different backgrounds to demonstrate the variation with 
background. 
2.10.3 Radial relation 
The radial relation for the zero background scans are given in figure 2.10.3-1. The centroid was determined using the 
method given in section 2.8.4. 
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Fig. 2.10.3-1 These are the radial distributions from the spheres when the background is zero. Even without 
background, the smaller volume spheres (0.5 cc, 1.0 cc and 2.0 cc) have profiles that intermingle, making it unlikely 
that they can be separated in the presence of background. 
2.10.4 Noise estimation 
The central 10 mm of the 16 cc sphere was used to estimate the noise. The mean normalized value was 0.9149, 
determined from 66 voxels, with a standard deviation estimated at 0.0353. In un-normalised pixel values this is a 
mean of 4.90x104 and a standard deviation of 1.89x103. The variance of the RAMLA reconstructed image is 
expected to be proportional to the image itself. The noise standard deviation in a single voxel is then modeled as the 
square root of the voxel to mean ratio multiplied by 1.89x103 as given in equation 2.10.4-1. 
4
3
_ 1090.4
_1089.1 ×××=
VALUEVOXEL
VOXELNOISEσ    Equation 2.10.4-1 
2.11 Brambillas equations:  
Finally it is instructive to review the results of Brambilla et al., and to compare these results with what we would 
expect using Brambilla’s results for the FWHM of the scanner84. As mentioned previously, Brambilla et al 
determined the following two equations using multiple linear regression methods85 on thresholds for segmenting 
spheres of FDG of known volume (hence known internal diameter, ID) imaged with a Brambilla’s PET/CT 
(Biograph 16 HI-REZ PET/CT scanner, Siemens, Hoffman Estates, IL, USA). 
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Sphere ID <= 10 mm  ( ) ID
BT
TH ×−⎟⎟⎠
⎞
⎜⎜⎝
⎛ −×−= 643.9119.1712.309%     Equation 2.11-1 
Sphere ID >10 mm ( ) ID
BT
TH ×−⎟⎟⎠
⎞
⎜⎜⎝
⎛ −×−= 976.0118.1011.151%   Equation 2.11-2 
Brambilla et al give FWHM values of 4.61 mm for the transaxial spatial resolution and 5.34 mm for the axial spatial 
resolution. To calculate theoretical thresholds to match, a single FWHM of 4.84 mm ( ) 312 34.561.4 ×= mm is 
used. Additionally for the purpose of estimating a noise level, it is assumed that there are 490 counts per pixel (in 
fact Brambilla used a range of concentrations.). From these we can obtain model predictions to compare with 
Brambilla’s results, shown in table 2.11-1 below. To maintain consistency with Brambilla’s work, the internal 
diameter (ID) of the spheres is given in mm. The radius, simply one half of the ID, is also quoted in mm. The 
λ value, the noiseless zero background threshold ratio given by equation 2.5.2-1, is simply a property of the radius 
and the FWHM. The volume in cubic millimeters is also quoted. Then the nearest integer number of 2.625 x 2.625 x 
2 mm voxels that fits within the volume is given. A mathematical quantity, ( ) N15.0  is the probability of any single 
voxel having a value less than equal to the maximum, assuming that every voxel within the sphere has the same 
chance of being less than or equal to the maximum value, and is used to calculate the increase in the maximum due 
to noise. The next column gives the noise correction, the increase to the denominator in equation 2.5.2-1 due to 
noise. NOISEδ  is given by 0.0452 times the number of standard deviations above the mean required to achieve the 
probability that a standard normally distributed variable will be less than or equal is the value of ( ) N15.0 . The 
column headed ∞=BT  gives the threshold percentage if the background signal is negligible but noise is present 
as calculated. These values can be calculated from Brambillas formula but there is no data measured by Brambilla 
that matches it. The next three columns give the threshold percentages at threshold to background ratios that were 
measured by Brambilla. The second entry in the last four columns are calculated by Brambillas formula. Only one 
set of values are given for the ID=10 row, because only the formula for ID>10 mm is considered. The ID=10 row is 
included only to demonstrate the reason for taking ID=10 mm as a break point between two models, at a FWHM of 
4.84 mm, the model predicts thatλ will take its minimum value of 0.3760 when the ID is 11.2 mm, between the 
observations at ID=10 mm and ID=13 mm. In this facet at least, the model predicts an observation.  
The closest match between the threshold percentages is a difference of 2.1, close to the experimental error, for the 
smallest sphere with ID>10 mm when there is tumour to background signal ratio of 23. Positive and negative 
differences are observed, and the largest difference is 26.5 for the largest sphere with a ratio of 23. This discrepancy 
is most likely a result of the rendering of the equation in Brambilla’s paper, since it predicts threshold percentages as 
low as 17.6%, while all threshold percentages graphed in the paper are greater than 30%. Comparing the model 
predictions to the actual experimental data, all the percentages tabulated for the tumour to background ratios of 3 and 
11 are within the 25%-75% interval. For the tumour to background ratio of 23, the threshold percentages are within 
and above the 25%-75% interval, but are contained within the interval defined by the outliers.      
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Table 2.11-1 Brambilla’s results 
I.D. R λ  V N ( ) N15.0  NOISEδ  ∞=BT  3=BT  11=BT  23=BT  
10 5 0.3800 524 38 0.9819 0.095 34.3 56.2 40.3 38.9 
13 6.5 0.3809 1150 83 0.9917 0.108 34.3 
36.6 
56.2 
70.5 
40.3 
45.9 
38.9 
41.0 
17 8.5 0.4038 2572 187 0.9963 0.121 36.0 
32.7 
57.4 
66.6 
41.8 
42.0 
40.6 
37.1 
22 11 0.4255 5575 405 0.9983 0.132 37.6 
27.8 
58.4 
61.8 
43.3 
37.1 
42.1 
32.3 
28 14 0.4414 11494 834 0.9992 0.142 38.7 
22.0 
59.1 
55.9 
44.2 
31.2 
43.2 
26.4 
37 18.5 0.4557 26522 1924 0.9996 0.153 39.5 
13.2 
59.7 
47.1 
45.0 
22.4 
44.1 
17.6 
 
Using the same multiple linear regression method used by Brambilla, using the same discrete points, the following 
equation is obtained to match ID > 10 mm spheres. 
( ) ID
BT
TH ×−⎟⎟⎠
⎞
⎜⎜⎝
⎛ −×−= 181.0116.588.92%  
The maximum discrepancy between this equation and the values predicated by the model is 1.6 (difference between 
percentages, 30% compared to 31.6% for example). 
Brambilla note that the threshold percentage decreases with increasing ID, the model predicts the reverse to be true. 
If the noise contribution was much larger, this might cause a decrease, but it would have to be much larger. 
 
It is considered that this indicates a limitation of this work with respect to PET scanners that use deconvolution with 
the point spread function to enhance the spatial resolution, as Brambilla’s scanner does86. The model calculates the 
threshold on the assumption that the imaging process introduces noise spatial blurring, but the image from the 
Brambilla’s PET/CT scanner has already had that spatial blurring partially counteracted as part of the imaging 
process. Intuitively, using the model with Brambilla’s PET/CT scanner raises suspicions of “double compensating” 
for the same effect, so the model should be applied with extreme caution to these scanners. Unfortunately such an 
investigation is beyond the scope of this work, due mainly to lack of access to a PET/CT like Brambilla’s. 
2.12 Clinical relevance. 
The underlying mechanisms behind the qualitative behaviour of the thresholds in the Erdi threshold have been 
determined, and a quantitative match has been obtained, although it was necessary to refine the simple initial model 
with the addition of a correction for image voxelisation and another for the noise in the image.  
It has also been possible to achieve some tying together of different models presented in the literature, though not in 
all cases. 
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A first principles method of segmenting tumours that are 
• Spherically shaped 
• Uniformly PET avid 
• Not affected by motion artifact 
• Acquired by a 2D-PET scanner 
has been determined, but real lesions are at best only approximately spherical, and often odd shapes. Real lesions do 
not necessarily have uniformly PET avid. Real tumours are known to move during the image acquisition and be 
subject to motion artifact. 
 
Departure from any or all of these three idealizations tends to decrease the threshold. The threshold method can then 
always be taken as an underestimate or minimum volume. From a clinical point of view, then, the method segments a 
lower limit of the clinical volume that should then be extended on the basis of clinical judgement. 
2.12.1 Envisioned implementation 
The mathematical modeling of PET thresholds has in the past attracted clinical criticism arising from the expectation 
that the automatic model might marginalize clinical impact. Therefore it is felt prudent and justified to put forth the 
envisioned implementation of the threshold based segmentation, even though the implementation is beyond the scope 
of this work. Nothing in the method confines it to spherical geometry, so the model can deal with lesions of arbitrary 
shape. The movement of lesions can be lessened to some extent by gating or motion compensation. That leaves only 
the problems of tumour heterogeneity in uptake and the classification of PET signal as physiologic or tumour related. 
The model could be extended to include tumour heterogeneity as a parameter set by the clinician. The clinician might 
have an expectation of the range of tumour heterogeneity expected, and examine the range of segmentation volumes 
predicted by the model for different heterogeneities, choosing that which in their clinical judgment best suited the 
clinical intent. This would also allow a documentation of the segmentation in terms of a heterogeneity parameter, so 
that the method of segmentation could be transferred from centre to centre more rapidly than local clinical 
knowledge. Clinical trial documentation could also be couched in terms of such a heterogeneity correction, so for 
example “The lesion should be segmented with a threshold ratio method, using a heterogeneity ratio of 1.0-1.5…” . 
The problem of classifying PET signal as physiological or tumour based would also require clinical input, but could 
be assisted by segmentation of anatomical structure on the CT scan of the PET CT. Here it should be possible to 
model the uptake of FDG by the organ, tissue or exudate and model the expected contribution to the distribution. The 
clinical input here would be the segmentation of the structures on the CT of the PET CT and the choosing of the 
clinically relevant parameters for the model. Trial methodology could also be couched in such terms viz “The kidney 
will be segmented from the PET CT scan using CT greyscales of upper level =A Hounsfield Units (HU) and lower 
level = B HU. And the FDG uptake will be modeled using the parameters of the model by XXX.” 
Although much of the above is speculative and involves procedures and algorithms beyond the scope of this work, it 
has been included as a statement of intent to allay the suspicions of the clinical establishment.      
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2.13 Conclusion 
A qualitative explanation for the behaviour of Erdi’s threshold has been obtained by treating the image as an 
idealized continuous function as seen in section 2.5.2. 
It was demonstrated experimentally by comparing the derived radial equation with the experimentally observed 
radial distribution that segmentation required noise to be taken into account (section 2.8), and in section 2.8.7 it was 
demonstrated that Erdi’s results could be predicted within experimental error by the inclusion of an approximation 
for the effect of noise.  
We have shown how the threshold for segmenting a motionless spherical tumour with uniform PET uptake imaged 
by a 2D PET scanner can be determined from the spatial resolution and the noise level of the PET scanner. These are 
both parameters that are extensively characterized when a PET scanner is commissioned. The predictions of the 
model are able to draw parallels between the published results of Black and Erdi, obtained by different investigators 
for a different range of volumes, uniting the two as predictions of a single model. 
Much clinical energy has been expended in conducting trials of PET for tumour volume marking, which require 
years of follow up evaluation to monitor outcomes. Inevitably, given the lack of consensus on tumour volume 
marking methods with PET, some of these trials have involved inappropriate tumour segmentation methods that may 
have biased the results. In many cases, the imaging equipment may simply no longer be available for subsequent 
testing. In this circumstance, the segmentation method proposed, since it relies only on two well documented 
properties, the spatial resolution and noise characteristics of a 2D PET scanner, may provide the best estimate, after 
the fact, of the difference between the volume segmented in the trial, and the more widely accepted estimate of the 
likely actual tumour, and thus provide an estimate of any bias introduced into the study by the methodology. 
Methods for segmenting tumours for radiotherapy treatment planning with functional imaging cannot be any great 
use if the information from functional imaging can not be transferred from the PET scanner to the radiotherapy 
treatment planning system for use in tumour volume marking. In the next chapter therefore the problems of 
information transfer for functional imaging will be explored. 
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“…I might not this believe 
Without the sensible and true avouch 
Of mine own eyes.” 
Hamlet Act 1, Scene 1. William Shakespeare 
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3.0 Information transfer 
It was seen in chapter 1 that a recurring problem with hybrid imaging in the radiotherapy context is the flow of 
information in digital form. When the use of Hybrid imaging was in the research phase, the focus was on accessing 
image files. There was little concern about how the images were transferred, because the initial patient numbers were 
relatively low. In the research phase, information transfer needed only to be possible, not efficient. As the use of 
hybrid imaging in radiotherapy has become more widespread and routine/clinical, the emphasis has shifted from 
possibility to practicality/reality, and the mechanism of access must be standardized and streamlined to allow the 
efficient transfer of this information. In the not so distant past, imaging information transfer was achieved by 
transport of hardcopy film images. The only equipment needed to view the image was a light box. In the modern 
hospital environment, images are now transferred in digital form, and require access to a picture archival and 
communication system (PACS) workstation to view the image. This applies to more than just images; schedules and 
appointments that were once maintained by paper systems are now handled digitally. Although there are a variety of 
formats for digital information transfer in radiotherapy (for example RTOG format, based on AAPM Report no 101) 
and Nuclear Medicine (for example Interfile2, also based on AAPM Report No 10), with the passage of time the 
majority of this information transfer has come to be mediated by the DICOM transfer protocol.3 Modern 
radiotherapy and imaging departments cannot function without information transfer governed by the DICOM 
standard. The most common and efficient way for this transfer to take place is over a local area network. In this 
circumstance, when two DICOM applications, for example a CT scanner and a radiotherapy treatment planning 
system, send images between them, they do so by the sender encoding the information into a byte stream which is 
then transmitted over the network to the receiver, where it is decoded into an image. There must be a method to 
determine from the network traffic between two DICOM compliant applications the information that has passed 
between them, because that is the way that the DICOM applications themselves communicate. The activity of a third 
party obtaining any of this data transfer by passively monitoring the network traffic between the two DICOM 
applications is termed DICOM packet sniffing.  
 
The primary rationale for undertaking this inherently complex task is to determine DICOM compliance. The 
majority of DICOM applications communicate successfully, but in a multi vendor environment, DICOM 
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communication problems are unavoidable4. Sometimes two applications from different vendors simply will not 
communicate, for reasons more complex than an incorrect setting of parameters from within the user or service 
interface. In the investigator’s direct experience in this circumstance the vendor always suggests the non compliance 
of the other vendor’s application, and will not initiate corrective action until their application is shown to be at fault. 
Even when there is a prime contractor, interface problems are one of the most significant technical difficulties with  
PACS5. Log files may exist on either application, but they may not provide the information required to determine 
why communication is not achieved. In this circumstance use of DICOM packet sniffing allows independent analysis 
of the problem. 
 
The data must be intercepted before it can be decoded. Interception is possible through passive interception at either 
endpoint or by inserting a passive listening device into the network between two endpoints6. Then the layers of 
network protocol data encapsulation need to be stripped away to obtain the DICOM information that passes between 
two applications. The DICOM standard is more than a file format for medical images (or Information Object 
Definitions, IODs, in DICOM terminology), it is also a protocol for data interchange between two endpoints7. This 
means the DICOM message layer must first be interpreted to determine the syntax before the underlying image data 
information can be accessed. Sometimes the reason two DICOM applications will not communicate will be found in 
the message layer. 
 
Chapter 1 showed multiple examples of DICOM Communication problems impacting on the use of functional 
imaging. The original RTPS (CADPLAN, Varian Medical Systems, Palo Alto, USA) would not accept PET scans at 
all, they had to be recast as CT images and swapped into the image files in the planning system to get them 
displayed. The early versions of a stereotactic RTPS (XKnife RT TM, Radionics, Burlington, MA, USA) would not 
allow use of SPECT, it had to be recast as an MRI scan. PET-CT scans could not be read properly by the planning 
system because it misread the slice specific pixel rescale value. The situation has and will improve, almost all 
planning systems now accept functional imaging, and third party systems are available8 to provide co-registration 
and segmentation functionality, but the use of functional imaging is increasing, and with that comes pressures of time 
that make work processes much less tolerant of even minor faults, while we are still experiencing major faults from 
time to time. It is instructive to review some further faults that demonstrate the type of problems encountered. 
 
There are procedural rather than software problems. For example, it has been determined that the DICOM tag “Body 
Part Examined” has an error rate of over 15% in clinical practice, due mainly to procedural error. The protocol 
selected by the CT operator will set the contents of the “Body Part Examined” tag automatically, but the operator 
will apply a protocol to improve image quality as the highest priority, without regard to any conflict that may occur 
between the body part for which the protocol was designed and the actual body part imaged.9  
 
There are errors with image representation that are a result of software errors in the representation of the correct 
image rather than DICOM errors. For example, users complained that PET images on the secondary contouring 
workstation were “fuzzy” in comparison to the images displayed on the associated RTPS (CMS Focus, 
Computerized Medical Systems, St Louis, MO, USA). To test this, a synthetic PET image of uniform intensity pixels 
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was sent to the RTPS. On the RTPS, the image displayed correctly, but on the secondary contouring screen it came 
out as an odd grey-scale tartan pattern (See Figure 3.0-1). This is a software image display problem, not a DICOM 
communication or interpretation problem, most probably resulting from an incorrect implementation of a 
decompression algorithm. Early versions of the RTPS also failed to implement the slice specific greyscale rescale 
slope for functional images,  resulting in the maximum intensity on all slices being scaled to the same value, and 
destroying any information on the variation of the relative intensity of the images in the superior-inferior direction, 
rendering the images useless for radiotherapy target volume marking.     
 
Fig. 3.0-1 Focal Ease 
rendering of a uniform 
intensity synthetic PET 
image comes out as an odd 
grey-scale tartan pattern, 
when it should be uniform 
grey. This is an example of a 
software image rendering 
problem, rather than a 
DICOM image transmission 
problem. This error was 
reported by the clinical users 
of the system, who noted 
variations from system to 
system of the appearance of 
the same image. 
 
Other errors in information transmission can cause geometric treatment errors through subtle corruption of processes 
due an unfortunate sequence of coincidence. For example, in the case of a transient network fault, not all of the 
images transmitted by a CT-PET might be received by the destination radiotherapy treatment planning system. The 
CT and the PET data, although innately co-registered, are transmitted in separate sessions, and so it is most likely 
that if such a transient network fault occurs, it will only stop transmission of slices from either the CT scan or the 
PET scan, but not both. If the network fault affects the transmission of only the last few slices of the PET data, for 
example, the operators may decide that retransmission is not necessary, especially if the remote receivers in 
radiotherapy have to telephone the operators in NM to request an operator initiated retransmission, and if the remote 
receivers already know that there is no FDG avid disease visible in the last few slices. Even though the PET and CT 
data is innately co-registered, the RTPS may not automatically recognize this, and the RTPS procedure may require 
both image sets to be selected and loaded into the fusion module to confirm this. Staff may learn that it is only 
necessary to enter the fusion module and save the registration immediately, without any alteration or image 
inspection, before proceeding to use the fused image data. When two data sets that are not innately co-registered are 
loaded into the fusion module, the two coordinate systems might be so different that one of the image sets is not even 
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visible on the screen display. This makes manual fusion for disparate sets very time consuming, as the user has to 
search around in co-registration space to find the missing image set. The vendor may choose to mitigate this by 
modifying the software to have the co-registration default to the center of gravity of both image sets, regardless of 
their coordinate system, so both image sets would always initially visible. Unfortunately this means that for innately 
co-registered CT-PET image sets, if there are two slices missing from one end of the CT data set, a geometric error 
of one slice separation will be introduced. Although the above example sounds like a far fetched scenario, it occurred 
in practice. Fortunately it was detected as a “near miss” that was intercepted just before treatment, and a review of 
the stored co-registration matrices for all previous CT-PET patients showed that no prior error had occurred. The 
ideal way to overcome this error is for CT-PET vendors to stamp both the CT and PET data with the same frame of 
reference UID, and for the RTPS vendors to implement their software so that where the frame of reference of two 
received image data sets is identical, to implement an appropriate co-registration matrix without user intervention. It 
takes time for vendors to develop robust procedures to handle DICOM data, and the procedures used in radiotherapy 
are becoming more complex, just as the DICOM protocol is constantly evolving. 
        
It is difficult to predict in advance the specifics of how DICOM communication problems might impede the use of 
functional imaging in a particular department, but a radiotherapy centre is increasingly likely to obtain its imaging 
information indirectly from a remote query of a PACS system, rather than by operator initiated direct transfer from 
the CT-PET, or CT-SPECT unit. An inability to access the PACS system by remote query will effectively stop all 
use of functional imaging. The primary illustrative example referred to will therefore be a PACS, subsequent to an 
upgrade, which would no longer allow a radiotherapy treatment planning system to access the PACS database. 
Suddenly the radiotherapy department had no access to PACS, and a number of patients had their treatment planned 
without reference to MRI scans that would otherwise have been available. Such a fault would also effectively stop 
the use of functional imaging in a department that was a heavy user of functional imaging, which is the direction that 
radiotherapy practice is heading10. This example is a real incident, and text in italic giving details of the actual 
incident in chronological order is interspersed within the text to give context to the generic descriptions of process 
rendered in the standard font. This disrupts the logical presentation order of the abstract concepts, but the order of 
events is typical of fault situations and provides a much needed narrative theme to an otherwise dull topic. 
 
A secondary illustrative example is a case of a new imaging modality unable to communicate with a radiotherapy 
treatment planning system. Direct transfer from the imaging modality to the radiation treatment planning system is 
becoming rarer, and tends only to be used when there is no PACS system available (or a potential workaround for a 
PACS system that is temporarily offline), or for really large size images that may be deemed to large to be stored on 
a PACS, or of interest to radiotherapy only and not required to be generally accessible (usually this means the PACS 
storage capacity has been under specified). The particular example is the case of a new CT installation, the first in 
Australia of that particular model, where it was found after installation that the main RTPS that previously received 
images from the old CT scanner could not do so with the new one. The vendors each suggested the non compliance 
of the other’s equipment. There was a great deal of pressure to fix the problem quickly because the radiotherapy 
treatment planning workload had mounted up while the new CT was being installed. 
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The third example is not directly related to functional imaging, but is included as an example of a fault tracing 
situation where the DICOM packet sniffing approach was the only possible approach, because the DICOM mediated 
process was automatic, so that it was not possible to break the problem down into steps and see where the fault arose 
within either application. The radiotherapy hybrid imaging workflow is not well enough established even to be able 
to predict now what the most important automated process within it will be, but whatever they are, they are all 
potentially vulnerable to problems arising from DICOM communication problems. The particular example that will 
be followed is a digital radiotherapy simulator with a DICOM Print function. When it was linked to a DICOM film 
printer the resulting output was not scaled correctly. This was initially important clinically because of a desire to 
reproduce the function of the previous simulator, which produced films of particular scales.  
 
This section of the thesis on information transfer focuses rigorously on the minutiae of information transfer, but these 
details have enormous consequences with readily identifiable economic value. Through the use of the technique of 
radiotherapy DICOM packet sniffing it has actually happened that subtle problems with interfacing multi million 
dollar equipment, which might otherwise have been unusable for the medical purpose for which it was purchased, for 
months or even years due to DICOM communication problems, have been solved in a single afternoon. 
3.1 Theoretical background 
This section begins with a description of the theoretical background of Radiotherapy DICOM Packet sniffing and 
concludes with a statement of the hypotheses. 
3.1.1 Network basics 
The size of a file representing a single CT image is typically bigger than half a megabyte. When this data is 
transmitted as a byte stream over a computer network, it is broken up into many packets each of about one and a half 
kilobytes with three layers of protocol encapsulating the DICOM CT data. 
3.1.2 The transmission Control Protocol 
All DICOM data is encapsulated within Transmission Control Protocol (TCP11) packets (Table 3.1.2-1). The parts of 
the TCP header that are relevant to accessing the DICOM transmission data are the Source Port, Destination Port and 
4 bit Data Offset. The sequence number and the acknowledgement number are required if the TCP packets arrive out 
of order, but can usually be neglected for test purposes. The initiator of a DICOM session will have been configured 
to assign a destination port to the transmission. The receiving DICOM application needs to be configured to expect a 
DICOM transmission on the same port for the communication to initiate successfully. The source port number is 
only an arbitrary number used to differentiate multiple sessions. In the reverse TCP traffic the port numbers will be 
interchanged. The fixed length part of the TCP header is followed by a variable length options field, then the 
encapsulated TCP data if any. The 4-bit Data Offset is thus required to find the start of the encapsulated DICOM 
data. The number of bytes from the beginning of the TCP header to the start of the encapsulated DICOM data is 
given by the value in the TCP Data Offset field multiplied by 4 as a consequence of the encapsulation rules of the 
TCP. The end of the encapsulated DICOM data can only be found by referring to the total length specified in the 
internet protocol (IP)12 header encapsulating the TCP packet. 
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Table 3.1.2-1 The structure of the TCP header, with elements required for decoding the encapsulated DICOM 
packets highlighted. 
Bit offset Bits 0-3 Bits 4-7 Bits 8-15 Bits 16-31 
0 Source Port (Bits 0-15) Destination port (Bits 
16-31) 
32 Sequence number (Bits 32-63) 
64 Acknowledgement number (Bits 64-95) 
96 Data Offset Reserved Flags Window size 
128 Checksum (Bits 128-143) Urgent pointer 
160 Options 
160/192+ Data… 
3.1.3 The Internet Protocol 
The term internet derives from the title of the original paper, "A Protocol for Packet Network Interconnection."13 The 
paper described an internetworking protocol for sharing resources using packet-switching among nodes, which 
subsequently became one of the determining elements that define the internet. The TCP packets are in turn 
encapsulated within IP packets (Table 3.1.3-1). The parts of the IP packet header that are relevant to DICOM data 
transmission are the header length, the total length, the protocol and the IP source and destination address. The fixed 
length part of the IP packet header is followed by a variable length option field, which can be effectively ignored, but 
its length needs to be known to determine where the next layer of encapsulated TCP data starts. The value in the 4 bit 
Header Length field indicates the total length of the IP header in multiples of 32 bit words. The Total Length field 
specifies the length of the IP packet, including both the variable length IP header and the encapsulated data packet. 
For all DICOM packets the 8-bit protocol field is always set to hexadecimal value 06 to signify that the protocol of 
the data encapsulated within the IP packet is TCP. The source and IP destination address are set by the configuration 
of the DICOM applications. 
Table 3.1.3-1 The structure of the IP header, with elements required for decoding DICOM packets highlighted. 
Bit Offset Bits 0-3 Bits 4-7 Bits 8-15 Bits 16-18 Bits 19-31 
0 Version Header 
Length 
Type of service Total Length (Bits 16-31) 
32 Identification (Bits 32-47) Flags Fragment 
offset 
64 Time to live (Bits 64-71) Protocol set to 
06 TCP 
Header Checksum (Bits 80-95) 
96 Source IP address (Bits 96-127) 
128 Destination IP address (Bits 128-159) 
160 Options (Zero or more multiples of four bytes) 
160 or 192+ Encapsulated TCP packet 
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3.1.4 The Media Access Control layer 
The IP packets are further encapsulated by the media access control (MAC) layer (Table 3.1.4-1). The structure of 
the MAC header consists of a six byte destination address, a six byte source address and a two byte type field. The 
type field is always set to hexadecimal 08 00 in all packets relevant to DICOM. This indicates that the encapsulated 
data is an IP packet. The length of the encapsulated data is not defined by the MAC header, but within the data itself. 
It is always between 46 and 1500 bytes. The encapsulated data is followed by a four byte cyclic redundancy check 
field. 
Table 3.1.4-1 The structure of the MAC Header 
MAC destination MAC source Type Encapsulated  
(IP Packet) 
Cyclic redundancy check 
1 2 3 4 5 6 7 8 9 10 12 12 13 14 45- 1500 BYTES +1 +2 +3 +4 
            08 00        
3.1.5 Functional description of network protocol layers encapsulating 
DICOM   
The TCP protocol is a connection oriented, reliable, byte stream service encapsulated within the IP protocol, which is 
an unreliable, connectionless datagram delivery service. The MAC layer uniquely identifies the sending and 
receiving network card for the packet by their MAC addresses. A detailed discussion of TCP/IP networking is 
outside the scope of this thesis, and is covered adequately by a suitable textbook14 or internet resource15.  
3.1.6 Strategies for capturing network traffic 
A DICOM transmission involves a conversation between two DICOM applications that always requires bidirectional 
information flow. The information transmitted by DICOM from a CT to a RTPS may be just as important to finding 
a solution to a problem as the communication in the opposite direction. When DICOM application A communicates 
with DICOM application B there are three places that the data can be intercepted, the computer running application 
A, the computer running application B and the network in between. Intercepting the data at a computer running an 
application is the same regardless of which end it is, so there are in fact only two scenarios to consider, intercepting 
at a computer running a DICOM application or intercepting over the network. 
3.1.7 Intercepting DICOM traffic at a computer running a DICOM application 
If access is possible to either endpoint host computer, it may be possible to intercept the network traffic there. On a 
windows PC, use of either the ethereal network protocol analyzer6, or its successor wireshark16,17, has the advantage 
of a built in DICOM standard protocol analyzer. Alternatively if the endpoint is on a linux or unix system, the 
tcpdump18 utility is available. Provided that tcpdump is executed by a user profile with sufficient security privileges, 
this will allow all the network data to be saved to a file for later analysis. If the saved file cannot be extracted from 
the host system, then it is possible to create code on the host to review it on the system. The tcpdump binary saved 
file structure is not standardised but can be generalized19  as a 24 byte file header with 16 byte packet headers 
(essentially a time stamp and packet length preceding the record of each packet) comprising an additional layer of 
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encapsulation of the DICOM data. It is also possible, but extremely tedious, to decode the captured byte stream by 
inspection, using a hex editor.  
3.1.8 Intercepting traffic over the intervening network 
The IP protocol was designed for redundant transmission, and the path that packets follow through the network can 
change dynamically in response to network congestion. The TCP protocol will tolerate the arrival of packets out of 
order and by different routes. Fortunately a computer running a DICOM application is usually only connected to the 
network by a single network cable, through which all of the required information has to flow.  
A network hub is an Open Systems Interconnection (OSI) model (ISO/IEC 7498-1:199420) layer 1 device, which 
means it simply copies the data packets it receives to all devices connected to its ports, without discriminating on the 
basis of any of the information in the packets. Hubs are not often used in networks today because they are too slow, 
multiple ports cannot transmit at the same time, so the speed of the hub is reduced by the number of different ports. 
Most information technology technicians will have at least one unused hub gathering dust somewhere. If a hub can 
be interposed between the network and a computer running a DICOM application then all required data can be 
captured (Figure 3.1.7-1). Normally the computer running a DICOM application is connected to the network by a 
single patch cable. With the addition of two extra patch cables, a hub and a laptop running wireshark, the laptop can 
view all DICOM data to and from the computer running the DICOM application. Disconnecting the host from the 
network requires caution, most systems will tolerate being disconnected from the network temporarily as the 
Ethernet cable connections are changed but it may be necessary to reboot the host or hosts in a specific order to re-
establish connection if they do not. Once the hub is in place, a passive listening computer can be connected to one of 
the ports of the hub to capture the network traffic. A fast laptop computer running ethereal or wireshark is ideal for 
this purpose. 
The method above can be described as a hardware method for intercepting traffic; an alternate method put forward 
by Cook21 involves using a laptop with two network cards connected to interpose the laptop between the network and 
the DICOM application computer. A software bridge is then implemented on the laptop to allow transmission and 
surveillance of network traffic. This outcome is identical, but Cook’s method avoids the use of a hub, which is an 
advantage if the IT department controlling the network refuses to allow a hub to be connected.  
A passive observer has no control of the transmission rate, and can sometimes lose packets during a test of a transfer. 
The loss of these packets will be reported by the capturing software, and the simple solution to this is to repeat the 
test. DICOM packet sniffing does not require the same reliability as direct DICOM transmission. Only one clean 
recording of the network transmission is required to access the information transfer between the two DICOM 
applications. 
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Fig. 3.1.7-1 Interposing a hub 
between a DICOM peer and the 
network. If an older hub is used, the 
connection between the network 
point and the hub may require a 
crossover cable, rather than the 
standard straight-through patch 
cable22 
 
 
 
3.1.9 Filtering network traffic 
Wireshark allows the display of captured network data to be limited to DICOM standard  protocol packets. One way 
to do this is to enter the three letters “dcm” in the filter box (Figure 3.1.8-1) within the wireshark application 
environment. This instructs wireshark to decode the upper levels of the DICOM protocol and display the information 
in graphical form. If implementing wireshark is not possible, then a crude but effective bit/byte level algorithm to 
filter out the DICOM standard protocol byte stream in one direction for analysis is to move a 14 byte window 
through the recorded network traffic byte by byte, checking for a match to a suitable MAC header. This avoids 
coding for all possible network protocols to be able to pick out the DICOM byte stream. 
 
Once the TCP header layer has been stripped away and all the packet contents joined together, what remains is a two 
way byte stream communication that is completely specified by the DICOM standard. There is a strict sequence to 
this communication; the reaction of one endpoint cannot begin until the prompting action from the other endpoint has 
finished. The rules for this sequence are defined in part 8 of the DICOM standard, Network Communication Support 
for Message Exchange, which defines the DICOM Upper Message Layer. The basics of these rules are described in 
the next section. 
Fig. 3.1.8-1 Wireshark allows 
automatic display limited to 
DICOM standard protocol 
packets, just by entering “dcm” 
in the Filter box 
. 
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3.1.10 DICOM Upper Message Layer  
All DICOM communications begin with the initiator sending an association request. The association request includes 
the Application Entity Titles of the sender and the receiver. The receiver then sends back an association request 
response. The forming of an association can be thought of as a negotiation about what services will be provided and 
how they will be named and encoded. Once an association is formed, the DICOM Upper Message layer “P-DATA-
TF” messages can be used to send encapsulated DICOM Messages, which carry all DICOM communication other 
than that involved in forming and ending DICOM associations, jointly referred to as the DICOM Message Layer.  
3.1.11 DICOM Message Layer  
The DICOM message layer is encapsulated within the presentation-data-value items of the DICOM Upper Message 
Layer. These encapsulation rules are specified in DICOM Part 8 Appendix E. All DICOM messages encapsulated 
within a Presentation-Data-Value Item address the presentation context defined within that item. DICOM messages 
are either data or command messages and are fragmented. Each fragment is preceded by a one byte header that 
designates if it is the last fragment of the message, and whether it is a command or data fragment. 
3.1.12 DICOM Information Objects  
All data transmitted within DICOM messages is comprised of information objects, whose structure and meaning is 
defined within part 3 of the DICOM standard, Information Object Definitions. An IOD used to represent a single 
class of Real-World Objects is called a Normalized Information Object.  An IOD which includes information about 
related Real-World Objects is called a Composite Information Object. DICOM Print is a normalised information 
object, as is DICOM store. DICOM query retrieve is a composite information object.  
3.1.13 Statement of Hypotheses 
Having described the theoretical basis, three hypotheses are advanced in respect of Radiotherapy DICOM Packet 
Sniffing. 
The first hypothesis is that there are a class of DICOM problems in a multi-vendor environment for which DICOM 
packet sniffing provides a method for identifying which vendor (or both or neither) is at fault. This hypothesis will 
be demonstrated practically by example with reference to the PACS scenario. 
The second hypothesis is that for a subset of the problems from the first hypothesis, it will be possible to implement 
a solution with local resources. The second hypothesis will be demonstrated practically by example with reference to 
the second example, the planning computer/CT interaction problem. 
The third hypothesis is that for a subset of the problems from first hypothesis, DICOM packet sniffing provides the 
only practical method for classifying the problem. This third hypothesis will be demonstrated by the third example, a 
problem involving a DICOM printer and a Radiotherapy Simulator. 
 
Absent from this list is the hypothesis that DICOM packet sniffing allows all DICOM problems to be classified, 
either on its own or in concert with other techniques. Unfortunately the DICOM protocol provides no prescribed 
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mechanism for determining DICOM compliance, rendering such a hypothesis strictly un-provable. Practical efforts 
to approach such a mechanism, such as the Dicom Verification Toolkit56 (DVTk), are large collaborative endeavors 
beyond the scope of this work.  
3.2 PACS 
This section details an extended incident at the Alfred Hospital that occurred when the PACS system was upgraded, 
but it will be seen that the underlying problem was potentially global in scope. Although the new PACS version was 
named as an upgrade to the prior version, commercial acquisitions meant that the two versions were completely 
different products and the process was a roll out of a new PACS system in all but name. The incident was not a drill, 
nor was it any way contrived. Excerpts from the record of the incident as it happened are put in italic in this section, 
and are given in chronological order, immediately following the appropriate technical considerations. 
3.2.1 PACS INSTALLATION 
Rollout of a PACS system is a major project for a hospital. The first step in acquiring a PACS for any healthcare 
enterprise involves performing a workflow analysis, and documenting user requirements23. Budgeting for such a 
project should include some provision to deal with interfacing problems24. It is recommended that the project be 
driven by multi-disciplinary steering committee with clinical, administrative and technical representation, a detailed 
and comprehensive implementation plan, and a staged installation25. PACS is considered a mission critical system 
for around-the-clock daily clinical operation26. When an older PACS is already in use, it may need to be run in 
parallel with the new system for months before reliable implementation of the new PACS is achieved27.   
One day in 2007 a radiation therapist from WBRC attempted to load an MRI scan into the Eclipse treatment 
planning system from the hospital PACS using the Eclipse PACS query retrieve software, following a documented 
procedure that had been used successfully many times before  The PACS database reported that there was no patient 
with that name in the database. The therapist then accessed the PACS database directly using a PACS web browser 
application and was able to display, but not import, the required patient images. When the discrepancy was reported 
to the PACS administrator, the therapist was informed that the hospital had upgraded the PACS system three months 
prior, and the database associated with the old PACS version was no longer being updated. The PACS administrator 
informed the therapist that they would need to query the new database to obtain the information. 
3.2.2 PACS query retrieve 
Prior to the implementation of PACS query retrieve service, image data was transferred directly from imaging 
modalities to the radiotherapy treatment planning system by a DICOM C-Store initiated by the imaging modality 
operator from the operating console. This transfer was often prompted by a phone call from a radiotherapy treatment 
planner, sometimes could not be initiated while the imaging modality was in an imaging session, and from time to 
time might need to be repeated. The images might also be requested after they had been archived, necessitating the 
retrieval of the images from backup media optimized for storage capacity at the expense of speed of access. The 
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image transfer could be made to work in clinical practice, but it was inefficient and frustrating for all concerned. 
Within the wider hospital, digital imaging modalities were often printed out and transported for review as films. This 
was a workable but inferior system, films were sometimes lost and always difficult to transport in an efficient and 
timely manner. Only a fraction of the digital image information could be recorded on film, and the rendering needed 
to be decided prior to printing, which was often prior to review.  
When PACS systems were introduced in imaging departments, the almost universal approach was to archive all 
images to the PACS system immediately after their acquisition, generally as an automated process that required no 
intervention from the imaging modality operator. The advent of remote query allowed the RTPS operator to use a 
query retrieve client to retrieve image data from the PACS immediately they became aware that the information was 
required. The superior efficiency of the remote query system allowed human resources to be re-allocated to higher 
priority planning tasks, at which point direct image transfer became a practical impossibility, and remote query 
became an essential network service that the radiotherapy department could not function properly without. In the 
wider hospital, digital images were reviewed on demand through PACS with adjustable information rendering. The 
Alfred Hospital Radiology Department, together with GE Healthcare Technologies, received a high commendation at 
the Victorian Engineering Excellence Awards for the first PACS system in 200528. 
 
With the assistance of the hospital PACS administrator, the Eclipse treatment planning system was reconfigured to 
access the new PACS database.  Although this made it possible to correctly browse the available patients, studies 
and series, whenever the primary function of retrieving a series to the radiotherapy treatment planning system was 
attempted, the remote query client returned a message that none of the selected objects could be imported. 
3.2.3 PACS RESPONSIBILITIES 
The question as to whether and to what extent medical physicists should assume PACS responsibilities was the 
subject of a point/counterpoint discussion in Medical Physics in 200229. Arguments for PACS responsibilities see the 
Medical Physicist as bridging gaps between information technology and PACS. Arguments against involvement are 
that it is for a Medical Physicist a distraction from the main task.  
A network analyst from the hospital IT department monitored the network traffic between the radiotherapy treatment 
planning system and the PACS server using ethereal6. They were able to observe that the radiotherapy treatment 
planning system was able to open a TCP session with PACS server and that TCP packets were reliably transmitted 
within that session. The hospital IT department indicated that their role was limited to support of network 
communication down to the level of TCP communication, and that in consequence they had no further responsibility 
or role in correcting the problem.     
3.2.4 PACS fault tracing using packet sniffing 
The network traffic between a RTPS (Varian Eclipse DICOM Query Retrieve Service V7.3) and a PACS (GE 
Centricity PACS 3.0, GE Healthcare Information Technologies, Mount Prospect, IL, USA) was captured by 
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interposing a network Hub between the RTPS and the network. A laptop running wireshark (Version 0.99.8) was 
used to capture the DICOM byte stream. Annotated screen dumps were compiled recording the user actions and the 
subsequent DICOM communication to and from the PACS.  
3.2.5 Sequential Details of the query/retrieve process 
In this section the query retrieve process as it appeared to the radiotherapy treatment planning system user is 
represented in 15 illustrated stages (Figures 3.2.5-1 to 3.2.5-7). Radiotherapy DICOM packet sniffing enabled the 
DICOM information exchange to be determined at each stage, and a brief description of this is given at each stage. 
 
Stage One: 
The user left clicks the mouse to select menu option “File”, then “Import”, then holds the left mouse button down 
without releasing it on the “Wizard…” option. There is no DICOM activity, but the RTPS displays the highlighted 
choice as shown in Figure 3.2.5-1. 
Fig. 3.2.5-1 There is no 
DICOM activity, but the 
RTPS displays the 
highlighted choice as the 
Import Wizard. Patient 
names have been obscured. 
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Stage Two: 
The user releases the left mouse button to complete the selection of the Import “Wizard…” option. There is no 
DICOM activity, but the RTPS opens the Import Wizard Filter window as shown in Figure 3.2.5-2 below. 
Fig. 3.2.5-2 There is no 
DICOM activity, but the 
RTPS opens the Import 
Wizard:Filter Selection 
Window. 
 
 
 
 
 
 
Stage Three: 
The user clicks and releases the left mouse button to select the “PACS Query Retrieve Service”. There is no DICOM 
activity, but the RTPS updates the Import Wizard Filter Selection Window to show the selection of the “PACS 
Query Retrieve Service” by highlighting it. All of the parameters required for the initiation of a DICOM association 
with the PACS have now been set, and await only user confirmation by clicking the “Next” button. 
 
Stage Four: 
The user clicks the “Next” button with the left mouse button to confirm the selection of the “PACS Query Retrieve 
Service”. This is immediately followed by the first DICOM activity. A TCP session is opened, and within it the 
client sends a DICOM association request and the PACS server responds with a DICOM association acceptance 
(This DICOM activity is analysed byte by byte in section 3.2.12). Subsequent to the DICOM association request 
being received, the “Import Wizard:DICOM Query Retrieve Service (V7.3) : Patient Selection” window opens in the 
Eclipse display, as shown in Figure 3.2.5-3. 
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Fig. 3.2.5-3 Subsequent to the DICOM 
association request being received, the 
“Import Wizard:DICOM Query Retrieve 
Service (V7.3) : Patient Selection” window 
opens in the RTPS display. The Local 
Application Entity Title “VDCM_E6” is a 
hardwired property of the RTPS. The Remote 
Application Entity title “GEPACSD034”, is 
a property of the PACS system that is 
specified in the configuration of the “PACS 
Query Retrieve service” in the RTPS, which 
is sent to the PACS system as part of the 
association request. 
Stage Five  
The user enters the patient ID, a numeric string, in this case seven digits NNNNNNN. There is no DICOM activity, 
because the name has not been confirmed. The RTPS display is updated to show the unconfirmed entered data.  
 
Stage Six 
The user clicks the left mouse button over the “Update List” button to confirm the patient name. The client sends a 
query retrieve at study level and the PACS server returns a C-FIND RSP. The RTPS display is then updated to 
display the matching patient name, and patient ID.  
 
Stage Seven 
RTPS User Action: The RTPS User selects the available patient and clicks on the next button. The client sends a 
query retrieve at study level and the PACS system sends back a C-FIND RSP containing a list of available studies 
for the selected patient. On the basis of this information, the RTPS display is updated to show a layered of the 
patient(s) and available studies. 
 
Stage Eight 
The RTPS User left clicks the mouse button on the single available study. The client sends a query retrieve at study 
level to the PACS. The PACS sends back a number of packets comprising a C-FIND RSP at study level, which 
contains a list of available series for the selected study. The RTPS display is updated to display these series as a 
layered list of the patient(s), study (studies), and series as shown in Figure 3.2.5-4. 
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Fig. 3.2.5-4 The RTPS display is 
updated to show a layered list of the 
patient(s), study (studies) and 
available series, in this MRIs. The 
patient name and ID have been 
obscured.  
 
 
 
 
 
 
 
Stage Nine 
The RTPS user left clicks the mouse on the required series to make an unconfirmed choice of the required 
information. As the choice is unconfirmed, there is no DICOM activity. The only action is an update of the RTPS 
display to highlight the selected series. 
 
Stage ten 
The RTPS user clicks on the “>>” button to confirm selection. The resulting DICOM activity is that the client sends 
a query retrieve at image level to the PACS server. Less than half a second later, the PACS system replies with a 
C_FIND RSP containing an A700 Out of Resources error. This is the reason that the two systems will not 
communicate. The A700 Out of resources error is not described in this context within the PACS DICOM 
conformance statement, but it is defined as a major fault by the GE DICOM conformance statement30. The client 
sends a query, and the PACS system replies with an error. The RTPS display is updated to show a layered list of 
patient(s), study(studies), series and no images on the right hand side of the display, as shown in Figure 3.2.5-5. 
 
Fig. 3.2.5-5 The RTPS display is updated 
to show a layered list of patient(s), 
study(studies), series and no images on the 
right hand side of the display. The patient 
name and ID have been obscured. 
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Stage Eleven 
The RTPS user selects a series on the right pane, making an unconfirmed selection of the series that is to be 
retrieved. There is no associated DICOM activity, because the choice has not been confirmed. The only action is that 
the RTPS display is updated to show that the series has been highlighted. 
 
Stage Twelve 
The RTPS user clicks the left mouse button on the next button to confirm the selected series for retrieval. The 
DICOM activity that results is that the client sends a DICOM Association Release Request to the PACS Server and 
the Server responds with a DICOM release response. Subsequently the RTPS displays an “Import/Export Summary” 
window, as shown in Figure 3.2.5-6. 
  
Fig. 3.2.5-6 After the user 
selects the next button, the 
RTPS displays an 
“Import/Export Summary” 
window.  
 
 
STAGE Thirteen 
The RTPS User now selects the show details button to see why the images could not be loaded. There is no DICOM 
activity. The RTPS display opens a “Log Details” window. This window is blank regardless of the selections made 
with regard to what is displayed. 
 
STAGE Fourteen 
The Eclipse user clicks the OK button in the “Log Details” window. The resultant DICOM activity is that the client 
sends a DICOM Association request to the PACS system, and the PACS system sends back a DICOM association 
acceptance. The Eclipse display goes back to the image selection stage. 
 
STAGE Fifteen 
The Eclipse user clicks the cancel button to abandon the unsuccessful attempt to import the images. The resulting 
DICOM activity is that a DICOM release request is sent by the client to the PACS server. The PACS server replies 
with a DICOM release response. The Eclipse display reverts back to the Eclipse main window from which the import 
wizard was initially launched in stage one, as shown in Figure 3.2.5-7. 
Fig. 3.2.5-7 The RTPS display reverts back to the 
RTPS main window from which the import 
wizard was initially launched in stage one. 
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It is instructive to review the description of steps 1-15 and look at figures 3.2.5-1 to 3.2.5-7 in turn and note that 
without the DICOM activity description, there is no information in the on screen display or the software logs that 
might allow the user to determine why the transfer did not work.  
3.2.6 Summary of the query/retrieve process 
The PACS responded to every image level query from the RTPS with an out of resources error. A summary of the 
DICOM interaction that led up to this is given in Table 3.2.6-1. The A-ASSOCIATE-AC message sent by the PACS 
included notification of the PACS application implementation class unique identifier as 1.2.840.113619.6.94; this 
identifier is also specified in the PACS conformance statement and is unique to the PACS. Effectively in this case it 
is a “digital fingerprint” that proves that it was the PACS that sent the “out of resources” error. The sending of the 
error code effectively meant that image retrieval was not possible because information on the images within the 
PACS could not be obtained. The RTPS formed an association with the PACS with three presentation contexts, of 
which only one, 1.2.840.10008.5.1.4.1.2.2.1 Study Root Query/Retrieve Information Model – FIND, was referenced 
in the subsequent DICOM information transfer. The PACS responded correctly to queries referencing this 
presentation context at study and series level, but always returned an A700 error when queried at image level. The 
appearance of the A700 error within the wireshark interface is shown in Figure 3.2.6-1. An A700 error is defined by 
the DICOM standard in this context as an “OUT OF RESOURCES” error. The DICOM conformance statement of 
the PACS system30 only defines the meaning of an A700 error in the context of an image being sent to the PACS by 
another application, where it indicates that the PACS storage or database subsystem is not functioning.  
Fig. 3.2.6-1 The 
appearance of the 
A700 error in the 
wireshark interface. 
172.22.7.34 is the IP 
number of the PACS. 
  
Chapter 3: Information transfer  
148 
Sender Action or Message  Information transfer summary 
RTPS A-ASSOCIATE-RQ   
PACS A-ASSOCIATE-AC   
USER User enters patient ID   
RTPS C-FIND-RQ (Study) Query Patient Name that matches Patient ID. 
PACS C-FIND-RSP Matching patient name returned. 
USER User selects patient.   
RTPS C-FIND-RQ (Study) Query Study UIDs that match Patient Name 
PACS C-FIND-RSP Matching study UIDs returned. 
USER User selects study   
RTPS C-FIND-RQ (Series) Query Series UIDs that match Study UID 
PACS C-FIND-RSP Matching series UIDs returned. 
USER User selects series   
RTPS C-FIND-RQ (Image) Query Image UIDs that match Study UID and SERIES UID 
PACS C-FIND-RSP Status A700 “Cannot execute query” 
RTPS A-RELEASE-RQ   
PACS A-RELEASE-RP   
Table 3.2.6-1 RTPS user, RTPS and PACS sequential information transfer summary.  
3.2.7 The role of the PACS administrator in a PACS rollout. 
A skilled PACS administrator is the single most important element in a PACS rollout31. Knowledge of the DICOM 
standard and DICOM gap analysis are widely accepted as important skills for a PACS administrator32. Detailed 
knowledge of the query retrieve process, and DICOM troubleshooting are a standard part of PACS administrator 
training courses33. At the Alfred Hospital the PACS administrator was an employee of the hospital working within 
the Department of Radiology, which took overall responsibility for the new PACS implementation. 
 
When advised that PACS was returning an A700 error and the meanings documented for that error in the PACS 
DICOM conformance statement, the PACS administrator acknowledged that there was a compatibility problem, but 
refused to consider the possibility that the PACS system could be at fault, arguing that a fault in the PACS system 
was not possible because other query/retrieve clients could interact with it successfully. They went on to state that 
because the fault was not with the PACS, GE was not required to provide any support. The PACS administrator 
passed on information from the GE global data base of another instance of a compatibility problem between the 
VARIAN query retrieve service and the GE PACS that was never resolved. The PACS administrator indicated that 
GE had been instructed not to allocate any further resources to the problem, insisting that the error must have been 
returned by the VARIAN client because the A700 error was also documented within the VARIAN DICOM 
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conformance statement. The PACS administrator refused to consider a re-activation of the old PACS system, or to 
give any time frame in which communication with the new PACS system might be possible34.  
3.2.8 Details of the DICOM standard query retrieve specification. 
It is necessary at this point to explain some details of the DICOM standard specification of the query/retrieve process 
relevant to the DICOM information exchange. The query/retrieve service class is defined in Annex C of part 4 
(Service Class Specifications) of the DICOM standard. The VARIAN query/retrieve client is classed under the 
standard as the service class user (SCU), and the GE PACS is classed as the service class provider (SCP) of the 
Query/Retrieve service. There are two available information models specified by the standard for use with 
query/retrieve, the Patient Root Query/Retrieve Information Model, and the Study Root Query/Retrieve Information 
Model. The patient root model is based on a four tier hierarchy, where a patient (layer 1) has studies (layer 2), which 
have series (layer 3) which are composed of images (layer 4). The study root model omits the patient layer and so 
has only three layers. Attributes of patients, such as the patient name or the patient unique ID are considered to be 
attributes of studies in this model. The standard provides three operations for query retrieve, “C-FIND”, “C-MOVE” 
and “C-GET”. The VARIAN query/retrieve client uses only the C-FIND operation with study root model. An SCU is 
required to indicate a query retrieve level (DICOM element 0008,0052) as part of each C-FIND request. Under the 
study root model the level must one of “STUDY”, “SERIES”, or “IMAGE”. Note that the user interface of the 
VARIAN query/retrieve client appears to be a patient root hierarchical search, but is implemented using a study root 
DICOM information object definition. A C-FIND request at series level must only search a single study, so the C-
FIND request must contain information that uniquely identifies the study to be searched for series. A C-FIND 
request at image level must only search a search a single series within a study, so the C-FIND request must contain 
information that uniquely identifies the study and the series to be searched for images.     
The DICOM standard also specifies requirements for a C-FIND RSP from an SCP. The DICOM standard specifies 
that the SCP must search the PACS database hierarchically. For a series level query, it must first search the list of 
studies to find the study that is uniquely identified in the request. It must then search for matches to the request only 
amongst the series that belong to that study. This limits the scope of the search and the resources required to perform 
it. For an image level query, the SCP must first search the list of studies to find the study that is uniquely identified in 
the request. Secondly, the SCP must search only amongst the series that belong to study to find the series uniquely 
identified in the request. Finally, the SCP must then search for matches to the request, only amongst the images that 
belong to the uniquely identified single series. This limits the scope of the test and the resources required to perform 
it. 
The C-FIND response is required to include a status. A value of A700 designates a failure to execute the search by 
the SCP, due to a lack of resources. Possibilities are that the database is inoperable or that the search is too large to 
be executed. If a PACS system returned an A700 error it would be reasonable to expect that the error would be 
logged by the PACS. 
 
At a meeting between the radiotherapy department, the radiology department and GE, GE stated that they could not 
find any A700 error in the PACS log files. GE did agree to accept information on the error and gave assurances that 
they would of course investigate it. 
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3.2.9 Budgeting for PACS. 
A multidisciplinary approach is recommended when planning the PACS budget35. Implementing a PACS system can 
cost more than expected unless extraordinary care is taken when devising the budget36. Placing the PACS budget 
under the control of the Radiology department ensures a tight coupling to the primary clinical users, so that financial 
priority will be given to addressing the clinical requirements of Radiologists, which may be to the detriment of those 
using PACS within the wider hospital. Placing the PACS budget under the control of the information technology 
department will shift the financial priority towards adequate hardware capability at the expense of clinical software 
functionality. There are arguments in favour of both approaches37. 
 
When I consulted with the head of the radiotherapy department to determine possible resolutions of the problem, he 
pointed out that while the radiotherapy department had been a partial sponsor of the previous PACS system, the 
radiology department had negotiated with the hospital management directly to fund the new PACS project, and so 
radiotherapy had no input into the governance of the new PACS project. 
3.2.10 PACS contracts and DICOM conformance statements.   
Typically the PACS vendors DICOM conformance statement forms part of the contract for the project. The DICOM 
standard part 2: Conformance specifies what a DICOM conformance statement is required to have in it. Although 
there are choices for vendors to make in determining what services they will offer and support, all PACS 
implementation are required to support remote query. Support of remote query requires support for queries at all 
levels of the information model. Additionally, support of remote query requires implementation of the hierarchical 
search algorithm mentioned in section 3.2.8 above, exactly as the DICOM standard defines it in part 4 of the DICOM 
standard.  
 
When I met with the head of the radiology department, he indicated that he had been given to understand that it was 
the way in which the VARIAN client software was making the query/retrieve that was causing the problem. He said 
that he understood that queries from the VARIAN query retrieve client attempted to search the entire PACS archive 
and consumed more memory resources than any PACS system could possibly provide. 
3.2.11 Query/Retrieve extended negotiation 
The DICOM standard also specifies an optional relational query retrieve service available through extended 
negotiation. The service is optional in the sense that only if both the SCU and the SCP support relational query, and 
if it is requested and accepted when an association is formed as part of extended negotiation, is the service required 
to be supported. Whereas in the hierarchical search, elements at all levels above the level of the query must be 
specified uniquely, in a relational query this restriction is removed. Relational queries can include any information at 
any level to be matched. For a relational query, the DICOM standard does not specify the search algorithm. PACS 
systems are expected to compete to implement faster relational queries using specialized algorithms. Clause 6.1.2.3.1 
of the new PACS DICOM conformance statement specifically states that only hierarchical query is supported, no 
relational query is supported. Image level relational queries can potentially be too large for a PACS to handle.    
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3.2.12 Association Negotiation 
As mentioned in section 3.1.10, all DICOM communications begin with association negotiation. It is instructive to 
review the details of the association negotiation when the VARIAN Q/R Client software forms an association with 
the GE PACS. As indicated in table 3.2.6-1, the client sends an A-ASSOCIATE-RQ and the PACS replies with an 
A-ASSOCIATE-AC. By reviewing the contents of these two DICOM upper message layer elements in detail, it can 
be seen whether any extended negotiation took place to allow the implementation of a relational Q/R service. It is 
useful also as an example to see what sort of information sniffing the association can determine. 
 
The ASSOCIATE-RQ is carried by a single packet, 372 bytes long, shown in Figure 3.2.12-1. Each element of this 
packet is reviewed below. Hexadecimal values are given the suffix “H” when mentioned in the text. Thus the first 
byte of the packet is 00H. Each of the first occurrences of the 18 different logical elements of which the 
ASSOCIATE-RQ is made up will be listed and explained. 
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00 00 0C 07 AC 02 00 0D 56 27 F1 C1 08 00 45 00 
01 66 58 43 40 00 80 06 2B 94 C0 01 02 81 AC 16 
07 22 04 F9 10 04 A8 75 F4 5B 0A DA EA FB 50 18 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
47 45 50 41 43 53 44 30 33 34 20 20 20 20 20 20 
56 44 43 4D 5F 45 36 20 20 20 20 20 20 20 20 20 
00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 
00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 
10 00 00 15 31 2E 32 2E 38 34 30 2E 31 30 30 30 
38 2E 33 2E 31 2E 31 2E 31 20 00 00 38 05 00 00 
00 30 00 00 1B 31 2E 32 2E 38 34 30 2E 31 30 30 
30 38 2E 35 2E 31 2E 34 2E 31 2E 32 2E 32 2E 32 
40 00 00 11 31 2E 32 2E 38 34 30 2E 31 30 30 30 
38 2E 31 2E 32 20 00 00 38 03 00 00 00 30 00 00 
1B 31 2E 32 2E 38 34 30 2E 31 30 30 30 38 2E 35 
2E 31 2E 34 2E 31 2E 32 2E 32 2E 31 40 00 00 11 
31 2E 32 2E 38 34 30 2E 31 30 30 30 38 2E 31 2E 
32 20 00 00 2E 01 00 00 00 30 00 00 11 31 2E 32 
2E 38 34 30 2E 31 30 30 30 38 2E 31 2E 31 40 00 
00 11 31 2E 32 2E 38 34 30 2E 31 30 30 30 38 2E 
31 2E 32 50 00 00 2D 51 00 00 04 00 01 00 00 52 
00 00 14 31 2E 32 2E 32 34 36 2E 33 35 32 2E 37 
30 2E 32 2E 31 2E 35 55 00 00 09 56 4D 53 20 44 
43 5F 31 30 
 
1 MAC Header 10 Item-type 
2 Internet Protocol Header 11 Item-length 
3 TCP Header 12 Application-context-name 
4 PDU TYPE 13 Presentation-context-ID 
5 RESERVED BYTE 14 Abstract-syntax-name 
6 PDU-length 15 Transfer syntax name 
7 Protocol-version 16 Maximum length received 
8 Called-AE-title 17 Implementation Class UID 
9 Calling-AE-title 18 Implementation version name 
Fig. 3.2.12-1 The ASSOCIATE-RQ packet. Each square represents a byte from the byte stream, in order from left to 
right and then down the page. Each square contains a hexadecimal representation of the byte contents. Each 
different colour represents a different logical element within the packet.  
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Fig. 3.2.12-2 Element 1: MAC Header (First occurrence bytes 1-14) 
00 00 0C 07 AC 02 00 0D 56 27 F1 C1 08 00 45 00 
Decoding the MAC Header according to table 3.1.4-1 finds it to be composed of a destination MAC address 00-00-
0C-07-AC-02H,  which is the unique six byte address of the PACS network card, and a source MAC address 00-0D-
56-27-F1-C1H, which is the unique six byte address of the radiotherapy treatment planning system computer. The 
last two bytes are the Type field 08 00H to signify that the encapsulated data is an IP packet. 
Fig. 3.2.12-3 Element 2: Internet Header (First occurrence bytes 15-34) 
00 00 0C 07 AC 02 00 0D 56 27 F1 C1 08 00 45 00 
01 66 58 43 40 00 80 06 2B 94 C0 01 02 81 AC 16 
07 22 04 F9 10 04 A8 75 F4 5B 0A DA EA FB 50 18 
Decoding the Internet header according to table 3.1.3-1, Byte 15=45H gives the IP version as 4 and the length of the 
IP header as 20 bytes in total. Byte 16 00H indicates the Type of Service. Bytes 17-18=01 66H  indicates 358 bytes 
total length. Bytes 19-20=58 43H gives 22595 as the Identification number of the packet. Bytes 21-22 must be 
interpreted at bit level: 40 00H= 01000000 00000000 which gives Flags=010 (Reserved Bit, Not Set; Don’t 
fragment, Set; More Fragments, Not Set) and 00000 00000000 Fragment Offset=0. Byte 23=80H gives the Time to 
live as 128. Byte 24=06H designates the protocol set to TCP. Bytes 25-26=2B 94H gives the Checksum. Bytes 27-
30=C0 01 02 81H gives192.1.2.129 as the Source IP Address. Finally bytes 31-34=AC 16 07 22H gives 172.22.7.34 
as the Destination IP Address. 
Fig. 3.2.12-4 Element 3: TCP Header (First occurrence Bytes 35-54) 
07 22 04 F9 10 04 A8 75 F4 5B 0A DA EA FB 50 18 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
Decoding the TCP header using table 3.1.2-1 Bytes 35-36= 04 F9H gives 1273 as the Source Port. Bytes 37-38=10 
04H gives 4100 as the Destination Port. Bytes 39-42=A8 75 F4 5BH gives the Sequence Number. Bytes 43-46=0A 
DA EA FBH gives the Acknowledgement Number. Byte 47=50H must be interpreted at Bit level, 0101 0000 where 
0101=5 So 5x4=20 Bytes offset, 0000 are Reserved. Byte 48=18H gives the Flags as 0001 1000 (0 Congestion 
Window Reduced (CWR): Not Set; 0 ECN-Echo: Not set; 0 Urgent: Not set; 1 Acknowledgement: Set; 1 Push: Set; 
0 Reset: Not set; 0 Syn: Not set; 0 Fin: Not set) Bytes 49-50=44 70H gives the Window Size as 17520. Bytes 51-
52=4D D4H gives the Checksum. Finally Bytes 53-54=00 00H sets the Urgent Pointer. No options are defined 
because the Bytes offset indirectly indicated that there would be none. 
Fig. 3.2.12-5 Element 4: PDU TYPE (First occurrence Byte 55) 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
Value 01H indicates that this is the start of an ASSOCIATE-RQ PDU. (See table 9-11 in part 8 of the DICOM 
standard for the structure of an A-ASSOCIATE-RQ PDU, which governs the interpretation of downstream bytes.) 
Fig. 3.2.12-6 Element 5: RESERVED BYTE (First occurrence Byte 56) 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
The ASSOCIATE-RQ PDU structure requires this byte to be sent as 00H, but receiving applications are required to 
ignore this byte regardless of its value. 
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Fig. 3.2.12-7 Element 6: PDU-length (First occurrence Bytes 57-60) 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
The four bytes 00 00 01 38H specify a length of 312 bytes for the remainder of the data in the A-ASSOCIATE-RQ 
PDU. The encoding of a multi-byte integer in an ASSOCIATE-RQ PDU is big endian, in accordance with clause 
9.3.1 of part 8 of the DICOM protocol. 
Fig. 3.2.12-8 Element 7: Protocol-version (First occurrence Bytes 61-62) 
44 70 4D D4 00 00 01 00 00 00 01 38 00 01 00 00 
The value 00 01H specifies that the VARIAN DICOM query retrieve program supports version 1 of the DICOM 
Upper Layer protocol. 
Fig. 3.2.12-9 Element 8: Called-AE-Title (First occurrence Bytes 65-80) 
47 45 50 41 43 53 44 30 33 34 20 20 20 20 20 20 
A fixed 16 byte long field specifying the called AE-Title in ASCII, with leading and trailing blanks (20H) ignored. 
The called AE-Title is “GEPACSD034”. 
Fig. 3.2.12-10 Element 9: Calling-AE-title (First occurrence Bytes 81-96) 
56 44 43 4D 5F 45 36 20 20 20 20 20 20 20 20 20 
A fixed 16 byte long field specifying the calling AE-Title in ASCII, with leading and trailing blanks (20H) ignored. 
The calling AE-Title is “VDCM_E6”. 
Fig. 3.2.12-11 Element 10: Item-type (First occurrence Byte 129) 
10 00 00 15 31 2E 32 2E 38 34 30 2E 31 30 30 30 
The value of 10H for this item-type byte designates that the item following is an application context item. This marks 
the start of the variable items of the ASSOCIATE-RQ PDU. The variable items of the ASSOCIATE-RQ PDU are 
required to include a single application context. 
Fig. 3.2.12-12 Element 11: Item-length (First occurrence Bytes 131-132) 
10 00 00 15 31 2E 32 2E 38 34 30 2E 31 30 30 30 
This two byte integer gives the length of the following Application-context-name. The value is 21 bytes. 
Fig. 3.2.12-13 Element 12: Application-context-name (First occurrence Bytes 133-153) 
10 00 00 15 31 2E 32 2E 38 34 30 2E 31 30 30 30 
38 2E 33 2E 31 2E 31 2E 31 20 00 00 38 05 00 00 
The application context name is 1.2.840.10008.3.1.1.1, which defines version of the standard supported as being that 
described in the 2009 DICOM standard (and other previous versions). 
Fig. 3.2.12-14 Element 13: Presentation-context-ID (First occurrence Byte 158) 
38 2E 33 2E 31 2E 31 2E 31 20 00 00 38 05 00 00 
This single integer is required to be an odd number, and is used as a single byte code for this presentation context in 
later data interchange after association. 
Fig. 3.2.12-15 Element 14: Abstract-syntax-name. (First occurrence Bytes 166-192) 
00 30 00 00 1B 31 2E 32 2E 38 34 30 2E 31 30 30 
30 38 2E 35 2E 31 2E 34 2E 31 2E 32 2E 32 2E 32 
These 27 bytes designate the abstract syntax name as 1.2.840.10008.5.1.4.1.2.2.2 in ASCII, which is the Study Root 
Query/Retrieve Information Model – MOVE. 
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Fig. 3.2.12-16 Element 15: Transfer syntax name (First occurrence Bytes 197-213) 
40 00 00 11 31 2E 32 2E 38 34 30 2E 31 30 30 30 
38 2E 31 2E 32 20 00 00 38 03 00 00 00 30 00 00 
These 17 bytes comprise the transfer syntax 1.2.840.10008.1.2 which is the UID for Implicit VR Little Endian, 
which is the DICOM default transfer syntax. Applications are required to offer and support Implicit VR Little 
Endian, so the Varian DICOM query retrieve service is effectively offering the minimum allowed functionality. 
Fig. 3.2.12-17 Element 16: Maximum length received (First occurrence Bytes 332-335) 
31 2E 32 50 00 00 2D 51 00 00 04 00 01 00 00 52 
This 4 byte integer specifies the sending association’s (VARIAN’s) restriction on the maximum size in bytes of a 
single PDU that can be sent within the association. The value set is 65 536 bytes. 
Fig. 3.2.12-18 Element 17: Implementation Class UID (First occurrence Bytes 340-359) 
00 00 14 31 2E 32 2E 32 34 36 2E 33 35 32 2E 37 
30 2E 32 2E 31 2E 35 55 00 00 09 56 4D 53 20 44 
These twenty bytes designate the implementation class UID as 1.2.246.352.70.2.1.5, which is not a unique identifier 
defined by the DICOM protocol. It is defined in the VARIAN DICOM conformance statement. It uniquely identifies 
the calling software. 
Fig 3.2.12-19 Element 18: Implementation version name (First occurrence Bytes 364-372) 
30 2E 32 2E 31 2E 35 55 00 00 09 56 4D 53 20 44 
43 5F 31 30 
These nine bytes specify the implementation version name as “VMS DC_10”. This can be thought of as the software 
name and version of the VARIAN DICOM query/retrieve client software application. 
 
The A-ASSOCIATE-RQ then has the following information content. 
 
Called AE_Title: GEPACSD034 
Calling AE_Title: VDCM_E6  
Application Context:  1.2.840.10008.3.1.1.1 (2009 DICOM Standard) 
Presentation Context:  5 
• Abstract Syntax: 1.2.840.10008.5.1.4.1.2.2.2 (Study Root Q/R Model MOVE) 
• Transfer Syntax: 1.2.840.10008.1.2 (Implicit VR Little Endian: DICOM Default) 
Presentation Context: 3 
• Abstract Sequence: 1.2.840.10008.5.1.4.1.2.2.1 (Study Root Q/R Model FIND) 
• Transfer Syntax: 1.2.840.10008.1.2 (Implicit VR Little Endian: DICOM Default) 
Presentation Context: 1 
• Abstract Syntax: 1.2.840.10008.1.1 (Verification) 
• Transfer Syntax: 1.2.840.10008.1.2 (Implicit VR Little Endian: DICOM Default) 
User Info 
• Max PDU Length: 65536 
• Implementation UID: 1.2.246.352.70.2.1.5 
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• Version: VMS DC_10 
 
This could be loosely translated as “Would like to be able to be find and be sent images, as well as run a 
communication test, using the default DICOM transfer syntax”. 
 
The ASSOCIATE-AC from the PACS is also carried by a single packet, in this case 293 bytes long, shown in Figure 
3.2.12-20. Each new unique element of this packet is reviewed below. Hexadecimal values are given the suffix “H” 
when mentioned in the text. Thus the first byte of the packet is 00H. The first appearance of each new unique 
element will be listed and explained below.  
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00 0D 56 27 F1 C1 00 0A 8B 99 E7 FC 08 00 45 00 
01 17 C5 32 40 00 3E 06 00 F4 AC 16 07 22 C0 01 
02 81 10 04 04 F9 0A DA EA FB A8 75 F5 99 50 18 
77 C4 B2 18 00 00 02 00 00 00 00 E9 00 01 00 00 
47 45 50 41 43 53 44 30 33 34 20 20 20 20 20 20 
56 44 43 4D 5F 45 36 20 20 20 20 20 20 20 20 20 
00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 
00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 
10 00 00 15 31 2E 32 2E 38 34 30 2E 31 30 30 30 
38 2E 33 2E 31 2E 31 2E 31 21 00 00 19 05 00 00 
00 40 00 00 11 31 2E 32 2E 38 34 30 2E 31 30 30 
30 38 2E 31 2E 32 21 00 00 19 03 00 00 00 40 00 
00 11 31 2E 32 2E 38 34 30 2E 31 30 30 30 38 2E 
31 2E 32 21 00 00 19 01 00 00 00 40 00 00 11 31 
2E 32 2E 38 34 30 2E 31 30 30 30 38 2E 31 2E 32 
50 00 00 31 51 00 00 04 00 00 70 00 52 00 00 13 
31 2E 32 2E 38 34 30 2E 31 31 33 36 31 39 2E 36 
2E 39 34 55 00 00 0E 43 45 4E 54 52 49 43 49 54 
59 5F 33 2E 30 
 
1 MAC Header 12 Application-context-name 
2 Internet Protocol Header 13 Presentation-context-ID 
3 TCP Header 15 Transfer syntax name 
4 PDU TYPE 16 Maximum length received 
5 RESERVED BYTE 17 Implementation Class UID 
6 PDU-length 18 Implementation version name 
7 Protocol-version 19 non zero Reserved Bytes  
10 Item-type 20 non zero Reserved Bytes 
11 Item-length 21 Result/Reason 
 
Fig. 3.2.12-20 The ASSOCIATE-AC packet. Each square represents a byte from the byte stream, in order from left to 
right and then down the page. Each square contains a hexadecimal representation of the byte contents. Each 
different colour represents a different logical element within the packet. In order to ensure that a change in encoding 
instructions is always accompanied by a change in colour, where there are abutting reserved regions that are 
required to take different values, the non zero reserved bytes are coloured according to the source of the values that 
they must take.   
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Fig. 3.2.12-21 Element 4: Protocol Data Unit (PDU) type (First appearance Byte 55) 
77 C4 B2 18 00 00 02 00 00 00 00 E9 00 01 00 00 
Value 02H indicates that this is the start of an ASSOCIATE-AC PDU. (See table 9-17 in part 8 of the DICOM 
standard for the structure of an ASSOCIATE-AC PDU. 
Fig. 3.2.12-22 Element 5: PDU-length (First appearance Bytes 57-60) 
77 C4 B2 18 00 00 02 00 00 00 00 E9 00 01 00 00 
The four bytes 00 00 00 E9H specify a length of 233 bytes for the remainder of the data in the ASSOCIATE-AC 
PDU. The encoding of a multi-byte integer in an ASSOCIATE-AC PDU is big endian, in accordance with clause 
9.3.1 of part 8 of the DICOM standard. 
Fig. 3.2.12-23 Element 19: Reserved non zero bytes (First appearance Bytes 65-80) 
47 45 50 41 43 53 44 30 33 34 20 20 20 20 20 20 
This reserved field must be set to the value of the called AE-Title in the ASSOCIATE-RQ PDU, but receiving 
applications are required to ignore the value. The field is coloured the same as the called AE Title in the 
ASSOCIATE-RQ because it is required to equal that value, and to differentiate it visually from the preceding 
reserved bytes which are required to hold a NULL value. 
Fig. 3.2.12-24 Element 20: Reserved non zero bytes (First appearance Bytes 81-96) 
56 44 43 4D 5F 45 36 20 20 20 20 20 20 20 20 20 
This reserved field must be set to the value of the calling AE-Title in the ASSOCIATE-RQ PDU, but receiving 
applications are required to ignore the value. The field is coloured the same as the calling AE Title in the 
ASSOCIATE-RQ because it is required to equal that value, and to differentiate it visually from the preceding 
reserved bytes which are required to hold different values. 
Fig. 3.2.12-25 Element 21: Result/Reason (First appearance Byte 160) 
38 2E 33 2E 31 2E 31 2E 31 21 00 00 19 05 00 00 
The value of zero in this single byte integer indicates acceptance of the presentation context. 
Fig. 3.2.12-26 Element 15: Transfer syntax name (First appearance Bytes 166-182) 
00 40 00 00 11 31 2E 32 2E 38 34 30 2E 31 30 30 
30 38 2E 31 2E 32 21 00 00 19 03 00 00 00 40 00 
These 17 bytes comprise the transfer syntax 1.2.840.10008.1.2 which is the UID for Implicit VR Little Endian, 
which is the DICOM default transfer syntax. Applications are required to offer and support Implicit VR Little 
Endian, so the GE PACS is effectively supporting the default transfer syntax. 
Fig. 3.2.12-27 Element 10: Item-type (First occurrence byte 183) 
30 38 2E 31 2E 32 21 00 00 19 03 00 00 00 40 00 
The value of 21H for this item-type byte indicates that the following item is a presentation context within an 
ASSOCIATE-AC PDU.  
Fig. 3.2.12-28 Element 16: Maximum-length (First occurrence bytes 249-252) 
50 00 00 31 51 00 00 04 00 00 70 00 52 00 00 13 
This four byte integer further constricts the maximum length of a P-DATA-TF PDU sent by the association requestor 
(VARIAN query/retrieve service) within the association to 28,672 bytes  
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Fig. 3.2.12-29 Element 17: Implementation class uid (First occurrence bytes 257-275) 
31 2E 32 2E 38 34 30 2E 31 31 33 36 31 39 2E 36 
2E 39 34 55 00 00 0E 43 45 4E 54 52 49 43 49 54 
These nineteen bytes contain the implementation class UID of the association acceptor (The GE PACS): 
1.2.840.113619.6.94, which matches the UID found in section 2.3.6.4 of the GE conformance statement.30 
Fig 3.2.12-30 Element 18: Implementation version name (First occurrence Bytes 280-293) 
2E 39 34 55 00 00 0E 43 45 4E 54 52 49 43 49 54 
59 5F 33 2E 30 
These fourteen bytes contain the implementation version name of the GE PACS, “CENTRICITY_3.0”. 
 
The A-ASSOCIATE-AC then has the following information content. 
 
[Called AE_Title]:   GEPACSD034 
[Calling AE_Title]:   VDCM_E6 
Application Context:    1.2.840.10008.3.1.1.1 (2009 DICOM Standard) 
Presentation Context Reply 
• Presentation Context ID: 5 
• Result:    0 (Accept) 
• Transfer Syntax:   1.2.840.10008.1.2 (Default DICOM transfer syntax) 
Presentation Context Reply 
• Presentation Context ID: 3 
• Result:    0 (Accept) 
• Transfer Syntax  1.2.840.10008.1.2 (Default DICOM transfer syntax) 
Presentation Context Reply 
• Presentation Context ID: 1 
• Result:    0 (Accept) 
• Transfer Syntax:  1.2.840.10008.1.2 (Default DICOM transfer syntax) 
User Info 
• Max PDU LEGTH:  28672 
• Implementation UID:  1.2.840.113619.6.94 
• Version:   CENTRICITY_3.0 
 
Which could loosely be translated as a message back from the PACS  saying “I will support query and move 
instructions under a three tier hierarchy of study, series, and image, and I will respond appropriately to a test 
(verification) call; all using the default communication rules”. 
  
The new PACS conformance statement indicates that the application entity titles are checked and rejected if not 
correct at the time an association is formed. The most common fault in DICOM communications is that the DICOM 
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peers are not correctly configured with each others application entity title and so fail to form an association. The 
above section shows that an association was formed and so the application entity titles are correctly configured. 
 
Three months later GE suggested that the fault was due to the wrong application entity title being specified for the 
VARIAN Query retrieve service38. 
 
3.2.13 OFFIS DICOM Toolkit:FINDSCU  
The OFFIS DICOM Tool Kit39 is a collection of libraries and applications implementing large parts of the DICOM 
standard that is freely available for down load40. In particular, an application called FINDSCU is available, which 
implements a service class user for the query retrieve service class. FINDSCU can be used to test service class 
providers of the query/retrieve service class. 
Using FINDSCU to test the response of a query/retrieve service class provider in place of a clinical application is 
useful for a number of reasons. Firstly, FINDSCU is a very flexible application. The command line syntax allows 
full control of the match criteria and the ability to select between the patient root or study root information model, 
which is not always possible with clinical applications. This flexibility allows investigation to determine the scope of 
a fault. By making arbitrary changes in the match criteria, it may be possible to determine an element in the match 
criteria that provokes the fault. Additionally, by varying the information model under which the query is made, it 
may be possible to determine if the fault is restricted to a particular information model. 
The second use for FINDSCU is to implement a local solution. If a way can be found to successfully query the 
clinically required information using FINDSCU, perhaps with a slightly different set of match criteria or under the 
alternative information model, it may be possible to quickly build up an alternative application based on OFFIS 
applications that may provide the clinically required functionality. This approach is not far fetched, it will be 
demonstrated in practice in section 3.3. It is also important to note that OFFIS DICOM Toolkit applications form the 
backbone of many commercial DICOM related applications. 
The third purpose served by the use of FINDSCU arises from the very fact that FINDSCU is a mature application39; 
showing that a fault persists when FINDSCU is utilized adds weight (if not rigor) to the suggestion that the service 
class provider may not be DICOM conformant. 
The remainder of this section summarizes 14 separate queries (Q1-Q14) made of the GE PACS using FINDSCU. 
These queries were made by loading the FINDSCU application on to the Eclipse planning computer and executing 
the queries from the command line prompt. The destination port and IP address were specified to match those used 
by the Q/R service (VARIAN Eclipse DICOM Query Retrieve Service V7.3, Varian Medical Systems, Palo Alto, 
USA); and since the queries were made from the same computer with the same IP address, the network traffic was 
identical to that of the clinical system for the MAC layer, IP layer and TCP layer. This had the added benefit of 
enabling the testing of the PACS system without requiring any resources from the PACS administrator or the 
hospital IT department. During association negotiation, however, differences emerge as FINDSCU transmits a 
different application entity UID. The full description of each query (given in appendix A.3.2.13-1) begins with an 
enumeration accompanied by an explanatory title, followed by the exact syntax of the command line FINDSCU 
query (Although where necessary, the patient UID is represented as XXXXXXX). The query syntax is followed by a 
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short description of the motivation for making the query test, which also summarizes the salient points of the query 
configuration. DICOM packet sniffing was used to decode the information that passed between the two applications, 
from which the match query information content and the PACS reply (if any other than an error message) are 
summarized in tabular format (Where necessary, the patient name is represented as NNNNNN and the patient UID is 
XXXXXXX). The tabular listing of the match query information is headed with a stipulation of whether the query 
was made under the study root information model (Option –S in the command line) or the patient root information 
model (Option –P in the command line)  The description of each query concludes with a progressive analysis of the 
observed responses. Following query fourteen the section is concluded by the final excerpt from the record of the 
actual incident. 
 
Query One: The first query was the simplest, safest query of the PACS, amounting to a request of the PACS to find 
all studies that matched the patient ID. It is a replication of the DICOM query sent to the PACS by the VARIAN 
DICOM query/retrieve application at stage six of the sequential details representation in section 3.2.5, to which the 
PACS response was known. The PACS responded correctly as expected. 
 
Query Two: The second query was a request of the PACS to find all studies for a particular patient. The PACS 
responded correctly as expected. 
 
Query Three: Conformance requires that the PACS must not include information that is not requested. When queried 
in a particular way to find all the studies for a particular patient, the PACS response included the patient ID and the 
series UID, even though this information was not requested. This was clear evidence of the PACS not being fully 
DICOM compliant. 
  
Query Four: This test was inconclusive. A deliberately non compliant image level request was made of the PACS, 
and the PACS returned an error.  
 
Query Five to Nine: These were five different but fully compliant simple image level queries. The query includes a 
specified Study UID, and a specified Series UID. The PACS responded to all of them with an error. This indicates 
non compliance to the DICOM standard. If the PACS cannot respond to image level queries, it is of no functional 
use for transferring information to the radiotherapy system.  
 
Queries Ten and Eleven: These were two different, non compliant image level queries, tried just in case the PACS 
would respond to a non compliant image level query. The PACS returned an error message in both cases. 
 
Query Twelve: This was a non compliant image level query. The purpose was an attempt to test whether the PACS 
was implementing the mandated hierarchical search algorithm, and if it was not, to attempt to exploit this non 
compliance to obtain image level information. The PACS simply gave an error message to this query, so the attempt 
failed. The error message returned suggested that the PACS incorrectly attempted to execute a relational search.  
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Query Thirteen: To test if the PACS was implementing a relational search algorithm, a query was made at series 
level, without any specific information about which study the series was in. Under the mandated hierarchical search, 
this is a non compliant query with no result. The PACS found one series, a result that is consistent with the PACS 
implementing a relational search. 
 
Query Fourteen: The final test was to include some image level data in a series level query. The PACS returned an 
error, which is consistent with a relational search. 
 
All attempts to obtain image level data failed, and this made it impossible to construct a query retrieve at image level 
using FINDSCU as a building block. The fact that the queries with FINDSCU also received error messages from the 
PACS provides a direct rebuttal to the erroneous suggestion that the PACS was fully DICOM conformant because it 
could interface with all other query retrieve implementations in the hospital.  
All of the observations were consistent with the PACS being unable to handle image level queries because it was 
ignoring the scope of the hierarchical query. This would mean all image level queries were mishandled as queries of 
the entire database, and thus too large to be executed without an error. If this was the case, as the size of the database 
grew, a point would be reached where queries at series level would fail. This had potential implications for the 
potential sudden failure of other query retrieve applications within the wider hospital that might be relying on series 
level query retrieve. This did not help to resolve the problem directly, but I was obliged to inform the Director of 
Radiology about the likelihood of this possibility. 
 
I sent the head of radiology an email outlining the concern that the PACS might in the near future fail to respond to 
queries at series level, suggesting that from a risk management point of view it would be prudent to enquire with the 
vendor in writing as to what elements of the PACS implementation were dependent upon series level query. The head 
of radiology acknowledged appreciation of the concerns by email.41 
 
On 5/3/2008 more than three months after the fault was reported the PACS was observed to respond correctly to 
image level queries. No information concerning this change in behavior of the PACS was received. 
3.2.14 Aftermath 
In the wake of these events, the final question that must be addressed is why the incident occurred. Specifically, why 
was the radiotherapy centre without warning unable to query the PACS system for more than three months? There 
were many contributing factors apart from the non DICOM conformance of the PACS query/retrieve service.  
The Alfred Hospital, as an organization, contributed in not being cognizant of the importance to the radiotherapy 
centre of the ability to query retrieve images from the previous PACS system. The radiotherapy centre could perhaps 
have tried harder to make the hospital administration aware of the importance of their access to PACS, and the 
Radiology department should perhaps have been better aware of who its clients were, but the major deficiency was in 
the administration of the previous PACS system. It is not possible to set up a remote query service without the 
cooperation of the PACS administration, and the PACS administration should have kept records of the remote query 
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access configuration of the old PACS and passed that information on to the group planning the roll out of the new 
PACS system. 
Although the old PACS system was maintained in parallel to the new PACS system, access to the PACS system 
could have been monitored for residual access which would have alerted the PACS installation team to the continued 
dependence of the radiotherapy department on the old PACS system.  
There was of course a technical problem in the DICOM conformance of the new PACS system. The new PACS, as 
originally installed, was not DICOM compliant. It did not support remote query. It did not implement the mandated 
hierarchical search. The service it did provide appeared to be equivalent to a relational query retrieve service.  
The VARIAN query retrieve client, although fully compliant for routine queries, did not handle the A700 error from 
the PACS appropriately. There was no information provided to the user that the A700 error had been received, and 
the VARIAN query retrieve log file did not record the A700 error, or indeed any events at all in the failed 
communication. The application simply behaved as if it had been asked to import a NULL list of images. 
The response of the radiation therapist operator to the fault deserves commendation. They established immediately 
that the patient information existed in the PACS database, so that it was very quickly determined that the client was 
querying the wrong database. The Alfred Hospital PACS administrator, however, lacked adequate training. Packet 
sniffing and knowledge of the DICOM protocol are both areas of expertise that feature in PACS administrator 
courses33 and are considered important skills for the PACS administrator to have within the PACS administrator 
community32. 
There are some aspects that cannot be resolved, due to an absence of quality information provided by the vendor. No 
reliable conclusion can be reached as to whether the PACS log contained any record of the A700 error. No reliable 
conclusion can be reached as to what caused the non DICOM compliance of the new PACS. It is not known if the 
fault was specific to the site or a fundamental design flaw of the PACS worldwide. The fact that the vendor reported 
a similar problem at one other site suggests that the problem occurred at at least two independent sites. There 
continue to be reports of problems with query retrieve for the PACS42, some users are dissatisfied with the vendor 
response43, but this could be said of most commercial PACS applications, and this information is not sufficient to 
support a conclusion on the scope of the problem. 
In summary it would be fair to say that the digital communication problems were mirrored by human communication 
problems. The digital communication problems took three months to resolve. The organizational culture problems 
continue to this day to retard the provision of adequate digital imaging management and electronic medical record 
management at the Alfred Hospital44,45. This problem is not unique to the Alfred, similar problems have been 
documented elsewhere in Australia46. The political dimension of the problem cannot be ignored, but the focus of this 
work is the technical aspect, which continues in the next section with an example of a new CT scanner unable to 
connect to a radiotherapy treatment planning system. 
3.3  CT SCANNER 
This section details an incident where a new CT scanner was found to be unable to communicate with a radiotherapy 
treatment planning system. The CT scanner was the first in Australia of the particular model. The vendors each 
suggested the non-compliance of the other’s equipment. There was a great deal of pressure to fix the problem quickly 
because the radiotherapy treatment planning workload had mounted up while the new CT was being installed. 
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3.3.1 Objective, Procedures, Equipment and Results 
The objective was to find out why a CT (Philips 16 slice Brilliance wide bore CT scanner47 , Philips Medical 
Systems, Cleveland, OH, USA) could not send images directly to an RTPS (Varian Eclipse, Varian Medical 
Systems, Palo Alto, USA). The network traffic between the CT scanner and the RTPS was monitored using a 
network hub and a Linux PC to run tcpdump. The department did not at the time have access to any laptops. The PC 
was an older tower unit that had been written off the hospital inventory. It was moved from place to place on a 
trolley to allow packet sniffing to be deployed where required. Additionally, no network protocol analysis software 
was available. The DICOM data sent from the CT scanner to the RTPS was extracted from the tcpdump output file 
by finding every occurrence of 14 contiguous bytes that match the information known to be in the relevant MAC 
Header. For each occurrence, using the Header Length and the total length in the in the IP header, together with the 
Data Offset in the TCP header, it was possible to find the start and finish of the encapsulated DICOM byte stream 
fragment. Data was not appended to the DICOM byte stream unless the IP Protocol, Source IP address and 
Destination IP Address matched. Data was also rejected if the TCP Source Port and Destination Port did not match 
the required values. A hex editor48 was used to view the DICOM byte stream. The DICOM upper message layer was 
decoded with reference to the parts of the DICOM standard listed in table 3.3.1-1. Many presentation contexts were 
defined in the association request, but only 1.2.840.10008.5.1.4.1.1.1 / Computed Radiography Image Storage was 
referenced by any DICOM Messages sent by the CT scanner. The only DICOM message layer command sent by the 
CT scanner was a C-STORE RQ which was decoded with reference to Table 9.3-1 of part 7 of the DICOM standard. 
The accompanying CT IMAGE IOD data was decoded according to the sections listed in table A.3-1 in part 3 of the 
DICOM standard. The complete CT data files were extracted from the captured network traffic, using a computer 
program written on the Linux c compiler to automate the process. 
When the DICOM byte stream was decoded by inspection nothing unusual was found that indicated the cause of the 
problem, so the details are omitted, since the application of the technique has already been covered in detail in 
section 3.2.12. DICOM CT image files were extracted from network traffic between the CT scanner and the 
radiotherapy treatment planning system. These images were burnt onto a CD and imported successfully into the 
planning system. Additionally, DICOM CT images were sent from the CT scanner to a PC running the OFFIS 
DICOM STORESCP application40. In essence, the application stores DICOM files sent to it by the C-STORE RQ of 
a DICOM peer, in this case the CT scanner. These images were then sent from the PC using the OFFIS DICOM 
STORESCU application40 to the RTPS. In essence, the STORESCU application initiates a C-STORE-RQ to transmit 
a CT scan as a byte stream to a DICOM peer that provides the C-STORE service, in this case the RTPS. These 
images were successfully received and imported into the RTPS. This was sufficient information to conclude that the 
RTPS was the cause of the lack of communication. 
3.3.2 The newest DICOM application is not always the cause of the fault. 
It is worth pointing out at this juncture that we have two conflicting results from the first two examples. In the first 
example, a new PACS system was introduced, and because it was not DICOM conformant, DICOM query retrieve 
was no longer possible. The vendors of the RTPS query/retrieve service made the common sense argument that their 
application was unchanged, and they could communicate with the old PACS system, so it must be the new 
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application’s fault, the PACS system’s fault, that they could not communicate with it successfully. In this particular 
case they were right. 
In the second example, the old CT scanner was able to send CT scans to the RTPS, but the new CT scanner could 
not. The vendors of the Radiotherapy Planning System storage service made the common sense argument that their 
application was unchanged, and they could communicate with the old CT scanner, so it must be the new 
application’s fault, the CT scanner’s fault, that they could not communicate with it successfully. In this particular 
case they were wrong. 
The reason why the newest DICOM application is not always the cause of the fault is explained conceptually by 
considering the nature of a DICOM conformant-limit model49. When trying to ensure that all modalities 
communicate, efforts to achieve this by proving that each application is DICOM conformant may not succeed. The 
applications negotiate, through the process of association, the way in which services are to be provided. There are 
multiple ways to communicate the same information under the DICOM protocol. When a new application is installed 
in a network, it may exercise capabilities of other DICOM applications that have not previously been required. In 
this circumstance if there is a fault either the old or the new application (or both or neither) may be responsible. 
3.3.3 Cause of the communication fault. 
This example was the first time that the department found a DICOM error that was associated with the network 
communication rather than the DICOM file format. The capability to deal with these faults had been under 
development within the department for some time but with minimal resources. Only the capability to intercept the 
traffic in one direction existed at the time that this fault was observed. The capability to view the transaction as a 
conversation was not available with the rudimentary tools that could be deployed. It has been conjectured50 that the 
radiotherapy treatment planning system was programmed with incorrect assumptions about the “p-data-tf” 
encapsulation rules for DICOM messages, and so ignored some of the transmitted fragments that contained the 
image, and so obtained an incomplete image as a result of each and every DICOM image transfer. The error reported 
by the RTPS was “Missing SOP common module”. The SOP Common Module is one of the first groups of tags 
included in the CT file, and gives the instance UID of the image, the serial number of the image, among other 
elements. Reports of it not being present were consistent with the conjecture.  
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Table 3.3.1-1 Decoding the CT Scanner DICOM Upper Message layer 
DICOM Upper layer element Relevant DICOM standard part for syntax 
Basic Syntax Big Endian Part 8 Section 9.3.1 
A-Associate-RQ PDU Part 8 Table 9-11 
Application Context Item Part 8 Table 9-12 
Presentation Context Item Part 8 Table 9-13 
Abstract Syntax Sub-Item Part 8 Table 9-14 
Transfer Syntax Sub-Item Part 8 Table 9-15 
USER INFORMATION ITEM FIELDS Part 8 Table 9-16 
MAXIMUM LENGTH SUB-ITEM (A-
ASSOCIATE-RQ) 
Part 8 Table D.1-1 
IMPLEMENTATION CLASS UID SUB ITEM (A-
ASSOCIATE-RQ) 
Part 7 Table D.3-1 
IMPLEMENTATION VERSION NAME SUB-
ITEM (A_ASSOCIATE-RQ) 
Part 7 Table D.3-3 
P-DATA-TF PDU Part 8 Table 9-22 
PRESENTATION-DATA-VALUE ITEM Part 8 Table 9-23 
3.3.4 Clinical Context of the CT communication fault. 
Due to difficulties with the installation, physics commissioning access to the CT scanner was reduced to a single 
Sunday afternoon, without an applications specialist available. In addition to rudimentary CT QA tests modeled on 
AAPM Report of task group 6651, all of activities detailed in section 3.3.1 were accomplished within that afternoon 
and the equipment was available for scheduled clinical use the next day. 
3.3.5 Resolution 
The CT was transmitting a CT scan and the RTPS was receiving it, but after the DICOM transaction was finished, 
when the RTPS automatically tried to read the DICOM CT images into its internal format, it was missing large parts 
of the file and so reported an error. The manufacturer undertook to take corrective action so that the RTPS correctly 
interpreted and stored the information in the DICOM byte stream. 
It was possible to implement a work around to commission the CT with the required DICOM functionality on 
schedule. The workaround was a DICOM repeater application, as shown in Figure 3.3.5-1, that was fully DICOM 
conformant and so able to receive images from the CT scanner, but that automatically re-transmitted the DICOM 
images to the RTPS in a way that the RTPS could correctly interpret. Direct DICOM transmission from the CT to the 
planning system failed because the planning system did not interpret the DICOM message layer data correctly. The 
workaround involved sending the CT scans to a dedicated intermediate computer that could interpret the DICOM 
message layer correctly. The application was set up simply to send every CT slice it received to the Eclipse RTPS. 
The application was constructed from the OFFIS STORESCP and STORESCU applications and an endless loop 
DOS batch file. STORESCP was run continuously to store CT data files to a nominated directory. The batch file put 
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a directory list into a file, then read the file and called STORESCU appropriately for each file to send it to the RTPS. 
The available disk space was limited (it was an old PC that was to be disposed of before the new CT went clinical, 
getting rid of it was one of the tasks scheduled for the Sunday afternoon), the time taken to transmit CT scans from 
the CT to the PC over the network was much less than the time taken to transmit files from the PC to the RTPS, and 
it was necessary to make sure that no attempt was made to send an image file that had not been completely received. 
All of these objectives were achieved by adding sleep commands at different points in the endless loop DOS batch 
file and adjusting the sleep times by trial and error. The RTPS was able to interpret the DICOM message layer of the 
OFFIS STORESCU application and so the retransmission was successful. The CT DICOM setup was reconfigured 
so that the work around was transparent to the users of the CT scanner, they simply selected the specified network 
interface for transmitting data to the RTPS and the transfer went through without further user intervention. So that 
the users of the CT scanner understood why the old PC was required, and did not themselves throw it out, a label was 
affixed to the side of the PC designating it the “CT RTPS Dicom Interface Box, Software written in an afternoon, 
running on a computer nobody wants, brought to you by Dodgey Software Inc.”.  The work around solution was in 
use for more than a year without incident before it was superseded by a new version of the RTPS which was able to 
receive data directly from the CT. DICOM radiotherapy packet sniffing in this case allowed the implementation of a 
solution to the problem with local resources in the available time without disruption to the clinical program. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3.5-1 The workaround solution using a DICOM repeater application to transmit CT data to the planning 
system. 
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DICOM 
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3.4 Radiotherapy Simulator 
This section details a problem with the output of a digital radiotherapy simulator as rendered by a DICOM film 
printer. The digital radiotherapy simulator had a DICOM print function, but when it was linked to a DICOM film 
printer the resulting output was not scaled correctly. This was initially important clinically because of a desire to 
reproduce the function of the previous simulator, which produced films of particular scales. 
3.4.1 Capture of DICOM data 
The network traffic between the simulator (Acuity, Varian Medical Systems, Palo Alto, USA) and the DICOM film 
printer (Drypro 75152, Konica Minolta, Tokyo, Japan) printer was monitored using a network hub and a Linux PC to 
run tcpdump. The DICOM data sent from the simulator to the printer was extracted from the tcpdump output file by 
finding every occurrence of 14 contiguous bytes that matched the information known to be in the relevant MAC 
Header. For each occurrence, using the Header Length and the total length in the IP header, together with the Data 
Offset in the TCP header, it was possible to find the start and finish of the encapsulated DICOM byte stream 
fragment. Data was not appended to the DICOM byte stream unless the IP Protocol, Source IP address and 
Destination IP Address matched. Data was also rejected if the TCP Source Port and Destination Port did not match 
the required values. A hex editor48 was used to view the DICOM byte stream. The information preceding the image 
was decoded by inspection with reference to the relevant sections of the DICOM standard. A computer program was 
then written on the Linux c compiler to automate the extraction of the image. Multiple images were collected for 
different settings of the printing configuration file of the acuity simulator. 
3.4.2 Decoding the simulator DICOM byte stream by inspection 
The sections of the DICOM standard that were referenced to decode the DICOM upper message layer are given in 
table 3.3.1-1. In this particular case there was only one presentation context defined in the association, 
1.2.840.10008.5.1.1.9 / Basic Greyscale Print Management, so all DICOM Messages sent by the simulator 
referenced that Information Object description. The sections of the DICOM standard that were referenced to decode 
the DICOM message layer are given in table 3.4.2-1. The syntax of the DICOM message layer was defined within 
the association to be the default DICOM transfer syntax, implicit VR little endian. 
Table 3.4.2-1 De-coding the DICOM Message layer for the simulator 
DICOM message Type DICOM reference 
BASIC GREYSCALE PRINT MANAGEMENT N-CREATE-RQ (FILM 
SESSION) 
Command Part 7 Table 10.3-9 
BASIC FILM SESSION N-CREATE ATTRIBUTE LIST Data Part 4 Table H.4-2 
BASIC GREYSCALE PRINT MANAGEMENT N_CREATE-RQ (FILM BOX) Command Part 7 Table 10.3-9 
BASIC FILM BOX N_CREATE ATTRIBUTE LIST Data Part 4 Table H.4-6 
BASIC GREYSCALE PRINT MANAGEMENT N-SET-RQ (IMAGE BOX) Command Part 7 Table 10.3-5 
BASIC GREYSCALE IMAGE BOX N-SET-RQ MODIFICATION LIST Data Part 4 Table H.4-
10 
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It was found that the printer was functioning correctly, but the simulator was not sending a correctly scaled output. 
The data sent by the simulator was a basic implementation of the DICOM print function. No use was made of the 
higher level pixel interpolation, image scaling or annotation functions available within the DICOM Print service. The 
DICOM printer was simply sent a 16 bit image. Scaling was implemented by surrounding the image with white 
space, and annotation was implemented by burning black pixels into the image. The image size was 36.5 MegaBytes, 
with 4,073 rows and 4,071 columns, compared to the native simulator full resolution digital image of 2,048 by 1,536 
pixels. 
The simulator DICOM byte stream began with an association request, followed by an N-CREATE-RQ to create the 
film session, the parameters of which are given in table 3.4.2-2. The simulator then sent a N-CREATE-RQ to create 
a basic film box, the parameters of which are given in table 3.4.2-3. An N-SET-RQ was then used to specify the 
single image within that box, the parameters of which are given in table 3.4.2-4. 
Table 3.4.2-2 SIMULATOR BASIC FILM SESSION N-CREATE ATTRIBUTE LIST (Format derived from DICOM 
part 4 Table H.4-2) 
Attribute Name Tag Value 
Number of Copies (2000,0010) 1 
Medium Type (2000,0030) CLEAR FILM 
Table 3.4.2-3 SIMULATOR BASIC FILM BOX N-CREATE ATTRIBUTE LIST (Format derived from DICOM Part 4 
Table H.4-6) 
Attribute Name Tag Value 
Image Display Format (2010,0010) STANDARD\1,1 
Referenced Film Session 
Sequence 
(2010,0500) 84 BYTES 
>Referenced SOP Class UID (0008,1150) 1.2.840.10008.5.1.1.1 
>Referenced SOP Instance UID (0008,1155) 1.2.246.352.70.2.1.8.6.9.16.10.9.105.0 
Film Orientation (2010,0040) PORTRAIT 
Film Size ID (2010,0050) 14INX17IN 
Magnification Type (2010,0060) NONE 
 
Chapter 3: Information transfer  
170 
Table 3.4.2-4 SIMULATOR BASIC GREYSCALE IMAGE BOX N-SET MODIFICATION LIST (Format derived from 
DICOM Part 4 Table H.4-10) 
Attribute Name Tag Value 
Image Position (2020,0010) 1 
Basic Greyscale Image Sequence (2020,0110) 38,291,944 Bytes 
>Samples Per Pixel (0028,0002) 1 
>Photomeric Interpretation (0028,0004) MONOCHROME2 
>Rows (0028,0010) 4703 
>Columns (0028,0011) 4071 
>Pixel Aspect Ratio (0028,0034) 1/1 
>Bits Allocated (0028,0100) 16 
>Bits Stored (0028,0101) 12 
>High Bit (0028,0102) 11 
>Pixel Representation (0028,0103) Unsigned Integer 
>Pixel Data (7FE0,0010) 38,291,826 Bytes 
3.4.3 Resolution 
The manufacturer of the simulator undertook to correct the simulator DICOM Print functionality to scale the output 
correctly with the next software update. Clinical implementation of the full digital use of the simulator progressed 
rapidly and the use of hardcopy images was outmoded before this change was made. The correct output of the 
DICOM Print functionality of the simulator would therefore only be of potential benefit to other centers installing a 
simulator of the same model. In this particular case, neither DICOM application was faulty. The Simulator sent a 
DICOM compliant print request, and the film printer interpreted that request correctly in accordance with the 
DICOM protocol. The hardcopy film printed was a faithful representation of the DICOM data sent by the Simulator. 
The problem was that the simulator application software did not scale its image data correctly in accordance with its 
configuration file before transmitting it. Since the image data that was sent to the film printer was determined by the 
simulator as required and sent immediately without storing it locally, and the film printer printed all image data 
without storing a digital copy, the only way to determine that the simulator was at fault was to use DICOM packet 
sniffing to obtain a copy of the transmitted image and check it. 
3.5 Discussion 
There are a range of applications for DICOM packet sniffing, such as Merge DPM53, Siemens observer54, DICOM 
Tool55, and the DVTk56. DICOM packet sniffing is a fast and efficient tool for determining which of two DICOM 
applications is responsible when two DICOM applications will not interact correctly. The availability of these tools 
has now reduced the challenges Medical Physicists face with the introduction of new DICOM applications to a 
tractable level. It is now possible to quickly and easily access the information transaction that causes a DICOM fault. 
This is of considerable assistance when investigating connectivity issues that may arise due to subtle errors in 
vendors’ implementations of the DICOM standard. 
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The potential problems with DICOM interaction are almost infinite57 so it is impossible to predict what particular 
knowledge of the DICOM standard will be required to diagnose a problem. Fortunately, the length of the byte stream 
causing the error will in most cases be manageable, of the order of hundreds of bytes. At commissioning, a digital 
record should be made of the DICOM byte stream for each interface. If detailed work instructions are available for 
the performance of tasks associated with information transfer, these should be annotated with the packet numbers 
that result from each user step. Such a record is invaluable when a fault is reported. It is not practical to analyze 
every DICOM transaction before an error is found, so in practice analysis is unlikely to begin until after the fault is 
reported. The first step should be to reproduce the fault and make a digital record of the DICOM byte stream 
communication involved. This new record can then be reviewed together with the pre-fault report record with 
reference to the relevant sections of the DICOM standard to determine which of the applications is DICOM 
conformant. At the very least, the nature of the fault can then be reported directly to the vendors in technical terms 
rather than in the language of the application users. Being able to tell the vendors that the PACS system returned an 
A700 error in reply to a study root query request at image level is more likely to enable the vendor to resolve the 
error than telling the vendors that the RTPS reported that it could not import any of the selected images. This 
assumes that the advice reaches a vendor representative with sufficient technical expertise to understand it, which 
can be harder to achieve than solving the original fault. As a practical example, the A700 error from the PACS was 
identified with wireshark and communicated to the vendor within a day of the problem being reported, whereas 
weeks later the PACS vendor’s best efforts through onsite investigations from day one were still unable to find any 
record of the error in the PACS log files, by which time through DICOM packet sniffing all of the relevant sections 
of the DICOM standard had already been identified, studied and assimilated, and the root cause of the fault identified 
and communicated to the vendor. It is not necessary to have an encyclopedic knowledge of the DICOM protocol to 
deal with these problems. The 2009 base standard has 16 parts running to a total length of 4,136 pages. It is sufficient 
to use the DICOM standard as a reference when decoding the DICOM byte stream.    
3.6 Conclusion 
In this chapter, three hypotheses have been proved with respect to DICOM packet sniffing. In all three examples 
reviewed, it was possible to identify which vendor was required to take action to rectify the fault. This is sufficient to 
establish that there is a class of DICOM problems for which the first hypothesis holds.  
The second hypothesis is proved by the second example, where the CT scanner could not communicate with the 
RTPS. It was possible to implement an alternate transmission method using only locally available resources on the 
same day that the fault was detected. More generally, it would be expected that more sophisticated solutions might 
take longer to implement, but might still be implemented faster than the vendor can implement an update. Finding a 
local solution is not always possible, attempts to do so in the first and third example failed.  
The third hypothesis is proved by the third example, with the DICOM printer. There simply was no other way to 
access the information to decide whether the simulator or the printer vendor was required to implement corrective 
action.  
The first example, with the PACS system, has important implications for the DVTk approach of exercising all of a 
DICOM application’s functionality at commissioning to determine if it is fully DICOM compliant. It is likely that 
the PACS would not have returned an error for image level queries if it was accessing a small database. Although it 
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might have been slower than expected, the PACS would probably have searched the whole database to return the 
correct reply to an image level query, but this response would have been constructed using the wrong search 
algorithm. Instead of searching only a tiny subset of the database in accordance with the mandated hierarchical 
search algorithm, the PACS would have searched every image in the small database to obtain the same result. Thus 
no matter how much development is put into DVTk, testing with DVTk alone will not be able to prove that DICOM 
applications are DICOM conformant. 
The standard of clinical care in radiotherapy is dependent on the continued function of DICOM communication. 
Applying DICOM packet sniffing to a working interface is the best way to learn about how the DICOM standard 
works, and a record of the network traffic is an invaluable reference if interoperability suddenly fails. 
Commissioning of DICOM capable radiotherapy units should ideally include recording the DICOM network 
information transfer for future reference. DICOM packet sniffing is the best method to determine which application 
is responsible for the failure of a DICOM communication. 
Having dealt in this chapter with the problem of information transfer from functional imaging modalities to 
radiotherapy applications, we move in the next chapter to consider the spatial registration of functional imaging to 
the radiotherapy treatment isocentre in the treatment room at the time of treatment. 
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Appendix A.3.2.13-1 OFFIS DCMTK FINDSCU QUERIES GEPACS  
 
Q1 Preliminary test of FINDSCU connection with GEPACS 
findscu -S -k 0008,0020  -k 0008,0030 -k 0008,0050 -k 0008,0052=STUDY -k 0010,0010 -k 0010,0020="1164278" 
-k 0020,000D -k 0020,0010 -xi -v -aet VDCM_E6 -aec GEPACSD034 172.22.7.34 4100 
 
Motivation: This query was the simplest, safest query of the PACS, amounting to a request of the PACS to find all 
studies that matched the patient ID. It is a replication of the DICOM query sent to the PACS by the VARIAN 
DICOM query/retrieve application at stage six of the sequential details representation in section 3.2.5, to which the 
PACS response was known. 
 
Table 3.2.13-1 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0020) 0 Study Date NULL 
(0008,0030) 0 Study Time NULL 
(0008,0050) 0 Acc Num NULL 
(0008,0052) 6 Q/R Level STUDY 
(0010,0010) 0 Patient Name NULL 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 0 Study UID NULL 
(0020,0010) 0 Study Num NULL 
 
Table 3.2.13-2 PACS REPLY: The PACS found one study. 
TAG BYTES NAME DATA 
(0008,0020) 8 Study Date 20071022 
(0008,0030) 6 Study Time 154233 
(0008,0050) 10 Acc Num MR07006692-65231 
(0008,0052) 6 Q/R Level STUDY 
(0008,0054) A Retrieve AE  GEPACSD034 
(0008,0056) 6 Instance 
Availability 
ONLINE 
(0010,0010) 14 Patient Name NNNNNNNNNNNNNN 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,0010) 6 Study Num 24368 
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Although it does not appear so, this response is identical to that received by the VARIAN query. The VARIAN 
query represents the query as a patient root query, but implements it as a study root query. In the graphical user 
interface, the information received that is additional to the patient name is simply not displayed. The record of the 
DICOM data exchange reveals from DICOM packet sniffing reveals that the two responses are effectively identical.  
 
Q2 Replication of stage seven 
findscu -S -k 0008,0020  -k 0008,0030 -k 0008,0050 -k 0008,0052=STUDY -k 0010,0010="NNNNNN^NNNN 
NNNNNNN" -k 0010,0020="1164278" -k 0020,000D -k 0020,0010 -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Motivation: This query was intended to replicate stage seven of the VARIAN DICOM query/retrieve process. The 
query amounts to a request of the PACS to find all studies for a particular patient. The patient name and the patient 
ID are both specified in the query. The PACS is asked to provide the study date, time, accession number, Study UID 
and Study Number for all studies found.  
Table 3.2.13-3 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0020) 0 Study Date NULL 
(0008,0030) 0 Study Time NULL 
(0008,0050) 0 Acc Num NULL 
(0008,0052) 6 Q/R Level STUDY 
(0010,0010) 14 Patient Name NNNNNNNNNNNNNN 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 0 Study UID NULL 
(0020,0010) 0 Study Num NULL 
 
Table 3.2.13-4 PACS REPLY: Found One Study 
TAG BYTES NAME DATA 
(0008,0020) 8 Study Date 20071022 
(0008,0030) 6 Study Time 154233 
(0008,0050) 10 Acc Num MR07006692-65231 
(0008,0052) 6 Q/R Level STUDY 
(0008,0054) A Retrieve AE  GEPACSD034 
(0008,0056) 6 Instance 
Availability 
ONLINE 
(0010,0010) 14 Patient Name NNNNNNNNNNNNNN 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,0010) 6 Study Num 24368 
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The PACS successfully provides all of the information requested. In the VARIAN graphical user interface, only the 
patient name, patient ID, Study Num, Study Date and Study Time are displayed. The Patient Accession Number, 
Instance Availability and Study UID are not displayed by VARIAN, but they were present in the PACS reply. Note 
that the patient ID uniquely defines the patient referenced, so there is no need for the patient name to be provided. 
The results indicate that provision of redundant information does not cause an error, at least at study level. 
 
Q3 Search for series with minimal information 
findscu -S -k 0008,0052=SERIES -k 0008,0060= -k 
0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 0020,0011 -xi -v -aet VDCM_E6 -aec 
GEPACSD034 172.22.7.34 4100 
 
Motivation: The PACS is asked to find the series number of all the series in a specified study. The query is different 
from the VARIAN query in that it does not explicitly query the Series UID, only the series number. The intent is to 
see if the PACS responds appropriately to the scope of the query.   
Table 3.2.13-5 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0052) 6 Q/R Level SERIES 
(0008,0060) 0 Modality NULL 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,0011) 0 Series Num NULL 
 
Table 3.2.13-6 PACS REPLY: Found Seven Series 
TAG BYTES NAME DATA 
(0008,0052) 6 Q/R Level SERIES 
(0008,0054) A Retrieve 
AE  
GEPACSD034 
(0008,0056) 6 Instance 
Availability 
ONLINE 
(0008,0060) 2 Modality MR 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
(0020,0011) 2 Series Num 3 
 
And the other six series were  
1.2.840.113619.2.176.3596.374670.7290.1193006931.264 
1.2.840.113619.2.176.3596.374670.7290.1193006931.265 
1.2.840.113619.2.176.3596.374670.7290.1193006931.266 
1.2.840.113619.2.176.3596.374670.7290.1193006931.267 
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1.2.840.113619.2.176.3596.374670.7290.1193006931.268 
1.2.840.113619.2.176.3596.374670.7290.1193006931.269 
 
This was a query at series level. The response of the PACS was the same as it was to the VARIAN query, despite the 
different information in the request put to the PACS. Strictly, the patient ID and series UID should not have been 
indicated in the PACS response since they were not queried. It is apparent at this point that the PACS is not 
implementing a DICOM conformant query/retrieve SCP. 
 
Q4: Search for images with extra random match data at IMAGE level. 
findscu -S -k 0008,0018 -k 0008,0052=IMAGE -k 0008,1150 -k 0008,1155 -k 0010,0020 -k 
0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263 -k 0020,0013 -k 300C,0006 -xi -v -aet 
VDCM_E6 -aec GEPACSD034 172.22.7.34 4100 
 
Motivation: The PACS is asked to find all of the images within a particular study, without any specification of the 
series. This is a deliberate non compliant query; there must be a unique identifier at all levels above the query level. 
Additionally, the query request contains some non standard items. The way in which they are replied to or omitted 
may indicate whether the PACS actually takes any notice of the queried items. 
 
Table 3.2.13-7 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
(0008,1150) 0 Referenced 
SOP Class 
UID 
NULL 
(0008,1155) 0 Referenced 
SOP 
Instance 
UID 
NULL 
(0010,0020) 0 Patient ID NULL 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 0 Series UID NULL 
(0020,0013) 0 Image 
Num 
NULL 
(300C,0006) 0 Referenced 
Beam 
Number 
NULL 
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Status 0xc001 ‘Failed: Unable to Process’ 
 
In this query, an image level query was made without a series UID. The error was different from A700. Technically, 
it is a DICOM violation to make a query without a specified series UID. The PACS response to return an error is the 
correct response. This does not provide much information on the PACS.  
 
Q5 Fully compliant, simple image level query. 
findscu -S -k 0008,0052=IMAGE -k 0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263 -k 0020,0013 -xi -v -aet VDCM_E6 -aec 
GEPACSD034 172.22.7.34 4100 
 
Motivation: The intent of this query is to simulate the cleanest possible request for information at image level. The 
query includes a specified Study UID, and a specified Series UID. The PACS is asked to provide the image number 
of all the images in a specified series. This is a fully compliant query and the PACS should respond if it is DICOM 
conformant. 
 
Table 3.2.13-8 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0052) 6 Q/R Level IMAGE 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
(0020,0013) 0 Image Num NULL 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
In this query a study UID and a series UID was provided, making this a valid query. The PACS could not respond. 
The PACS query/retrieve SCP function is not DICOM conformant. The cause of the fault is not too much 
information in the query, as a minimal required information image level query produces an error. 
 
Q6 Fully compliant image level image UID query. 
 
findscu -S -k 0008,0052=IMAGE -k 0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263 -k 0008,0018 -xi -v -aet VDCM_E6 -aec 
GEPACSD034 172.22.7.34 4100 
 
Motivation: The intent in this query was to test whether the PACS could respond to an image level query if both the 
levels above were uniquely specified and the image unique identifier was queried.    
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Table 3.2.13-9 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
In this query a study UID and a series UID was provided, making this a valid query. The image uid was left blank. 
Essentially the PACS was asked to report all the images in a series. The PACS could not respond, which is further 
proof that the PACS SCP function is not DICOM conformant. 
 
Q7 Image level query of Image UID with Patient ID specified. 
findscu -S -k 0008,0018 -k 0008,0052=IMAGE -k 0010,0020="XXXXXXX" -k 
0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263  -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Table 3.2.13-10 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
(0010,0020) 8 Patient ID XXXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
It was thought that the PACS might be universally implementing the patient root information model, even though the 
study root model was specified in the query. In this query at image level the patient ID was added, and the PACS still 
responded with an error. This shows that addition of a patient ID field specification in the query does not resolve the 
error. 
 
Chapter 3: Information transfer  
179 
Q8 Query the PACS on a single image. 
 
findscu -P -k 0008,0018 -k 0008,0052=IMAGE -k 0010,0020="1164278" -k 
0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263  -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Motivation: There was a suggestion that the PACS was searching too widely for images, so the PACS was queried at 
image level with a unique specification for the study, the series, and the image. 
 
Table 3.2.13-11 ASSOCIATED BY PATIENT ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
(0010,0020) 8 Patient ID XXXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
The result from the PACS was an error. The DICOM protocol requires the PACS to search hierarchically, first 
among the studies to find the unique study specified; then among the series that belong to that study to find the 
unique series specified; then among the images that belong to that series to find if one particular image is present. It 
is not possible to construcy an image level query that should require less resources. The PACS still returns an error, 
indicating that for whatever reason, the PACS is unable to reply to a study root query at image level with anything 
more than an error. 
 
Q9 Minimum scope patient root query at image level  
findscu -P -k 0008,0018=1.2.840.113619.2.176.3596.374670.7216.1193007195.742 -k 0008,0052=IMAGE -k 
0010,0020="1164278" -k 0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263  -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Motivation: If the PACS cannot respond correctly to an image level query under the study root model, perhaps it can 
respond correctly under the patient root model. 
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Table 3.2.13-12 ASSOCIATED BY PATIENT ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 34 Image UID 1.2.840.113619.2.176.3596.374670.7216.1193007195.742 
(0008,0052) 6 Q/R Level IMAGE 
(0010,0020) 8 Patient ID XXXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
This query was made using the patient root model, and a specified patient ID was added to provided unique 
specification at all four levels of the model. This amounts to asking the PACS if it has the specified image in its 
database. The PACS should search first the patients to find the single match, then search the studies that belong to 
the patient to find the unique match, then search the series that belong to the study to find the unique series specified, 
then search the images that belong to the particular unique series to find the specified image. If the hierarchical 
search algorithm specified by the DICOM protocol is implemented, this search should consume the least resources of 
any image level query. The fact that the PACS could not respond suggests that the PACS can never respond to an 
image level query/retrieve. 
 
Q10 Non compliant image level query under patient root model. 
findscu -P -k 0008,0018=1.2.840.113619.2.176.3596.374670.7216.1193007195.742 -k 0008,0052=IMAGE -k 
0020,000D=1.2.124.113532.172.22.17.132.20071022.151143.2301463 -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263  -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Motivation: The goal here is to make an image level query under the patient root model without a patient specied, 
which is a protocol violation for any query under the patient root model not at patient level.  
 
Table 3.2.13-13 ASSOCIATED BY PATIENT ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
This query omits the patient specification, which is a protocol violation, because the query is made under patient 
root. The PACS returns an error, which is the correct response. 
Chapter 3: Information transfer  
181 
 
Q11 Scopeless image level query 
findscu -P -k 0008,0018=1.2.840.113619.2.176.3596.374670.7216.1193007195.742 -k 0008,0052=IMAGE -xi -v -
aet VDCM_E6 -aec GEPACSD034 172.22.7.34 4100 
 
Motivation: This query is intended to determine if the PACS takes any account of match data at levels above the 
level of the query to restrict the scope of the search. 
 
Table 3.2.13-14 ASSOCIATED BY PATIENT ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image UID NULL 
(0008,0052) 6 Q/R Level IMAGE 
Failed 0xc001 ‘Failed: Unable to Process’ 
Error Comment Unknown processing exception 
 
This query is basically asking the PACS to report the UID of every image that it has. The PACS returns an error, 
which is the correct response, but is consistent with the PACS ignoring search scope instructions and trying to search 
the whole database everytime it has an image level query. 
 
Q12 Series level query requesting data at image level under the patient root model. 
 
findscu -P -k 0008,0018=1.2.840.113619.2.176.3596.374670.7216.1193007195.742 -k 0008,0052=SERIES -xi -v -
aet VDCM_E6 -aec GEPACSD034 172.22.7.34 4100 
 
Motivation: The aim here is to test if the presence of an image level information request in a series level query will 
cause an error. 
 
Table 3.2.13-15 ASSOCIATED BY PATIENT ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 34 Image 
UID 
1.2.840.113619.2.176.3596.374670.7216.1193007195.742 
(0008,0052) 6 Q/R Level SERIES 
 
The PACS replies to this query with a “Status A700 Cannot Execute Query” message. This suggests that rather than 
rejecting the query as a non compliant query under the hierarchical search algorithm, the PACS attempted a search of 
every image in the database and failed die to the search scope being to large. This would be appropriate behavior if 
the PACS was implementing a relational query. Relational queries are supported under DICOM, but only as a result 
of extended negotiation between the DICOM PEERS at association stage, and no such association occurred with 
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PACS, either with the VARIAN or the OFFIS application. Additionally, the GE PACS conformance statement states 
that the PACS does not support relational queries.   
 
Q13 Non compliant series level query. 
 
findscu -S -k 0008,0052=SERIES -k 0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263  -xi -v -
aet VDCM_E6 -aec GEPACSD034 172.22.7.34 4100 
 
Motivation: To test if the PACS is implementing a relational search algorithm, a reply is required from the PACS. 
This query is made at series level. By omitting any specification at the Study level, the query is an invalid 
hierarchical query, but a valid relational query. The PACS is known to have previously responded correctly to series 
level queries.  
 
Table 3.2.13-16 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0052) 6 Q/R Level SERIES 
(0020,000E) 34 Series 
UID 
1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
 
Table 3.2.13-17 PACS REPLY: Found One Series 
TAG BYTES NAME DATA 
(0008,0052) 6 Q/R Level SERIES 
(0008,0054) A Retrieve 
AE  
GEPACSD034 
(0008,0056) 6 Instance 
Availability 
ONLINE 
(0010,0020) 8 Patient ID XXXXXXX 
(0020,000D) 34 Study UID 1.2.124.113532.172.22.17.132.20071022.151143.2301463 
(0020,000E) 34 Series UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
 
This query was a series level query, without a specified study uniquely defined. The PACS was asked to search for a 
study that contained a specific series. The PACS should return an error if implementing the required hierarchical 
search algorithm. The data returned is consistent with the GE PACS implementing a relational query. 
  
So this is consistent with a relational search, not a hierarchical search. The inability to process an image level query 
due to lack of memory is also consistent with the GE PACS erroneously executing a relation query when it should be 
executing a hierarchical query. 
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Q14 Series level query with Image level data. 
 
findscu -S -k 0008,0018 -k 0008,0052=SERIES -k 
0020,000E=1.2.840.113619.2.176.3596.374670.7290.1193006931.263 -xi -v -aet VDCM_E6 -aec GEPACSD034 
172.22.7.34 4100 
 
Motivation: The addition of the image UID to the search list of a series level query tests whether it is the level of the 
query or the presence of image level data that provokes the A700 error from the PACS. 
 
Table 3.2.13-18 ASSOCIATED BY STUDY ROOT QUERY RETRIEVE 
TAG BYTES NAME DATA 
(0008,0018) 0 Image 
UID 
NULL 
(0008,0052) 6 Q/R Level SERIES 
(0020,000E) 34 Study UID 1.2.840.113619.2.176.3596.374670.7290.1193006931.263 
 
The PACS responds with an A700 Out of Resources error. This is further evidence that the PACS is implementing a 
relational search. The presence of an image level element in the query is sufficient to provoke the PACS to return an 
error, which it does not otherwise do at series level. 
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Chapter 
4 
Registration to the treatment isocentre 
 
“…how can you possibly award prizes when everybody missed the target?” said Alice. “Well,” 
said the Queen, “Some missed by more than others, and we have a fine normal distribution of 
misses, which means we can forget the target” 
Lewis Carroll, Alice’s Adventures in Wonderland 
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4.0 PET data co-registration in the radiotherapy treatment 
room. 
We saw in chapter one the emergence of three recurrent themes of functional imaging in a chain of dependence in 
radiotherapy; 
 
1. There was a controversy over the threshold of significance to use in segmenting tumours using functional 
imaging. 
2. There is a problem with the communication of functional imaging data in a timely, practical and useful way 
for use in Radiation Oncology 
3. There is an emerging awareness of the problem with the coregistration of functional imaging data to the 
radiotherapy treatment isocentre in the treatment room. 
 
In this chapter we consider the third of these challenges, the problem of coregistration to the treatment isocentre. All 
three of these problems are vital, there is no point to the use of functional imaging for tumour volume marking if we 
do not know the threshold of significance to use to segment a tumour, but having the capability to reliably segment 
the tumour volume is of no use unless we can communicate that information, or the image data required to obtain it, 
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into radiotherapy treatment planning systems. Even given these two accomplishments, we still require confidently to 
be able to position an isocentre within a patient at the radiotherapy treatment room in registration with the functional 
imaging in order to be able to utilize the information that we have obtained and interpreted for the advantage of the 
patient’s treatment. 
We begin by exploring the environment in which the solution must be implemented, the radiotherapy treatment 
room. Then we review the different methods available to position the patient treatment isocentre under image 
guidance. Then we narrow our focus to a particular image guidance system (IGS) implementation that offers 
affordable speed and accuracy in the placement of the isocentre (ExacTrac, BrainLab AG, Feldkirchen, Germany). 
We re-examine the requirements of the registration problem in the context of the IGS, and state the hypotheses we 
will prove in respect of it.   
We continue with some preparatory descriptions of coordinate systems. Then we establish the method of statistical 
inference that we will use to prove the accuracy of the IGS in clinical practice. We describe in turn the clinical 
treatment procedures implemented with this system, and the clinical data set collated from the implementation of the 
regime.  
Our results commence with the general results of inference on the full data set, and progress to examine in turn the 
effects of the pass conditions set, the number of iterative isocentre corrections applied with the system, the distance 
moved in those corrections, the number of identical treatment sessions the patient has, and artifacts of the method of 
inference. For completeness, we examine the results of a determination of the accuracy of the orientation patient. 
We conclude by reviewing the results established against the hypotheses proved, and exploring the implications of 
the proof of those hypotheses.       
We do not in this chapter consider the problem of respiratory motion compensation. It is an active area of research 
that receives substantial attention from other investigators. It is beneficial for some treatments, but not for all, and it 
lies outside the scope of this work. 
4.1 Particular circumstances in the Radiotherapy treatment room. 
Increasingly, functional imaging for radiotherapy involves hybrid imaging1, either a CT/PET2 combined scanner, or a 
CT-SPECT3 combined scanner. In this circumstance, much effort has been expended to provide registration of 
functional and anatomical imaging4 even to the extent of compensating for respiratory motion5,6. This registration of 
the functional imaging to the diagnostic CT scan is of limited use for radiotherapy treatment unless information from 
the diagnostic CT scan can be used to accurately position the radiation treatment isocentre. There is rarely a CT 
scanner available in the treatment room to test the alignment of the patient, and although prototype7 and commercial8 
in room CT scanners exist, the provision of such equipment is expensive. When the linear accelerator is used for 
treatment the CT is idle, when the CT is used to check positioning the linear accelerator is idle. Radiotherapy 
treatment of one patient can involve 30 separate daily visits or fractions, and the availability of radiotherapy 
treatment units is the critical resource in radiotherapy treatment capacity. The patient must be positioned quickly, 
accurately, and economically. 
 
It is important to understand the reason for the need to position the patient accurately in the radiotherapy treatment 
context. The radiotherapy treatment units themselves are capable of delivering more accurate and conformal 
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treatments through the use of multileaf collimators9 implementing IMRT10. A limiting spatial resolution of between 
2.5-3 mm11 applies to the beam edge, but the technical problems relating to sub millimeter placement and dynamic 
control of the field edge, shape and intensity have all been solved12. The current limiting factor in radiotherapy is 
thus the ability to determine and maintain the patient and tumour position13,14. 
4.2 Review of ways to position the patient. 
The ability to position the patient and the tumour has always been a fundamental underpinning capability of 
radiotherapy15. We now review the evolution of the various methods of positioning the patient.  
4.2.1 Palpation of bony landmarks. 
Prior to the availability of in room imaging, patients were positioned by radiation therapists feeling with their fingers 
the position of, for example, the sternal notch, as a landmark for positioning patients16. For some radiotherapy 
treatments for which this method was used errors of greater than 10 mm occurred for 45% of the patients17, because 
no allowance for internal position variation could be made. 
4.2.2 Tattoos and skin marks 
Skin marks were made at the time and place of the diagnostic CT acquisition. Just as for palpation, this method made 
no allowance for internal motion, and accuracy could be further degraded by motion of the skin relative to bone18. 
Redundancy of markers went some way to reducing this effect; if the patient had two lateral skin marks a subsequent 
disagreement at the treatment room was generally resolved by positioning to the average position.  
4.2.3 Megavoltage Portal Imaging 
Megavoltage portal imaging uses the treatment beam itself to take an image of the patient from the direction of 
treatment to verify that the patient is in the correct treatment position. The megavoltage beam interacts primarily by 
the compton effect, and in consequence the image quality is poor19, generally only air cavities can be visualized with 
diagnostic imaging clarity. Bone shadows may be poorly defined but sufficiently visible to allow verification of 
accurate beam alignment.20 Double exposure port films can be used with the treatment portal and a larger field being 
used, this has the advantage of imaging the treatment beam outline and bony landmarks that are outside the treatment 
field.21 The main disadvantages are the poor image quality and the extra dose to the patient.22 When film is used as 
the image medium, the delay for development of the film is a major disadvantage that retards patient throughput and 
degrades accuracy as the patient will move while the film is being developed. Even with the use of electronic portal 
imaging and automatic matching, many centres still choose to implement offline review23; where the megavoltage 
portal images are not used to correct patient position immediately prior to treatment, but potentially to adjust the 
specification of correct patient position prior to the next patient treatment. Another disadvantage is that taking one or 
more electronic portal images adds significantly to the fraction treatment time.24 The review of portal images may 
need to be performed by a radiation oncologist, and this can delay treatment significantly if one is not available25. 
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4.2.4 Gantry mounted in room kilovoltage imaging. 
Kilovoltage x-rays produce superior image quality, but one must have a source of kilovoltage x-rays to acquire such 
images. The idea is not new: one of the first therapy linear accelerators installed at Stanford University had a 
diagnostic source that could be driven in and out of the beam 15 cm below the megavoltage target26,27. The idea was 
revived in a non commercial implementation of a kV source mounted on the gantry of a linear accelerator at an angle 
of 37 degrees from the megavoltage treatment head28. Commercial implementations29,30 use gantry mounted kV 
sources and detectors that are orthogonal to the Megavoltage beam. The detector is generally retractable or 
detachable, but safety and clearance31 is an issue.  3D localization by kV imaging requires that the gantry be rotated 
by 90 degrees. There is a maximum speed of rotation for the gantry of 15 seconds for 90 degrees32, so this involves a 
minimum 15 second delay in acquiring the second image. This degrades efficiency through the delay and accuracy 
through the patient movement33. The quality of isocentric rotation is also an important factor34. 
4.2.5 In room Megavoltage Cone beam CT 
By rotating the gantry while the MV beam is on, one can acquire a wide beam CT scan with a single rotation of the 
gantry. This takes either 30 seconds or a full minute to acquire, depending on whether a full or half rotation is 
utilized. The advantage of this technique is 3D image acquisition. The MV images can be more useful for imaging 
patients with hip prostheses. Disadvantages are the high dose to the patient, susceptibility to motion artifact due to 
the long acquisition time33, and the intrinsically bad image quality19. The 3D imaging can be as much a curse as a 
blessing. Contouring the tumour takes time24, and may require a radiation oncologist25. This has been mitigated by 
the use of image fusion, and the advent of adaptive radiotherapy35, where the 3D image is used to select between a 
number of pre prepared plans. Some of these decisions could be made just as easily using planar kV or MV imaging. 
4.2.6 In room kV cone beam CT 
A gantry mounted kV source and detector can be used to obtain a kV cone beam CT. The image quality is superior to 
the MV cone beam CT, and the dose is decreased, but the problems of acquisition time motion artifacts33, 
efficiency25 and interpretation remain24. Although the dose is decreased, it is not insignificant compared to the 
therapy dose; daily cone beam CT imaging throughout a fractionated treatment, up to 1.2 Gy from imaging compared 
to 64 Gy from therapy in a trial of image guided radiotherapy36. The decision as to whether to take the imaging dose 
into account as part of the treatment planning process58, and the technical question of how this may be achieved37, as 
well as the radiobiology of imaging versus therapy dose58, are all current areas of investigation. The limiting factor 
for registration accuracy for 3D-3D matching is the cone beam CT slice thickness38. For practical reasons, the cone 
beam CT can only be acquired at couch zero, so non coplanar beam registration cannot be verified immediately prior 
to treatment.     
4.2.7 In room diagnostic CT 
A boutique solution is a diagnostic CT scanner mounted on rails in the treatment room. The relocation of the CT 
gantry centre of reconstruction to the isocentre is achieved to within an accuracy of about 3 mm. The most 
significant problem is the movement of the patient when being moved between the treatment position and the 
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imaging position compared to as single isocentre system39. Economic limitations are that the diagnostic quality CT 
scanner cannot be used for CT scans while the Linear Accelerator is being used for treatment, and vice versa. 
4.2.8 In room Ultrasound 
There is a commercial system (BAT®, Nomos, Sewickley, PA, USA) that uses ultrasound in the treatment room40. A 
problem was that the pressure of the transducer on the abdomen moved the prostate41,42,43. Clinical comparison 
suggests prostate localization within 4 mm, compared to 2-3 mm with CT on rails44. The ultrasound images can be 
difficult to interpret correctly45. Trans cranial ultrasound in adults presents technical difficulties in adults because of 
the skull barrier to sound transmission, but has been shown to have some application to Glioma target volume 
marking for radiotherapy46.   
4.2.9 Implanted fiducials 
Rather than register to bony anatomy, fiducials can be implanted in the tumour and imaged radiographically45. The 
primary advantage is that localization is direct to tumour, although whether this can be compromised by migrating 
fiducials47 is disputed48. The primary disadvantage is that the procedure is invasive. Implanted fiducials are not 
suitable for all patients. The fiducials must be imaged, and there is some uncertainty over the best way to accomplish 
this39.   
4.2.10 Implantable Radio transponders 
A system of implanted radio-transponding fiducials (Calypso, Calypso Medical Technologies, Seattle, WA, USA) is 
commercially available. The accuracy achieved in phantom measurements is sub millimetre49, and the devices can be 
implanted directly within the tumour. Since there is no radiological burden to determining the position of the 
markers, they are ideally suited to continuous real time tracking.50 The disadvantage is that the devices have to 
implanted, which is invasive. It is contended that the transponders do not migrate.51 
4.2.11 Measuring to patient surface. 
Standard radiotherapy frequently uses a single point probe of distance, either with a physical or an optical check. The 
use of backpointers, and pin and arc techniques in the early days of radiotherapy with non isocentric machines were 
reliable, practical solutions to the problem of patient positioning. The radionics depth helmet used in stereotactic 
radiosurgery to check the placement of a neurosurgical frame to the skull is the ultimate use of a physical probe to 
check position52. A commercially available 3D surface image registration system (Align RT, Vision RT, London, 
UK) uses stereoscopic cameras and sophisticated surface matching algorithms to position the patient with a standard 
deviation of 0.75 mm53. The advantages are the practicality, and that these techniques are not invasive. The 
disadvantages are the time taken, and that the registration is determined from the patient skin surface. If the target is 
located within the patient, any internal motion relative to the patient skin cannot be accounted for. 
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4.2.12 Patient Fixation 
Bite blocks, vacuum bags and other methods of patient fixation can be used to help the patient retain position for 
treatment after the initial positioning is achieved. Some fixation is also used to establish the patient position. The 
least sophisticated approach is an alignment mark on the fixation to indicate the isocentre if the patient is positioned 
correctly within the patient fixation device. The ultimate sophistication of this technique is the neurosurgical frame, 
which is kept in place from imaging to treatment to establish patient positioning to the isocentre to sufficient 
accuracy for stereotactic treatment to be achieved. The disadvantage is the invasiveness. The patient head also moves 
within the frame when the patient lies down. It is necessary to anaesthetize young children who require this 
localization52. 
4.2.13 Rotating the patient out of the horizontal plane. 
All of the previous methods have limitations compensating for patient rotation. Although the patient support system 
enables a rotation of the patient in the horizontal plane, rotation out of the plane ideally requires a tiltable couch, 
which is now commercially available (Hexapod54, Medical Intelligence, Schwabmünchen, Gemany). There is a 
controversy over the way to achieve optimal alignment with planar imaging in the absence of a capacity to rotate the 
patient in three dimensions89,90,91.  Correct orientation of the patient to the level of accuracy required for planar image 
matching is not required for radiotherapy treatment per se. Angles of less than 2.5 degrees are acceptable in standard 
practice. 
4.2.14 Summary of patient positioning. 
A wide variety of methods have been used to position patients in radiotherapy, but all of them suffer from 
limitations. Not all of them establish a registration to the 3D treatment planning CT scan.  Some of them are only 
practical to use for offline review, or require registration between kV and Megavoltage imaging. Some are invasive, 
and some relate only to the patient surface. An ideal patient positioning system must be efficient, accurate and 
economic.  One system that provides these three fundamental advantages without any of the above limitations is the 
BrainLab ExacTrac system, which is the subject of the next section. 
4.3 IGS (ExacTrac, BrainLab AG, Feldkirchen, Germany). 
The IGS is an efficient, accurate and economic system for positioning the patient within the radiotherapy treatment 
room to a position determined by CT imaging performed remotely from the treatment room. This 3D imaging could 
be a CT scan from a CT PET scanner, so the problem of coregistering functional imaging to the treatment isocentre 
in the treatment room can be solved by the IGS. The envisioned co-registration chain for functional imaging to the 
treatment isocentre is: from the PET scan to the intrinsically registered CT scan of the PET-CT; DRRs calculated 
from the CT are then registered to planar images in the treatment room to achieve registration of the skull. For the 
intracranial lesions considered, registration of the skull amounts to registration of the tumour. The IGS uses kV 
imaging in the treatment room, but it is not gantry mounted. Instead, two x-ray tubes, that are recessed into the floor 
of the treatment room, point at two kV digital detector panels mounted on the ceiling. The IGS is modular, and can 
be put to many uses for different clinical sites, ranging from frameless intracranial stereotactic treatments to prostate 
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treatments using implanted fiducials. Compared to in room cone beam CT, the IGS offers faster image acquisition 
and processing, lower dose, superior spatial accuracy, and the ability to image immediately before treatment at any 
couch angle. Cone beam CT provides 3D imaging, which the IGS cannot. This can be mitigated by the use of 
implanted fiducials, but that is a topic outside the scope of this thesis. The description given here for components and 
procedure relates to the IGS as implemented for frameless intra cranial stereotactic treatments, which is the 
application with the most stringent spatial accuracy requirement. The determination of the spatial accuracy of this 
system in clinical practice is the major theme of this chapter. 
4.3.1 IGS components. 
The IGS consists of hardware and software deployed at the CT scanner and at the treatment unit. At the CT scanner, 
all of the additional IGS equipment is demountable. A carbon fiber base (marked by an A in Figure 4.3.1-1) locates 
on top of the flat CT couch. The base adapts a thin, lightweight mount (marked by a C in Figure 4.3.1-1) for a mask 
based individual patient head immobilizer. A target positional localizer (TARPO-marked by a D in Figure 4.3.1-1) is 
mounted to the base, over the patient head, during CT imaging and carries fiducials that provide stereotactic 
localization to the CT data set. 
At the treatment room, the IGS is a permanent installation, consisting of the floor recessed x-ray units (marked by 
two Cs in Figure 4.3.1-2), the roof mounted cameras (Marked by two As in Figure 4.3.1-2), an infrared projection 
and detection system mounted on the roof between the two kV x-ray flat panel detectors (Marked by a B in Figure 
4.3.1-2), and a tiltable couch top, termed the “robotic couch” mounted permanently in place of the standard couch 
top (marked by a D in Figure 4.3.1-2). The couch top adapts a projecting attachment (Marked by an F in Figure 
4.3.1-2) that holds a thin lightweight mount for a mask based immobliser identical to that mounted on the CT couch. 
This attachement can also adapt the TARPO or an array of six infra red reflective spheres over the top of the patient 
head. The control room of the treatment unit has an extra keyboard and screen for the IGS software (marked as A in 
Figure 4.1.3-3), as well as a joint kilovoltage x-ray control unit (marked as B in Figure 4.3.1-3). The software is also 
accessible in the treatment room for pre-positioning control purposes through a touch screen. A kV generator unit 
(marked as A in Figure 4.3.1-4 ) and the primary IGS computer system (marked as B in Figure 4.3.1-4) are also 
located in the treatment room behind the treatment unit. 
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Fig. 4.3.1-1 The IGS treatment 
room and CT equipment placed 
side by side. Since the CT 
equipment is entirely 
demountable, it is possible to 
transport it to the treatment 
room and show the two systems 
side by side. The CT equipment 
includes a demountable carbon 
fibre baseboard (A) which is 
aligned to the CT couch top by 
two universal locators (B). The 
baseboard supports a mask 
holder extension (C) that is 
identical to that on the linear 
accelerator. The TARPO (D) mounts to the mask holder extension and carries the fiducials that provide the 3D 
stereotactic localization function of the CT The system on the linear accelerator can mount an array of optical 
marker spheres (E). Since the geometry of the TARPO and the array are known, the stereotactic coordinates of the 
treatment target, determined by reference to the fiducials visible on the CT scan, can also be used in the treatment to 
place that target at the linac treatment isocentre by moving the bed until the array is in the required position. In 
clinical practice the patients head is rarely in the same position relative to the mask extension at treatment and 
imaging, so this pre-positioning almost always (99.25% of the time under WBRC standard treatment pass conditions 
– see table 4.11.1-1) requires correction. 
Fig. 4.3.1-2 The IGS 
equipment in the linear 
accelerator treatment unit 
room. A- Roof mounted kV 
detector panels, B- roof 
mounted optical detection 
system. C- Floor recessed kV 
x-ray tubes D- IGS Robotic 
Couch top providing pitch and 
roll adjustment of the couch 
top. E- Robotic couch blue 
tooth communication module. 
F- Mask holder extension. 
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Fig.  4.3.1-3 Linac control room IGS 
hardware. The control room contains an 
extra computer screen (A) and keyboard for 
the IGS software. The screen is shown here 
in pre-positioning mode, with Anterior-
Posterior and Lateral Digitally 
Reconstructed Radiographs calculated from 
the stereotactic planning CT scan showing 
the expected position of the patient based on 
the position of the optical marker sphere 
array. A joint kilovoltage x-ray control unit 
(B) is used to set x-ray tube settings (kV, mA) 
and initiate kV exposures.  
 
Fig. 4.3.1-4 IGS treatment room auxiliary 
installations. The treatment room also contains 
the shared generator unit for the two kV x-ray 
tubes (A) and the central control computer for 
the IGS (B). These installations provide kV 
power and computing power/storage. Direct 
user interaction with these units is limited. 
 
 
 
4.3.2 IGS x-ray sub system 
The IGS x-ray sub system is made up of a pair of kV x-ray tubes mounted recessed into the floor, each aimed at a 
roof mounted detector, powered by a shared generator and controlled by a manual control unit linked to the IGS 
software. One of the kV x-ray tubes (Varian R-21: Varian Medical Systems, Palo Alto, CA USA) can be seen in its 
floor recess with the cover removed in Figure 4.3.2-1. A close up of one of the roof mounted kV x-ray detectors is 
seen in Figure 4.3.2-2. The detectors have a pixel size of 0.4 mm with a sensitive area of 20.5 x20.5 cm (model XRD 
512-400 AL1:Perkin Elmer, Waltham, MA).55 The detector critical frequency, f50, (the point at which the response 
frequency is 50% of the maximum relative modulation transfer function) is 0.7-0.9 line pairs per mm.55 The field of 
view of the detectors is 130 mm by 130 mm at the isocentre, the nominal pixel size is 0.254 mm by 0.254 mm at 
isocentre (see Figures 4.3.2-3 and 4.3.2-4). The unique characteristic of the IGS x-ray sub system is its use of non 
orthogonal paired kV image acquisition at relatively large source isocentre (2.24 m) and source-detector distances 
(3.62 m).55 The system has the advantage of rigidity compared to gantry mounted systems, but the system is 
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registered to the isocentre by a frequent (daily or weekly) two step daily calibration process. 55,56 (See Figures 4.3.3-
2, 4.3.3-3, and 4.3.3-4). The system allows variable settings of kV and mA and ms, but in practice for intracranial 
work it is generally sufficient to use for the majority of patients exposure settings of 82 kVp, 160 mA, 80 mS, 12.8 
mAs, with occasional use of a “hard head” setting of 101 kVp, 100 mA, 130 mS, 13.0 mAs and the dose required to 
obtain one cranial image was found at WBRC to be 0.1 mGy57, which is in agreement with published 
measurements58. 
 
Fig. 4.3.2-1 One of the floor recess mounted kV x-ray 
tubes of the IGS, shown with the floor cover removed. 
The manually adjustable collimator housing (Linear 
MC-150-C) collimator housing is set to a square field 
size of approximately 12.5 cm at 180 cm FID, which 
corresponds to 15.5 cm at isocentre, given a source to 
isocentre distance of 2.24 m. The x-ray tube has a 
maximum kVp of 120. 
 
 
 
 
 
Fig. 4.3.2-2 One of the roof mounted kV x-ray imager 
systems in close up. The detector has a pixel size of 0.4 
mm with a sensitive area of 20.5 x20.5 cm (model XRD 
512-400 AL1:Perkin Elmer, Waltham, MA). 
 
 
Fig. 4.3.2-3 Image of a 1 cm radio-opaque ruler inside 
the IGS software. The object being imaged was set up at 
the isocentre perpendicular to the kV beam axis. Despite 
the utmost care in the set up, the object was still imaged 
with a small angle. This indicates that the on screen 
display is the raw data, before the geometry is corrected 
by a transformation derived from the calibration of the kV 
system. The blue cross in the centre of the image indicates 
the position of the isocentre derived from the calibration. 
Note also that the software is requesting another image to 
be taken. If there is not sufficient attenuation in the 
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acquired kV image the system will not proceed to registration. This frustrates attempts to do phantom experiments 
with simple ball bearing phantoms in air. 
Fig. 4.3.2-4 High Dose Rate (HDR) check position source 
ruler that was imaged in Figure 4.3.2-4. Despite meticulous 
setup of the phantom, the image still had a visible angle, 
leading to the conclusion that the physical alignment of the x-
ray detectors is only approximate; factors determined through 
calibration are used to correct the image geometry to obtain 
information registered to the isocentre. 
 
4.3.3 IGS Optical sub system 
The purpose of the IGS optical sub system is to accurately determine the relative position of the patient from the 
position of the optical marker spheres. The IGS optical sub system is required because the point at which the couch 
pivots is remote from the isocentre, to the extent that it is impractical to determine the position of the patient to the 
level of accuracy required for stereotactic treatment from the physical angle of the IGS robotic couch. The IGS 
optical sub system is made up of a roof mounted infra red projection and detection system. The system relies on 
stereoscopic detection of infrared (IR) reflective marker spheres. The IGS optical sub system is described by Wagner 
et al59.  It includes 2 stereoscopic infrared cameras on a single roof mounted assembly (see Figure 4.3.3-1). The 
optical system provides real time tracking of spherical IR reflectors at a frequency of approximately 10 times per 
second. The calibration of the optical system is achieved relative to the treatment room isocentre lasers using a 
phantom (see Figure 4.3.3-2 and 4.3.3-3). Once the optical system is calibrated it is used in turn to position a kV 
imaging phantom at the isocentre to calibrate the IGS kV imaging sub system. Adjusting the pitch of the couch as 
part of the clinical procedure requires the couch to tilt about a point about 1.7 metres from the isocentre. Although 
the angular readout is accurate to 0.1 degrees, at this distance a pitch of 0.1 degree will change the height of the 
patient relative to the isocentre by about 3 mm. Achieving stereotactic accuracy by setting the couch pitch angle 
would thus be extremely challenging and expensive to achieve, if it could be done at all. The optical tracking system 
allows relative movements and rotations of the patient to be achieved to sufficient accuracy to allow the kV imaging 
system to deliver a final confirmation of patient positioning to within the accuracy required for stereotactic 
treatments.  
 
Fig. 4.3.3-1 IGS optical sub system roof mounted infrared 
projection/detection system. The infrared light is seen in this 
image as two blue rings composed of smaller discrete blue 
dots. The infra red light is visible to the digital camera used 
to obtain this image, but is not normally visible to the naked 
eye.  
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Fig. 4.3.3-2 The IGS optical sub system calibration 
phantom. It is essentially a tablet that has three 
orthogonal lines that are matched by eye to the 
treatment lasers that indicate the isocentre. The five 
reflective marker spheres on top of the tablet are then 
localized by the optical tracking sub system, and this 
information, together with the known geometry of the 
tablet, is used to calibrate the optical tracking sub 
system to the linear accelerator treatment isocentre. The 
marker sphere array is asymmetric, and the tablet must 
be positioned in the orientation shown on the upper 
surface of the tablet to correctly calibrate the orientation of the optical system to the linac coordinate system.   
 
Fig. 4.3.3-3 The IGS optical sub system calibration 
phantom, shown aligned to the treatment room lasers 
that indicate the isocentre.  
 
 
 
 
 
 
Fig. 4.3.3-4 Calibration of the IGS x-ray sub system. 
Once the IGS optical sub system has been calibrated, it 
is used in turn to position a kV imaging phantom at the 
isocentre of the linear accelerator. This phantom 
contains fiducials that are imaged in turn by the kV 
units, to calibrate the IGS kV sub system to the 
isocentre. The arrow marked C indicates the insertion 
point for a fiducial. The arrow marked B indicates one 
of four IR reflective circular surfaces that enable the IR 
sub system to position the phantom accurately. The 
arrow marked A shows the light field for a patient 
specific mini-multileaf collimator field. The light field has been turned on with the gantry at zero degrees (beaming 
vertically downwards) to provide an orientation of the image. 
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4.3.4 IGS clinical procedure 
A brochurial description of the IGS frameless intracranial stereotactic clinical treatment procedure can be found in 
the literature.60 The relevant parts of the IGS clinical treatment procedure for frameless intracranial stereotactic 
treatment are for the purposes of this work best explained by following the hidden target test with an ANTHROP 
head phantom. The hidden target test attempts to test the full imaging and treatment process with a phantom with an 
embedded fiducial. Figures 4.3.4-1 to 4.3.4-9 illustrate the procedure. The final step of the hidden target test is a 
Winston Lutz test61 of the position of the hidden target, but the final stage for a patient is for the treatment beams at 
that couch angle to be given. The clinical decision process is shown in Figure 4.3.4-10.   
The clinical procedure provides four enveloping layers of patient positioning accuracy:  
Layer 1 Initial Linac patient pre positioning at couch zero. (see Figure 4.3.4-7) 
Layer 2 TARPO check.  (see Figure 4.3.4-8) 
Layer 3 kV images and auto fusion  (see Figure 4.3.4-9) 
Layer 4 Review of image fusion. (see Figure 4.3.4-9) 
The enveloping layers of accuracy provide protection from adverse clinical results that might be caused by the failure 
of a single component of the procedure. 
For the purpose of this research work it is important to note that in the standard clinical procedure at WBRC, when 
the couch is rotated to a new angle, if the position is found to be out of optical tolerance, this is corrected by 
unlocking the bed and manually adjusting its position in the longitudinal and lateral directions to achieve optical 
tolerance at the new couch angle. (The system displays the deviation from isocentre detected by the optical system 
on a computer screen in the treatment room; the operator can view this in real time as they manually adjust the bed.) 
It is rare that the motorized vertical motion of the bed is required to regain a position within optical tolerance. In 
Figure 4.3.4-10, this is summarized simply as “Rotate treatment couch to next angle under IR guidance”. 
 
Fig. 4.3.4-1 Step 1 of the hidden target test. The 
ANTHROP head phantom with an inserted ball bearing 
is placed on the CT scanner in a custom made mask. The 
mask mounts to the mask holder to position the phantom 
rigidly. The mask holder is mounted on a carbon fibre 
base that is located on the treatment couch by universal 
locators, one of which can just be seen in position at the 
top of the CT couch. (see Figure 4.3.1-1 for an 
explanation of the IGS CT equipment.) 
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Fig. 4.3.4-2 Stage 2 of the hidden target test. The TARPO is 
attached and a stereotactic CT data set is acquired. 
 
 
 
 
 
 
 
Fig. 4.3.4-3 A close up of the TARPO, showing the V pattern 
fiducials used to establish the stereotactic coordinates. 
 
 
 
 
 
 
 
 
Fig. 4.3.4-4 Stage 3 of the hidden target test, the CT 
scan is imported into the IGS RTPS and the 
stereotactic fiducials (the six white dots in the image) 
are auto-detected. 
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Fig. 4.3.4-5 Stage 4 of the hidden target test, The 
isocenter is placed on the fiducial imaged in the 
stereotactic CT scan, from which the IGS RTPS is 
able to determine the stereotactic coordinates, seen 
on the bottom right of the screen. For a patient, the 
isocentre would be placed inside a marked tumour 
volume. 
 
 
 
 
 
 
Fig. 4.3.4-6 Stage 5 of the hidden target test, export 
of data to the IGS. The CT data set and the 
isocentre coordinates are exported from the IGS 
RTPS to the IGS. This concludes the planning part 
of the clinical process. 
 
 
 
 
 
Fig. 4.3.4-7 Stage 6 of the hidden target test. In the 
treatment room, the patient/phantom is pre-
positioned to isocentre under optical guidance. The 
initial positioning is a pure translation with a level 
couch. If the phantom/patient is positioned in an 
identical position in the mask at imaging and 
treatment, the isocentre is now in the correct 
position. In practice this does not happen, but this 
supplies the first of four layers of positioning. 
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Fig. 4.3.4-8 Stage 7 of the hidden target test. While the 
couch is level, the TARPO is adapted to the treatment couch 
(the TARPO adapts to both the treatment and imaging 
couch). IGS RTPS isocentre and field outlines can be 
overlaid to check against lasers and light beam. This 
supplies a second layer of positioning. 
 
 
 
Fig. 4.3.4-9 Stage 8 of the hidden target test. Paired kV 
images are acquired and fused with digitally reconstructed 
radiographs (DRRs) calculated from the CT scan within the 
IGS software. If the correction required is within tolerance, 
this supplies the third layer of positioning. If the correction 
is outside tolerance for position or rotation, a correction is 
made to angle and position. Operator review of the image 
fusion is the fourth layer of positioning.  
 
 
 
Fig. 4.3.4-10 Frameless stereotactic treatment decision path. 
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4.3.5 IGS scientific reports 
A search of the literature gives over 450 references that deal with the IGS.  The IGS can be used for many different 
clinical sites, for example treatment of liver metastases62, spinal tumours63, prostate cancer64, and gated treatment of 
lung cancer65, but the primary interest in this work is in intracranial treatments. Extracranial treatments involve 
additional patient positioning considerations, not dealt with in this thesis, that reduce the achievable spatial accuracy. 
This thesis concentrates on intracranial treatments because they have the most demanding clinical requirement for 
maximal spatial accuracy. The clinical spatial accuracy of the IGS is thus most important when it is used for 
intracranial treatments.  
The IGS has evolved over time, beginning as simply an optical system66, and evolving to include planar kV imaging. 
Although the motivation to introduce the kV system is not well documented in the literature, Verellen67 credits 
Mitsubishi Electronics Co. in collaboration with the Hokkaido University with pioneering the room mounted kV 
imaging approach68,69 , followed by UZ Brussel in collaboration with the IGS vendor to produce an early version of 
the IGS with kV x-ray concept70, with roof mounted x-ray tubes and a single couch mounted kV imaging device. The 
focus in this work is on the contemporary version of the IGS, with paired floor recessed x-ray tubes and roof 
mounted kV detectors. 
Reports in the literature on the equivalence of clinical results between frame based intracranial stereotactic 
treatments and frameless intracranial stereotactic treatments with the IGS71, while of great comfort to clinical 
practitioners, are not particularly useful in determining whether the system will be adequate for registration of 
functional imaging to the treatment isocentre, and so are only of passing interest to this work. Similarly there are a 
range of studies that use the IGS to rate the effectiveness of various patient immobilization strategies,72,93 but the 
focus in this work is on the accuracy that the IGS itself can achieve in clinical practice, not the use of the IGS to rate 
other systems that are inferior to the IGS. Sophisticated experimental studies that establish the dosimetric 
consequences of misalignment in various practical SRT planning scenarios73,74 are vital indicators of the requirement 
of spatial accuracy for general stereotactic practice, but are peripheral to the point of interest in this work. 
There are many reports in the literature of phantom based measurements of the accuracy of the IGS frameless 
intracranial stereotactic system.75,76,77,78 Although measuring the accuracy with which a phantom has been placed to 
the order of 1 mm is a challenge for most medical physics departments, some of the phantom measurements are 
sufficiently accurate to be able to discriminate between the results obtained with segmented and rigid phantoms.70  
The justification for extending these findings to clinical practice is generally one of necessity. Clinical verifications 
of the accuracy of the IGS frameless intracranial stereotactic system are fewer and more varied. One method is to 
check IGS positioning with Cone Beam CT; Walls et al.79 found agreement within 1.1 mm. Ma et al.80 used 
essentially the same method and placed a limit of 0.5 mm for phantoms, and 1.5 mm for patients, on the clinical 
accuracy of the IGS for intracranial frameless stereotaxy. Jin et al88 ingeniously masked different areas of the kV x-
ray images as a method of determining the accuracy of the 6D fusion algorithm. Verbakel et al81 used repeat IGS kV 
images during treatment to assess patient motion. 
The IGS implements translation in and rotation about all three axes. Most other planar patient alignment systems 
implement only translations. There has been theoretical discussion in the literature about whether correction by 
translation alone is adequate89,90,91. The expectation is that translation is sufficient for implanted fiducials, but 
susceptible to error when boney anatomy remote from the tumour is used for localization. This is exactly the clinical 
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scenario for central intracranial lesions localized using planar kV images of the skull. Measurements with the IGS 
showed that correction by combined rotation and translation provided superior localization to correction by 
translation alone.83 
It has been determined that the slice thickness of the stereotactic CT scan has a strong influence on the accuracy of 
planar radiographic patient positioning for radiosurgery.82 Measurements with the IGS have also demonstrated the 
dependency of accuracy on CT slice thickness.83       
4.4  Phantoms vs Patients: Hypotheses 
Before stating the hypotheses it is useful to summarize the context in which the hypotheses arise. The need for 
functional imaging registration to the treatment room isocentre has been established.  The requirements for such 
registration have been outlined (section 4.1); cost, accuracy, efficiency. Currently available methods for positioning 
the patient have been reviewed (section 4.2), and it has been shown that the IGS may be a suitable system for 
achieving registration of functional imaging in the treatment room (section 4.3). IGS clinical procedure has been 
described and the literature reporting it has been reviewed (section 4.3.5).  
What remains is the question of whether the IGS will be sufficiently accurate in clinical practice. The IGS output 
will always eventually report that the patient is correctly positioned within the specified tolerance, and phantom 
measurements support this, but phantom measurements are not exactly the same as patient treatments. A primary 
remaining concern is how a clinical radiotherapy department might verify the clinical accuracy of an IGS. Published 
studies from other groups are of some utility, but are not in themselves sufficient. To be valid, such a determination 
must be specific to the procedures and techniques used in the department, and for the patients treated in that 
department. A related concern is whether the procedures used by the department are satisfactory, or if they should be 
modified. An answer to this question should be provided by a verification of the clinical accuracy of the IGS specific 
to the department’s techniques and patients. In the remainder of this chapter ten related hypotheses with respect to 
the accuracy of IGS in clinical practice for frameless intracranial SRS and SRT will be tested.   
The first hypothesis is that the IGS can be used in clinical practice with sufficient spatial accuracy for frameless 
intracranial stereotactic radiosurgery (SRS) and frameless intracranial stereotactic radiotherapy (SRT). The required 
accuracy is to some extent dependent on available technology, and claimed accuracy can vary from department to 
department, but in general it is usual to refer to the AAPM guidelines84 for a specification of the spatial accuracy 
required for stereotactic treatment.   
The second hypothesis is that the clinical accuracy of the IGS can be determined from a review of results obtained 
from the IGS itself in standard clinical practice. 
The third hypothesis is that there will be aspects of the clinical accuracy of the IGS that can be determined from a 
review of IGS treatment data that cannot be demonstrated by phantom experiments.  
The fourth hypothesis is that a review of the results obtained with the IGS in clinical practice can be used to guide 
changes in treatment technique, if required, to improve accuracy. 
The fifth hypothesis is that review of the results obtained with the IGS in clinical practice can show that tightening 
the pass criteria provides diminishing returns in terms of clinical accuracy. 
The sixth hypothesis is that the larger the distance translated by the last correction, the less accurate the patient 
positioning with the IGS will be in clinical practice.  
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The seventh hypothesis is that the accuracy of the IGS positioning in clinical practice will be dependent on the 
number of iterative 6D corrections it took to achieve that positioning. 
The eighth hypothesis is that the accuracy of positioning with the IGS in clinical practice will improve after the first 
two fractions of stereotactic radiotherapy (SRT). 
The ninth hypothesis is that the angle corrections determined by the IGS can be determined to be correct by 
reviewing the results obtained with the IGS in standard clinical practice. 
The tenth and final hypothesis is that it will be possible to estimate the influence of artifacts of the method used to 
determine the clinical accuracy of the IGS, paradoxically again by reviewing the IGS results from standard clinical 
use of the IGS. 
The first step in the investigation and analysis is to formally define a coordinate system.  
4.5 Coordinate systems definition. 
The IGS reports translations and rotations as they apply to a patient in the head first supine (HFS, patient resting on 
their back, with their face to the ceiling, head closer than feet to the treatment unit) orientation on the treatment 
couch. Since this coordinate system is relative to the patient, it rotates when the treatment couch is rotated. There are 
two logical choices for the alignment of a fixed coordinate system in which to interpret these results, alignment to the 
axis of rotation of the couch, and alignment to the plane containing the axes of the non orthogonal kV imaging 
beams. This gives three separate coordinate systems, and it is necessary to describe them fully before proceeding to 
use them for analysis. 
4.5.1 Rigid real world coordinate system. 
It is necessary to define the following right handed three dimensional rectilinear coordinate system that is 
independent of couch rotation and aligned to the axis of rotation of the treatment couch. 
 
fi  is a unit vector in the x_zero axis, the superior (SUP) direction (with the patient in the head first supine 
orientation) zero at isocentre, positive towards the gantry. 
 
fj  is a unit vector in the y_zero axis, the patient RIGHT direction (with the patient in the head first supine 
orientation) zero at isocentre, positive away from the maze entrance. 
 
fk  is a unit vector in the z_zero axis, patient anterior (ANT) direction (with the patient in the head first supine 
orientation) zero at isocentre, positive vertically above the isocentre. 
 
We call this coordinate system the “real world” coordinate system, as illustrated in Figure 4.5.1-1. 
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Fig. 4.5.1-1 The real world coordinate system. The red arrow 
marked x indicates the x_zero axis. fi  is a unit vector in the 
fixed x_zero axis, the SUP direction (with the patient in the 
head first supine orientation) positive towards the gantry. The 
green arrow marked y indicates the y_zero axis. fj  is a unit 
vector in the fixed y_zero axis, the patient RIGHT direction. 
The blue arrow marked z indicates the z_zero axis. fk  is a 
unit vector in the fixed z_zero axis, the patient ANT direction. 
The origin is at the isocentre. Two lines of string have been run 
to indicate the kV beam axes, these run from the kV x-ray sources in the floor (one visible, one off screen below 
screen right), to the kV x-ray cameras on the roof (one visible, one off screen above screen). The two lines of string 
are seen to intersect at the isocentre.    
4.5.2 Rotating couch based coordinate system.  
It is necessary to define a right handed three dimensional rectilinear coordinate system dependent on couch rotation. 
 
θi  , or simply i  where the couch angle is not required, is a unit vector in the couch longitudinal axis, zero at 
isocentre, positive beyond the isocentre away from couch support. 
 
θj , or simply j  where the couch angle is not required, is a unit vector in the couch lateral axis, zero at isocentre, 
positive beyond the isocentre towards the patient right in HFS orientation. 
 
θk , or simply k  where the couch angle is not required, is a unit vector in the vertical direction, zero at isocentre, 
positive vertically above the isocentre. 
 
We call this coordinate system the couch based coordinate system. 
4.5.3 Relationship between real world and couch based coordinate system. 
We can strengthen our definition of the real world and couch based coordinate systems by determining the 
transformations that map between the two coordinate systems. Since the couch based system rotates with the 
treatment couch, and the real world coordinate system does not, transformations that map between the two systems 
depend on the couch rotation angle, θ . At the WBRC, θ  is zero when the long axis of the couch is aligned to the 
axis of rotation of the treatment gantry. The couch rotation angle increases when the couch is rotated towards the 
patient’s right in the HFS orientation.   
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The transformation from the real world coordinate system to the couch based coordinate system is given by equation 
4.5.3-1. 
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The reverse transformation from the couch based coordinate system to the real world coordinate system is given by 
equation 4.5.3-2.  
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
−=
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
θ
θ
θ
θθ
θθ
k
j
i
k
j
i
f
f
f
100
0cossin
0sincos
     Equation 4.5.3-2 
4.5.4 Real world coordinate system specification of kV beam orientations. 
To define a rigid coordinate system aligned to the plane containing the two kV image beams, and its relationship to 
the real world coordinate system, the direction of the kV beams must be defined in the real world coordinate system. 
Installations of the IGS vary from centre to centre, and there have been design iterations in the setup of the kV x-ray 
beam geometry. What is described here is the geometry of the kV beams as installed at WBRC. The kV x-ray tubes 
are located in the floor at an angle of 45 degrees either side of the gantry. On an overhead view, as installed, the lines 
from the kV sources to the kV imagers thus make an angle of 90 degrees with each other viewed from above the 
isocentre, as shown in Figure 4.5.4-1 
 
Fig. 4.5.4-1 The lines from the kV sources to the kV imagers 
make an angle of 90 degrees with each other viewed from 
above the isocentre. The string lines visible in the image mark 
the kV beam axes. The image is taken from above the isocentre. 
The angle markings on the turntable thus function as a 
protractor. 
 
 
 
The cameras are mounted in the roof such that the lines from the kV sources to the kV imagers make a maximum 
angle of 45 degrees with the horizontal plane. Both lines pass through the isocentre. 
 
From the above configuration it can be determined that the two unit vectors parallel to the lines from the kV sources 
to the kV imagers are 
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This implies that the angle α between the two beams is 60 degrees, as 
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And this can be observed in practice as shown in Figure 4.5.4-2.  
 
Fig. 4.5.4-2 The two kV beams are not orthogonal, but make an angle 
of 60 degrees.  This arises from simple geometry but is here 
demonstrated visually. As in the previous figures, string lines indicate 
the kV beam lines. A large, crudely fashioned protractor is held in the 
plane of the kV beam axes to show that the beam axes make an angle 
of 60 degrees in the plane. Thus, the kV beams are non-orthogonal, 
which has implications for the accuracy of localization achieved with 
the system. 
 
So the two kV beams are not orthogonal. The accuracy of the localization provided by non orthogonal beams in a 
particular axis is not isotropic but depends upon the orientation of the vector relative to the beams. To describe this 
expectation properly requires the definition of a rigid coordinate system aligned to the geometry of the kV imaging 
system, which we proceed to define in the next section. 
4.5.5 Definition of a rigid coordinate system aligned to the kV beam 
geometry. 
From the orientation of the kV beams defined in the previous section, we can proceed to define a rigid coordinate 
system aligned to the geometry of the kV imaging system. A vector perpendicular to both kV beam axes is given by 
equation 4.5.5-1. 
⎟⎠
⎞⎜⎝
⎛+⎟⎟⎠
⎞⎜⎜⎝
⎛ −=×=
2
1
2
1ˆˆ ff kibaN        Equation 4.5.5-1 
A unit vector perpendicular to both kV beam axes is given by equation 4.5.5-2. 
⎟⎟⎠
⎞⎜⎜⎝
⎛+⎟⎟⎠
⎞
⎜⎜⎝
⎛==
3
1
3
21ˆ
ff kiNN
N       Equation 4.5.5-2 
A unit vector that bisects the angle between the two kV beam axes is given by equation 4.5.5-3. 
( ) ⎟⎟⎠
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B       Equation 4.5.5-3 
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Since the bisector is coplanar with aˆ  and bˆ  , a third unit vector perpendicular to both Nˆ  and Bˆ   is given by  
fjBNL =×= ˆˆˆ         Equation 4.5.5-4 
The three unit vectors Nˆ , Bˆ  and Lˆ  form a right handed coordinate system aligned to the kV beam geometry. As 
the kV beams are not orthogonal, it is expected that the isocentre will be better localised in the Lˆ  axis than the Bˆ  
axis, due to the foreshortening of any localization error in the Bˆ  axis.  Localisation accuracy in the Nˆ  axis is 
expected to be intermediate. This trend should emerge over a large enough sample.  A competing effect is expected 
due to the non-isotropic spatial resolution of the 3D CT scan used to construct the DRRs to which the kV images are 
fused. The spatial resolution of the CT scan is worse (1.25 mm) in the  fi  axis compared to the fj and the fk  axis 
(Both 0.9375 mm) when the couch angle is zero. 
 
The rigid coordinate system aligned to the kV beam system can be expressed in terms of the coordinate system 
dependent on the couch rotation system as follows in equations 4.5.5-5, 4.5.5-6, and 4.5.5-7. 
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( ) ( )θθ θθ cossinˆ jiL +−=       Equation 4.5.5-7 
So the conversion from the rigid coordinate system, fi  , fj  , fk  to the rigid coordinate system n,b,l, is given by 
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      Equation 4.5.5-8 
The reverse transformation, from the rigid coordinate system n,b,l to the rigid coordinate system fi  , fj  , fk  is 
given by 
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      Equation 4.5.5-9 
The relative orientation of the two rigid coordinate systems and the kV beams is shown in Figure 4.5.5-1. 
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Fig. 4.5.5-1. The linear accelerator used for stereotactic treatments showing the orientation of the fixed coordinate 
systems and the kV beam axes. Lines of string have been tied from the kV sources to the imagers as a visual cue to 
indicate the kV image plane. 
4.5.6 Software output. 
The IGS defines the coordinates in terms of a HFS patient, and it is necessary to define how this output maps to the 
coordinate systems established. After an automatic image fusion, the IGS reports a recommended rigid body 
translation, referred to as a “6D correction” that involves six parameters, three translations and three rotations. They 
are listed and defined in turn below: 
 
1. A Vertical (VERT) translation: the positive direction is ANT, same as θk  
2. A Longitudinal (LONG) translation: the positive direction is SUP, same as θi  
3. A Lateral (LAT) translation: the positive direction is patient left, opposite of θj  
4. A Rotation about the Lateral axis: positive rotation is for the feet to move down and the head to raise. It is termed 
“pitch” by the IGS documentation.85 The equivalent is to rotate around θj  in the opposite direction. 
5. A Rotation about the longitudinal axis: positive rotation is for the patient left to move down and the patient right to 
move up. It is termed “roll” by the IGS documentation.85 The equivalent is to rotate around θi  in the same direction. 
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6. A rotation about the vertical axis: positive rotation means the patient’s feet move to the left. It is termed “table 
rotation” by the IGS documentation85, and is also referred to as couch rotation in the linear accelerator 
documentation86. The equivalent is to rotate around θk  in the same direction. 
 
The order of rotation in a rigid body transformation operation is normally required, but in this particular case the 
couch rotation angle physically constrains the angles about which the couch rolls and pitches, so the order in which 
they are executed is not important. Attention must now be given to the definition of a rotation in the fixed coordinate 
systems. 
4.5.7 ROTATION 
It is sought, upon the assumptions of normal distribution and rotational invariance, to infer the accuracy of the IGS in 
clinical practice. There are competing reasons for assuming invariance with respect to the real world coordinates or 
the couch based coordinates, which will be explored later in this chapter (See section 4.8), but in order to be able to 
resolve this dilemma it is necessary to first determine the implications of rotational invariance in both coordinate 
systems. In practice the way the system implements a 6D correction is to change the roll (rotation about the θi  axis) , 
pitch (rotation about the θj  axis) and yaw (rotation about the θk  axis) angles, and then subsequently compensate 
for any positional change owing to the eccentricity of any or all of the rotations and implement the translation by 
adjusting the couch VERT, LONG and LAT position under infra red control until the positioning is back within infra 
red positioning tolerance, modified by the implementation of the translation. In terms of the result of the combined 
actions, this means that the couch VERT, LONG and LAT are all carried by the couch, whereas the pitch and roll 
corrections do not change the position of the isocentre, but simply rotate the patient about the isocentre. To make 
inferences on the basis of rotational invariance, we need to compare results before and after a rotation of the couch.  
If we apply rotational invariance to the rotating system, the result is trivial: all of the rotations and translations should 
be the same before and after translation. A pedantic way of stating this is that equations 4.5.7-1, 4.5.7-2, and 4.5.7-3 
are expected to hold, where 1θ  is the couch angle before rotation and 2θ  is the couch angle after rotation.  If instead 
we apply rotational invariance to the position of the patient in the real world coordinate system, the relationship is 
more complex. 
21 θθ ii =         Equation 4.5.7-1 
21 θθ jj =         Equation 4.5.7-2 
21 θθ kk =         Equation 4.5.7-3 
After a successful image localisation at one gantry angle, the couch is rotated and another pair of images taken. Prior 
to the rotation, with the couch at angle 1θ  we have a displacement in LAT LONG and VERT that we can convert to 
1θi  , 1θj , 1θk  coordinates. We can then convert these coordinates to the couch invariant coordinate system 1fi  
, 1fj  , 1fk . For the subsequent couch angle 2θ  we again have a LAT LONG and VERT displacement which we can 
convert to 
2θi  , 2θj , 2θk and then to  2fi  , 2fj  , 2fk . The application of the assumption of rotational invariance in 
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this circumstance is then that the real world position of the isocentre does not change, and we can expect that the 
relationships that are specified in equations 4.5.7-4, 4.5.7-5 and 4.5.7-6 should hold.   
21 ff ii =         Equation 4.5.7-4 
21 ff jj =         Equation 4.5.7-5 
21 ff kk =         Equation 4.5.7-6 
In practice none of these equations will hold in general, there will always be a discrepancy. To give these errors a 
constant sense, we will always subtract the first values from the second. The resulting displacement errors are 
defined by equations 4.5.7-7 to 4.5.7-12. 
12 θθθ iii −=Δ         Equation 4.5.7-7 
12 θθθ jjj −=Δ         Equation 4.5.7-8 
12 θθθ kkk −=Δ        Equation 4.5.7-9 
12 fff iii −=Δ         Equation 4.5.7-10 
12 fff jjj −=Δ        Equation 4.5.7-11 
12 fff kkk −=Δ        Equation 4.5.7-12 
In the real world coordinate system we can look for differences in the magnitude of errors between  kΔ  on one hand 
(pixel size) and iΔ  and  jΔ on the other hand (mixture of pixel size and slice thickness depending on couch angle).  
Finally we can transform into the kV image Nˆ , Bˆ  and Lˆ  system aligned to the kV image axis. The magnitude of 
errors should line up Bˆ > Nˆ > Lˆ . 
 
If angles are involved, these may be a rotation around the LAT, LONG and/or VERT axis. Rotations about the LAT 
and LONG axis are effected by the robotic couch. The couch tilt mechanism is mounted on the linac couch, so 
translation movements of the linac couch carry the couch tilt mechanism with it. Rotations about the VERT axis are 
effected by rotation of the linac couch turntable, and so carry the LAT, LONG and VERT axis with them. Assuming 
that the linac couch rotates perfectly, then if we have, prior to the rotation, with the couch at angle 1θ we have a 
displacement in LAT LONG and VERT and a suggested couch rotation 1θΔ that we can convert to 1θi  , 1θj , 1θk  
coordinates. We can then convert these coordinates to the couch invariant coordinate system fi  , fj  , fk . For the 
subsequent couch angle 2θ , with suggested corrections LAT2, LONG2 and VERT2 with suggested couch rotation 
2θΔ  we can convert from  2θi  , 2θj , 2θk  to fi  , fj  , fk  coordinate system. 
 
Transformations from one axis to another if couch rotation is θΔ . 
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Rigid coordinate transformation vectors in standard scenario with perfect couch rotation. 
 
Example Scenario 
A kV image set is taken at couch angle 1θ the subsequent autofusion  suggests a correction of displacement 1LAT , 
1LONG , and 1VERT  and a suggested couch rotation 1θΔ  . Couch then rotated to angle 2θ ,where a second kV 
image set is taken with suggested corrections 2LAT , 2LONG , and 2VERT  with suggested couch rotation 2θΔ . 
Before the rotation, exactrac determined the isocentre position to be 1fi  , 1fj  , 1fk  in the rigid coordinate system. 
After the rotation, exactrac will determine the isocentre position to be 2fi  , 2fj  , 2fk . The average of these two 
vectors, ( ) ( ) ( )212121 5.05.05.0 ffffff kkjjii +++ , is then an estimate of the true position of the isocentre. 
One half the difference of these two vectors is taken as a measure of the error in the estimate of the isocentre, 
( ) ( ) ( )121212 5.05.05.0 ffffff kkjjii −−− . 
 
The transformations are as follows 
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The next step is to use this information to infer the clinical accuracy of the IGS. 
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4.6 The method of inference 
We assume the coordinate reported by the software is normally distributed about the true position of the target 
relative to the isocentre. A rotation of the treatment couch then gives us two successive samplings that are normally 
distributed around the same point. The average magnitude of the difference between these two successive samplings 
is an estimate of twice the standard deviation divided by π  (see Keen and Page 195387). 
( ) ( ) σππσ σ
2
2
1
12
2
212
2
2
1
2
2
=−=
+−∞
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∞
∞−
∫ ∫ dxdxexxd
xx
     Equation 4.6-1 
where  
d is the average of the magnitude of the difference between the pre and post rotation coordinate 
σ is the standard deviation of the normal distribution of the reported coordinates about the actual coordinate. 
If we apply the assumption of rotational invariance to the rotational coordinate system, then equations 4.6-2, 4.6-3, 
and 4.6-4 apply. If we apply the assumption of rotational invariance to the real world system, then equations 4.6-5, 
4.6-6 and 4.6-7 apply. 
ii iiid σπθθθ
2
12
=−=Δ=        Equation 4.6-2 
jj jjjd σπθθθ
2
12
=−=Δ=       Equation 4.6-3 
kk kkkd σπθθθ
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=−=Δ=       Equation 4.6-4 
iffi iiid σπ
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12 =−=Δ=        Equation 4.6-5 
jffj jjjd σπ
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12 =−=Δ=        Equation 4.6-6 
kffk kkkd σπ
2
12 =−=Δ=        Equation 4.6-7 
This method of obtaining the standard deviation for normal or nearly normal distributions is referred to as the 
method of successive differences87. The method allows the standard deviation to be calculated even though we can 
only determine the difference between successive position determinations before and after a couch rotation. Once a 
correction is implemented at a particular couch angle, the link with prior points at different couch angles is broken by 
the correction. Furthermore, when a patient is set up they may be placed at any point within the frame, and so from 
fraction to fraction there is no continuity. Except for two points separated only by a couch rotation, local factors 
predominate. So it is not useful to use the sum square differences to obtain the standard deviation. 
The disadvantage of this method is that the variance of the estimate is larger than the standard method. That is to say, 
for a given sample size, the confidence interval is larger for a determination based upon the method of successive 
differences than it is for one based upon the sum square differences method. The formula for the variance of an 
estimate obtained from the method of successive differences is given by Keen and Page87 as equation 4.6-8 below.  
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For a given axis, we average over all rotations in the data set or a subset of it, to obtain an estimate of the standard 
deviation of the distribution of coordinates in that subset about the true value: iσ , jσ  and kσ  respectively for the 
x, y and z axes. The standard deviation of these estimates is obtained from the variance calculated by the formula 
given by Keen and Page87, as specified by equation 4.6-8. 
( )( )
( )12
1/5113.0653.12
−
−−=
N
NVar σσ        Equation 4.6-8 
The method requires that we assume normal or near normal distribution. Takakura et al have identified the normal 
distribution as the most appropriate.76  
4.7 Clinical Treatment Regime. 
For a description of SRS and SRT implemented using the IGS head and neck localiser system, the reader is referred 
to an illustrated description of treatment and quality assurance found in the literature (Chen et al.60).  Important 
details specific to WBRC clinical implementation are that the CT scans are contiguous 1.25 mm thick slices, IGS x-
ray positional and rotational tolerances are 0.7 mm and 0.5 degrees respectively, and optical positioning tolerance is 
0.5 mm. The primary treatment techniques are dynamic conformal arcs and static shaped beams. A manual 
adjustment of the couch longitudinal and lateral position is used to restore patient positioning found to be out of 
optical tolerance after couch rotation; only very rarely is the motorised couch vertical movement utilised. 
4.8 Clinical Data Set 
The clinical data set consists of couch angle and image fusion results (comprising lateral, longitudinal and anterior-
posterior shifts, and corresponding rotational corrections) for 109 SRS patients and 166 SRT patients treated from 
March 2008 to September 2009. The data for SRS comprises 927 image pairs, of which 532 pass the standard IGS 
tolerances, from which 319 couch rotations were analysed. The data for SRT comprises 15983 image pairs, 10050 
classified as passes, from which 8701 couch rotations were analysed. 
Although the hypotheses relate to the underlying clinical accuracy of the IGS, that theme will be preceded by a 
review of the raw data reported by the IGS software. Figure 4.8-1 shows combined histograms of the IGS data, for 
the displacement from the isocentre, for SRT and SRS image pairs that were within the 0.7 mm displacement and 0.5 
degrees rotation to be classified as a pass. Inspection of Figure 4.8-1 shows that the SRS and SRT data reported by 
the software exhibit comparable behaviour. In the rotating representation the k axis has a lower standard deviation 
than i and j axes, and this is true for both SRS and SRT. The clinical data were also represented in the two fixed 
geometries as summarised by Table 4.8-1. In the rotating coordinate system, for SRT and SRS, the standard 
deviation of all axes is decreased in the post correction subset compared to the global set. This marginal decrease of 
positioning accuracy is the dominant feature of the positions reported in all three representations. The only means 
that are statistically different between SRS and SRT are the fixed (p=0.0004) and rotational (p=0.0009) i axes, and 
the n axis (p=0.0002).  The standard deviations show that the influence of couch rotation dominates over the 
influence of the kV imaging geometry, even in the post correctional sub-group.  
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Fig. 4.8-1. Histogram of target displacements as directly reported by the IGS software in superior-inferior (i), left-
right (j), and anterior-posterior (k) axes for all SRT and SRS kV image pairs that passed the 0.7 mm and 0.5 degree 
clinical tolerance. The SRT and SRS data have similar properties. For both, the i axis is the most asymmetric, and 
the k axis histograms have higher central peaks in comparison to the i and j axes, but a lower standard deviation 
than the i and j axes. 
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Table 4.8-1. Means and standard deviations of the raw results reported by the IGS software within clinical tolerance 
for SRT and SRS. Results for SRS and SRT are similar. Figures in brackets are derived from a subset that have had 
at least one kV image-mediated 6D position correction, which excludes positioning found to be within clinical 
tolerance immediately after a couch rotation without the need for a correction. The results in brackets are expected 
to be less influenced by local factors and more globally applicable. The means are all less than 0.1 mm in 
magnitude, but the maximum deviation from zero is found in the axis normal to the plane of the kV imaging system. 
The salient feature is a reduced Standard Deviation in the k axis, these numbers are underlined for emphasis.    
 
SRT 
Representation Quantity Axis 
 i (mm) j (mm) K (mm) 
Mean  -0.086 (-0.076) -0.005 (-0.007) -0.048 (-0.019) 
Standard IGS 
rotational system 
Standard 
Deviation 
0.307 (0.281) 0.273 (0.218)  0.222 (0.190) 
 if (mm) jf (mm) kf (mm) 
Mean -0.087 (-0.062) 0.020 (0.003) -0.048 (-0.019) 
Fixed system 
aligned to axis of 
couch rotation. Standard 
Deviation 
0.298 (0.265) 0.286 (0.242) 0.222 (0.190) 
 n (mm) b (mm) L (mm) 
Mean -0.099 (-0.062) 0.011 (0.021) 0.020 (0.003) 
Fixed system 
aligned to plane 
of kV image 
system 
Standard 
Deviation 
0.275 (0.242) 0.244 (0.218) 0.286 (0.242) 
 
SRS 
Representation Quantity Axis 
 i (mm) j (mm) K (mm) 
Mean  -0.039 (-0.054) -0.007 (0.000) -0.031 (-0.008) 
Standard IGS 
rotational system 
Standard 
Deviation 
0.314 (0.288) 0.286 (0.233) 0.228 (0.200) 
 if (mm) jf (mm) kf (mm) 
Mean -0.039 (-0.037) -0.006 (0.002) -0.031 (-0.008) 
Fixed system 
aligned to axis of 
couch rotation. Standard 
Deviation 
0.305 (0.268) 0.296 (0.259) 0.228 (0.200) 
 n (mm) B (mm) L (mm) 
Mean -0.050 (-0.035) -0.003 (0.014) -0.006 (0.002) 
Fixed system 
aligned to plane 
of kV image 
system 
Standard 
Deviation 
0.291 (0.251) 0.246 (0.221) 0.296 (0.259) 
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The major cause of the underlined lower standard deviation observed for the k axis shown in Table 4.8-1 is that close 
to half of the passes (205 out of 532 for SRS, 4941 out of 10050 for SRT) are achieved immediately following a 
couch rotation with kV x-ray position verification, but without any image-guided position adjustment at that couch 
angle. The couch rotates about the k axis, and in consequence the i and j axes results reported by the software are 
affected more by the couch rotation runout, and the rotational variance of the optical system. Anecdotally the 
radiation therapists report that they rarely have to adjust the vertical coordinate of the bed.  
There is some redundancy in Table 4.8-1, in the fixed representation aligned to the axis of couch rotation, the k axis 
is identical, by definition, to the rotational system, so the tabulated values for k and kf are identical. The two fixed 
axes that lie in the plane of the rotation both have a larger standard deviation than the k axis. For both SRT and SRS, 
the fixed if axis has a standard deviation of about 0.01 mm better than the rotational i axis. The error is simply 
redistributed, since the converse holds for the j axis.  
In a fixed geometry aligned to the kV image system, since the kV x-ray beams are not orthogonal but make an angle 
of 60 degrees with each other, we expect to see that the patient is positioned less accurately in the axis that bisects 
the angle (b-as defined in figure 4.5.5-1), and more accurately in the perpendicular axis in the plane of the kV image 
system (L). In the axis perpendicular to the plane (n) an intermediate value should be expected. We observed that for 
both SRT and SRS, the standard deviation in the L axis was slightly (0.01 - 0.05 mm) larger than n axis standard 
deviation, which was considerably (0.03 - 0.045mm) larger than the b axis standard deviation. L lies completely 
within the rotational plane, while n has a projection into the rotational plane that is twice that of b. So the results 
demonstrate, as previously noted, that the influence of rotation dominates over the influence of the kV imaging 
geometry, even in the post correctional group.  
With regards to the non zero means listed in Table 4.8-1, there are plausible reasons why the i axis might have a 
small bias to negative numbers; initial setups begin with the couch fully retracted, and the axis of rotation of the 
couch is located away from the isocentre by more than one metre in the negative direction, so if the couch pitch is 
changed from zero, the foreshortening of the couch will bias positioning towards the negative. The maximum offset 
is however in the n axis at 0.1 mm. This is well within SRS and SRT tolerance. To put this in context, a kV image 
pixel projected back to isocentre is 0.25 mm square. So an offset of this magnitude could be caused by a roundoff 
error in the interpretation of the image, or a slight bias from always moving the kV calibration phantom into position 
from above. 
The average number of couch positions per treatment session is 3.3 for SRS and 3.9 for SRT. Initial setups at couch 
zero are expected to have an influence on i axis accuracy because the i axis is the last to come within tolerance at 
pre-positioning. Thus, positioning at couch zero has a bias towards negative i axis coordinates. The different 
proportion of initial setups in SRS and SRT therefore accounts for the statistically significant difference in reported i 
axis means for SRS and SRT in Table 4.8-1. The n axis variation is a further consequence of the difference in the i 
axis.  
While information reported by the IGS software can sensibly be used to determine bias in the positioning, the 
derived standard deviation should not be considered proof that the localisation is accurate to within 0.7 mm; the 
report from any measuring system must be subject to some uncertainty, and the question is how to evaluate what this 
uncertainty is in clinical practice. 
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To put this another way, the IGS raw results indicate that all of the patient positions are within the specified 
tolerance, but in clinical practice we expect that this is not the case. It can always be said that all values are within 
the range, so we cannot trust the IGS raw results to tell us directly about the accuracy of the system. According to the 
IGS, all that is required to obtain increased spatial localization is to reduce the tolerance, but it is obvious even from 
phantom experiments that at some point reducing the tolerance produces no improvement. 
4.9 Results of Inference. 
Table 4.9-1 lists the standard deviations of the distributions of the IGS reported coordinates about the actual 
coordinates inferred from the full clinical data set under the standard pass conditions of 0.7 mm and 0.5 degrees. The 
quoted interval is the 95% confidence interval. We define the derived value ρ as the difference in quadrature between 
the average of the σ values in the plane of couch rotation and the value of σ perpendicular to the plane which is 
calculated according to equation 4.9-1. We expect ρ to be indicative of the uncertainty in the calibration of the kV 
image system to the isocentre in the k axis, which the method of inference used is insensitive to. The standard 
deviation of ρ, in terms of the standard deviation of iσ , jσ  and kσ  is given from standard error propagation 
analysis by equation 4.9-2, where ijCOV for example is the covariance of iσ  and jσ . The 95% confidence interval 
for the ρ is 0.234-0.259 mm for SRT and 0.190-0.332 mm for SRS.  
 
Table 4.9-1 Inferred standard deviations of the raw IGS values about the true values, determined for the full clinical 
data sets, under standard clinical tolerances. SRS values are larger than SRT values for all three axes by a 
statistically significant amount (See section 4.14.6 for a discussion of the probable cause). The 95% confidence 
intervals are tabulated; the intervals are larger for SRS because the SRS sample size is smaller. From the data in this 
table, we expect that if the IGS software reports a result of 0.00 mm in the i axis for an SRT treatment, we can expect 
that the actual value will be within the range -0.296 to +0.296 mm, 65% of the time. 
 
iσ  (mm) jσ   (mm) kσ   (mm) 
SRT 0.290 - 0.302 0.306 - 0.319 0.174 - 0.182 
SRS 0.323 - 0.393 0.337 - 0.409 0.231 - 0.281 
 
( ) ( ) ( )22
2
1,, kjikjif σσσσσσρ −⎟⎠
⎞⎜⎝
⎛ +==      Equation 4.9-1 
 
jk
kj
ik
ki
ij
jikji
COV
ff
COV
ff
COV
fffff
kjki
jikji
σσσσ
σσσσσρ
σσσσσσσσ
σσσσσσσσσσσ
⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂
⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂
⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+
⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂
⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂=
22
22
2
2
2
2
2
2
 Equation 4.9-2 
 
Chapter 4: Registration to the treatment isocentre 
222
4.10 Variation of accuracy with pass conditions. 
At the WBRC, the IGS is configured with standard kV x-ray tolerances of 0.7 mm and 0.5 degrees, with an auxiliary 
tolerance of 0.5 mm in the IR system. All of the results reported by the IGS show that localization is always within 
0.7 mm. (See Figure 4.8-1). If the tolerance is reduced, all of the results will be within that reduced tolerance. This 
clearly will not represent the real situation, there will be some points outside this tolerance, as mentioned at the end 
of section 4.8. The method of inference given in section 4.6 provides a way of statistically estimating the distribution 
of the IGS results about the actual results.  The decision on what limits the IGS should be configured with is an 
important one, involving a trade off between accuracy and efficiency. In this section we will use the method of 
inference, coupled with an appropriately filtered clinical data set to show how spatial localization and efficiency can 
be expected to vary with the pass conditions. 
4.10.1 Filtering the clinical data, scope, and assumptions. 
To use the method of inference to explore the effect of changing the pass conditions, it is necessary to filter the 
clinical data to represent what would happen if the pass conditions were changed. If the pass conditions are relaxed, 
all of the kV image pairs that are no longer required, because they were acquired subsequent to a prior kV image pair 
at the same couch angle that under the new pass conditions would be re-classified as a pass, are filtered out. This 
filtered data set can be used to estimate the efficiency at relaxed pass conditions, as the number of image pairs 
required decreases, and this is a measure of the efficiency gain. It is not possible to obtain an estimate of how the 
accuracy diminishes, since the method of inference relies for this on pre and post couch rotation values without an 
intervening 6D correction. The moment the first image pair is eliminated, we no longer have an unbiased estimate of 
the accuracy because we do not have a full set of rotations.  
If the pass conditions are tightened, there is a separate procedure for estimating spatial accuracy and efficiency. For 
estimating spatial accuracy, all pre rotation passes that do not meet the tightened pass conditions are filtered out. For 
estimating efficiency, we could use the same filtration method as we used for estimating the spatial accuracy, but we 
would be eliminating all of the localizations that might have taken more image pairs due to the tightened pass 
criteria, and this would be an over estimate of the efficiency. Alternatively, we can use the entire data base without 
filtration to estimate the efficiency. For those image pairs reclassified as a fail from a pass, extra images must be 
acquired and the problem is to estimate the number that will be acquired. At the standard pass conditions, there are 
three distinct subpopulations with very different pass rates. The lowest pass rate, of 0.75%, occurs for the first kV 
image pair of a treatment session at couch zero, when the patient has been positioned under IR guidance only (This 
subgroup is termed the “infra red guidance” subgroup). An intermediate pass rate of around 67% is achieved 
immediately after a couch rotation when the patient has been positioned by a rotation of the couch from a position 
that the kV image system classified as a pass (This subgroup is termed the “post rotational” sub group). The best pass 
rate of about 90% comes from the post correctional subgroup, the population that have had at least one prior 6D 
correction at that couch angle (This subgroup is termed the “post correctional” subgroup). It is the last pass rate, the 
best, that governs how many extra images will be required. As the pass conditions are tightened, it is to be expected 
that the post rotational pass rate will decrease. Although there is some evidence that the pass rate also decreases with 
the number of preceding corrections, we assume that the post correctional pass rate does not change with the number 
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of corrections, and for a given set of pass conditions it can be estimated from the pass rate of the post correctional 
subgroup within the filtered clinical data set.      
4.10.2 Variation of raw pass ratio with pass conditions. 
The raw pass ratio is simply the proportion of images within the clinical data set that would be classified as a pass 
under the variable pass conditions. It is unlikely to be of any predictive value for anything but very small changes, 
but it involves no assumptions to calculate, and so gives an unbiased estimate of the quantity. To calculate the pass 
ratio for a given pass criteria requires only to re-assess the pass/fail status of each image pair against the revised 
criteria, and then divide the total number of image pairs that pass by the total number of image pairs. Pedantically, 
this relationship is given by equation 4.10.2-1, where RAWλ  is the raw pass ratio when the maximum allowed 
distance from isocentre determined by the IGS that is classified as a pass is delta (in units of mm). Under standard 
clinical pass conditions, delta is set to 0.7 mm.  More generally, delta can vary, and deltaN  is the number of image 
pairs that are classified as a pass for that value of delta, and totalN is the total number of image pairs, which does not 
vary with delta. 
total
delta
RAW N
N=λ         Equation 4.10.2-1 
The error bars for a given value of RAWλ can be calculated from the normal approximation to the binomial 
distribution. The general form is given by equation 4.10.2-2, where σ  is the standard deviation, n is the total 
number of trials that can pass or fail, and p is the pass rate, all three of which are pure numbers. 
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n
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The specific form for this circumstance is given by equation 4.10.2-3, where 
RAWλσ is the standard deviation of 
RAWλ , and all the other quantities are as defined for equation 4.10.2-2. RAWλ  is an estimate of the pass probability 
p . 
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Figure 4.10.2-1 shows the raw SRT pass rate variation as the pass conditions are tightened, calculated according to 
equation 4.10.2-1. The graph shows a sigmoidal descent to the origin. Equation 4.10.2-1 calculates the pass rate from 
a smaller and smaller subset as the pass conditions are tightened. Data filtered out is not considered in the model, but 
in clinical practice would have required one or more additional 6D corrections to achieve the tighter tolerance. The 
curve will not resemble the actual results in clinical practice unless the pass rate in the filtered data set is the same as 
the pass rate in the data filtered out. Unfortunately, the global population includes three distinct subsets, (infra red 
guidance, post rotational, and post correctional) two of which (infra red guidance and post rotational) have pass rates 
much lower than will be expected in the new images. The third group (post correctional) has a pass rate similar to 
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that of the new images. This makes it unlikely that the assumptions made in calculating the raw pass rate will hold in 
clinical practice, so it is necessary to refine the model.  
Figure 4.10.2-1 SRT raw pass rate
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Fig. 4.10.2-1 This graph shows the SRT raw pass rate against the tolerance for distance from the isocentre in mm. 
The raw pass rate is calculated from equation 4.10.2-1, the error bars from equation 4.10.2-3. Delta is the maximum 
allowed distance from isocentre determined by the IGS that is classified as a pass (patient adequately positioned for 
treatment). Lambda raw ( RAWλ ) is an estimate of the pass rate. For values of delta other than 0.7 mm, lambda raw 
is determined by filtering the data set, and calculated under the assumption that the estimated pass rate from the 
filtered data set is equal to the pass rate that would have occurred for the data filtered out.  
4.10.3 Variation of maximum pass ratio with pass conditions. 
The simplest extension to the raw pass rate, to get closer to the expected clinical pass rate, is to assume that any extra 
images that will be required as the clinical pass conditions are tightened will all pass the tighter clinical pass 
conditions. This is an upper limit on the clinical pass rate, and is also a better than expected approximation, because 
the pass rate amongst the post correctional subgroup, at least close to the standard clinical conditions, is about 90%. 
The maximum pass ratio is given by equation 4.10.3-1, where MAXλ  is the maximum pass ratio, 7.0N  is the number 
of image pairs that pass under the standard clinical delta value of 0.7 mm, and all other terms are as previously 
defined for equation 4.10.2-1  
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Determining the standard deviation of MAXλ is complicated because equation 4.10.3-1 contains values that are 
derived from the pass ratio of the standard clinical pass rate, and values that are derived from the pass ratio of the 
variable pass criteria. The complication is that these values are determined from the same data set of image pairs. All 
of the passes under the tighter variable pass conditions are a subgroup of the passes under the standard clinical 
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conditions. To do an error analysis thus requires an evaluation of the Pearson correlation coefficient of the two 
distributions. This should be determined completely by the two pass ratios and the total number of images. This 
results in equation 4.10.3-13, the full derivation and testing of which is given in Appendix A.4.10.3-1 
 
( ) ( ) ( )babaabnMAX −+−−+= 111
11
2λσ     Equation 4.10.3-13 
 
We proceed to use equations 4.10.3-9 and 4.10.3-13 on the SRT data set to predict the variation of MAXλ with delta, 
as shown in Figure 4.10.3-2. MAXλ is expected to be a gross over estimate of the pass rate as delta gets smaller, but it 
does provide a hard upper limit to the possible values of MAXλ . 
Figure 4.10.3-2 SRT maximum pass rate
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Fig. 4.10.3-2 Variation of the maximum pass rate for SRT with delta, the IGS positional tolerance. This estimate 
assumes that all extra images that need to be acquired because of the tightened pass criteria will pass the tightened 
criteria.  MAXλ  is thus the maximum value that the overall pass rate could reasonably be expected to achieve at the 
tightened pass criteria, and this is the reason it is called the maximum pass rate. 
4.10.4 Estimate pass rate using post correctional pass rate. 
The essence of the problem of estimating the pass rate is determining how many extra image pairs will need to be 
acquired to obtain an extra pass for every new fail caused by the tightened pass criteria. A new fail is an image pair 
that was classified as a pass with the delta value at 0.7, but is reclassified as a fail at the tighter pass criteria with 
delta less than 0.7 mm. 
 
In section 4.10.2 it was noted that there are 3 different subgroups of image pairs with vastly different pass rates. To 
determine the overall pass rate, it is prudent to first consider each of the three subgroups separately.  
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The first group is the initial set up image pair. This image pair is the first pair taken subsequent to the patient being 
placed in the mask and moved under infra red guidance only into treatment position. The pass rate is very low, 
0.75% for SRT, and no passes observed for SRS at all for this subgroup (An exact binomial test shows that the 
difference in pass rate between the two groups is not statistically significant. If SRT has a pass rate of 0.75%, it is 
likely that SRS will not have any passes observed. This is explained in detail in appendix A.4.10.4-1). A low pass 
rate is expected because the patient may not have been placed into the mask system in exactly the same way at the 
CT scanner and in the treatment room. A low pass rate is also expected because no corrections to patient position 
based on x-ray localization have been applied yet, it is just an x-ray check of infra red positioning. The software is 
set up to force all initial set up images to be taken at zero degrees. At 0.7 mm, this group is the smallest group in 
terms of number of observations in it. 
 
The second group is the post rotational group. This is the initial image pair taken at a new couch rotation angle, 
immediately after a couch rotation. The pass rate is around 55-65%. The pass rate is higher than the initial setup 
group because a correction of the infra red positioning has already been determined at another couch angle. This 
correction may not be as applicable to the current couch angle because of couch rotation imperfections. Additionally, 
the rotation may cause patient movement artifact, which will also change the correction required. Thirdly, the fusion 
algorithm is presented with a new problem, a DRR reconstructed at a different couch angle, although derived from 
the same CT data set. In principle the algorithm should converge to the same point but there is no certainty of this. 
Lastly there is the procedural offset, the system is biased towards a point slightly different from isocentre, this bias 
may be different at the new couch angle. At 0.7 mm, this group is the largest group in terms of observations in it. 
 
The last group is the post correction group. These are image pairs taken after a correction has been executed. The 
pass rate is about 90%. There is some evidence that the pass rate decreases with the number of prior corrections at 
the same couch angle, but it is not statistically strong. The pass rate is quite high, so the size of the subgroup with 
more than one correction is an order of magnitude less. Any additional image pairs required due to new fails will by 
definition be part of this group. The assumption we use to determine the pass ratio of the extra images that must be 
acquired due to the tightened criteria is that the pass ratio will be the same as the pass rate amongst this subgroup, 
with the tightened criteria, determined using the images that were taken. This is termed the post correctional constant 
pass rate assumption. 
 
To restate the post correctional constant pass rate assumption: 
We take the best estimate of the pass rate for new images as the pass rate amongst the existing post correction image 
population using the tighter pass criteria.  
 
We call this pass rate Aλ . To determine the constant pass rate assumption formula for Aλ , it is first necessary to 
define some variable quantities (A-P), whose value is determined by the SRT observations and the new pass 
threshold criteria C, and describe the pass rate Aλ  in terms of some of them. Those quantities that depend on C are 
in italic. Those quantities that are fixed values of the data set are listed with their value. All of these quantities (A-P) 
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are derived from the clinical data set obtained from a threshold of 0.7 mm, from them, we seek to obtain an estimate 
of the average pass rate for thresholds other than 0.7 mm, using the post correctional constant pass rate assumption. 
 
A=number of passes at 0.7 (10,050) 
B=number of images at 0.7 (15,983) 
C=new threshold (in mm) 
D=new fails at C  
E=number of 1+ passes at threshold C 
F=number of 1+ images total at threshold 0.7 (5747) 
Pass rate =A/(B+D*F/E)  
G=number of 0 passes at threshold C 
H=number of 0 images total at threshold C (10,236) 
I=number of passes (both groups) at threshold C (=E+G) 
J=total number of images at C (15,983) 
K=number of 1+ passes at threshold 0.7 (5066) 
L=number of 1+ images total 0.7 threshold (5747) 
M=number of 0 passes at threshold 0.7 (4984) 
N=number of 0 images at threshold 0.7 (10,236) 
O=new fails from 0 group only at threshold C 
P=new fails from 1 group only at threshold C 
 
We can then express the consequences of the post correctional pass rate assumption mathematically, in equation 
4.10.4-1. 
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Equation 4.10.4-1 can be evaluated for any value of delta (C) less than 0.7 mm. There is an ambiguity about the 
definition of delta at the level of 0.01 mm, the resolution at which the delta values are reported. It has been observed 
directly from the clinical data set, that although the software reports a value with resolution 0.01 mm, it sometimes 
classifies 0.70 mm as a pass, sometimes as a fail. To resolve this, the convention is followed that a clinically 
configured pass specification of 0.70 mm means that a result of 0.70 mm is classified as a pass, but 0.71 mm is 
classified as a fail. 
 
Although equation 4.10.4-1 allows the calculation of the pass ratio, Aλ  , determining the statistical uncertainty in Aλ  
is too complex to conveniently express as a formula. Every sub category (B, D, E and F) has a different effect on the 
ratio, and one compartment cannot statistically fluctuate without causing a weighted reverse fluctuation on all the 
other compartments. So for example if due to statistical fluctuation quantity E (the number of passes in the post 
correction group under the tightened delta=C pass criteria) increases byΔ , this must partially correlate with 
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decreases in all the other subgroups, because the increase in passes must balance out as a distributed decrease in all 
the other subgroups.   
 
Calculating the error in the overall pass ratio requires looking in turn at each compartment, considering the effect of 
a variation in the compartment and the associated counter variations in all the other compartments on the overall pass 
ratio. An alternative method is to obtain a statistical estimate of the standard deviation through Monte Carlo 
simulation. Since in the previous section we were able to show that the Monte Carlo simulation matched the analytic 
prediction, we will omit the derivation of the analytical solution and rely solely on a Monte Carlo statistical estimate 
of the error. To perform the Monte Carlo calculation, we must be aware of the way in which all of the different 
subsections are related. This is shown in a schematic form in Table 4.10.4-1. 
 
Pass criteria Group one and two, initial setup and post 
rotation. 
Group 3 post correction. 
0.7 mm Pass Fail Pass Fail 
 M  K  
 N L 
C Pass Fail Pass Fail 
  New Fail   New Fail  
 G O  E  P  
 H F 
Table 4.10.4-1 Compartments of SRT data for Aλ .  This table shows in schematic form the way in which the 
separate subgroups used to calculate Aλ  are inter-related. Although the statistical fluctuation in any one 
compartment is easily evaluated using the normal distribution approximation to the binomial distribution, evaluation 
of the impact of this variation on Aλ  requires evaluation of the weighted counter fluctuations on other 
compartments. The vertical lines in the table can be thought of as having an associated probability. The first vertical 
line, the left most, which demarcates the start of all the group one and two, initial setup and post rotation 
compartments, can be thought of as corresponding to probability value zero. The second vertical line demarcates the 
end of group one and two, initial setup and post rotation subgroup that pass under the tighter pass conditions C, and 
so is associated with probability G/J. As defined above, G is the number of “no correction required after rotation or 
setup” passes at threshold C, and J is the total number of images at delta value C, 15,983, so G/J is the probability 
that an element of the global SRT falls within this subset. The third vertical line has associated probability M/J. The 
fourth vertical line has associated probability N/J. The fifth vertical line has associated probability (N+E)/J. The 
sixth vertical line has value (N+K)/J. The seventh vertical line demarcates the end of the universal SRT set, and thus 
has associated probability of value 1.  
 
The boundaries of the subgroups given in Table 4.10.4-1 can be used to randomly assign an observation to a 
compartment in a way that the overall distribution will reflect the estimate of the distribution to the different 
compartments by sampling a pseudo random variable uniformly distributed in the interval 0-1 and using its value to 
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assign it to a compartment. We sample 15,983 random numbers (the same as the number of observations in the data 
set) and calculate an overall pass ratio to constitute one trial. From 10,000 trials we estimate the standard deviation of 
the overall pass ratio, and take twice this number as an estimate of one half of the 95% confidence interval for the 
overall pass rate at delta = C. This simulation is repeated for each value of C from 0.02 to 0.70 mm at 0.01 mm 
resolution. The code used to perform this simulation is included as appendix A.4.10.4-2. Figure 4.10.4-1 compares 
these errors to the errors determined by the normal approximation to the binomial distribution. Figure 4.10.4-2 plots 
the variation of Aλ  with delta. Aλ  is the most accurate estimate that can be made of the pass ratio for tightened pass 
criteria that can be determined with the data available, but predictions for delta values of less than 0.4 mm should 
still be treated with caution. Having determined the pass rate for tightened pass criteria, we next move to an estimate 
of the pass rate for relaxed criteria in the next section. 
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Fig. 4.10.4-1 Binomial versus Monte Carlo error bars. 
The values obtained from the Monte Carlo method given in appendix A.4.10.4-2 are plotted with the expected 
pattern of binomial type error sqrt(p(1-p)/n). As indicated by the y axis label, the values plotted correspond to the 
value of two standard deviations of the estimated pass ratio. The two curves meet at the extremes, as expected. They 
are most divergent in the centre, where the Monte Carlo error estimate is about 25% larger than the binomial 
distribution estimate. The Monte Carlo values are a more reliable estimate of the error bars, because the binomial 
distribution estimate does not account for the increase in error caused by the double use of the same SRT data to 
estimate the pass rate amongst the images that were taken and to obtain an estimate of the pass rate amongst the 
images that were not taken. 
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Figure 4.10.4-2 Lambda A vs delta
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Fig. 4.10.4-2 Variation of Aλ  with delta. 
The pass rate in figure 4.10.4-2 is determined under the post correctional constant pass rate assumption: that the pass 
rate observed amongst the post correctional subgroup at a particular value of delta will be representative of the pass 
rate of any new images that would have been required under the tightened pass criteria. This pass rate is about 0.9 at 
the standard clinical pass conditions, and does not degrade significantly until delta is about 0.4, which accounts for 
the linearity in this region. There is some evidence that the pass rate in the post correctional group degrades for three 
or more successive corrections. As the pass rate decreases, the average number of images required increases, and the 
characterization of the post correctional rate at lower rejection rates becomes less and less likely to be representative. 
This is the best estimate that can be made of the pass ratio for tightened pass criteria, but it should still be viewed 
with caution below delta values of 0.4 mm. 
4.10.5 Determining the pass rate for relaxed pass criteria. 
The pass rate can also be determined when the pass conditions are relaxed, when the maximum translation required 
in any one axis is allowed to be greater than 0.7 mm. There are two considerations that are particular to estimating 
the pass rate for relaxed pass criteria. The first is that not all of the images will pass, even if delta is increased to 
infinity, because some image pairs fail on angle considerations alone. An adjunct to this first consideration is that we 
will see (Figure 4.10..5-1) that it is not useful to increase the value of delta if the only remaining fails are group 1 
initial set up image pairs. These will be found to have inferior spatial localization and so it is not advantageous to 
continue to relax the pass criteria would be best if they were classified as fails. So the critical value of delta at which 
the only image pairs that will be designated as fails are group 1 initial setup pairs, or image pairs that fail angular 
limits needs to be determined. These two groups overlap, which complicates the determination. The pass rate at the 
critical value of delta should be taken as a limiting value or maximum practically achievable pass rate. 
 
The second consideration is a procedural problem. We need to remove from the calculation of the pass rate all image 
pairs that would not have been taken because a previous image pair has been reclassified from a fail to a pass under 
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the relaxed pass criteria. Standard procedure involves imaging and correcting at the same couch angle until a pass is 
obtained, but this is not universally followed in clinical practice. Sometimes the radiation therapists exercise 
professional judgment and on their own initiative abandon an effort to achieve a localization at one couch angle and 
rotate the patient to a new couch angle. Sometimes the radiation therapists reject an image pair that would be 
classified as a pass by the IGS and choose to obtain another image pair at that couch angle.  
To deal with these exceptions, and still calculate a pass ratio, the following two rules are adopted. The first rule is 
that nothing is changed until there is a change in pass criteria within a couch angle sequence. To say that another 
way, not until one of the image pairs at that couch rotation changes from a fail at 0.7 to a pass at the current relaxed 
criteria is any change made in the way those images are used to calculate the pass ratio.  
The second rule is that once there is a change in pass criteria within a couch angle sequence, image pairs are 
eliminated from the couch angle sequence strictly in accord with what would have been required under the standard 
clinical procedure. The image pairs that are eliminated are not used to calculate the pass ratio for the relaxed pass 
criteria. The relaxed pass rate Rλ  for relaxed delta R mm is then given by equation 4.10.5-1, where RFILTEREDN ,  is 
the total number of image pairs excluding those that have been eliminated and RN  is the total number of image pairs 
classified as a pass, excluding those that have been eliminated. 
RFILTERED
R
R N
N
,
=λ        Equation 4.10.5-1 
The standard deviation of Rλ  is calculated using the standard binomial method using equation 4.10.5-2, but 
RFILTEREDN ,  decreases as R increases due to the elimination of image pairs that are rendered obsolete by the relaxed 
pass criteria R. 
( )
RFILTERED
RR
NR ,
1 λλσλ −=        Equation 4.10.5-2 
The critical value of delta is found for the SRT data set to be 11.32 mm and the corresponding value of Rλ  is 0.703. 
The predicted variation of the SRT pass ratio over the range of delta values up to 1 mm are plotted in Figure 4.10.5-
1. 
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Figure 4.10.5-1 SRT pass ratio
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Fig. 4.10.5-1 Variation of SRT pass ratio with acceptance threshold. The pass ratios shown in this figure have been 
calculated according to equation 4.10.4-6 for values of delta less than 0.7 mm and equation 4.10.5-1 for values of 
delta greater than 0.7 mm. The error bars are set at 2 standard deviations for a 95% confidence interval. The 
standard deviation is calculated according to equation 4.10.5-2 for pass ratios for delta greater than 0.7 mm. For 
values of delta less than 0.7 mm, the standard deviations are those shown in figure 4.10.4-1 which have been 
obtained from Monte Carlo calculations. The horizontal line at a pass ratio of 0.703 is the pass ratio achieved at a 
delta of 11.32 mm. The only remaining fails that can be converted to passes by a relaxation of the pass rate are 
group 1 initial setup pairs. When delta is 0.4 mm, the average number of corrections required is expected to be 
three. At the standard clinical pass condition of delta equal to 0.7 mm, there are very few scenarios that require 
more than 3 corrections, to the extent that the SRT data set does not allow accurate characterization of the pass rate 
for this sub group. The pass rate below delta values of 0.7 mm is calculated on the assumption that the post 
correctional subgroup pass rate does not vary with the number of corrections, so all pass ratios determined for delta 
values less than 0.4 mm are speculative and must be used with caution.   
4.10.6 Variation of sigma for tightened pass criteria. 
For estimating spatial accuracy under tightened pass conditions, all pre rotation passes that do not meet the tightened 
pass conditions are filtered out, and only the remaining passes that meet the tightened pass criteria are used to 
estimate the accuracy. The calculations are performed using equations 4.10.6-1, 4.10.6-2, and 4.10.6-3. The 
summations indicated in the formulae are performed only over those observations for which the image pair taken 
immediately before rotation is classified as a pass under the tightened pass conditions. If the image pair in the dataset 
immediately preceding a rotation is reclassified as a fail under the tightened pass conditions, that rotation is excluded 
from the summation. The image pair immediately after rotation does not need to pass any criteria. This procedure 
allows the calculation of an estimate of iσ , jσ  and kσ  for every value of delta less than 0.7 mm. The standard 
deviations for these estimates are given by equation 4.6-8, where N reduces as the pass conditions are tightened. The 
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results are in Figures 4.10.6-1 to 4.10.6-6. It is useful to review the values of iσ , jσ  and kσ  on the one graph, and 
this is plotted in Figure 4.10.6-7. It is necessary to apply a slight offset to some of the data to better visualize the 
distinction between iσ  and jσ  . 
ii iiid σπθθθ
2
12
=−=Δ= ∑∑      Equation 4.10.6-1 
jj jjjd σπθθθ
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=−=Δ= ∑∑      Equation 4.10.6-2 
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Figure 4.10.6-1 SRT variation of sigma i with pass criteria
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Fig. 4.10.6-1 SRT variation of iσ  with delta. iσ  is determined from equation 4.10.6-1 applied to the SRT dataset 
filtered to exclude all observations that do not classify as a pass under the tightened pass conditions. The error bars 
represent the 95% confidence interval and are larger for small values of delta because the SRT data set is filtered to 
a smaller subset. There is a slight reduction in iσ  as delta decreases but it is about the same magnitude as the 
smallest error bars and needs an exploded view (Figure 4.10.6-2) to appreciate it. 
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Figure 4.10.6-2 SRT variation of sigma i with pass criteria (Exploded view)
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Fig. 4.10.6-2 Exploded view of the data in figure 4.10.6-1. This demonstrates that the slight reduction in iσ  with 
delta is comparable to the magnitude of the error bars. A constant value for iσ  of 0.29 mm is an alternative 
conclusion that fits the data within error. 
Figure 4.10.6-3 SRT variation of sigma j with pass criteria
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Fig. 4.10.6-3 SRT variation of jσ  with delta. jσ  is determined from equation 4.10.6-2 applied to the SRT dataset 
filtered to exclude all observations that do not classify as a pass under the tightened pass conditions. The error bars 
represent the 95% confidence interval and are larger for small values of delta because the SRT data set is filtered to 
a smaller subset. There is a slight reduction in jσ  as delta decreases but it is about the same magnitude as the 
smallest error bars and needs an exploded view (Figure 4.10.6-4) to appreciate it. 
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Figure 4.10.6-4 SRT variation of sigma j with pass criteria (exploded view)
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Fig. 4.10.6-4 Exploded view of the data in figure 4.10.6-3. This demonstrates that the slight reduction in jσ  with 
delta is larger than the magnitude of the error bars. A constant value for jσ  will not fit the data within error. 
Figure 4.10.6-5 SRT variation of sigma k with pass criteria
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Fig. 4.10.6-5 SRT variation of kσ  with delta. kσ  is determined from equation 4.10.6-3 applied to the SRT dataset 
filtered to exclude all observations that do not classify as a pass under the tightened pass conditions. The error bars 
represent the 95% confidence interval and are larger for small values of delta because the SRT data set is filtered to 
a smaller subset. There is a slight reduction in kσ  as delta decreases but it is about the same magnitude as the 
smallest error bars and needs an exploded view (Figure 4.10.6-6) to appreciate it. kσ  is generally smaller than iσ  
and jσ . 
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Figure 4.10.6-6 SRT variation of sigma k with pass criteria (exploded view)
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Fig. 4.10.6-6 Exploded view of the data in figure 4.10.6-5. This demonstrates that the slight reduction in kσ  with 
delta is larger than the magnitude of the error bars. A constant value for kσ  will not fit the data within error. 
Figure 4.10.6-7 SRT variation of sigma with pass criteria
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Fig 4.10.6-7 SRT variation of confidence with pass criteria. This graph shows the values of iσ , jσ  and kσ  as the 
pass criteria is changed. The top right trace is sigma j, offset slightly to the right in the x axis. Sigma i is offset 
slightly to the left of its actual delta value, so that when the two error bars merge, sigma j is the rightmost of the 
pair. Sigma k is the lowest trace on the y axis. Values below delta equal to 0.3 mm were felt to be too strongly 
influenced by statistical error to be useful to display in this comparison. It is interesting that iσ  and jσ  are 
different for larger values of delta, but almost overlap when delta is reduced to 0.3 mm. It is thought that the 
difference is caused by some of the rotations involving an optical guided correction after rotation. As the tightening 
of the pass criteria is simulated by filtering the SRT clinical data set, those rotations that were more likely to be 
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adjusted under optical guidance are preferentially filtered out. The simulation is a simulation of tightening the x-ray 
image pair pass criteria while leaving the optical tolerance unchanged. In a clinical scenario, the optical tolerance 
would also be reduced, and in this circumstance there might be a difference between iσ  and jσ  even for small 
values of delta. 
 
We now proceed to examine the variation of spatial accuracy with the changes in the pass criteria. 
4.10.7 Variation in spatial accuracy with tightened pass criteria. 
An estimate of iσ , jσ  and kσ  for every value of delta less than 0.7 mm, has been calculated. The SRT data set 
contains the reported coordinates from the IGS prior to rotation of the couch, and we can filter this data set to 
exclude coordinates from image pairs that would not be classified as a pass under the tightened pass criteria. By 
convolving the filtered coordinates with a Gaussian spread function with the appropriate value of σ , we can build 
up a probability distribution graph. The code used to perform this calculation is given in appendix A.4.10.7-1 for the 
i axis, A.4.10.7-2 for the j axis, and A.4.10.7-3 for the k axis. Figure 4.10.7-1 shows the probability distribution 
about the isocentre in the i axis. Figure 4.10.7-2 shows the probability distribution about the isocentre in the j axis. 
Figure 4.10.7-3 shows the probability distribution about the isocentre in the k axis as it would be if the x-ray system 
was perfectly calibrated to the linac isocentre in the k axis. In practice this is not the case, but the method of 
inference used does not detect any errors in the calibration of the kV image system isocentre to the linac isocentre. 
This results in tighter distributions in the k axis than for the i and j axes, in which the calibration of the isocentre does 
impact on the distribution. All three distributions have been normalized so that if the curve is sampled at 0.01 mm 
intervals, the sum of the values is unity. The y axis values on the graph can then be interpreted as the “Discrete 
probability of observation at 0.01 mm resolution.” For example, if the curve passes through the point x=0.00, y=0.01, 
then there is a 1% chance of observing a value of 0.00 mm reported by the IGS software. 
In the probability distributions for all three axes (Figures 4.10.7-1, 4.10.7-2 and 4.10.7-3) it can be seen that the 
distribution gets tighter as the pass conditions are tightened, but that a small proportion of outliers more than 1 mm 
from isocentre remain. The proportion of outliers does decrease as the pass criteria are tightened, as shown in table 
4.10.7-1.  There are in practice no discrete observations beyond 1.5 mm from isocentre. Although in theory 
distributions can be calculated for pass criteria below 0.4 mm down to 0.03 mm, 0.4 mm is taken as a lower limit for 
estimating the distributions. Below that the filtered SRT data set is probably not representative of a clinical data set 
that would be observed if the tightened pass criteria were implemented 
In Figure 4.10.7-1 it can be seen that the i axis probability distribution is asymmetric for the standard and tightened 
pass criteria. This observed asymmetry can be explained as a consequence of clinical procedure, the 0.5 mm 
tolerance of the optical positioning system, and the way that the IGS robotic couch guides the patient into position. 
At initial set up, the bed is lowered below isocentre in the k axis and retracted away from the isocentre in the i axis. 
This allows the radiation therapists to have clear and workable access to the patient from above to achieve optimal 
patient positioning and immobilization as the patient is placed in the mask. Pre treatment localization is then 
achieved by moving the couch until the optical guidance system is within the 0.5 mm optical guidance system 
tolerance. As the couch is extended in the i axis, there is a bias towards positioning the patient within tolerance but 
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slightly retracted from the isocentre. As the couch is raised in the k axis, there is a bias towards positioning the 
patient within tolerance but slightly below isocentre. In the j axis, the patient begins approximately centred, and the 
treatment isocentre is equally likely to be to the right or left, so there is no bias to the positioning observed from the 
SRT data set from prepositioning in the j axis. A secondary cause is the implementation of a 6D correction. The 
couch first rotates, rolls and pitches until the optical system confirms that the desired angles have been reached. It is 
then translated back to isocentre, again within optical tolerance. The fulcrum point for the pitch of the couch 
(rotation about the j axis) is a full 1.67 metres from the isocentre in the negative direction. At this distance, any 
change from the initial zero pitch angle results in some foreshortening of the couch, effectively a retraction of the 
couch in the i axis. This will be adjusted by extension back to within optical tolerance, but again introduces a bias in 
the positioning towards negative values of i. In contrast, the fulcrum point for roll of the couch (rotation about the i 
axis) is in the centre of the couch, so no bias is observed over the population. The couch rotation (rotation about the k 
axis) is also about the isocentre, so no bias is expected to be detected over the population.  
 
The asymmetry seen in the graphs is readily explained by these two effects. Pre positioning and correction bias do 
not impact on the j axis probability distribution, and so Figure 4.10.7-2 shows the least asymmetry. Pre positioning 
and correction bias impact on the i axis probability distribution, and figure 4.10.7-1 has the most asymmetric 
distribution of the three graphs. Pre positioning bias affects the k axis but correction bias does not, so the asymmetry 
observed in Figure 4.10.7-3 is intermediate. Both the i axis and the k axis are biased towards the negative, as 
expected. The procedurally introduced bias has not been widely commented on by phantom based studies. The 
limiting factor is generally that the phantom measurements involve relatively few samples, and are not accurate 
enough to pick up a bias of the order of 0.1 mm. Jin et al88 for example note that the residue setup error for a solid 
anthropomorphic phantom is small; they obtain deviations of -0.37±0.29 mm in the i axis, 0.11±0.16 mm in the j axis 
and -0.14±0.30 mm in the k axis. This bias has already been demonstrated in table 4.8-1, but the graphs here show 
that the bias has a significant impact on the accuracy achieved in clinical practice, regardless of the kV positional 
tolerance used. This might be reduced significantly by decreasing the optical tolerance with the kV imaging 
tolerance, but the method used to determine the distribution does not allow that to be simulated with the data 
recorded.   
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Fig. 4.10.7-1 i axis positional 
accuracy vs pass conditions. 
This figure shows probability 
distributions about the 
isocentre in the i axis, the 
longitudinal axis of the patient 
couch, for the standard clinical 
SRT pass condition of 0.7 mm, 
and for three other tighter pass 
conditions, 0.6, 0.5 and 0.4 mm 
as indicated by the legend. A 
positive value on the i axis 
indicates that the couch has 
been overextended, and the 
stereotactic megavoltage 
treatment is being delivered to a point inferior to the lesion. The probabilities are scaled so that the sum of the 
probabilities at 0.01 mm resolution is unity, so they can be thought of as the probability of a specific result. For 
example, the graph predicts that if the pass conditions are set to 0.5 mm, the probability of the isocentre being 
placed within 0.005 mm of the isocentre (at 0.00 mm) in the i axis is about 1%. The graph shows that the spatial 
accuracy improves as the pass conditions are tightened. Outliers beyond 1.0 mm remain in all four scenarios, but 
reduce significantly as the pass criteria are tightened. The asymmetry of the distribution is caused by treatment 
procedures and the location of the axis of rotation for the pitch of the couch approximately 1.67 metres in the 
negative direction of the i axis away from the isocentre.  
Fig. 4.10.7-2 j axis positional 
accuracy vs pass conditions.  
This figure shows probability 
distributions about the 
isocentre in the j axis, the 
lateral axis of the patient 
couch, for the standard 
clinical SRT pass condition of 
0.7 mm, and for three other 
tighter pass conditions, 0.6, 
0.5 and 0.4 mm as indicated 
by the legend. A positive 
value on the j axis indicates 
that the couch has been 
moved too far to the patient 
left, and the stereotactic megavoltage treatment is being delivered to a point  to the right of the lesion. The 
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probability is scaled so that the sum of the probabilities at 0.01 mm resolution is unity, so they can be thought of as 
the probability of a specific result. For example, the graph predicts that if the pass conditions are set to 0.5 mm, the 
probability of the isocentre being placed within 0.005 mm of the isocentre (at 0.00 mm) in the j axis is about 1%. The 
graph shows that the spatial accuracy improves as the pass conditions are tightened. Outliers beyond 1.0 mm remain 
in all four scenarios, but reduce significantly as the pass criteria are tightened. The relative symmetry of the 
distribution is a result of pre-treatment procedures and the location of the axis of rotation for the roll of the couch 
being the centre of the couch.   
 
Fig. 4.10.7-3 k axis self 
consistency vs  pass 
conditions. This figure shows 
probability distributions 
about the isocentre in the k 
axis, the vertical axis of the 
patient couch, for the 
standard clinical SRT pass 
condition of 0.7 mm, and for 
three other tighter pass 
conditions, 0.6, 0.5 and 0.4 
mm as indicated by the 
legend. Unlike the 
distributions in figures 
4.10.7-1 and 4.10.7-2, this 
distribution is valid relative to the isocentre only if the calibration of the kV imaging system to the isocentre is 
perfect in the k axis. In practice this is rarely the case, and this is the reason that the k axis distribution is much 
tighter than the i and j axis distribution. The k axis distribution is termed a self consistency distribution because it is 
not affected by the error in the calibration of the kV imaging system to the isocentre. A positive value on the k axis 
indicates that the couch is too high, and the stereotactic megavoltage treatment is being delivered to a point 
posterior to the lesion. The probability is scaled so that the sum of the probabilities at 0.01 mm resolution is unity, so 
they can be thought of as the probability of a specific result. For example, the graph predicts that if the pass 
conditions are set to 0.5 mm, the probability of the isocentre being placed within 0.005 mm of the isocentre (at 0.00 
mm) in the k axis is about 1.5%. The graph shows that the spatial accuracy improves as the pass conditions are 
tightened. Outliers beyond 1.0 mm are negligible in all four scenarios. The intermediate asymmetry of the 
distribution is caused by pre treatment procedures.  
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Table 4.10.7-1 Probabilities of deviations greater than 0.5 and 1.0 mm. This table shows the probability that a 
specific axis is outside 0.5 mm or 1.0 mm, for pass criteria of 0.7, 0.6, 0.5 and 0.4 mm. The i>1 column, for example, 
lists the probability that the i axis localisation relative to the isocentre will be out by 1 mm or more. In all cases, the i 
axis is the worst localized, although sometimes barely worse than the j axis. The k axis shows the best results by a 
clear margin, but the k axis probabilities are not influenced by any error in the calibration of the kV imaging system 
to the isocentre in the k axis.  
Delta (mm) i>1 i>0.5 j>1 j>0.5 k>1 k>0.5 
0.7 0.0171 0.2493 0.0138 0.2190 0.0004 0.0750 
0.6 0.0112 0.2230 0.0103 0.2037 0.0002 0.0642 
0.5 0.0072 0.1959 0.0070 0.1829 0.0000 0.0511 
0.4 0.0039 0.1616 0.0035 0.1492 0.0000 0.0335 
 
Data presented in this section on the estimated variation of the efficiency and accuracy of the IGS localization in 
clinical practice serve as a useful guide in determining whether the setting of 0.7 mm is a suitable selection for 
stereotactic radiotherapy. 
4.11 Variation of accuracy with number of corrections. 
The practice of frameless SRS and SRT determines and iteratively implements 6D (6D in this context means a rigid 
body transformation; see Takakura et al 76 ) image fusion corrections until those parameters are below the 
customisable threshold. Clinically we are concerned that multiple corrections may indicate a decrease in isocentre 
positioning accuracy. To determine this, we stratified the kV image pairs that were classified as a pass by the number 
of preceding 6D image fusion corrections taken to achieve that pass. If the kV image system determines the patient is 
adequately positioned immediately after a couch rotation, that image pair is placed in the zero corrections subset. We 
must consider the initial patient setup separately, since the first image pair, with the patient positioned only by infra 
red guidance, almost always fails, but more than half of the images taken after a couch rotation pass. Rather than take 
the coordinates reported by the IGS software at face value, we convolve with a Gaussian spread relevant to the axis 
to obtain a probability distribution function that incorporates the intrinsic inaccuracy of the results reported by the 
IGS software. We use the average of iσ  and jσ  to convolve in three dimensions to obtain a radial distribution.  
4.11.1 Basic pass rate.  
Table 4.11.1-1 shows the variation in pass rate with the number of corrections. Italicised figures show statistically 
significant differences in pass rates for SRT and SRS for comparable compartments. Observations with more than 
three corrections were too few to justify tabulation.  
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Table 4.11.1-1 Variation of pass rate percentages with different number of corrections for the initial setup at couch 
zero, and the subsequent patient positioning after a couch rotation. The initial setup is achieved under optical 
guidance, and thus almost always requires a kV image fusion 6D correction. Subsequent setups are more likely to 
pass with no corrections, but the highest pass rates are only achieved by 1 or more corrections, when the patient is 
re-positioned according to kV image fusion at that couch angle. There is some evidence that the pass rate gets worse 
for more than 1 correction. Those pass rates amongst the 2 and 3 correction subsets that have a pass rate lower by a 
statistically significant amount (at the p=0.05 level) are in italics. 
Number of corrections 0 1 2 3 
SRS Initial 0% 85% 75% 50% 
 Subsequent 52% 87.5% 60% 67% 
SRT Initial 0.75% 88.3% 83% 81% 
 Subsequent 64.7% 92.2% 83% 54% 
4.11.2 Probability distribution curves for initial setups.  
The probability distribution curves for initial setup corrections are given in Figures 4.11.2-1, 4.11.2-2, and 4.11.2-3 
for the i, j and k axes of SRT respectively, generated by code detailed in appendices A.4.11.2-1, A.4.11.2-2 and 
A.4.11.2-3 respectively. Figure 4.11.2-4 shows the radial probability distribution curve, generated by code detailed in 
appendix A.4.11.2-4. “Zero corrections” in this context refers to optical patient positioning that is successfully 
verified by an x-ray image pair, without any image guided 6D correction. The probabilities have been scaled to 
represent the chance of a discrete observation at the resolution reported by the software, 0.01 mm. The SRS data 
were not analysed because the sample size was too small, despite representing more than a year of clinical SRS 
treatments.  
The zero correction subset for initial setups has markedly worse accuracy, particularly in the i axis as seen in Figure 
4.11.2-1, and this carries through to the radial distributions shown in Figure 4.11.2-4. (Since the radial distribution is 
a summation in quadrature of the i, j and k axis values, strong trends in any one axis influence the radial 
distribution.) For the j and k axes, aside from the zero correction subgroup (Figures 4.11.2-2 and 4.11.2-3) the 
localisation accuracy (j) and self consistency (k) decreases marginally as the number of corrections increases. For the 
i axis the progression is less ordered, three corrections is best, one correction is intermediate and two corrections is 
worst. In the radial distribution, one and three corrections gives the best accuracy, with two corrections marginally 
degraded, and no corrections the worst.  
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Fig. 4.11.2-1. This graph 
shows the positional 
accuracy of IGS in the i axis 
for SRT for the couch zero 
first patient setup of the 
treatment session. Zero 
corrections in this context 
means that the patient was 
positioned under optical 
guidance with only a single 
kV image being required for 
the IGS to classify the patient 
as correctly positioned 
without a 6D correction. A 
positioning system with a 
global accuracy identical to that of the zero correction group would not be adequate for stereotactic treatment. As it 
turns out, the zero correction subgroup is a clinically insignificant proportion of the localisations. The positional 
accuracy is much better for the vast majority (99.25%) which have one or more 6D corrections. Three corrections 
has the highest accuracy, one correction is intermediate and two corrections is the lowest amongst this group, but 
the differences are marginal and all of these distributions are adequate. There is a definite asymmetry to all of these 
distributions. Initial setup localisation is slightly more accurate than the post rotational localisation shown in figure 
4.11.3-1. 
 
Fig. 4.11.2-2 This graph 
shows the positional accuracy 
of the IGS in the j axis for 
SRT for the couch zero first 
patient setup of the treatment 
session. Zero corrections in 
this context means that the 
patient was positioned under 
optical guidance with only a 
single kV image pair being 
required for the IGS to 
classify the patient as 
correctly positioned without a 
6D correction. The zero 
correction subset is more 
skew and less accurate than the other subsets, but much less so than the i axis distribution. The most accurate 
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subgroup is the 1 correction subgroup. The 2 and 3 correction subgroups both have marginally inferior spatial 
accuracy. All of the j axis distributions (including the zero correction subgroup) are adequate. Initial setup 
localisation is slightly more accurate than the post rotational localisation shown in figure 4.11.3-2.  
 
 
Fig. 4.11.2-3 This graph 
shows the SRT k axis self 
consistency of the IGS for the 
couch zero first patient setup 
of the treatment session. Zero 
corrections in this context 
means that the patient was 
positioned under optical 
guidance with only a single 
kV image pair being required 
for the IGS to classify the 
patient as correctly 
positioned without a 6D 
correction. The zero 
correction subset is more skew and less accurate than the other subsets, but less so than the i axis distribution. The 
most accurate subgroup is the 1 correction subgroup. The 2 and 3 correction subgroups both have marginally 
inferior self consistency. The initial setup subgroups with 1, 2, and 3 corrections, all have a more peaked distribution 
than any of the post rotational subgroups shown in figure 4.11.3-3. Assuming that the influence of ρ is the same for 
initial setup and post rotational conditions, this indicates that localisation of the corrected initial setup subgroups, 
which comprise the vast majority (99.25%), is better than the localisation of the post rotational subgroups.   
 
 
Fig. 4.11.2-4 This graph 
shows the assumed radial 
distribution of the IGS 
positional accuracy for the 
couch zero first patient setup 
of the treatment session.  
Obtaining a radial 
distribution involves making 
assumptions about the 
distribution of the reported 
coordinates about the true 
Chapter 4: Registration to the treatment isocentre 
245
coordinates in 3 dimensions. Although we have information on the distribution in the i and j axes, we have only self 
consistency information in the k axis. The assumption we make is that the reported coordinates are normally 
distributed in 3 dimensions with a σ value equal to the average of iσ  and jσ . Zero corrections in this context 
means that the patient was positioned under optical guidance with only a single kV image pair being required for the 
IGS to classify the patient as correctly positioned without a 6D correction. Zero corrections has the worst spatial 
accuracy. A stereotactic localisation procedure with the accuracy of the zero correction subgroup would be 
inadequate for stereotactic intracranial patient treatment. As it happens the zero corrections subgroup are a very 
small (0.75%) fraction of the total zero couch results, so the clinical consequences are negligible. Amongst the 
corrected subgroups, 1 correction and 3 corrections are almost identical, while two corrections is marginally worse. 
This ordering is a function of the ordering of the curves in figure 4.11.2-1 and figure 4.11.2-2 only; the information 
on the ordering of the subgroups in figure 4.11.2-3 has no impact owing to the assumption made about the 
distribution of the reported coordinates in 3 dimensions. The initial setup radial distributions for the subgroups with 
at least one correction are more accurate than those of the post rotational group shown in figure 4.11.3-4, and this 
conclusion is supported by a comparison in the i axis (figure 4.11.2-1 and figure 4.11.3-1), the j axis (figure 4.11.2-2 
and figure 4.11.3-2) and the k axis (figure 4.11.2-3 and figure 4.11.3-3). 
4.11.3 Probability distribution curves for post rotational subgroups.  
The probability distribution curves for post rotational subgroups are shown in Figures 4.11.3-1, 4.11.3-2, and 4.11.3-
3 for the i, j and k axes respectively, generated by code detailed in appendices A.4.11.3-1, A.4.11.3-2, and A.4.11.3-3 
respectively. The meaning of “zero corrections” in this context is that immediately after a rotation from a successful 
x-ray image pair verification at another couch angle, the positioning of the isocentre was verified by an x-ray image 
pair as within tolerance, without requiring to implement a 6D correction. Figure 4.11.3-4 shows the radial probability 
distribution curve, generated by code detailed in appendix A.4.11.3-4. 
Fig. 4.11.3-1 This graph 
shows the positional 
accuracy of the IGS in the i 
axis for SRT for the post 
rotational positioning of the 
patient. This means all setups 
other than the first of the 
treatment session. Zero 
corrections in this context 
means that the patient was 
positioned by a rotation of 
the couch with only a single 
kV image being required for 
the IGS to classify the patient 
as correctly positioned 
without a 6D correction at that couch angle, although one may have been performed at the previous couch angle. 
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The positional accuracy for the three corrections subgroup, if it was representative of the overall population 
distribution, would not be adequate for stereotactic treatment. The positional accuracy is much better for the vast 
majority which have less than three 6D corrections, including the zero correction subgroup. One correction will 
yield the highest accuracy, zero corrections is intermediate and two corrections is the lowest of the three, but the 
differences are marginal and all of these distributions are adequate. There is a definite asymmetry to all of these 
distributions. Post rotational localisation is slightly less accurate than the initial setup localisation shown in figure 
4.11.2-1. 
The worst of the post rotational subgroups is the “3 corrections” subgroup. (As seen in Figures 4.11.3-1, and 4.11.3-
4) The other three groups have acceptable accuracy for stereotactic treatment, with the pattern in the i, and k axes 
and the radial distribution being that one correction is best, zero corrections is marginally worse, and two corrections 
is marginally worse again. The i axis shows the most asymmetry and is the only axis to have an unacceptable 
distribution for a subgroup.  
Fig. 4.11.3-2 This graph 
shows the positional 
accuracy of the IGS in the j 
axis for SRT for the post 
rotational positioning of the 
patient. This means all setups 
other than the first of the 
treatment session. Zero 
corrections in this context 
means that the patient was 
positioned by a rotation of 
the couch with only a single 
kV image being required for 
the IGS to classify the patient 
as correctly positioned 
without a 6D correction at that couch angle, although one may have been performed at the previous couch angle. 
The zero correction subgroup has the largest number of observations in this group and the worst spatial localisation, 
but the accuracy is adequate for stereotactic treatment. 3 corrections is the most accurate subgroup, 1 correction is 
next and 2 corrections is last amongst the corrected subgroups, but the corrected subgroups are all clearly better 
than the zero correction subgroup. In general the positional accuracy of the post rotational subgroups is slightly 
worse than the couch zero subgroups with at least one correction shown in figure 4.11.2-2, but much better than the 
zero correction subgroup in figure 4.11.2-2.   
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Fig. 4.11.3-3 This graph 
shows the SRT k axis self 
consistency of the IGS for the 
post rotational positioning of 
the patient. This means all 
setups other than the first of 
the treatment session. Zero 
corrections in this context 
means that the patient was 
positioned by a rotation of 
the couch with only a single 
kV image being required for 
the IGS to classify the patient 
as correctly positioned 
without a 6D correction at 
that couch angle, although one may have been performed at the previous couch angle. The zero correction subgroup 
has the largest number of observations in this group, and is the most skew, although it has the second best 
amplitude. The most accurate subgroup is the 1 correction subgroup. The 2 and 3 correction subgroups both have 
similar but inferior amplitude compared to the zero and 1 correction subgroups, but do not have the skewness of the 
zero correction subgroup. In general, the post rotational subgroups all have a lower amplitude than any of the initial 
setup subgroups with 1, 2, or 3 corrections shown in figure 4.11.2-3, but better than the zero correction subgroup. 
Assuming that the influence of ρ is the same for initial setup and post rotational conditions, this indicates that 
localisation of the corrected initial setup subgroups, which comprise the vast majority (99.25%), is better than the 
localisation of the post rotational subgroups.   
 
Fig. 4.11.3-4 This graph 
shows the assumed radial 
distribution of the IGS 
positional accuracy for the 
post rotational positioning of 
the patient. This means all 
setups other than the first of 
the treatment session. Zero 
corrections in this context 
means that the patient was 
positioned by a rotation of the 
couch with only a single kV 
image being required for the 
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IGS to classify the patient as correctly positioned without a 6D correction at that couch angle, although one may 
have been performed at the previous couch angle.  Obtaining a radial distribution involves making assumptions 
about the distribution of the reported coordinates about the true coordinates in 3 dimensions. Although we have 
information on the distribution in the i and j axes, we have only self consistency information in the k axis. The 
assumption we make is that the reported coordinates are normally distributed in 3 dimensions with a σ value equal 
to the average of iσ  and jσ . Zero corrections is the largest subgroup and has equal second best spatial accuracy, 
along with the two correction subgroup. The 1 correction subgroup has the best localisation and the 3 corrections 
subgroup has the worst. This ordering is a function of the ordering of the curves in figure 4.11.3-1 and figure 4.11.3-
2 only; the information on the ordering of the subgroups in figure 4.11.3-3 has no impact owing to the assumption 
made about the distribution of the reported coordinates in 3 dimensions. The initial setup radial distributions for the 
subgroups with at least one correction shown in figure 4.11.2-4 are more accurate than those of the post rotational 
group, and this conclusion is supported by a comparison in the i axis (figure 4.11.2-1 and figure 4.11.3-1), the j axis 
(figure 4.11.2-2 and figure 4.11.3-2) and the k axis (figure 4.11.2-3 and figure 4.11.3-3). 
4.11.4. Clinical modifications indicated by observed variation 
Initial couch setup passes were usually (25 out of 41) rejected by the Radiation Therapists on their own initiative, but 
the few (16) that preceded a rotation can be seen in Figures 4.11.2-1 and 4.11.2-4 to have poorer spatial localisation. 
These events are rare enough to be a clinically insignificant group, but they are an easily recognisable subgroup with 
an obvious remedy. For SRS, we now insist on commencing treatment after rotating to a different couch position, so 
that we have two successful image passes to triangulate the target. For SRT, WBRC treatment policy is now that any 
initial couch setup passes have a correction implemented even if they do not require it.  
Amongst the three correctional initial setup subgroups, the i axis is best for three corrections, and worst for two, with 
one correction being intermediate. The j axis has one correction as best with two and three corrections similar. There 
are a range of competing effects at play which makes the order quite complex. A correction may improve an axis that 
failed while degrading an axis that passed. In the k axis, where there are less factors involved, the order is 
straightforward. One correction is better than two corrections and two corrections better than three, indicating that 
the image fusion accuracy is lower the more corrections are required. Effectively, the more difficult fusion cases 
remain and the accuracy is degraded accordingly. The radial distribution shown in Figure 4.11.2-4 for the initial 
setup subgroup shows a different distribution for initial setup zero corrections.  
For the post rotational subset, three corrections appears to provide worse localisation in the i axis (Figure 4.11.3-1), 
but not in the j axis(Figure 4.11.3-2). In the k axis (Figure 4.11.3-3), zero and one corrections were comparable, both 
better than two and three corrections, which were also comparable. We reviewed all of the three or more correction 
post rotational events in the SRT data set, and categorised them due to one of four causes; statistical fluctuation, 
inferior image fusion, patient immobilisation problems and patients for whom the optical marker spheres could not 
be locked into place. We are fabricating an adapter to fix the optical markers for those patients for whom the 
standard method can not be achieved. For all other cases, we would propose repositioning the patient in the frame 
and recommencing. This is time consuming, but infrequent enough to be practical.  
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4.11.5 Concluding remarks on multiple corrections. 
This section is concluded by giving some thought as to why multiple corrections may be required. In the vast 
majority of cases, one correction will suffice at initial setup, and mostly a rotation of the couch from a correct 
position does not require a further correction. So those cases requiring a refining correction are in the minority. After 
a couch rotation the couch rotation runout may take the patient position out of tolerance and it may require 
adjustment. It is also entirely possible for a slight patient movement between the image pair taken to determine the 
required translation and the image pair taken to confirm the correction to cause another correction to be indicated. 
Unfortunately we do not have a description of the fusion algorithm, so it is difficult to understand how the fusion 
process itself may require multiple corrections as part of its working. We do know what input data the system uses, it 
makes comparisons of oblique kV images with digitally reconstructed radiographs to arrive at a 6D correction. The 
system cannot know the 3D position of on object that is far enough from the isocentre to show up in only one of the 
kV images. It is difficult in this circumstance for the algorithm to determine whether a rotation or a translation is 
required89,90,91. The practical circumstance where this might come into effect is a central tumour, where the bony 
feature that provides localization in one image is part of the skull, and is visible in one radiograph but not the other. 
In this circumstance the verification image may show that a translation would have been better.  
It is known from phantom experiments that the algorithm can find inaccurate solutions that are within tolerance even 
when the slice thickness is an order of magnitude larger than the tolerance.92  
We know also from clinical experience that the system does not always converge to a solution. We have one record 
of the system proposing multiple corrections that clearly moved the patient away from the isocentre. This occurred 
only at one couch rotation where the view in one projection had a large area of zero attenuation due to a near 
tangential image of a peripheral isocentre close to the surface of the skull.   
We also know that the system may refuse to calculate a correction if there is not enough attenuation in the beam. 
Experiments to test the system by imaging and localizing a single ball bearing in air fail for this reason.  
The design of the system is to get the patient setup in as close to the treatment position as possible before kV 
imaging is used. The kV imaging clearly will only converge to the correct solution if it starts not far from it. It may 
be that for some cases the distance is too great to allow the system to converge immediately. There is some support 
in the literature from phantom based measurements for hypothesis six, that the larger the distance translated by the 
last correction, the less accurate that correction will be. We explore this possibility in the next section. 
4.12 Variation with distance moved 
Van Santvoort et al.93  reported the accuracy of the IGS improves for translations less than 5 mm, based on phantom 
measurements. If the accuracy of the IGS improves in clinical practice as the translations decrease below 5 mm, it 
may be able to improve the accuracy by administratively implementing a translation distance based rejection of 
corrections. So for example as well as requiring the standard pass conditions of 0.7 mm and 0.5º, it might also be 
required that corrections that translate more than say, 2.5 mm, are automatically repeated as if they had failed, 
whether they did or did not under the 0.7 mm and 0.5º criteria. It was investigated if this had any relevance to the 
IGS in clinical practice by graphing the distance translated against the magnitude of the difference in coordinates 
after rotation. The three dimensional distance moved and the three dimensional difference in coordinates were also 
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considered. The data for all movement axes was plotted against all difference axes for SRS and SRT to determine if 
there was any variation. This is a total of 32 graphs. Additionally, SRS and SRT were split into high and low subsets 
on the basis of the median travel in each axis, and the change in confidence in results between the two halves was 
reviewed. Again, there are 32 different results in this series. 
4.12.1 SRT variation with distance moved. 
The graphs in this section (Figures 4.12.1-1 to 4.12.1-16) are scatter graphs of distance moved in the x axis with the 
difference observed after rotation. The difference observed after a rotation is a surrogate for the error. Over a large 
enough sample, it should indicate whether the results are more or less accurate with distance moved. The image pairs 
used for this analysis are a subset of the global SRT data set. Only those image pairs which have at least one prior 6D 
correction at the same couch rotation, qualify as a positioning within tolerance under the 6D verification 
specification of required translation less than 0.7 mm and required rotation 0.5º, and are followed by a couch rotation 
to a point where a new image pair is acquired, can be included in the data set. For the SRT data set there were 3,915 
of these image pairs. There are four movement distances graphed, the i, j and k axes, and R, the 3D distance moved 
(Given by equation 4.12.1-1). There are also four error surrogates, absdi, absdj, absdk and R_distance_error. The last 
two are imperfect measures of error. Absdk is termed a self consistency because it is not affected by an error in the k 
axis calibration of the kV imaging system to the isocentre, as explored in section 4.10.7. In consequence, 
R_distance_error is also compromised, because it depends on absdk as shown by equation 4.12.1-2.   
222 000 kji dddR ++=       Equation 4.12.1-1 
Where id0  is the distance moved in the correction in the i axis, jd0  is the distance moved in the correction in the j 
axis, and kd0  is the distance moved in the correction in the k axis. 
222__ absdkabsdjabsdierrdisR ++=     Equation 4.12.1-2 
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Fig. 4.12.1-1  R distance error vs R distance moved (SRT). 
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Fig. 4.12.1-2 absdi vs R distance moved  (SRT). 
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Fig. 4.12.1-3 absdj vs R distance moved (SRT). 
 
Fig. 4.12.1-4 absdk vs R distance moved (SRT) 
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Fig. 4.12.1-5 absdi vs d0i (SRT). 
 
Fig. 4.12.1-6 absdj vs d0i (SRT) 
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Fig. 4.12.1-7 absdk vs d0i (SRT) 
 
Fig. 4.12.1-8  absdi vs d0j (SRT) 
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Fig. 4.12.1-9 absdj vs d0j (SRT) 
 
Fig. 4.12.1-10 absdk vs d0j (SRT) 
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Fig. 4.12.1-11  absdi vs d0k (SRT) 
 
Fig. 4.12.1-12  absdj vs d0k (SRT) 
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Fig. 4.12.1-13 absdk vs d0k (SRT) 
 
Fig. 4.12.1-14 R distance error vs d0i (SRT) 
SRT R vs d0i
y = 0.0121x + 0.2987 
R2 = 0.0038 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
0 2 4 6 8 10 12 14 16 18
d0i (mm)
R
 (m
m
) 
SRT absdk vs d0k
y = 0.0058x + 0.1016 
R2 = 0.0049 
0 
0.5 
1 
1.5 
2 
2.5 
3 
0 5 10 15 20 25
d0k (mm)
ab
sd
k 
(m
m
) 
Chapter 4: Registration to the treatment isocentre 
258
 
Fig. 4.12.1-15 R distance error vs d0j (SRT) 
 
Fig. 4.12.1-16  R distance error vs d0k (SRT) 
4.12.2 SRS Graphs 
The graphs in this section (Figures 4.12.2-1 to 4.12.2-16) are scatter graphs of distance moved in the x axis with the 
difference observed after rotation in the y axis, as in section 4.12.1, but this time derived from a subset of the SRS 
data set. For the SRS data set there were 224 of these image pairs.  
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Fig. 4.12.2-1 R distance error vs R distance moved (SRS) 
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Fig. 4.12.2-2 absdi vs  R distance moved (SRS) 
R distance moved vs R distance error SRS
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Fig. 4.12.2-3 absdj vs R distance moved (SRS) 
 
Fig. 4.12.2-4 absdk vs R distance moved (SRS) 
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Fig. 4.12.2-5 absdi vs d0i (SRS) 
 
Fig. 4.12.2-6 absdj vs d0i(SRS) 
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Fig. 4.12.2-7 absdk vs d0i (SRS) 
 
Fig. 4.12.2-8 absdi vs d0j (SRS) 
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Fig. 4.12.2-9 absdj vs d0j (SRS) 
 
Fig. 4.12.2-10 absdk vs d0j (SRS) 
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Fig. 4.12.2-11  absdi vs d0k (SRS) 
 
Fig. 4.12.2-12  absdj vs d0k (SRS) 
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Fig. 4.12.2-13 absdk vs d0k (SRS) 
 
Fig. 4.12.2-14 R distance error vs d0i (SRS) 
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Fig. 4.12.2-15 R distance error vs d0j (SRS) 
 
Fig. 4.12.2-16 R distance error vs d0k (SRS)  
4.12.3 Large distance translation in SRT. 
Figure 4.12.1-13 shows a distinct group of 70 image pairs which have a k axis correction distance greater than 5 mm. 
These observations were associated with six different patients, designated D0K1, D0K2, D0K3, D0K4, D0K5 and 
D0K6. They occurred for a correction applied to the first image pair of each fraction, for fraction 10 for D0K1, 
fractions 2-4,7-14, 17, 20,22-23 and 25 for D0K2, fractions 1-6,9-11,17-18,20, and 24-30 for D0K3, fractions 3-
6,10-11, 14-23, 26, and 28-30 for D0K4, fractions 2-3, 5-8, 10, and 12-15 for D0K5, and fractions 1 and 26 for 
D0K6. For all of these occurrences, the optical marker sphere array could not be mounted to the mask extension in 
the standard way, from a combination of the physical size of the patient and a lack of patient flexibility. The optical 
marker sphere array was instead balanced on top of its normal mounting point, and in consequence an adjustment of 
SRS R vs d0j
y = 0.0482x + 0.358
R2 = 0.0086
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 
d0j (mm)
R
 (m
m
) 
SRS R vs d0k
y = 0.0025x + 0.3852 
R2 = 4E-05
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
0 0.5 1 1.5 2 2.5 3 3.5 4 
d0k (mm)
R
 (m
m
) 
Chapter 4: Registration to the treatment isocentre 
267
greater than 5 mm was indicated after the first image pair of each session. Table 4.12.3-1 shows the values of iσ , 
jσ , and kσ determined for the 70 image pairs compared with the global SRT data set. There is no significant 
difference between the global SRT data set and the DOK1-6>5 mm data set sigma values.  
 
Table 4.12.3-1 Large translation initial setups are not significantly worse. 
SRT 
iσ  jσ  kσ  
Global 0.289-0.304 0.306-0.318 0.173-0.178 
D0K1-6>5mm 0.27-0.39 0.26-0.38 0.17-0.25 
p value 0.28 0.68 0.12 
4.12.4 Comparison of long and short corrections. 
To maximize the statistical possibility of detecting a correction distance dependant variation within the SRT data set, 
the 3,915 image pairs were split into roughly equal sub groups on the basis of the median distance moved in each 
axis and the 3D distance moved. Values of iσ , jσ , and kσ were calculated for each subgroup and t tests were used 
to determine if the difference between the values was significant.  
Corrections that move more than the median distance in the i axis have no significant difference in any sigma value 
with those that move less than the median value. Corrections that move less than the median distance in the j axis 
have a reduction in kσ that is statistically significant. The magnitude of this difference is less than 0.02 mm, and is 
unlikely to be of clinical consequence, especially since kσ is a self consistency measure.  
Corrections that move less than the median distance in the k axis have an increase in jσ that is statistically 
significant, and a decrease in kσ that is also statistically significant. The magnitude is again quite small, 
jσ increases by less than 0.02 mm, kσ decreases by less than 0.04 mm.  
Corrections that move less than the median 3D distance moved have an increase in jσ that is statistically significant, 
and a decrease in kσ that is also statistically significant. The magnitude is again quite small, jσ increases by less 
than 0.02 mm, kσ decreases by 0.02 mm.   
None of the changes in iσ  are statistically significant. 
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Table 4.12.4-1 Sigma values for long and short corrections. 
  i j k 
Highσ  0.315 0.304 0.196 
Lowσ  0.300 0.316 0.182 
LowHigh σσ −  0.015 -0.011 0.014 
id0  
p value 0.13 0.15 0.08 
Highσ  0.314 0.314 0.198 
Lowσ  0.301 0.305 0.179 
LowHigh σσ −  0.014 0.009 0.019 
jd0  
p value 0.17 0.25 0.02 
Highσ  0.314 0.301 0.207 
Lowσ  0.301 0.319 0.171 
LowHigh σσ −  0.013 -0.018 0.035 
kd0  
p value 0.20 0.03 <0.00001 
Highσ  0.315 0.301 0.199 
Lowσ  0.300 0.319 0.179 
LowHigh σσ −  0.015 -0.017 0.020 
R 
p value 0.14 0.03 0.01 
 
The reasons for the observed variations are not clear. It is difficult to resolve cause and effect for such small 
distances that are below the threshold for optical positioning tolerance, kV x-ray positional tolerance, and even kV 
image pixel size. A complex interplay of factors is likely, the self consistency nature of the k axis making it 
especially sensitive to any underlying decrease in accuracy with distance moved. The results, tabulated in table 
4.12.4-1, show that there is no practical application of this relationship that will give improved positional accuracy. 
4.12.5 Tabulation of linear fits. 
Tables 4.12.5-1 and 4.12.5-2 show a summary of the available data for SRT and SRS respectively. The largest value 
of R2 is 0.036 for SRS (absdk vs d0j) and 0.0049 for SRT (absdk vs d0k). R2 can be thought of as the proportion of 
the variation that is accounted for by the linear trend. The gradients are all very close to zero.  
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Table 4.12.5-1 SRT linear fits 
Move Error absdi Absdj absdk R 
M 0.0073 0.0002 0.0089 0.0121 
C 0.1671 0.1746 0.0989 0.2987 
id0  
R2 0.0021 4E-06 0.0048 0.0038 
M 0.004 0.0105 0.0095 0.0169 
C 0.1714 0.1692 0.1016 0.3002 
jd0  
R2 0.0002 0.0019 0.0016 0.0021 
M 0.0023 -0.0003 0.0058 0.0054 
C 0.1716 0.1751 0.1016 0.3047 
kd0  
R2 0.0005 2E-05 0.0049 0.0018 
M 0.0012 0.001 0.0028 0.0038 
C 0.1719 0.1735 0.103 0.3044 
R 
R2 0.0003 0.0004 0.0027 0.0021 
 
Table 4.12.5-2 SRS linear fits 
Move Error absdi Absdj absdk R 
M 0.009 -0.0376 0.0021 -0.0206 
C 0.205 0.2437 0.1447 0.404 
id0  
R2 0.001 0.021 8E-05 0.003 
M 0.0176 0.0137 0.0606 0.0482 
C 0.202 0.2043 0.1101 0.358 
jd0  
R2 0.002 0.0015 0.0336 0.0086 
M 0.0038 -0.0031 0.0168 0.0025 
C 0.2098 0.2147 0.1347 0.3852 
kd0  
R2 0.0002 0.0001 0.0044 4E-05 
M 0.0056 -0.0193 0.011 -0.0081 
C 0.2063 0.234 0.1343 0.3959 
R 
R2 0.0006 0.008 0.003 0.0007 
4.12.6 Null result 
The effects of the distance translated in a 6D correction are small and non uniform. There is no evidence of any 
benefit that might be gained by introducing a limiting correctional distance above which the following kV 
verification image pair would be classified as a fail, regardless of the position and angle results. 
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4.13 Fraction variation 
It is reasonable to expect that if SRT is different from SRS, a possible cause may be the multiple fraction nature of 
SRT. It is reasonable to expect such effects should cause an observable variation in the results from SRT with 
fraction number. In this section, the variation of the spatial accuracy and sigma values with fraction number for SRT 
is investigated, and the results are compared with SRS to determine the extent to which the multifraction nature of 
SRT is responsible for the difference between SRT and SRS.  
4.13.1 Resolution of ambiguous fraction numbers. 
Every image pair within the SRT data set was assigned an integer fraction number. In general this was 
straightforward but there were some anomalies that needed resolving. These are detailed in appendix A.4.13.1-1. In 
summary these anomalies involved multiple isocentre treatments, multiple treatment sessions on the same day, plans 
modified during treatment, and SRS interspersed with SRT.   
4.13.2 Variation of sigma with fraction number 
The SRT observations were put into subgroups all having the same fraction number, for each of which the values of 
σ were determined. Figures 4.13.2-1, 4.13.2-2, and 4.13.2-3 show the variation of iσ , jσ  and kσ  respectively with 
fraction number. The most significant variation with fraction number occurred for iσ , which decreased from 0.31 
mm to 0.26 mm with fraction number. In the i axis there is no statistically significant difference between the σ values 
of SRT fraction 1 and SRS. Variation with fraction number only partially explains the difference in σ values in the j 
and k axes between SRT fraction 1 and SRS. 
Fig. 4.13.2-1 This figure shows 
the variation of iσ  with SRT 
fraction number. The value of 
iσ  decreases as the fraction 
number increases, indicating 
that the IGS values for 
isocentre position in the i axis 
get more reliable for 
subsequent treatment sessions. 
The error bars increase as the 
fraction number increases 
fewer patients are treated with 
that many fractions, the 
variation is thus vulnerable to 
a patient selection bias. 
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Fig. 4.13.2-2 This figure 
shows the variation of jσ  
with SRT fraction number. 
The value of jσ  increases 
slightly as the fraction 
number increases when a 
linear fit is performed, but a 
constant value is also a 
reasonable fit to the data. So 
it is expected that the IGS 
values for isocentre position 
in the j axis stay the same or 
get slightly less reliable for 
subsequent treatments. The 
error bars increase as the fraction number increases because fewer patients are treated with that many fractions, the 
variation is thus vulnerable to patient selection bias.  
Fig. 4.13.2-3 This figure 
shows the variation of kσ  
with SRT fraction number. 
The value of kσ has a 
negligible increase as the 
fraction number increases 
when a linear fit is 
performed, but a constant 
value is a more reasonable fit 
to the data. It is expected that 
the IGS values for isocentre 
position in the k axis have the 
same reliability for 
subsequent treatments. The 
error bars increase as the 
fraction number increases because fewer patients are treated with that many fractions, the variation is thus 
vulnerable to patient selection bias.  
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4.13.3 Variation of significance and difference with fraction split. 
The SRT data set is large, but when split into 30 fractions each subgroup fraction is small enough that statistical error 
is increased. It would be ideal to compare the probability distribution curve for fraction 1 with the global average 
from SRT, but the error bars may be so large that they obscure the correct conclusion.  A more pragmatic approach 
would be to compare the first n fractions with the global average from SRT, but the averaging over multiple fractions 
may also mask the effect. To aid the choice of how many of the first fractions to include, the difference in the sigma 
values and the associated p values were determined for all values of n from 1 to 30, and graphed in figure 4.13.3-1, 
4.13.3-2, and 4.13.3-3 for iσ , jσ  and kσ  respectively. The ideal value of n gives a maximum difference and a 
minimum p value. From the graphs it was decided to group the first two fractions and compare them with the global 
SRT average.  
Fig. 4.13.3-1 Variation of iσ with 
fraction split and associated p 
value. 
 
 
 
 
 
 
 
Figure 4.13.3-2 Variation of jσ  
with fraction split and associated p 
value. 
 
 
 
 
 
 
Fig. 4.13.3-4 Variation of kσ with 
fraction split and associated p 
value. 
 
Sigmai split in two groups by fraction
0
0.02
0.04
0.06
0.08
0.1
0.12
0 5 10 15 20 25 30 35
Fraction Split
D
iff
er
en
ce
 m
m
Difference
p
Sigmaj fraction split
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0 5 10 15 20 25 30 35
Fraction split
D
iff
er
en
ce
 x
 1
0
Difference
p value
Sigmak fraction split
-0.2
-0.1
0
0.1
0.2
0.3
0.4
0.5
0 5 10 15 20 25 30 35
Fraction split
D
iff
er
en
ce
Difference
p value
Chapter 4: Registration to the treatment isocentre 
273
4.13.4 Variation of spatial accuracy between first two fractions and global 
SRT average. 
The subgroups representing fractions one and two were put into a set, and compared to the global SRT set. For these 
two sets σ values were determined, then used to convolve the observed coordinates in each group with the set 
specific spread function. Figures 4.13.4-1, 4.13.4-2, and 4.13.4-3 show the probability of specific observations in the 
i, j, and k axis respectively for the first two fractions compared to the SRT average. The i axis and k axis show 
improvement with fraction number, but not the j axis.  
 
Fig. 4.13.4-1 This graph 
shows the probability 
distribution in the i axis for 
first 2 fractions compared to 
the SRT average. The first 
two fractions have inferior 
spatial localisation compared 
to the average. Note the 
asymmetry of both 
distributions, which is most 
pronounced in this axis.  
 
 
 
Fig. 4.13.4-2 This graph 
shows the probability 
distribution in the j axis for 
the first 2 fractions compared 
to the SRT average. The two 
distributions are almost 
identical, the largest 
difference in the y axis values 
is less than 0.0001, which is 
not resolved by the resolution 
of the graph and causes only 
a thickening of the line at 
some points.  The j axis 
distribution is also much 
more symmetrical than the i 
axis distribution. The fulcrum 
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point for the roll of the couch is located in the centre of the couch, whereas the fulcrum point for the roll of the couch 
is located more than a metre from the isocentre; this is one cause of the symmetry of the j axis distribution.  
Additionally, the j axis is often the first positioned by the optical system, which means it is adjusted almost to zero 
error by the optical system, so there is less procedural bias arising from the position being moved to just within 
optical tolerance.  
 
Fig. 4.13.4-3 This graph 
shows the probability 
distribution in the k axis self 
consistency for the first 2 
fractions compared to the 
SRT average. The first two 
fractions have inferior spatial 
localization compared to the 
average over all fractions. 
There is some asymmetry in 
this axis, but much less than 
in the i axis. The k axis 
distribution is termed self 
consistency because it is not 
affected by a positional error 
in the calibration of the kV x-ray system to the isocentre. For this reason, the k axis distribution is much tighter than 
the i and j axis distributions. The degradation of the probability distribution for the first two fractions, as measured 
by the relative decrease factor in the maximum discrete probability, is almost the same in the k axis (0.930) as the i 
axis (0.932). 
The expectation is that with increased fraction number, patients relax and fit more firmly into the fixation, leading to 
less patient movement. It is not possible from this work to determine whether this is a reduction in patient motion 
that affects treatment, or a reduction in patient motion that is caused by rotation of the couch and is thus a 
measurement artefact.  
4.14 Artefacts of measurement 
The method of inference is subject to competing extraneous factors as discussed below. In this section an estimate of 
these effects is made, with the aim of differentiating between artefacts of the measurement method and true sources 
of patient localisation error at the time at which the patient position was determined. For this purpose, we divided the 
factors into those dependent and independent of couch rotation, and estimated the magnitude of the factors 
separately. It is important to remember that errors of patient localization are not the same as errors in treatment 
positioning, as patient intrafraction motion will degrade the achieved patient localization after it has been achieved, 
until the next patient positioning 6D correction is executed. This study is not able to differentiate between 
intrafraction motion and couch rotation influenced artifact. To do so would require at least that the exact time of each 
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correction be recorded. It might then be possible to estimate patient intrafraction motion by a correlation between 
time interval and error magnitude, as intrafraction motion is expected to increase with time94. 
4.14.1 Couch rotation dependent factors: effect of couch offset. 
The couch does not rotate perfectly about the isocentre. If this influences the values of iσ , jσ  and kσ  that are 
determined by inference from the assumption of rotational invariance using equations 4.6-2, 4.6-3 and 4.6-4 
respectively, then it should be possible to determine the magnitude of this influence by correcting for it. For each 
discrete couch angle we allow there to be a vector offset in position in the three dimensions, i, j, and k given by 
( )θθθ koffsetjoffsetioffset ,,  . Allowing for this adjustment modifies equations 4.6-2, 4.6-3 and 4.6-4 to 
equations 4.14.1-1, 4.14.1-2 and 4.14.1-3 respectively. 
∑∑ +−−== POSTPREPREPOST ioffsetioffsetiiNabsdiNi θθθθππσ 2  Equation 4.14.1-1 
∑∑ +−−== POSTPREPREPOST joffsetjoffsetjjNabsdjNj θθθθππσ 2  Equation 4.14.1-2 
∑∑ +−−== POSTPREPREPOST koffsetkoffsetkkNabsdkNk θθθθππσ 2  Equation 4.14.1-3 
PRE
ioffsetθ , PREjoffsetθ , and PREkoffsetθ are the values of ( )θθθ koffsetjoffsetioffset ,,  that apply for the couch 
angle that is rotated from. 
POST
ioffsetθ , POSTjoffsetθ , and are the values of ( )θθθ koffsetjoffsetioffset ,,  that apply for the couch angle that 
is rotated to. 
PRE
iθ , PREjθ , PREkθ  are the rotational system i, j, and k coordinates before rotation. 
POST
iθ , POSTjθ , POSTkθ  are the rotational system i, j, and k coordinates after rotation. 
N is the total number of rotations. 
In practice the offset values only need to be determined at 5 degree resolution in couch angle and to within 0.01 mm 
in magnitude. 5 degrees is the increment at which angles are chosen in the planning process, 0.01 mm is the 
increment reported in the results. 
The aim of this section is to find the couch angle offset values that will produce the minimal iσ , jσ  and kσ values. 
The magnitude of the reduction in iσ , jσ  and kσ achieved by optimal offset values gives an upper limit on the 
influence of the imperfect couch rotation on the determination of iσ , jσ  and kσ . 
4.14.2 Couch rotation dependent factors: initial gradient method. 
Method: It was thought initially that the data set was large enough to look at the transition from couch zero to all 
other couch angles in turn and then get an estimate from the deviation from zero of the average of the signed 
differences. There is however a bias in the way couch angles are transitioned. After zero, practice is generally to 
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swing the couch to the furtherest negative couch angle, and then sweep the couch back in the positive direction 
through the remaining couch angles. This had the benefit of treating the patient faster, but made it impossible to 
compare all couches to zero directly. It will be seen in the triples analysis in this section that there are artifacts 
associated with each couch transition, so although offsets transfer, comparing indirectly to couch zero has problems 
of error propagation. 
 
Instead of comparing indirectly to couch zero, we seek to derive a particular offset for each couch angle. The offset 
for a transition is then calculated from the difference of the offsets for the initial and final couch position. We seek to 
determine these by optimisation.  In the naïve model that we are using, the optimization decouples into three separate 
problems. LONG offsets affect iσ , LAT offsets affect jσ , and VERT offsets effect kσ . 
 
Initially, a gradient search method was used. This requires us to evaluate the gradients of iσ , jσ  and kσ with 
respect to each discrete offset  θioffset , θjoffset , and θkoffset . In practice there is no cross talk between axes, 
and the only non zero gradients to be determined are 
θ
σ
ioffset
i
∂
∂
, 
θ
σ
joffset
j
∂
∂
, and 
θ
σ
koffset
k
∂
∂
. 
From equation 4.14.1-1, it is clear that 
θ
σ
ioffset
i
∂
∂
depends only upon those elements in the summation that depend 
upon the particular θioffset being considered. Elements are influenced by a particular value of θioffset either 
because they involve a rotation from the specific couch angle θ or to the specific couch angle θ . In each case the 
contribution of the element to 
θ
σ
ioffset
i
∂
∂
is designated ⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ
θ
σ
ioffset
i and can be determined as follows. 
If the element in the summation involves a rotation to the specific couch angle θ ,  
then if 0>+−−
POSTPREPREPOST
ioffsetioffsetii θθθθ  
  
Nioffset
i πσ
θ
5.0=⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ     Equation 4.14.2-1 
 else (if 0≤+−−
POSTPREPREPOST
ioffsetioffsetii θθθθ ) 
  
Nioffset
i πσ
θ
5.0−=⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ     Equation 4.14.2-2 
Else if the element in the summation involves a rotation from the specific couch angle θ ,  
then if 0>+−−
POSTPREPREPOST
ioffsetioffsetii θθθθ  
  
Nioffset
i πσ
θ
5.0−=⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ     Equation 4.14.2-3 
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 else (if 0≤+−−
POSTPREPREPOST
ioffsetioffsetii θθθθ ) 
  
Nioffset
i πσ
θ
5.0=⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ     Equation 4.14.2-4 
Else 0=⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂Δ
θ
σ
ioffset
i        Equation 4.14.2-5 
By following the above method we can determine by summation the value of 
θ
σ
ioffset
i
∂
∂
for every value of 
θioffset at 5 degree intervals. The determination of 
θ
σ
joffset
j∂ , and 
θ
σ
koffset
k
∂
∂
follow an analogous procedure. 
 
Once we have the gradient, the question is how far to travel. The minimum quantum of distance is 0.01mm. A 
reasonable approach might then be to start moving an average of 0.1 mm in the direction of maximum gradient, 
recalculating the gradient at each step. Then, when the gradient begins to oscillate around zero, decrease to 0.01 mm, 
then less than 0.01 mm. Once the movement for any point is less than 0.005 mm, there is no point to further changes.  
Another approach is to choose the step size at each interval to make sure that the value of iσ  is reduced at each step, 
and to recalculate the gradient after each step. This was the method implemented for the initial optimization. A 
relative step size of 1, 0.15,-0.015 and -0.01 was used to get iσ  from 0.2961 to 0.2813. 
Note that some offsets represent angles that are not rotated from or to. Specifically -5 degrees and 10 degrees are not 
represented. So these offsets can contain any entry without changing the outcome. Also, all of the offsets can be 
changed by a uniform constant without changing the end result, since only the differences between offsets are 
important. 
The gradient dependent optimization method was implemented under direct human control using an excel 
spreadsheet to obtain an initial crude optimization. This was subsequently enhanced by automated processes.  
4.14.3 Automated optimization methods. 
The automated optimization consisted of applying first a linear optimization of each offset in turn, then a two 
parameter area search for every possible pair of offsets, and finally a monte carlo simulation allowing all offsets to 
vary randomly simultaneously. The solution was observed to be stable through the last two steps. The code which 
executes the linear optimization in the i axis is given in appendix A.4.14.3-1. The code which executes the area 
search is given in appendix A.4.14.3-2. The code which executes the Monte Carlo simulation in the i axis is given in 
appendix A.4.14.3-3. The procedures for the j and k axes are analogous. 
4.14.4 Optimization results 
The results of the optimization on iσ , jσ , and kσ are given in table 4.14.4-1. The values of the offsets are given in 
table 4.14.4-2. The changes observed through optimization give an estimate of the maximum effect of the imperfect 
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rotation of the couch about the isocentre, but will be seen in section 4.14.6 to be negligible compared to couch 
rotation independent effects.  
 
Table 4.14.4-1 Effect of optimisation 
 Pre optimization value Post optimization value 
iσ  0.2961 0.2726 
jσ  0.3122 0.2814 
kσ  0.1782 0.1698 
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Table 4.14.4-2 Optimised offsets. Note that some rows represent angles that are not rotated from or to. Specifically -
5 degrees and 10 degrees are not represented. So these rows can contain any entry without changing the outcome. 
Also, all of the entries can be changed by a uniform constant without changing the end result, since only the 
differences between offsets are important. 
Couch Angle ioffset (mm) joffset (mm) koffset (mm) 
-90 0.06 0.17 0.08 
-85 0.01 0 0.06 
-80 0.01 0.08 0.09 
-75 0.07 0.13 0.06 
-70 0 0.06 0.12 
-65 -0.02 0.10 0.06 
-60 -0.01 0.12 0.05 
-55 -0.05 0.14 0.08 
-50 -0.02 0.21 0.03 
-45 -0.03 0.19 0.07 
-40 -0.04 0.18 0.05 
-35 -0.02 0.26 0.04 
-30 -0.04 0.26 0.04 
-25 0 0.22 0.08 
-20 -0.5 0.22 0.01 
-15 0 0.19 0.02 
-10 0.08 0.17 -0.01 
-5 0 0 0 
0 -0.02 0.24 0.02 
5 0.06 0.25 0 
10 0 0.21 0 
15 0 0.17 -0.07 
20 -0.05 0.25 0.07 
25 0.05 0.23 0.07 
30 0.05 0.23 0.07 
35 0.1 0.21 0.04 
40 0.07 0.25 0.07 
45 0.1 0.21 0.06 
50 0.12 0.18 0.06 
55 0.11 0.21 0.13 
60 0.17 0.23 0.08 
65 0.18 0.22 0.08 
70 0.21 0.27 0.08 
75 0.19 0.34 0.09 
80 0.12 0.35 0.05 
85 0.18 0.32 0.02 
90 0.10 0.38 0.06 
4.14.5 Direct measurement of offsets 
Measurements were made of the couch mechanical isocentre runout in three axes using the standard linac installation 
front pointer and microdial gauges (Starrett Tools, Athol USA). A determination was made of the variation of the 
optical system using the “Track Marker Movement” software option, which dumped the coordinates determined in 
real time to a file as the couch rotated. All attempts to use the couch rotation mechanical runout, the infrared system 
rotational runout, or the sum or difference of the positive or negative of the two quantities in place of the offsets 
determined by the optimisation process in every case made the σ values worse. The failure of the experimentally 
determined offsets to improve any of the σ values indicates that the offsets are composite quantities arising from an 
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interplay of physical properties and clinical procedural influences. The contribution of couch dependent factors is 
much smaller than that of couch independent factors. 
4.14.6 Couch rotation independent factors: analysis of triples and 
quadruples. 
Often (3068 times out of 4902 possibilities in the SRT database) a second pass is obtained immediately after a couch 
rotation, and this is termed a “triple” because it provides three coordinates in sequence for analysis. A triple allows 
estimation of couch independent factors. The standard method of inference compares the correction determined 
immediately before and after a single couch rotation, a triple enables instead comparison of the correction 
determined before and after two successive couch rotations. Values inferred in this way have more influence from 
artefacts, since the couch has been rotated twice instead of once, and the difference between the two and one couch 
rotation inference method on the triples subset set is expected to be an estimate of the couch independent factors. The 
first couch rotation of a triple must be a pass, so values determined from one couch rotation using the triples 
subgroup has a selection bias towards events that are less affected by couch independent artefacts. Since the single 
couch rotation σ is subtracted from the double couch rotation σ to obtain the estimate, the estimate is biased by 
selection towards an overestimate by the superior localisation of the initial couch rotations in the triples subset.  
Less commonly (1076 times out of 2661 possibilities in the SRT database) three passes are obtained in succession, 
termed a quadruple, because it provides four coordinates in sequence for analysis. Quadruples allow comparison of 
the standard one couch rotation inference method and the two couch rotation inference method on the quadruples 
subset, and comparing the effect of two couch rotations versus one, with all rotations being from and to a kV image 
pair that passes the ExacTrac clinical tolerance. This estimate is biased by selection towards an underestimate of the 
global SRT artefact, because we consider only a subset selected for good localisation. 
The couch independent artefacts were estimated to be in the range 0.10-0.19 mm depending on the axis as shown in 
table 4.14.6-1. The variation between values of σ inferred from one as opposed to two couch rotations was in all 
cases statistically significant (p < 0.03). Couch independent factors are the major source of measurement artefact.  
The triples artefact estimate is biased towards an overestimate because the one couch rotation inference method is 
executed on a subset that is preferentially selected for low couch-independent artefact, but the two couch rotation 
method is executed on a subset more representative of the global SRT set. Conversely, the quad estimate of the 
artefact under-estimates the artefact, because the quad set estimate is an unbiased estimator for the quad subset, but 
the quad set which will have less patient movement artefact than the global SRT set. So we take the average of these 
two values as our best estimate of the couch independent measurement artefact. Couch-independent artefact is 
expected to be primarily due to patient motion, and the artefacts determined are comparable to those determined by 
Hoogeman et al94 for an equivalent time. 
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Table 4.14.6-1 SRT Couch independent artefacts. This table shows the values of σ inferred from observing the 
magnitude of the change after one or two couch rotations averaged over the triples subset and the quadruples subset 
of SRT. T-test values are the p values from two tailed tests, and all indicate statistically significant difference 
between one and two couch rotations. This is expected because the two rotation value is increased by extra couch 
angle independent artfefacts. The difference in quadrature is tabulated as a measure of the couch angle independent 
artefact determined using the triples and quadruples subset. The triples subset estimate is expected to be an 
overestimate, and the quadruples subset estimate to be an underestimate, of the global SRT artefact. The estimate for 
the global SRT artefact is taken as the average of the two.  
Subset Method of inference 
iσ (mm) jσ (mm) kσ (mm) 
A: One rotation 0.225 0.268 0.152 
B: Two rotations 0.325 0.324 0.196 
P value t-test A vs B 5E-5 0.03 9E-5 
Triples 
Artefact= 22 AB −  0.23 0.18 0.12 
 
Subset Method of inference 
iσ (mm) jσ (mm) kσ (mm) 
C: One rotation 0.212 0.252 0.141 
D: Two rotations 0.258 0.271 0.165 
P value t-test C vs D 8E-9 0.01 1E-5 
Quadruples 
Artefact= 22 CD −  0.15 0.1 0.085 
 
Couch independent artefact estimate 
= 2222 5.05.0 CDAB −+−   
0.19 0.14 0.1 
4.14.7 Expected results from a perfect determination of IGS accuracy 
We expect that if a perfect system for measuring the accuracy of the IGS reported coordinates at the instant they are 
determined existed, it would measure iσ as 0.20 mm, jσ as 0.24 mm and kσ self consistency as 0.14 mm. The 
equivalent values reported by Verbakel et al 81 from extra kV images at the same couch angle were 0.27 mm, 0.23 
mm and 0.20 mm respectively. The expected indirect laser calibration error from our estimates was 0.17 mm, within 
the experimental error range centred on 0.18 mm determined by Hayashi et al 95. In clinical practice, patient intra 
fraction movement degrades this accuracy with time (Hoogeman et al94). The shorter treatment session times for 
SRT compared to SRS are expected to be one of the reasons for better spatial localisation for SRT. 
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4.15 Angle self consistency 
The self consistency of the angles reported by the IGS software were determined by applying equation 4.6-1 to the 
angles reported before and after a rotation. This gives equation 4.15-1, where θΔ is the average of the magnitude of 
the change in the angular correction indicated ( xθ , yθ , or zθ ) before and after a couch rotation. 
θσπθ
2=Δ         Equation 4.15-1 
Table 4.5-1 shows the values of σ determined for the self consistency of the angles reported by the IGS software for 
SRT and SRS. 
  
Table 4.5-1. Angular self consistency of the IGS. This table shows the self consistency values for the rotations about 
the respective axes. The 95% confidence intervals in brackets have been rounded to the nearest tenth of a degree as 
a realistic limitation of accuracy. The intervals in brackets show that the SRS values are larger than the SRT values, 
but the k axis rotation angle is the worst, where the k axis translation σ was the best.  
Angle 
iθσ (degrees) jθσ (degrees) kθσ (degrees) 
SRT (degrees) (0.187 - 0.196) 
0.2 
(0.154 - 0.160) 
0.2 
(0.193 - 0.202) 
0.2 
SRS (degrees) (0.218 - 0.273) 
0.2 
(0.173 - 0.212) 
0.2 
(0.243 - 0.311) 
0.3 
 
The σ values are largest for rotation about the k axis, which is expected because a couch rotation is a rotation about 
the k axis. Round off error may affect the value in the k axis differently before and after rotation; this is expected to 
be the cause of the increased σ values. Verbakel et al.81 reported 0.2° standard deviation for each rotation axis 
determined by taking extra kV image pairs at the same couch position, a method vulnerable to underestimating the 
uncertainty through bias toward a specific pixel. Our method is vulnerable to overestimating the uncertainty due to 
artefact, so agreement validates both studies. The observed SRS angle self consistency values are larger than those 
for SRT; the differences are statistically but not clinically significant. 
4.16 Conclusion 
This chapter concludes with a review of the original hypotheses and a reflection on the implications of the results in 
respect of these hypotheses. The original hypotheses were first stated in section 4.4, and the reader is referred there 
for the details. 
4.16.1 First hypothesis: IGS has adequate spatial accuracy.   
The first hypothesis was that the IGS could be used in clinical practice with sufficient accuracy for frameless 
intracranial SRS and frameless intracranial SRT. Using the assumption of rotational invariance and normal 
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distribution, statistical analysis of the clinical results from the IGS have shown that the spatial accuracy in the 
horizontal plane is adequate for SRS and SRT. Adequate here means that it meets the AAPM guidelines, as stated in 
section 4.4. In the vertical axis only self consistency results can be obtained, to determine spatial accuracy requires 
knowledge of the calibration error of the kilovoltage system with respect to the isocentre in the vertical axis. There is 
another source from which the vertical calibration can be determined: phantom measurements, and values found in 
the literature agree with indirect determinations from the difference between the accuracy in the horizontal plane and 
the self consistency in the vertical axis. The first and most important hypothesis has been proved. 
4.16.2 Second hypothesis: IGS clinical accuracy can be inferred. 
The second hypothesis was that the clinical accuracy of the IGS could be determined from a review of results 
obtained from the IGS itself in standard clinical practice. The proof of the first hypothesis was achieved entirely by a 
review of the IGS clinical results. It was not necessary to obtain any extra images. The method of inference from 
rotational invariance and successive differences was sufficient to establish the clinical accuracy of the IGS. 
4.16.3 Third hypothesis: Clinical inferrence reveals more than phantoms.   
The third hypothesis was that there would be aspects of the clinical accuracy of the IGS that could be determined 
from a review of the IGS treatment data that could not be demonstrated by phantom experiments. Two different 
unexpected aspects of the clinical accuracy of the IGS were in fact determined by the review. The difference between 
SRS and SRT accuracy, primarily caused by patient movement, would never have been observed with phantom 
measurements. Likewise fraction variation would never be observed with a phantom. The third hypothesis has been 
proved. 
4.16.4 Fourth hypothesis: Changes in Clinical Technique 
The fourth hypothesis was that a review of the results obtained with the IGS in clinical practice could be used to 
guide changes in treatment technique, if required, to improve accuracy. As a result of the review, clinical practice has 
been changed to now obtain localization at two different couch angles to triangulate the tumour before commencing 
treatment. This is in part as a result of the poor spatial localization observed for the rare cases of the uncorrected 
setup being specified as correct by the IGS. Additionally, the observation that SRT localization was better than SRS 
has caused a review of SRS treatment tolerances. This review is guided by information about the variation of the 
pass rate and the spatial accuracy with pass criteria that was determined by the review. For the few patients who 
cannot fit into the mask system, an adapter is being fabricated to allow more clearance for the optical marker sphere 
array to lock into place. Non initial setup positioning that takes three or more iterations to achieve is now checked 
against a known set of criteria that indicate whether there is a possibility that the image fusion accuracy may be sub 
standard, so that the treatment can be modified if necessary. All of these changes are a result of information provided 
by this work.   
4.16.5 Fifth hypothesis: Diminishing returns from tightened pass criteria. 
The fifth hypothesis was that a review of the results obtained with the IGS in clinical practice would be able to show 
that tightening the pass criteria provides diminishing returns in terms of clinical accuracy. This hypothesis has not 
been strictly proven in clinical practice. To do that would require comparison of results from different treatment 
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regimes. A method of predicting the results when the pass criteria has been changed has been derived, but this 
hypothesis cannot be proved because currently there are no available results using other pass criteria to check the 
predictions against. This may change in the future if the SRS parameters are refined. 
4.16.6 Sixth hypothesis: Effect of correction distance on accuracy. 
The sixth hypothesis was that the larger the distance translated by the last correction, the less accurate the patient 
positioning with the IGS will be in clinical practice. This hypothesis was not proved. To provide a useful means of 
improving the accuracy, distance moved would have had to have been shown to affect all three axes in the same way, 
or at least improved the accuracy in at least one axis without making the accuracy in any other axis worse, and this 
was definitely not observed. Exhaustive analysis yielded no statistically and clinically significant difference in 
accuracy with distance moved. There is strong evidence that this hypothesis has been disproved, despite the inherent 
difficulty of proving the absence of a relationship. 
4.16.7 Seventh hypothesis: Effect of number of corrections on accuracy.   
The seventh hypothesis was that the accuracy of the IGS positioning in clinical practice will be influenced by the 
number of iterative 6D corrections it took to achieve that positioning. This hypothesis had to be abandoned, because 
of the discovery of the existence of two different subgroups within the clinical data set. Initial setups at couch zero 
behaved completely differently, in terms of behaviour with number of corrections, compared to post rotational 
localizations. Two alternate hypotheses were proved instead. For the initial setups at couch zero, it was proved that 
the accuracy of patient localizations that required no corrections was inferior to all other subgroups. In consequence 
of this result, treatment procedures have been modified for SRS so that treatment does not commence until an initial 
setup and a post rotational localization have been achieved, as noted above. For the post rotational localizations, it 
was determined that those localizations that required three corrections to achieve were the worst of the post rotational 
sub group. As a consequence of this observation, clinical practice has been modified so that all of these localizations 
are now investigated at the time they occur, and categorized according to the observations from the review, from 
which a decision as to whether the patient treatment plan must be modified can be made. 
4.16.8 Eighth Hypothesis: Effect of fraction number on accuracy.     
The eighth hypothesis was that the accuracy of positioning with the IGS in clinical practice would be seen to 
improve after the first two fractions of SRT. The result here was equivocal. The largest variation was observed in the 
i axis, but even for this axis, no change with fraction number was a possible (but statistically highly improbable) 
interpretation of the results. The observed variation with fraction number in the i axis was enough to completely 
explain the difference in accuracy between SRS and SRT in that axis.  
4.16.9 Ninth hypothesis: Angular accuracy can be inferred. 
The ninth hypothesis was that the angle corrections determined by the IGS could be determined to be correct by 
reviewing the results obtained with the IGS in standard clinical practice. The angles were determined to be correct to 
within 0.2º. The accuracy determined by inference based on rotational invariance is biased to an overestimate the 
variation. Published results from repeat kV imaging can be expected to underestimate the error due to single pixel 
bias. Fortunately, the two values are found to agree, which validates the results and proves the hypothesis. 
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4.16.10 Tenth hypothesis: Estimation of artefacts. 
The tenth and final hypothesis was that it was possible to estimate the influence of artifacts of the method used to 
determine the clinical accuracy of the IGS by reviewing the IGS results from standard clinical use of the IGS. The 
triples and quadruples analysis and the angular dependent optimization allowed the determination of measurement 
artifact corrected estimates. The very close agreement between the determined value of ρ and the values of quantities 
equivalent to ρ found in the literature prove this hypothesis, which is a counterintuitive result.   
4.16.11 Reflection 
Reflecting on the significance of these findings by first putting them another way, a method has been developed to 
determine the accuracy of the IGS in clinical practice, closing the gap between phantom experiments and in-vivo 
verification of localization accuracy. This method can be implemented at any centre that is equipped with the IGS, 
since it does not require any additional measurement system, but relies instead on inferring the accuracy by assuming 
rotational invariance. This method is sufficiently accurate to detect the degradation of accuracy caused by 
intrafraction motion or degraded fusion accuracy of tangential kV beams, down to the level of 0.1 mm. 
The predictions made by the method for the kV image system isocentre calibration error, and the angular self 
consistency, agree with values in the literature determined by other methods. The artifact compensated spatial 
accuracy agrees closely with the values determined by repeat imaging. 
Although the method can only provide statistical estimates of the accuracy achieved, and cannot provide direct 
measurement of spatial accuracy for specific incidents, the method can be used to determine the accuracy achieved in 
clinical practice by standard procedures, and may indicate areas where clinical practice can be improved.      
In contrast, the raw results reported by the software provide no indication of the limits of the spatial accuracy of the 
IGS, since the system will by rejection always report results that are within the specified tolerance. 
The method provides a way for any centre to bridge the gap between the accuracy of the system determined by 
phantom measurements at commissioning, and the accuracy of the system in clinical practice. The high accuracy of 
the method is generally superior to that achieved with direct measurements on phantoms. This allows the potential 
for the IGS user community to collate and compare results worldwide from different centres implementing different 
imaging and treatment protocols. 
The method has allowed WBRC to verify that the IGS, as implemented at WBRC, is a fast and accurate system for 
frameless stereotactic treatments. It provides an accurate, efficient and relatively economical solution to the problem 
of coregistration of functional imaging data from PET-CT data to the radiotherapy treatment isocentre in the 
treatment room. PET-CT units provide registration of the PET image to the CT image. The IGS utilizes DRRs 
calculated from a CT scan to register the treatment isocentre to the CT scan. For intracranial treatments, localization 
of the skull is sufficient to localize the brain, and thus the tumour. The combination of PET-CT and the IGS thus 
allows fast and accurate coregistration of functional imaging to the treatment isocentre.  
The last of the three recurring concerns with respect to the use of functional imaging in radiotherapy, registration of 
functional imaging to the treatment isocentre in the radiotherapy treatment room, has thus been addressed, and the 
next chapter is the formal conclusion to this work. 
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Appendix A.4.10.3-1. The standard deviation of MAXλ  
To determine the standard deviation of MAXλ , we must calculate the covariance of two ratios estimated from the 
same population. We begin by considering the essence of the problem, two binomial distributions, one with p=a, one 
with p=b, determined from the same sample data. Let 0<a<b<1. For the particular case of MAXλ  p=b for standard 
clinical conditions, p=a for the variable conditions. Pass or fail for both is evaluated by looking at the same variable 
Z, which we can liken to the i axis correction required. If abs(z)<A, x=1, otherwise x=0. If abs(z)<B, y=1, otherwise 
y=0. Y is the standard clinical pass binomial distribution with p=b. X is the tighter variable pass conditions binomial 
distribution, with p=a. B>A. N is the same for both distributions. 
The sample correlation coefficient (used to estimate the population Pearson correlation coefficient) between X and Y 
is 
( )( )
( ) yx
n
i ii
xy ssn
yyxx
r
1
1
−
−−= ∑ =       Equation 4.10.3-2 
Consider three different subpopulations 
1: 0<z<A Pass for both criteria. 
2:A<z<B Pass for standard clinical criteria only. Fail for tighter variable criteria. 
3:B<z Fail for both criteria. 
 
Subpopulation 1 
The proportion of the total for which z<A is a, the pass ratio of the tighter variable criteria. For this subpopulation: 
;1=ix ;ax = ;1=iy ;by =  
 
Subpopulation 2 
The proportion of the total for which A<z<B is b-a, the pass ratio of the standard clinical conditions minus the pass 
ratio of the tighter variable criteria. For this subpopulation: 
;0=ix ;ax = ;1=iy ;by =  
 
Subpopulation 3 
The proportion of the total for which B<z is 1-b, unity minus the pass ratio of the standard clinical conditions, or if 
you prefer, the fail ratio of the standard clinical conditions. For this subpopulation: 
;0=ix ;ax = ;0=iy ;by =  
 
Knowing this, we can evaluate ( )( )∑ = −−ni ii yyxx1  as a weighted sum over the three subpopulations. 
( )( ) ( )( ) ( )( )( ) ( )( )( )babnbaabnbanayyxxn
i ii
−−−+−−−+−−=−−∑ = 00110111  
         Equation 4.10.3-3 
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−=−−∑= 11       Equation 4.10.3-4 
If we apply the normal approximation to the binomial distribution to both X and Y, we can estimate the standard 
deviations according to 
( );1 aaSx −=        Equation 4.10.3-5 
( );1 bbSY −=        Equation 4.10.3-6 
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         Equation 4.10.3-7 
For our purposes it is sufficient and appropriate to implement the formula 
( )
( )ab
ba
ba −
−=
1
1
,ρ        Equation 4.10.3-8 
Note that  b>a implies b-ab>a-ab or b(1-a)>a(1-b). So the denominator is always greater than the numerator. So 
10 << xyρ  for b>a as expected. The correlation is greater than zero because all factors positive. So the formula 
predicts that there is no negative correlation! Equation 4.10.3-8 can be tested by the Monte Carlo method as shown in 
Figure 4.10.3-1. 
Figure 4.10.3-1 Check of correlation coefficient formula p1=0.9, p2=0.01-0.99
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Fig. 4.10.3-1 Equation 4.10.3-8 was used to calculate the correlation coefficient for two binomial distributions based 
on a test on the same data set with different probabilities of success. Each point in the graph corresponds to a 
different value of p2. For each point, 11,801 random trials were used to estimate the correlation coefficient from 
direct evaluation. The two graphs overlap, indicating that equation 4.10.3-8 is correct. 
. 
So now armed with the correlation coefficient we can go ahead and derive the error in maximum pass ratio. 
In the same nomenclature used to define the Equation 4.10.3-8 
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The maximum pass ratio MAXλ  is given by ;1 ab
b
MAX −+=λ   Equation 4.10.3-9 
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Note that in the limit when a=b 
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So since it behaves as expected in the limit equation 4.10.3-13 is feasible. 
 
CHECKING THE REVISED FORMULA 
 
To further test whether equation 4.10.3-13 predicts error propagation correctly a Monte Carlo trial is conducted. 
100,000 separate trials are run with n=10,000 each, a set at 0.50 and b set at 0.54 . From these 100,000 trials, 95,465 
trials had a value of MAXλ within the two sigma limit predicated by equations 4.10.3-9 and 4.10.3-13, from basic 
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statistics we expect 95,450 trials to be within the two sigma limit. The observed value of 
MAXλσ  is 0.00470797,  
compared to the average standard deviation calculated from estimates of  
MAXλσ  from equation 4.10.3-13 over each 
of the 100,000 trials of 0.00470691. It is concluded that equation 4.10.3-13 is a reasonable estimate of the standard 
deviation in the circumstance. The MATLAB code used to generate this check is included as appendix A.4.10.3-2. 
 
Appendix A.4.10.3-2. MATLAB TEST OF COVARIANCE FORMULA 
First we saved the file below as binomtest.m 
p1=0.54; 
p2=0.50; 
nn=10000; 
bpc=p1/(1+p1-p2); 
sdc=1/sqrt(nn)/(1+p1-p2)/(1+p1-p2)*sqrt((1-p2)*p1*(1+p2-p1)); 
for k=1:100000 
    for n=1:10000 
        z(n)=rand; 
        if (z(n)<p1)  
            x(n)=1; 
        else 
            x(n)=0; 
        end 
        if (z(n)<p2) 
            y(n)=1; 
        else 
            y(n)=0; 
        end 
    end 
    b=mean(x); 
    a=mean(y); 
    sde=1/sqrt(nn)/(1+b-a)/(1+b-a)*sqrt((1-a)*b*(1+a-b)); 
    bpe=b/(1+b-a); 
    u(k)=sde; 
    v(k)=bpe; 
    diff=abs(bpe-bpc); 
    check=2*sde; 
    if(diff<check) 
        w(k)=1; 
    else 
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        w(k)=0; 
    end 
end 
wm=mean(w); 
um=mean(u); 
wm*10000.0 
0.95450*10000.0 
sv=std(v); 
sv*10000.0 
um*10000.0 
Then ran binomtest in the matlab environment and got the following output. 
 
ans =  9.5465e+003 
ans =   9.5450e+003 
ans =   47.0797 
ans =   47.0691 
 
Which means: 100,000 trials, 95,465 trials within the two sigma limit, expect 95,450. Observed standard deviation of 
BEST PASS 0.00470797, average standard deviation calculated from estimates 0.00470691. 
Appendix A.4.10.4-1 Exact binomial test 
It is usual to apply the normal approximation to the binomial distribution for hypothesis testing. There are 
circumstances in which the normal approximation to the binomial distribution is not valid. In the infra red 
positioning subgroup, the pass rate is 0.75% for SRT, and 0.0% for SRS. There are 16 passes out of 2121 
observations in the SRT infra red positioning subgroup, and zero passes out of 104 observations in the SRS infra red 
positioning subgroup. To determine if these differences are statistically significant, it is not possible to use the 
normal distribution approximation to the binomial distribution, but the exact binomial distribution probabilities must 
be calculated. 
We take as the null hypothesis that the SRS pass rate is equivalent to the SRT pass rate of 0.75%, then determine the 
exact binomial probability of observing results at least as extreme as those actually observed for SRS. Since zero 
passes were actually observed for SRS, there cannot be any result more extreme than zero, so we need simply to 
determine the probability of observing zero passes from 104 observations for a binomial distribution with a pass rate 
of 0.75%. This probability is given by 455.0
2121
161
104
≅⎟⎠
⎞⎜⎝
⎛ − , which is also the p value in this circumstance. Since 
the p value is greater than 0.05, and thus not significant, the null hypothesis cannot be rejected. So the exact binomial 
test does not demonstrate a statistically significant difference between the number of passes observed for SRT and 
SRS, despite the fact that the most extreme result possible, no passes, was observed for SRS. At these very low pass 
rates, the 106 samples in the SRS data set are two few to allow differentiation between 0.75% and 0%.   
Chapter 4: Registration to the treatment isocentre 
291
Appendix A.4.10.4-2 Monte Carlo calculation method for error bars. 
Here is the Matlab code to calculate the error bars (See Figure 4.10.4-1). 
% Program Calculating error bars for pass rate with different pass 
% criteria 
% Created on April 4, 2010 by T. Ackerly 
%   
% Input Variable: 
% The values A-P as defined in the section 4.10.4 
% "The best estimate of the pass rate at delta is the pass rate amongst the 
% corrected image subpopulation using the current delta" 
% These values are imported from a file  
% and from there put into the vectors A-P(n) where n is 1 to 71 for values of 
% delta 0.01 to 0.71 mm (0 to 0.7 mm) 
% Intermediate Variables: 
%  
% A1-P1(m), where m is 1 to 1000 an index of repeat trial number. Each A1 
% is a sampling. 
%  
% Output variables 
% s2d(n) value of 2 standard deviations for confidence of the pass ratio  
% 
% First import data file SRTpass 
% Input parameters 
A=SRTpass(:,1); 
B=SRTpass(:,2); 
C=SRTpass(:,3); 
D=SRTpass(:,4); 
E=SRTpass(:,5); 
F=SRTpass(:,6); 
G=SRTpass(:,14); 
H=SRTpass(:,15); 
I=SRTpass(:,16); 
J=SRTpass(:,17); 
K=SRTpass(:,18); 
L=SRTpass(:,19); 
M=SRTpass(:,20); 
N=SRTpass(:,21); 
O=SRTpass(:,22); 
P=SRTpass(:,23); 
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% loop over criteria 
for kk=1:70 
% 
% loop over trials 
for mm=1:10000 
% 
% loop over points 
% A=10050; B=15983; C=0.5; D=2216; E=4446; F=5747; G=3388; H=10236; I=7834; 
% J=15983; K=5066; L=5747; M=4984; N=10236; O=1596; P=620; 
A1=0; B1=0; C1=C(kk); D1=0; E1=0; F1=0; G1=0; H1=0; I1=0; J1=0; K1=0; L1=0; 
M1=0; N1=0; O1=0; P1=0; 
  
for ll=1:15983 
    rr=rand(); 
    if rr<N(kk)/J(kk) 
        H1=H1+1; 
        N1=N1+1; 
    else 
        F1=F1+1; 
        L1=L1+1; 
    end 
    if rr<G(kk)/J(kk) 
        G1=G1+1; 
        I1=I1+1; 
    end 
    if rr<M(kk)/J(kk) 
        M1=M1+1; 
        A1=A1+1; 
    end 
    if ((rr>G(kk)/J(kk))&(rr<M(kk)/J(kk))) 
        D1=D1+1; 
        O1=O1+1; 
    end 
    % 1+ subgroup 
    if ((rr>N(kk)/J(kk))&(rr<(N(kk)+K(kk))/J(kk))) 
        K1=K1+1; 
        A1=A1+1; 
    end 
    if ((rr>N(kk)/J(kk))&(rr<(N(kk)+E(kk))/J(kk))) 
        E1=E1+1; 
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        I1=I1+1; 
    end 
    if ((rr>(N(kk)+E(kk))/J(kk))&(rr<(N(kk)+K(kk))/J(kk))) 
        P1=P1+1; 
        D1=D1+1; 
    end 
    B1=B1+1; 
    J1=J1+1; 
end 
pasrat(mm)=A1*E1/(B1*E1+B1*D1-A1*D1); 
end 
y(kk)=std(pasrat); 
y(kk) 
end 
 
Which produces the output 
EDU>> y 
y =  Columns 1 through 8  
    0.0039    0.0038    0.0039    0.0039    0.0040    0.0040    0.0040    0.0041 
  Columns 9 through 16  
    0.0041    0.0041    0.0042    0.0043    0.0043    0.0043    0.0043    0.0044 
  Columns 17 through 24  
    0.0044    0.0044    0.0045    0.0046    0.0046    0.0046    0.0047    0.0046 
  Columns 25 through 32  
    0.0047    0.0048    0.0048    0.0049    0.0049    0.0049    0.0049    0.0050 
  Columns 33 through 40  
    0.0051    0.0050    0.0051    0.0052    0.0051    0.0052    0.0052    0.0052 
  Columns 41 through 48  
    0.0052    0.0051    0.0052    0.0051    0.0051    0.0051    0.0050    0.0049 
  Columns 49 through 56  
    0.0048    0.0047    0.0046    0.0044    0.0044    0.0042    0.0041    0.0037 
  Columns 57 through 64  
    0.0035    0.0033    0.0031    0.0028    0.0026    0.0022    0.0019    0.0016 
  Columns 65 through 70  
    0.0013    0.0010    0.0007    0.0005    0.0003       NaN 
 
Where column 1 relates to 0.71 (0.7)  
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Appendix A.4.10.7-1 Matlab code: figure 4.10.7-1 
Here is the Matlab code to calculate figure 4.10.7-1 
si=[0.2961, 0.2958, 0.2961, 0.2956, 0.2950, 0.2948, 0.2941, 0.2939, 0.2934, 
0.2930, 0.2927, 0.2927, 0.2931, 0.2931, 0.2929, 0.2929, 0.2926, 0.2916, 
0.2910, 0.2914, 0.2911, 0.2908, 0.2901, 0.2888, 0.2891, 0.2873, 0.2866, 
0.2859, 0.2867, 0.2855, 0.2865, 0.2864, 0.2858, 0.2854, 0.2854, 0.2859, 
0.2864, 0.2845, 0.2842, 0.2811, 0.2835, 0.2828, 0.2831, 0.2821, 0.2823, 
0.2811, 0.2794, 0.2784, 0.2795, 0.2822, 0.2819, 0.2833, 0.2725, 0.2730, 
0.2734, 0.2796, 0.2819, 0.2889, 0.2830, 0.2904, 0.2661, 0.2597, 0.2740, 
0.2960, 0.3344, 0.3811, 0.3342, 0.3486, 0.4077, 0.0532]; 
for l=1:70 
x(:,l)=SRTivp(:,2*l-1); 
end 
for l=1:70 
    nc(l)=0; 
    for j=1:7253 
        if(isnan(x(j,l))==1) 
        else 
            nc(l)=nc(l)+1; 
        end 
    end 
end 
  
for i=1:1201 
    for i1=1:70 
    z(i1,i)=0; 
    end 
end 
for i1=1:70 
    for i=1:1201 
    y=(i-601)/100.0; 
        for j=1:7253 
            if(isnan(x(j,i1))==1) 
            else           
                z(i1,i)=z(i1,i)+1/nc(i1)*1/sqrt(2*pi*si(i1)*si(i1))*exp(-1*(y-
x(j,i1))*(y-x(j,i1))/2/si(i1)/si(i1)); 
            end 
        end 
    end     
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end 
for i1=1:70 
    normi(i1)=0; 
    for i=1:1201 
        normi(i1)=normi(i1)+z(i1,i); 
    end 
end 
for i1=1:70 
    for i=1:1201 
        z(i1,i)=z(i1,i)/normi(i1); 
    end 
end 
  
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
  
plot(u,z(1,:),'-k',u,z(11,:),'--k',u,z(21,:),':k',u,z(31,:),'-.k'); 
Appendix A.4.10.7-2 Matlab code: figure 4.10.7-2 
Here is the Matlab code that calculates figure 4.10.7-2 
sj=[0.3122,0.3121,0.3121,0.3118,0.3114,0.3109,0.3107,0.3098,0.3100,0.3091,0.30
88,0.3083,0.3082,0.3078,0.3070,0.3068,0.3061,0.3059,0.3043,0.3036,0.3036,0.302
9,0.3015,0.3000,0.2991,0.2976,0.2964,0.2951,0.2938,0.2926,0.2922,0.2918,0.2902
,0.2904,0.2889,0.2880,0.2872,0.2868,0.2855,0.2829,0.2829,0.2840,0.2843,0.2839,
0.2845,0.2811,0.2781,0.2790,0.2783,0.2797,0.2773,0.2747,0.2743,0.2697,0.2644,0
.2637,0.2648,0.2704,0.2679,0.2659,0.2653,0.2661,0.2632,0.2660,0.2619,0.2709,0.
2342,0.2442,0.3124,0.0266]; 
for l=1:70 
x(:,l)=SRTjvp(:,2*l-1); 
end 
for l=1:70 
    nc(l)=0; 
    for j=1:7253 
        if(isnan(x(j,l))==1) 
        else 
            nc(l)=nc(l)+1; 
        end 
    end 
end 
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for i=1:1201 
    for i1=1:70 
    z(i1,i)=0; 
    end 
end 
for i1=1:70 
    for i=1:1201 
    y=(i-601)/100.0; 
        for j=1:7253 
            if(isnan(x(j,i1))==1) 
            else           
                z(i1,i)=z(i1,i)+1/nc(i1)*1/sqrt(2*pi*sj(i1)*sj(i1))*exp(-1*(y-
x(j,i1))*(y-x(j,i1))/2/sj(i1)/sj(i1)); 
            end 
        end 
    end     
end 
for i1=1:70 
    normi(i1)=0; 
    for i=1:1201 
        normi(i1)=normi(i1)+z(i1,i); 
    end 
end 
for i1=1:70 
    for i=1:1201 
        z(i1,i)=z(i1,i)/normi(i1); 
    end 
end 
  
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
  
plot(u,z(1,:),'-k',u,z(11,:),'--k',u,z(21,:),':k',u,z(31,:),'-.k'); 
%plot(u,(z(1,:)+z(2,:)+z(3,:)+z(4,:)+z(5,:))/5,u,(z(6,:)+z(7,:)+z(8,:)+z(9,:)+
z(10,:))/5,u,(z(11,:)+z(12,:)+z(13,:)+z(14,:)+z(15,:))/5,u,(z(16,:)+z(17,:)+z(
18,:)+z(19,:)+z(20,:))/5,u,(z(21,:)+z(22,:)+z(23,:)+z(24,:)+z(25,:))/5,u,(z(26
,:)+z(27,:)+z(28,:)+z(29,:)+z(30,:)+z(31,:))/6); 
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%plot(u,z(1,:),u,z(2,:),u,z(3,:),u,z(4,:),u,z(5,:),u,z(6,:),u,z(7,:),u,z(8,:),
u,z(9,:),u,z(10,:),u,z(11,:),u,z(12,:),u,z(13,:),u,z(14,:),u,z(15,:),u,z(16,:)
,u,z(17,:),u,z(18,:),u,z(19,:),u,z(20,:),u,z(21,:),u,z(22,:),u,z(23,:),u,z(24,
:),u,z(25,:),u,z(26,:),u,z(27,:),u,z(28,:),u,z(29,:),u,z(30,:),u,z(31,:)); 
%plot(u,a1,u,a2,u,a3); 
  
  
for i1=1:70 
    sum1=0; 
    for i=1:1201 
        if abs(u(i))>1 
            sum1=sum1+z(i1,i); 
        end     
    end 
    sum1 
end 
Appendix A.4.10.7-3 Matlab code: figure 4.10.7-3 
Here is the Matlab code that calculates figure 4.10.7-3 
sk=[0.1782,0.1777,0.1777,0.1777,0.1777,0.1775,0.1771,0.1770,0.1770,0.1767,0.17
66,0.1766,0.1764,0.1767, 0.1763, 0.1760, 0.1755,0.1751,0.1752,0.1749, 
0.1751,0.1749, 0.1748, 0.1732,0.1735,0.1721, 0.1723,0.1717, 0.1712,0.1705, 
0.1699, 
0.1698,0.1691,0.1692,0.1691,0.1679,0.1682,0.1677,0.1675,0.1647,0.1649,0.1644,0
.1644,0.1623, 0.1617, 0.1596,0.1602,0.1573, 0.1586,0.1599, 0.1617, 
0.1583,0.1583,0.1597, 0.1613, 0.1618, 0.1658,0.1661, 
0.1663,0.1636,0.1562,0.1568, 0.1463,0.1430, 0.1486, 0.1282,0.1228, 
0.1290,0.1219,0.1861]; 
for l=1:70 
x(:,l)=SRTkvp(:,2*l-1); 
end 
for l=1:70 
    nc(l)=0; 
    for j=1:7253 
        if(isnan(x(j,l))==1) 
        else 
            nc(l)=nc(l)+1; 
        end 
    end 
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end 
  
for i=1:1201 
    for i1=1:70 
    z(i1,i)=0; 
    end 
end 
for i1=1:70 
    for i=1:1201 
    y=(i-601)/100.0; 
        for j=1:7253 
            if(isnan(x(j,i1))==1) 
            else           
                z(i1,i)=z(i1,i)+1/nc(i1)*1/sqrt(2*pi*sk(i1)*sk(i1))*exp(-1*(y-
x(j,i1))*(y-x(j,i1))/2/sk(i1)/sk(i1)); 
            end 
        end 
    end     
end 
for i1=1:70 
    normi(i1)=0; 
    for i=1:1201 
        normi(i1)=normi(i1)+z(i1,i); 
    end 
end 
for i1=1:70 
    for i=1:1201 
        z(i1,i)=z(i1,i)/normi(i1); 
    end 
end 
  
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
  
plot(u,z(1,:),'-k',u,z(11,:),'--k',u,z(21,:),':k',u,z(31,:),'-.k'); 
%plot(u,(z(1,:)+z(2,:)+z(3,:)+z(4,:)+z(5,:))/5,u,(z(6,:)+z(7,:)+z(8,:)+z(9,:)+
z(10,:))/5,u,(z(11,:)+z(12,:)+z(13,:)+z(14,:)+z(15,:))/5,u,(z(16,:)+z(17,:)+z(
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18,:)+z(19,:)+z(20,:))/5,u,(z(21,:)+z(22,:)+z(23,:)+z(24,:)+z(25,:))/5,u,(z(26
,:)+z(27,:)+z(28,:)+z(29,:)+z(30,:)+z(31,:))/6); 
%plot(u,z(1,:),u,z(2,:),u,z(3,:),u,z(4,:),u,z(5,:),u,z(6,:),u,z(7,:),u,z(8,:),
u,z(9,:),u,z(10,:),u,z(11,:),u,z(12,:),u,z(13,:),u,z(14,:),u,z(15,:),u,z(16,:)
,u,z(17,:),u,z(18,:),u,z(19,:),u,z(20,:),u,z(21,:),u,z(22,:),u,z(23,:),u,z(24,
:),u,z(25,:),u,z(26,:),u,z(27,:),u,z(28,:),u,z(29,:),u,z(30,:),u,z(31,:)); 
%plot(u,a1,u,a2,u,a3); 
  
  
for i1=1:70 
    sum1=0; 
    for i=1:1201 
        if abs(u(i))>1 
            sum1=sum1+z(i1,i); 
        end     
    end 
    sum1 
end 
Appendix A.4.11.2-1 Matlab code: figure 4.11.2-1 
Here is the Matlab code that generates Figure 4.11.2-1 
x(1)=-0.41; 
x(2)=-0.41; 
x(3)=-0.23; 
x(4)=-0.02; 
x(5)=0.07; 
x(6)=0.09; 
x(7)=0.32; 
x(8)=0.36; 
x(9)=0.36; 
x(10)=0.46; 
x(11)=0.53; 
x(12)=0.54; 
x(13)=0.57; 
x(14)=0.67; 
x(15)=0.68; 
x(16)=0.69; 
  
for i=1:1201 
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    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:16 
        z(i)=z(i)+1/16*1/sqrt(2*pi*0.521*0.521)*exp(-1*(y-x(j))*(y-
x(j))/2/0.521/0.521); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:1858 
        z1(i)=z1(i)+1/1858*1/sqrt(2*pi*0.289*0.289)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.289/0.289); 
    end 
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:205 
        z2(i)=z2(i)+1/205*1/sqrt(2*pi*0.337*0.337)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.337/0.337); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
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    for j=1:34 
        z3(i)=z3(i)+1/34*1/sqrt(2*pi*0.264*0.264)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.264/0.264); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
tz=0; 
tz1=0; 
tz2=0; 
tz3=0; 
  
for i=1:1201 
    tz=tz+z(i); 
    tz1=tz1+z1(i); 
    tz2=tz2+z2(i); 
    tz3=tz3+z3(i); 
end 
for i=1:1201 
    z(i)=z(i)/tz; 
    z1(i)=z1(i)/tz1; 
    z2(i)=z2(i)/tz2; 
    z3(i)=z3(i)/tz3; 
end 
  
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k'); 
Appendix A.4.11.2-2 Matlab code: figure 4.11.2-2 
Here is the MATLAB code that generates figure 4.11.2-2 
for i=1:1201 
    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:16 
        z(i)=z(i)+1/16*1/sqrt(2*pi*0.305*0.305)*exp(-1*(y-x(j))*(y-
x(j))/2/0.305/0.305); 
    end 
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end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:1858 
        z1(i)=z1(i)+1/1858*1/sqrt(2*pi*0.293*0.293)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.293/0.293); 
    end 
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:205 
        z2(i)=z2(i)+1/205*1/sqrt(2*pi*0.324*0.324)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.324/0.324); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:34 
        z3(i)=z3(i)+1/34*1/sqrt(2*pi*0.343*0.343)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.343/0.343); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
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zsum=0; 
for i=1:1201 
    zsum=zsum+z(i); 
end 
for i=1:1201 
    z(i)=z(i)/zsum; 
end 
zsum1=0; 
for i=1:1201 
    zsum1=zsum1+z1(i); 
end 
for i=1:1201 
    z1(i)=z1(i)/zsum1; 
end 
zsum2=0; 
for i=1:1201 
    zsum2=zsum2+z2(i); 
end 
for i=1:1201 
    z2(i)=z2(i)/zsum2; 
end 
zsum3=0; 
for i=1:1201 
    zsum3=zsum3+z3(i); 
end 
for i=1:1201 
    z3(i)=z3(i)/zsum3; 
end 
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k');  
Appendix A.4.11.2-3 Matlab code: figure 4.11.2-3 
Here is the Matlab code that generates figure 4.11.2-3. 
for i=1:1201 
    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:16 
        z(i)=z(i)+1/16*1/sqrt(2*pi*0.294*0.294)*exp(-1*(y-x(j))*(y-
x(j))/2/0.294/0.294); 
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    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:1858 
        z1(i)=z1(i)+1/1858*1/sqrt(2*pi*0.178*0.178)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.178/0.178); 
    end 
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:205 
        z2(i)=z2(i)+1/205*1/sqrt(2*pi*0.189*0.189)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.189/0.189); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:34 
        z3(i)=z3(i)+1/34*1/sqrt(2*pi*0.220*0.220)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.220/0.220); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
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end 
zsum=0; 
for i=1:1201 
    zsum=zsum+z(i); 
end 
for i=1:1201 
    z(i)=z(i)/zsum; 
end 
zsum1=0; 
for i=1:1201 
    zsum1=zsum1+z1(i); 
end 
for i=1:1201 
    z1(i)=z1(i)/zsum1; 
end 
zsum2=0; 
for i=1:1201 
    zsum2=zsum2+z2(i); 
end 
for i=1:1201 
    z2(i)=z2(i)/zsum2; 
end 
zsum3=0; 
for i=1:1201 
    zsum3=zsum3+z3(i); 
end 
for i=1:1201 
    z3(i)=z3(i)/zsum3; 
end 
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k'); 
Appendix A.4.11.2-4 Matlab code: figure 4.1.2-4 
Here is the Matlab code for the radial dist for figure 4.11.2-4 
x=couch00x2D0R; 
x1=couch00x2D1R; 
x2=couch00x2D2R; 
x3=couch00x2D3R; 
  
for ri=1:601 
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    zz(ri)=0; 
    for rj=1:2001 
        z(ri,rj)=0; 
        z1(ri,rj)=0; 
        z2(ri,rj)=0; 
        z3(ri,rj)=0; 
    end 
end 
for ri=1:601 
    ri 
    cr=(ri-201)*0.01; 
    for rj=1:2001 
        b=(rj-1)*0.001; 
        for ppi=1:16 
            rpt=sqrt((cr-x(ppi))*(cr-x(ppi))+b*b); 
            if (b==0) 
                
z(ri,rj)=z(ri,rj)+1/16*2*pi*0.001/3*1/sqrt(2*pi*0.413*0.413)*exp(-
1*rpt*rpt/2/0.413/0.413); 
            else 
                z(ri,rj)=z(ri,rj)+1/16*2*pi*b*1/sqrt(2*pi*0.413*0.413)*exp(-
1*rpt*rpt/2/0.413/0.413); 
            end 
        end 
        for ppi=1:1858 
            rpt=sqrt((cr-x1(ppi))*(cr-x1(ppi))+b*b); 
            if (b==0) 
                
z1(ri,rj)=z1(ri,rj)+1/16*2*pi*0.001/3*1/sqrt(2*pi*0.291*0.291)*exp(-
1*rpt*rpt/2/0.291/0.291); 
            else 
                z1(ri,rj)=z1(ri,rj)+1/16*2*pi*b*1/sqrt(2*pi*0.291*0.291)*exp(-
1*rpt*rpt/2/0.291/0.291); 
            end 
        end    
        for ppi=1:205 
            rpt=sqrt((cr-x2(ppi))*(cr-x2(ppi))+b*b); 
            if (b==0) 
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z2(ri,rj)=z2(ri,rj)+1/16*2*pi*0.001/3*1/sqrt(2*pi*0.330*0.330)*exp(-
1*rpt*rpt/2/0.330/0.330); 
            else 
                z2(ri,rj)=z2(ri,rj)+1/16*2*pi*b*1/sqrt(2*pi*0.330*0.330)*exp(-
1*rpt*rpt/2/0.330/0.330); 
            end 
        end  
        for ppi=1:34 
            rpt=sqrt((cr-x3(ppi))*(cr-x3(ppi))+b*b); 
            if (b==0) 
                
z3(ri,rj)=z3(ri,rj)+1/16*2*pi*0.001/3*1/sqrt(2*pi*0.304*0.304)*exp(-
1*rpt*rpt/2/0.304/0.304); 
            else            
                z3(ri,rj)=z3(ri,rj)+1/16*2*pi*b*1/sqrt(2*pi*0.304*0.304)*exp(-
1*rpt*rpt/2/0.304/0.304); 
            end 
        end  
    end 
end 
  
for ri=1:801 
    zz(ri)=0; 
    zz1(ri)=0; 
    zz2(ri)=0; 
    zz3(ri)=0; 
end 
  
for ri=1:601 
    cr=(ri-201)*0.01; 
    for rj=1:2001 
        b=(rj-1)*0.001; 
        rpt=sqrt(cr*cr+b*b); 
        index1=floor(rpt/0.01); 
        index2=ceil(rpt/0.01); 
        w1=rpt/0.01-index1; 
        w2=index2-rpt/0.01; 
        zz(index1+1)=zz(index1+1)+w2*z(ri,rj); 
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        zz(index2+1)=zz(index2+1)+w1*z(ri,rj); 
        zz1(index1+1)=zz1(index1+1)+w2*z1(ri,rj); 
        zz1(index2+1)=zz1(index2+1)+w1*z1(ri,rj); 
        zz2(index1+1)=zz2(index1+1)+w2*z2(ri,rj); 
        zz2(index2+1)=zz2(index2+1)+w1*z2(ri,rj); 
        zz3(index1+1)=zz3(index1+1)+w2*z3(ri,rj); 
        zz3(index2+1)=zz3(index2+1)+w1*z3(ri,rj);        
    end 
end 
  
zztot=0; 
zz1tot=0; 
zz2tot=0; 
zz3tot=0; 
for ri=1:length(zz) 
    zztot=zztot+zz(ri); 
end 
for ri=1:length(zz1) 
    zz1tot=zz1tot+zz1(ri); 
end 
for ri=1:length(zz2) 
    zz2tot=zz2tot+zz2(ri); 
end 
for ri=1:length(zz3) 
    zz3tot=zz3tot+zz3(ri); 
end 
for ri=1:length(zz) 
    zz(ri)=zz(ri)/zztot; 
end 
for ri=1:length(zz1) 
    zz1(ri)=zz1(ri)/zz1tot; 
end 
for ri=1:length(zz2) 
    zz2(ri)=zz2(ri)/zz2tot; 
end 
for ri=1:length(zz3) 
    zz3(ri)=zz3(ri)/zz3tot; 
end 
for ri=1:601 
    u(ri)=(ri-1)*0.01; 
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    zzt(ri)=zz(ri); 
    zzt1(ri)=zz1(ri); 
    zzt2(ri)=zz2(ri); 
    zzt3(ri)=zz3(ri); 
end 
  
plot(u,zzt,u,zzt1,u,zzt2,u,zzt3); 
Appendix A.4.11.3-1 Matlab code: figure 4.11.3-1 
Here is the Matlab code that generates figure 4.11.3-1 
 
for i=1:1201 
    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:3322 
        z(i)=z(i)+1/3322*1/sqrt(2*pi*0.282*0.282)*exp(-1*(y-x(j))*(y-
x(j))/2/0.282/0.282); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:1668 
        z1(i)=z1(i)+1/1668*1/sqrt(2*pi*0.316*0.316)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.316/0.316); 
    end 
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
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    for j=1:118 
        z2(i)=z2(i)+1/118*1/sqrt(2*pi*0.381*0.381)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.381/0.381); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:13 
        z3(i)=z3(i)+1/13*1/sqrt(2*pi*0.586*0.586)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.586/0.586); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
zsum=0; 
for i=1:1201 
    zsum=zsum+z(i); 
end 
for i=1:1201 
    z(i)=z(i)/zsum; 
end 
zsum1=0; 
for i=1:1201 
    zsum1=zsum1+z1(i); 
end 
for i=1:1201 
    z1(i)=z1(i)/zsum1; 
end 
zsum2=0; 
for i=1:1201 
    zsum2=zsum2+z2(i); 
end 
for i=1:1201 
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    z2(i)=z2(i)/zsum2; 
end 
zsum3=0; 
for i=1:1201 
    zsum3=zsum3+z3(i); 
end 
for i=1:1201 
    z3(i)=z3(i)/zsum3; 
end 
  
  
  
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k'); 
Appendix A.4.11.3-2 Matlab code: figure 4.11.3-2 
Here is the Matlab code that generates figure 4.11.3-2 
 
for i=1:1201 
    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:3322 
        z(i)=z(i)+1/3322*1/sqrt(2*pi*0.315*0.315)*exp(-1*(y-x(j))*(y-
x(j))/2/0.315/0.315); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:1668 
        z1(i)=z1(i)+1/1668*1/sqrt(2*pi*0.324*0.324)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.324/0.324); 
    end 
Chapter 4: Registration to the treatment isocentre 
312
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:118 
        z2(i)=z2(i)+1/118*1/sqrt(2*pi*0.340*0.340)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.340/0.340); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:13 
        z3(i)=z3(i)+1/13*1/sqrt(2*pi*0.296*0.296)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.296/0.296); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
zsum=0; 
for i=1:1201 
    zsum=zsum+z(i); 
end 
for i=1:1201 
    z(i)=z(i)/zsum; 
end 
zsum1=0; 
for i=1:1201 
    zsum1=zsum1+z1(i); 
end 
for i=1:1201 
    z1(i)=z1(i)/zsum1; 
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end 
zsum2=0; 
for i=1:1201 
    zsum2=zsum2+z2(i); 
end 
for i=1:1201 
    z2(i)=z2(i)/zsum2; 
end 
zsum3=0; 
for i=1:1201 
    zsum3=zsum3+z3(i); 
end 
for i=1:1201 
    z3(i)=z3(i)/zsum3; 
end 
  
  
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k'); 
Appendix A.4.11.3-3 Matlab code: figure 4.11.3-3 
Here is the Matlab code that generates figure 4.11.3-3 
 
for i=1:1201 
    z(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:3322 
        z(i)=z(i)+1/3322*1/sqrt(2*pi*0.165*0.165)*exp(-1*(y-x(j))*(y-
x(j))/2/0.165/0.165); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z1(i)=0; 
end 
for i=1:1201 
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    y=(i-601)/100.0; 
    for j=1:1668 
        z1(i)=z1(i)+1/1668*1/sqrt(2*pi*0.196*0.196)*exp(-1*(y-x1(j))*(y-
x1(j))/2/0.196/0.196); 
    end 
end 
for i=1:1201 
    z2(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:118 
        z2(i)=z2(i)+1/118*1/sqrt(2*pi*0.250*0.250)*exp(-1*(y-x2(j))*(y-
x2(j))/2/0.250/0.250); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
for i=1:1201 
    z3(i)=0; 
end 
for i=1:1201 
    y=(i-601)/100.0; 
    for j=1:13 
        z3(i)=z3(i)+1/13*1/sqrt(2*pi*0.276*0.276)*exp(-1*(y-x3(j))*(y-
x3(j))/2/0.276/0.276); 
    end 
end 
for i=1:1201 
    u(i)=(i-601)/100.0; 
end 
zsum=0; 
for i=1:1201 
    zsum=zsum+z(i); 
end 
for i=1:1201 
    z(i)=z(i)/zsum; 
end 
zsum1=0; 
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for i=1:1201 
    zsum1=zsum1+z1(i); 
end 
for i=1:1201 
    z1(i)=z1(i)/zsum1; 
end 
zsum2=0; 
for i=1:1201 
    zsum2=zsum2+z2(i); 
end 
for i=1:1201 
    z2(i)=z2(i)/zsum2; 
end 
zsum3=0; 
for i=1:1201 
    zsum3=zsum3+z3(i); 
end 
for i=1:1201 
    z3(i)=z3(i)/zsum3; 
end 
  
plot(u,z,'-k',u,z1,'--k',u,z2,':k',u,z3,'-.k'); 
Appendix A.4.11.3-4 Matlab code: figure 4.11.3-4 
Here is the Matlab code that generates figure 4.11.3-4 
x=couch0x2100x2D0R; 
x1=couch0x2100x2D1R; 
x2=couch0x2100x2D2R; 
x3=couch0x2100x2D3R; 
  
for ri=1:601 
    zz(ri)=0; 
    for rj=1:2001 
        z(ri,rj)=0; 
        z1(ri,rj)=0; 
        z2(ri,rj)=0; 
        z3(ri,rj)=0; 
    end 
end 
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for ri=1:601 
    ri 
    cr=(ri-201)*0.01; 
    for rj=1:2001 
        b=(rj-1)*0.001; 
        for ppi=1:3322 
            rpt=sqrt((cr-x(ppi))*(cr-x(ppi))+b*b); 
            if (b==0) 
                
z(ri,rj)=z(ri,rj)+1/3322*2*pi*0.001/3*1/sqrt(2*pi*0.298*0.298)*exp(-
1*rpt*rpt/2/0.298/0.298); 
            else 
                z(ri,rj)=z(ri,rj)+1/3322*2*pi*b*1/sqrt(2*pi*0.298*0.298)*exp(-
1*rpt*rpt/2/0.298/0.298); 
            end 
        end 
        for ppi=1:1668 
            rpt=sqrt((cr-x1(ppi))*(cr-x1(ppi))+b*b); 
            if (b==0) 
                
z1(ri,rj)=z1(ri,rj)+1/1668*2*pi*0.001/3*1/sqrt(2*pi*0.320*0.320)*exp(-
1*rpt*rpt/2/0.320/0.320); 
            else 
                
z1(ri,rj)=z1(ri,rj)+1/1668*2*pi*b*1/sqrt(2*pi*0.320*0.320)*exp(-
1*rpt*rpt/2/0.320/0.320); 
            end 
        end    
        for ppi=1:118 
            rpt=sqrt((cr-x2(ppi))*(cr-x2(ppi))+b*b); 
            if (b==0) 
                
z2(ri,rj)=z2(ri,rj)+1/118*2*pi*0.001/3*1/sqrt(2*pi*0.360*0.360)*exp(-
1*rpt*rpt/2/0.360/0.360); 
            else 
                
z2(ri,rj)=z2(ri,rj)+1/118*2*pi*b*1/sqrt(2*pi*0.360*0.360)*exp(-
1*rpt*rpt/2/0.360/0.360); 
            end 
        end  
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        for ppi=1:13 
            rpt=sqrt((cr-x3(ppi))*(cr-x3(ppi))+b*b); 
            if (b==0) 
                
z3(ri,rj)=z3(ri,rj)+1/13*2*pi*0.001/3*1/sqrt(2*pi*0.440*0.440)*exp(-
1*rpt*rpt/2/0.440/0.440); 
            else            
                z3(ri,rj)=z3(ri,rj)+1/13*2*pi*b*1/sqrt(2*pi*0.440*0.440)*exp(-
1*rpt*rpt/2/0.440/0.440); 
            end 
        end  
    end 
end 
  
for ri=1:801 
    zz(ri)=0; 
    zz1(ri)=0; 
    zz2(ri)=0; 
    zz3(ri)=0; 
end 
  
for ri=1:601 
    cr=(ri-201)*0.01; 
    for rj=1:2001 
        b=(rj-1)*0.001; 
        rpt=sqrt(cr*cr+b*b); 
        index1=floor(rpt/0.01); 
        index2=ceil(rpt/0.01); 
        w1=rpt/0.01-index1; 
        w2=index2-rpt/0.01; 
        zz(index1+1)=zz(index1+1)+w2*z(ri,rj); 
        zz(index2+1)=zz(index2+1)+w1*z(ri,rj); 
        zz1(index1+1)=zz1(index1+1)+w2*z1(ri,rj); 
        zz1(index2+1)=zz1(index2+1)+w1*z1(ri,rj); 
        zz2(index1+1)=zz2(index1+1)+w2*z2(ri,rj); 
        zz2(index2+1)=zz2(index2+1)+w1*z2(ri,rj); 
        zz3(index1+1)=zz3(index1+1)+w2*z3(ri,rj); 
        zz3(index2+1)=zz3(index2+1)+w1*z3(ri,rj);        
    end 
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end 
  
zztot=0; 
zz1tot=0; 
zz2tot=0; 
zz3tot=0; 
for ri=1:length(zz) 
    zztot=zztot+zz(ri); 
end 
for ri=1:length(zz1) 
    zz1tot=zz1tot+zz1(ri); 
end 
for ri=1:length(zz2) 
    zz2tot=zz2tot+zz2(ri); 
end 
for ri=1:length(zz3) 
    zz3tot=zz3tot+zz3(ri); 
end 
for ri=1:length(zz) 
    zz(ri)=zz(ri)/zztot; 
end 
for ri=1:length(zz1) 
    zz1(ri)=zz1(ri)/zz1tot; 
end 
for ri=1:length(zz2) 
    zz2(ri)=zz2(ri)/zz2tot; 
end 
for ri=1:length(zz3) 
    zz3(ri)=zz3(ri)/zz3tot; 
end 
for ri=1:601 
    u(ri)=(ri-1)*0.01; 
    zzt(ri)=zz(ri); 
    zzt1(ri)=zz1(ri); 
    zzt2(ri)=zz2(ri); 
    zzt3(ri)=zz3(ri); 
end 
  
plot(u,zzt,u,zzt1,u,zzt2,u,zzt3); 
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Appendix A.4.13.1-1 Fraction number anomaly resolution. 
What follows is a list of all the anomalies in converting the fraction text in column B to a numerical value and how 
these were resolved. In some cases modifications were made to the text in column B. 
  
Fraction Number Anomalies 
 
Row 1123 Fraction Anomalous Patient 1 
2 isos.  
1 iso 1, 1 iso 2 renamed as 1. 
2 iso 1, 2 iso 2 renamed as 2. 
3 iso 1, 3 iso 2 renamed as 3 
1123-1169 
 
Row 1220 Fraction Anomalous Patient 2 
n iso 1 becomes n 
n iso 2 becomes n 
Fraction number changed to increment 1 each day. Expect patient put in frame only once, so made following changes 
to synchronise iso 2 fraction with concurrent iso 1 fraction  
Anomaly at B1331 “1 iso 2” probably should be “13 iso 2”: Changed 
Anomaly at B1342 “2 iso 2” probably should be “14 iso 2”: Changed   
Anomaly at B1357 “3 iso 2” changed to “15 iso 2” 
Anomaly at B1369 “4 iso 2” changed to “16 iso 2” 
Anomaly at B1369 “5 iso 2” changed to “17 iso 2” 
1220-1474 
 
Row 2219 Fraction Anomalous Patient 3 
1 iso 1 becomes 1 
1 iso 2 becomes 1 
2 iso 2 becomes 2 
3 iso 2 becomes 3 
2219-2242 
 
Row 2314 Fraction Anomalous Patient 4 
1 iso 1 becomes 1 
1 iso 2 becomes 1 
2 iso 1 becomes 2 
2 iso 2 becomes 2 
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3 iso 1 becomes 3 
3 iso 2 becomes 3 
2314-2325 
 
Row 3910 Fraction Anomalous Patient 5 
7 again replaced with 8 in cell 3910. There were only 7 fractions and a 7 again, so no need for subsequent fraction 
incrementation. 
 
Row 4774 Fraction Anomalous Patient 6 
B4774 “1 Plan 1” replaced with “1” 
B4782 “2 Plan 2” replaced with “2” 
B4790 “3 Plan 2” replaced with “3” 
B4798 “4 Plan 2” replaced with “4” 
B4808 “5 Plan 2” replaced with “5” 
B4817 “6 Plan 2” replaced with “6” 
B4826 “7 Plan 2” replaced with “7” 
 
Row 6693 Fraction Anomalous Patient 7 
m iso 1 translates to m 
n iso 2 translates to n  
6693-6756 
 
Row 17360 Fraction Anomalous Patient 8 
B17360 1 SRT changed to 1 
B17367 2 SRT changed to 2 
B17372 2 SRS#1 changed to 2 
B17376 3 SRT changed to 3 
 
Row 18288 Fraction Anomalous Patient 9 
m iso 2 interpreted as m 
n iso 1 interpreted as n 
B18334 “5 SRS iso 3” changed to 5 
18288-18443 
 
End of adjustments. By means of these adjustments every image pair was allocated a fraction number. 
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Appendix A.4.14.3-1 Linear range optimization 
Here is the Matlab code optix.m that executes the linear range optimization for each parameter. 
  
sigmai=0; 
for i=1:7253 
    sigmai=sigmai+abs(y(i)-x(ci(i))+x(cf(i))); 
end  
sigmamin=sigmai; 
for n=1:10 
    for k=1:37 
        xmin=x; 
        for j=-20:20 
            x1=x; 
            x1(k)=x(k)+j/100; 
            sigmatry=0; 
            for i=1:7253 
                sigmatry=sigmatry+abs(y(i)-x1(ci(i))+x1(cf(i))); 
            end 
            if sigmatry<sigmai 
                xmin=x1; 
                sigmamin=sigmatry; 
            end 
        end 
        if sigmamin<sigmai 
            sigmai=sigmamin; 
            x=xmin; 
            x 
            sigmai/7253*sqrt(pi) 
        end 
    end 
    n 
end 
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Appendix A.4.14.3-2 Two parameter area search 
Here is the code optix2.m that does the two parameter area search. 
 
sigmai=0; 
for i=1:7253 
    sigmai=sigmai+abs(y(i)-x(ci(i))+x(cf(i))); 
end 
sigmamin=sigmai; 
for n=1:10 
    n 
    for k=1:36 
        k 
        for k1=k:37 
            k1 
            xmin=x; 
            for j=-20:20 
                for j1=-20:20 
                    x1=x; 
                    x1(k)=x(k)+j/100; 
                    x1(k1)=x(k1)+j1/100; 
                    sigmatry=0; 
                    for i=1:7253 
                        sigmatry=sigmatry+abs(y(i)-x1(ci(i))+x1(cf(i))); 
                    end 
                    if sigmatry<sigmamin 
                        xmin=x1; 
                        sigmamin=sigmatry; 
                    end 
                end 
            end 
            if (sigmamin<sigmai) 
                x=xmin; 
                sigmai=sigmamin; 
            end 
        end 
    end 
end 
sigmai/7253*sqrt(pi) 
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Appendix A.4.14.3-3 Monte Carlo optimization 
Here is the Matlab Monte Carlo code optixmc.m 
x=[0.06,0.01,0.01,0.07,0,-0.02,-0.01,-0.05,-0.02,-0.03,-0.04, -0.02,-0.04, 0,-
0.05,0,0.08,0,-0.02,0.06,0,0,-
0.05,0.05,0.05,0.1,0.07,0.1,0.12,0.11,0.17,0.18,0.21,0.19,0.12,0.18,0.1]; 
  
  
sigmai=0; 
for i=1:7253 
    sigmai=sigmai+abs(y(i)-x(ci(i))+x(cf(i))); 
end 
sigmamin=sigmai; 
for n=1:1000000 
    xmin=x; 
    for k=1:37 
        x1(k)=x(k)+round(rand()*100-50)/200; 
    end 
    sigmatry=0; 
    for i=1:7253 
        sigmatry=sigmatry+abs(y(i)-x1(ci(i))+x1(cf(i))); 
    end  
    if sigmatry<sigmamin 
        x=x1; 
        sigmamin=sigmatry; 
        sigmatry/7253*sqrt(pi)        
    end 
end 
x 
sigmamin/7253*sqrt(pi) 
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5 
Synergy 
 
My model for business is The Beatles: They were four guys that kept each other’s negative 
tendencies in check; they balanced each other. And the total was greater than the sum of the 
parts. Great things in business are never done by one person, they are done by a team of people. 
Steve Jobs  
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5.0 Synergy 
Most theses finish with a conclusion, but in this thesis there is a conclusion to each section, since each section deals 
with a unique topic, linked by the common thread of functional imaging in radiotherapy. Just as the thesis began with 
a prelude rather than an introduction, so too it finishes here with a synergy, rather than a conclusion. Synergy is the 
theme as well as the heading of this chapter, synergy of functional and anatomic imaging, of multiple treatment 
centers to conduct trials and share data, and of multiple disciplines to the practice of radiation therapy. This chapter 
is also a drawing together of the conclusion from the three separate chapters. 
 
The work in the prelude dealt with efforts to introduce functional imaging at a particular institution. The field of 
functional imaging in radiotherapy has matured to the stage where the late arriving majority is now using functional 
imaging. The stakes have been raised, instead of exploring how functional imaging might be used, the activity now is 
about setting standards for the widespread use of functional imaging in clinical practice.  
 
Chapter 2 dealt analytically with the uncertainty of margins for tumour volume marking. The resolution of the 
clinical question about the usefulness of functional imaging for target volume marking can only be accomplished by 
multi centre clinical trials, implementing a common methodology, including the threshold of significance for tumour 
volume marking. The most illuminating conclusion in this chapter is the explanation of the relative threshold 
behaviour seen by Erdi, as a simple consequence of spatial blurring. Where a 2D PET clinical trial is suspected of 
being subject to bias due to the methodology of tumour segmentation employed, the more elaborate calculations 
incorporating noise allow, if the spatial resolution and noise characteristics of the scanner are known, even from 
published generic values, an estimate of the error in tumour segmentation to be made. Although the work has limited 
applicability to 3D PET, where a modeling of 3D threshold requires a breakpoint in tumour volumes, the first place 
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to try a breakpoint has been shown theoretically to be when the radius of the tumour is 1.1612 times the full width at 
half maximum of the PET scanner. There appears also to be a minimum threshold in tumour volume (2cc) at which 
the relative threshold method can no longer determine volumes. If accurate tumour volume marking is required for 
clinical radiotherapy at these scales, it cannot be accomplished by relative threshold methods. 
 
Chapter 3 dealt with the problem of information flow. Radiotherapy centres must have the technical expertise to 
ensure the adequate flow of information to support the clinical objectives. It was shown that in a multi vendor 
environment, DICOM packet sniffing can be used to progress the resolution of faults by identifying the vendor 
required to initiate corrective action. It can also be used to identify and support the rapid implementation of short 
term solutions to problems using local resources, and there are some problems that realistically can only be solved by 
DICOM packet sniffing. Information flow developments are market driven, and often lag so far behind that they 
impede clinical implementation. To drive these developments faster, the consumers need to more discriminating, and 
in practice that means that individual hospitals must develop and maintain the expertise to implement DICOM packet 
sniffing, not just to enable advanced practice but also to ensure the continuity of provision of all medical services 
that require electronic rendering of medical images.  
 
Chapter 4 dealt with the problem of registration of functional imaging to the radiotherapy treatment isocentre. 
Application of the technique of inference from rotational invariance allows review of clinical practice to determine 
overall spatial accuracy, in practice, for the patients treated. Comparative questions can be resolved with regard to 
local clinical practice, such as whether accuracy varies with treatment fraction. As the method does not require any 
special equipment, it can be implemented by any centre that is equipped with the IGS. Spatial accuracy can be 
compared between different centres implementing different treatment tolerances and imaging guidelines, and 
collation and publication of this data would inform and potentially improve accuracy of treatment at all centres. 
 
A recurring theme is that it is beyond the resources of any single department to resolve all of the considerations 
relating to the use of hybrid imaging in radiotherapy. The way forward lies with a synergy of efforts.  
 
Proposers of clinical trials should enforce tumour volume marking criteria, even to the extent of publishing 
applications that implement the mechanics of the process while empowering the clinical decisions. Such applications 
should be designed to import and process DICOM image input and export DICOM structure output, allowing them 
to plug into the treatment process of any DICOM compliant radiotherapy centre. This will allow the implementation 
of protocol requirements in advance of the universal capability to implement the trial requirements on the equipment 
of all vendors and ensure the widest possible base for the trial. 
 
DICOM protocols need to keep up with the technical developments. There should be more user input into the 
DICOM committees, which can only be achieved if the professional societies should insist that appropriate 
knowledge of DICOM should be taught to the members. A practical method of determining DICOM compliance 
needs to be found and implemented at an international level. Modern radiotherapy cannot function without 
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information transfer mediated by the DICOM protocol. The corollary of this statement is that the impairment of 
DICOM information transfer is the impairment of treatment.   
 
Individual radiotherapy centers considering introducing the use of functional imaging may not be able to decide how 
to begin. Participation in a multi centre trial is a good way for a department to introduce functional imaging. The trial 
provides external guidance in the form of a well defined motivation and goal for the clinical program.  
 
Cancer is cellular disease. Functional imaging is the closest thing to cellular imaging available. The synergy of 
radiotherapy with functional imaging is a necessary enhancement that requires solutions to the problems of tumour 
segmentation, information transfer and registration to the treatment isocentre. The sum of these solutions will 
improve the efficacy of radiotherapy treatment, something that could not be achieved by solving just one of these 
three problems. 
 
